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ABSTRACT
The Synthesis of Oxazole-containing Natural Products
Thomas H. Graham, PhD
University of Pittsburgh, 2006
The first section describes the synthesis of the C1’ to C11’ side chain of
leucascandrolide A.  The key step of the synthesis is a modified Robinson-Gabriel
synthesis of the oxazole.  The C1’ to C11’ side chain was constructed in 9 steps and 7%
overall yield.
The second section describes the synthesis of 2-alkynyl oxazoles and
subsequent transformations into a variety of useful motifs.  The conjugate addition of
nucleophiles to 2-alkynyl oxazoles under basic conditions affords vinyl ethers, vinyl
thioethers and enamines.  The addition of ethanedithiol affords dithiolanes that can be
transformed into ethyl thioesters and ketones.  Nucleophilic additions of thiols to 2-
alkynyl oxazolines affords oxazoline thioethers.  Additions of halides under acidic
conditions stereoselectively affords vinyl halides that can be further transformed by
Sonogashira cross-coupling reactions.
The third section describes the synthesis of (-)-disorazole C1 and analogs.  The
macrocycle was constructed with minimal protecting group manipulations, using mild
esterification and Sonogashira cross-coupling reactions.  The convergent synthesis of
disorazole C1 allowed for the synthesis of additional analogs.  These analogs include
the C14-t-butyl and C17-18-cyclopropane derivatives.  Results from preliminary biological
evaluations of synthetic intermediates, analogs and derivatives are also discussed.
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11. Synthesis of the C1’-C11’ Segment of Leucascandrolide A
1.1. Introduction
1.1.1. The Biology of the Leucascandrolides
Leucascandrolide A and B were isolated by Pietra and coworkers in 1996
from a calcareous sponge Leucascandra caveolata collected along the east coast of
New Caledonia, Coral Sea (Figure 1).1,2  The structure of these macrolides were
determined by HRMS, MS-MS and 2D NMR, and their absolute configuration was
derived from degradation and Mosher ester studies.  Significant quantities of
leucascandrolide A were isolated (70 mg from 240 g, 0.03% yield) during the original
expedition; however, subsequent expeditions failed to isolate additional material.
Importantly, the original sponges were necrotic, suggesting that the specimens were
extensively colonized by other organisms.  The necrotic nature of the sponges, the
unique architecture of the leucascandrolides that is uncommon to the calcareous
sponges and the inability to isolate additional compound suggest that the
leucascandrolides may be microbial in origin.
2Figure 1.  The leucascandrolides.
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Several distinctions between the two leucascandrolides can be noted.
Leucascandrolide B is a 16-membered macrolide incorporating one pyran and lacking
the oxazole-containing side-chain.  Leucascandrolide B demonstrated no significant
cytotoxic and antifungal activity.  Leucascandrolide A is an 18-membered macrolide
which incorporates two pyrans and the oxazole-containing side-chain.  In addition,
leucascandrolide A demonstrates strong cytotoxic activity in vitro in KB and P388 cells
(IC50’s of 50 and 250 ng/mL), as well as very strong inhibition of Candida albicans
(inhibition diameter of 26/40, 23/20, and 20/10 mm/mg per disk).  The Pietra group
removed the side chain from the macrolide, and determined that the macrolide portion
1 was essential for cytotoxic activity (Scheme 1).  The oxazole-containing side-chain 2
was responsible for the anti-fungal activity.1
3Scheme 1.  Separation of leucascandrolide A into two major segments.
H
H
H
O
O N
HN
O OMe
O
O
MeO
H
O
O O
leucascandrolide A
1'
5'
7'
9'
H
H
H
O
O
MeO
H
O
O OH O
O N
HN
O OMe
MeO 1'
5'
7'
9'
Na2CO3
MeOH
rt, 2 d
77%
1 2
The cytotoxic and antifungal activities of leucascandrolide A warrant further
investigation of its pharmacological and clinical potential, but the supply is limited by
the inability to isolate additional quantities from the natural source.2 The only method
presently available for obtaining a steady supply of leucascandrolide A is synthesis.  To
date, several total syntheses have been completed by the groups of Leighton,3
Kozmin,4 Carreira,5 Paterson6 and Panek.7  Several synthesis of the macrolide segment
were also reported.8,9  As part of a project focused on the synthesis of
leucascandrolide A, the C1’ to C11’ side chain segment was synthesized.
10
1.1.2. Approaches to the Synthesis of the C1’-C11’ Segment
Five syntheses of the leucascandrolide A side chain have been reported and
each can be distinguished by the method used to install the oxazole ring.11  Leighton
used the cyclization-oxidation of a hydroxyamide.3  Kozmin’s synthesis used a rhodium
4carbenoid mediated cyclization.4  Both Panek12 and Paterson6 used a modified
Sonogashira cross-coupling between a 2-trifluoromethylsulfonyl oxazole and a terminal
alkyne.  The synthesis by Wipf (Section 1.2.2) used an oxidation-cyclization (Robinson-
Gabriel) route.10
1.1.2.1. Leighton’s Synthesis
The Leighton synthesis commenced with the carboxylation of alkyne 3 followed
by semi-reduction with hydrogen and Lindlar catalyst to afford the (Z)-alkene in 73%
yield (Scheme 2).  Coupling with serine methyl ester afforded hydroxyamide 4 in 75%
yield.  The hydroxyamide was then cyclized using DAST and oxidized with BrCCl3/DBU
to afford the oxazole 5 in 64% yield.13  The methyl ester was reduced to the alcohol in
86% yield using diisobutylaluminum hydride and the alcohol was converted to the
bromide 6 in 83% yield.  Stille cross-coupling afforded 7 which was chemoselectively
converted to the alcohol using 9-BBN and hydrogen peroxide.  Swern oxidation
afforded the aldehyde 8 in 71% yield for the two steps.  The aldehyde was then
coupled with a phosphonoacetate derivative of the leucascandrolide A macrolide in
55% yield.  The side chain segment was prepared in 10 steps and 8% overall yield.
5Scheme 2.  Leighton's synthesis of the leucascandrolide A side chain.
MeO2CHNH
N
O
MeO
1) n-BuLi then CO2, THF;
2) H2, Lindlar, quinoline, 
    EtOAc, 73% (2-steps);
3) IBCF, NMM, then
    Ser-OMe•HCl, THF, 75%
N
H
O CO2Me
OH
N
O
MeO2CHN
DAST, CH2Cl2,
then BrCCl3, DBU,
64%
N
O
MeO2CHN
N
O
MeO2CHN
CO2Me Br
N
O
MeO2CHN
O
H
1) DiBAl-H, THF, 86%;
2) CBr4, PPh3, 2,6-lutidine, 
    CH3CN, 83%
n-Bu3SnCH=CH2,
Pd2(dba)3, TFP,
THF, 82%
1) 9-BBN, THF, H2O2;
2) oxalyl chloride, DMSO,
    Et3N, CH2Cl2, 
    71% (2-steps)
3 4
5 6
7 8
1.1.2.2. Kozmin’s Synthesis
Kozmin and coworkers utilized an application of the rhodium carbenoid-
mediated cyclization of nitriles and α-diazoketones (Scheme 3).4  The required nitrile 9
was formed in 72% yield using an optimized, one-pot procedure consisting of TIPS-
protection of the amide and cyanation using solid tosyl cyanide.4b  The key cyclization
of 9 and diazodimethylmalonate (10) using Helquist’s methodology14 afforded oxazole
11 in 60% yield after TIPS removal.  Semi-reduction installed the (Z)-alkene and
reduction of the methoxyoxazole and the methyl ester afforded the alcohol which was
6converted to bromide 6 in 51% yield for the three steps.  A two-carbon homologation
(86% yield) followed by conversion of the aldehyde to the second (Z)-olefin using the
Still-Gennari conditions15 afforded 2 in 75% yield.  Leucascandrolide A was completed
by saponification of 2 in 89% yield followed by condensation with the C5-epimer of
macrolide 1 using Mitsunobu conditions.16  The side chain segment 2 was completed in
9 steps and 14% yield.
Scheme 3.  Kozmin's synthesis of the leucascandrolide A side chain.
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71.1.2.3. Panek’s Synthesis and the Paterson Variant
Panek’s synthesis began with the nearly quantitative protection of 4-penten-1-ol
(14) as the TBDPS ether, followed by dihydroxylation of the olefin in 95% yield and
selective oxidation of the seconday alcohol to afford the hydroxy ketone 15 in 95%
yield.  A highly efficient cyclization step using phosgene and ammonium hydroxide
afforded 16 in 85% yield.  The 2-trifluoromethylsulfonyl oxazole 17 was then formed in
80% yield.  Palladium catalyzed cross-coupling of 17 and alkyne 3 occurred in 84%
yield.  Semi-reduction and removal of the TBDPS group afforded the 3,5-disubstituted
oxazole 18 in 80% for the two steps.  Finally, Dess-Martin oxidation
17
 gave the
aldehyde in 99% yield, and subsequent Still-Gennari olefination15 afforded 2 in 72%
yield.  The side chain segment was completed in 10 steps and 29% yield.
Leucascandrolide A was completed by saponification of 2 and condensation with the
macrolide 1 using Mitsunobu conditions.7
Paterson’s route followed a path similar to Panek’s.  Condensation of the lithium
anion of 19 with propargyl bromide 20 afforded 21 in 65% yield.  The hydroxy ketone
21 was converted to 22 in 49% yield by trichloroacetylisocyanate treatment followed
by heating at reflux with 4 Å molecular sieves.  The formation of triflate 23 and
palladium-catalyzed cross-coupling with 3 is analagous to the Panek synthesis.
Removal of the PMB group with DDQ afforded 24 and oxidation of the alcohol to the
acid afforded 25 in 36% yield over the 5 steps (from 22).  The side chain was attached
to the macrolide portion via a Mitsunobu esterification16 and the two alkynes were then
8reduced to afford leucascandrolide A.  Paterson completed the masked side chain acid
25 in 9 steps and 11% overall yield.
Scheme 4.  Panek's synthesis of the leucascandrolide A side chain.
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9Scheme 5.  Paterson's synthesis of the leucascandrolide A side chain.
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1.2. Synthesis of the C1’-C11’ Segment of Leucascandrolide A
1.2.1. Retrosynthesis
The oxazole moiety of the leucascandrolide A side chain (2) was envisioned to
be a key point of disconnection and was derived from hydroxyamide 26 (Figure 2).10
The hydroxyamide arose from aminoalcohol 27 and alkynoic acid 28.  Fragment 27
was derived from glutamic acid and fragment 28 could be obtained from propargyl
amine.  The (Z)-alkenes would be installed by Lindlar semi-hydrogenation and Still-
Gennari olefination.15
Figure 2.  Retrosynthetic approach to the leucascandrolide A side chain.
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1.2.2. Completion of the C1’–C11’ Segment
Our approach to the synthesis of the leucascandrolide side chain required the
cyclization of a suitably functionalized hydroxyamide.10  The formation of 2,4-
disubstituted oxazoles from hydroxyamides can occur by two general pathways (Figure
3).  One route involves a dehydrative cyclization of 29 to the corresponding oxazoline
30 followed by an oxidation to oxazole 31 (Figure 3, path A).13,18,19  Many methods for
the oxazoline oxidation require a C4-substituent (i.e. R2) that is electron withdrawing.
18
Most notable is the BrCCl3/DBU system, which takes advantage of an enolizable C4-
proton and is believed to proceed through a C4-bromooxazole intermediate.
13  The
cyclization-oxidation route was used by Leighton and coworkers for the synthesis of
the leucascandrolide A side chain (Scheme 2).  Several groups reported the synthesis
of 2,4-disubstituted oxazoles by the oxidation of oxazolines that lack the C4-electron
withdrawing group and reagents used for this transformation include DDQ,20,21 and
chloranil.22  Notably, McGarvey and coworkers reported the formation of a variety of
2,4-disubstituted oxazoles in excellent yields (85-95%) by heating a mixture of the
oxazoline and DDQ at reflux in benzene for 30-60 min.20
An alternate pathway involves modifications of the Robinson-Gabriel synthesis
(Figure 3, path B).23  Oxidation to the formylamide 32 followed by cyclization affords
oxazole 31.24,25  Importantly, these methods do not rely on the C4-substituent to be
electron withdrawing.
12
Figure 3.  Synthesis of 2,4-disubstituted oxazoles from hydroxyamides.
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The hydroxyamide 26 for our synthesis of leucascandrolide A is derived from
glutamic acid and therefore lacks the electron withdrawing substituent that is utilized
for the facile oxidations of the oxazolines to the oxazoles (BrCCl3/DBU and
CuBr2/DBU).  Based on the available literature, DDQ could reasonably be expected to
mediate the oxidation of the oxazoline to the oxazole (Figure 3, path A) while a
modified Robinson-Gabriel synthesis was explored for the oxidation-cyclization
sequence (Figure 3, path B).
1.2.2.1. Cyclization–Oxidation Approach to the Synthesis of the Oxazole
Hydroxyamide 26 was readily synthesized from fragments 27 and 28 (Scheme
6).  N-Acylation of propargylamine with methylchloroformate followed by deprotonation
with lithium hexamethyldisilazide and carboxylation of the anion with carbon dioxide
13
provided alkynoate 28 in 55% overall yield.  The aminoalcohol 27 was obtained by
selective protection of the known aminodiol 33.
26
  Condensation of acid 28 with amino
alcohol 27 using PyBrOP
27
 afforded hydroxyamide 26 in 82% yield.
Scheme 6.  Synthesis of the hydroxyamide.
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Attempts to cyclize 26 using Deoxofluor resulted in low yields of the oxazoline.28
Cyclization of 26 using Burgess reagent29,30 afforded the oxazoline in 53% yield.
Attempts to oxidize the oxazoline to the oxazole with DDQ resulted in extensive
decomposition and only traces of the oxazole 34.
Scheme 7.  Attempted synthesis of the oxazole by cyclization-oxidation.
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    reflux, 75 min 34
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1.2.2.2. Oxidation–Cyclization Approach to the Synthesis of the Oxazole
A second pathway involving the oxidation-cyclization pathway that ultimately
proved more rewarding was explored concurrently with the previously discussed
studies (Scheme 8).  Oxidation of hydroxyamide 26 with Dess-Martin periodinane17
afforded the formylamide that was subjected to the modified Robinson-Gabriel
conditions.24  Cyclodehydration with triphenylphosphine in the presence of 2,6-di-t-
butyl-4-methylpyridine provided the intermediate bromooxazoline 35, which readily
eliminated hydrogen bromide upon treatment with DBU to give the oxazole 34 in 32%
overall yield.  The alkyne was then reduced to the (Z)-alkene using Lindlar conditions
31
and the primary alcohol was deprotected with TBAF in THF to afford 18 in 60% yield.
The primary alcohol of 18 was oxidized with Dess-Martin periodinane17 in 86% yield
and the resulting aldehyde was condensed with the Still-Gennari reagent15 to afford the
methyl ester 2 in 90% yield.  All spectroscopic data, in particular the 1H and 13C NMR
resonances of 2, were in close agreement with the corresponding shifts reported for
the natural product.1  The leucascandrolide A side chain 2 was completed in 9 steps
and 7% overall yield.
15
Scheme 8.  Completion of the leucascandrolide A side chain.
O
N
Br
1) Dess-Martin, CH2Cl2;
2) PPh3, (CBrCl2)2,
    2,6-di-t-butyl-
    4-methyl pyridine
1) H2, Lindlar, 
    quinoline, EtOAc;
2) TBAF, THF,
    60% (2 steps)
1) Dess-Martin,
    CH2Cl2, 86%;
2) 13, KHMDS,
    18-C-6, THF, 90%
DBU,
 
CH2Cl2, 
32% (2 steps)
N
H
O OH
OTBS
NHCO2Me 26
NHCO2Me
O
N
NHCO2Me O
N
MeO2CHN
O
N
MeO2CHN
MeO2C
35
34 18
2
OH
PCF3CH2O
CF3CH2O
O O
OMe
13
OTBS
OTBS
1.3. Summary and Conclusions
The C
1’
-C
11’ side chain of leucascandrolide A was completed in 9 steps and 7%
overall yield for the longest linear sequence.  The key transformation was the
preparation of the oxazole moiety by a mild process involving oxidation-
cyclodehydration-dehydrohalogenation of the hydroxyamide 26 .  The semi-
hydrogenation of the alkyne moiety installed the cis-alkenyl oxazole derivative and a
Still-Gennari olefination was used for the remaining cis-alkene.
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1.4. Experimental Part
1.4.1. General
All moisture sensitive reactions were performed using syringe-septum
techniques under an N2 atmosphere and all glassware was dried in an oven at 140 °C
for more than 4 h prior to use.  Reactions at -78 °C employed a solid CO2-acetone
bath.  THF and ethyl ether were distilled from sodium/benzophenone ketyl.  Methylene
choride and toluene were filtered through activated alumina prior to use.  Reactions
were monitored by TLC analysis (pre-coated silica gel 60 F254 plates, 250 µm layer
thickness) and visualized using a UV light (254 nm) or by staining with KMnO4 or
phosphomolybdic acid.  Flash chromatography on SiO2 was used to purify compounds
unless otherwise stated.  Concentration refers to removal of the solvent on a rotary
evaporator at water aspirator pressure.  Melting points are uncorrected.  Infrared
spectra were acquired using KBr pellets or thin films on NaCl plates (i.e. neat).
Chemical shifts were reported in parts per million and the residual solvent peak was
used as an internal reference.  1H NMR spectra were acquired in CDCl3 at a frequency
of 300 MHz unless stated otherwise and are tabulated as follows: chemical shift
(multiplicity, number of protons, coupling constants).  13C NMR were acquired in CDCl3
at a frequency of 75 MHz using a proton decoupled pulse sequence unless otherwise
stated.
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1.4.2. Experimental Procedures
H2N MeO2CHN
MeCO2Cl, Et3N,
CH2Cl2
Prop-2-ynylcarbamic acid methyl ester.  A solution of propargyl amine (1.0 g,
18 mmol) and triethylamine (3.5 mL, 25 mmol) in CH2Cl2 (30 mL) was cooled to 0 °C
and treated dropwise with methyl chloroformate (1.50 mL, 19.5 mmol).  The reaction
mixture was allowed to warm to room temperature, stirred overnight, and quenched
with 6 N HCl (3 mL) and water (20 mL).  The aqueous layer was extracted with ethyl
acetate and the combined organic layers were washed with brine, dried (Na2SO4),
filtered and concentrated onto SiO2.  Purification by chromatography on SiO2 (30% to
60% ethyl acetate/hexanes) afforded prop-2-ynyl-carbamic acid methyl ester (1.36 g,
67%) as a colorless oil:  Rf 0.5 (40% ethyl acetate/hexanes); IR (neat) 3296, 2955, 2123,
1712, 1530, 1256 cm-1; 1H NMR δ 5.3-5.1 (b, 1 H ), 3.92 (bs, 2 H), 3.64 (s, 3 H), 2.21 (s,
1 H); 13C NMR δ 156.8, 80.0, 71.5, 52.5, 30.9; MS (EI) m/z (rel intensity) 113 (M+, 49), 98
(100), 82 (18); HRMS m/z calcd for C5H7N1O2 113.0477, found 113.0479.
MeO2CHN
LiHMDS then CO2,
THF MeO2CHN
CO2H
28
4-Methoxycarbonylaminobut-2-ynoic acid (28).  A solution of lithium
hexamethyldisilazide (1.06 M, 11.5 mL, 12.2 mmol) in THF (120 mL) was cooled to –78
°C and treated dropwise with a solution of prop-2-ynyl-carbamic acid methyl ester (649
mg, 5.74 mmol) in THF (10 mL).  The reaction mixture was stirred for 1 h at –78 °C.
18
Subsequently, carbon dioxide (from dry ice) was bubbled through the solution for 2 h.
The reaction mixture was quenched at –78  °C by aqueous, saturated NaHCO3 (5 mL).
After warming to room temperature, the solution was acidified with 6 N HCl and
extracted with ethyl acetate.  The combined organic layers were concentrated and the
residue was dissolved in aqueous NaHCO3 and washed with CH2Cl2.  The aqueous
layer was acidified by slow addition of concentrated HCl and extracted with ethyl
acetate.  The combined organic extracts were dried (Na2SO4), filtered and concentrated
to yield of 28 (770 mg, 85%) as a slightly yellow oil that crystallized to a white solid
upon standing:  Rf 0.4 (40% ethyl acetate, 1% TFA/hexanes); Mp 95–96 °C; IR (neat):
3337, 2959, 2244, 1708, 1532, 1255 cm-1; 1H NMR (CD3OD) δ 4.04 (s, 2 H), 3.68 (s, 3
H); 13C NMR (CD3OD) δ 159.3, 156.1, 85.2, 75.8, 53.0, 31.2; MS (EI) m/z (rel intensity)
157 (M+, 54), 139 (38), 113 (7), 98 (100), 82 (15), 81(15), 59 (20); HRMS m/z calcd for
C6H7N1O4 157.0375, found 157.0380.
NaH,
TBDMS-Cl,
THF
HO
H2N
OTBS
HO
H2N
OH
33 27
2-Amino-5-(tert-butyldimethylsilyloxy)-pentan-1-ol (27).  To a suspension of
freshly washed (hexanes) sodium hydride (60% dispersion in mineral oil, 41 mg, 1.03
mmol) in THF (40 mL) was added a solution of 2-amino-1,5-pentanediol (122 mg, 1.03
mmol) in hot THF (10 mL).  The reaction mixture was stirred for 8 h at room
temperature and then treated dropwise with tert-butyldimethylsilyl chloride (1 M in
THF, 1 mL, 1 mmol).  After 20 min, the reaction mixture was evaporated onto SiO2 and
chromatography on SiO2 (5% to 10% MeOH/CH2Cl2 to 10% MeOH, 1%
19
NH4OH/CH2Cl2) afforded 27 (160 mg, 68%) as a pale yellow oil:  Rf 0.3-0.4 (10%
MeOH/CH2Cl2, 3-fold developed); IR (neat) 3345, 2929, 2858, 1635, 1521, 1471, 1388,
1361, 1255, 1098, 836, 776 cm-1; 1H NMR δ 4.05-3.95 (b, 4 H), 3.69 (t, 1 H, J = 9.4 Hz),
3.63 (t, 3 H, J = 5.7 Hz), 3.45 (t, 1 H, J = 9.4 Hz), 3.07 (bs, 1 H), 1.65-1.49 (m, 4 H), 0.88
(s, 9 H), 0.05 (s, 6 H); 13C NMR δ 65.0, 63.1, 53.4, 29.3, 26.2, 18.6, -5.1; MS (EI) m/z (rel
intensity) 202 ([M-CH2OH]
+, 27), 176 (4), 159 (34), 141 (10), 129 (7), 101(12), 84 (47), 75
(84), 70 (100), 56 (20); HRMS m/z calcd for C10H24NOSi (M-CH2OH) 202.1627, found
202.1629.
CO2H
HO
H2N
OTBS
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O OHPyBrOP,
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NHCO2Me
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27
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{3-[4-(tert-Butyldimethylsilyloxy)-1-hydroxymethylbutylcarbamoyl]-prop-2-
ynyl}-carbamic acid methyl ester (26).  To a solution of 27 (149 mg, 0.639 mmol) and
28 (84 mg, 0.54 mmol) in CH2Cl2 (2 mL) was added diisopropylamine (186 µL, 1.07
mmol).  The reaction mixture was cooled to –10 °C, treated with PyBrOP (350 mg,
0.751 mmol) and allowed to warm to room temperature.  After 6 h, the reaction was
quenched with aqueous NaHCO3.  The organic layer was diluted with CH2Cl2 (8 mL),
sequentially washed with 0.1 N HCl, water and brine, and dried (Na2SO4).  The solvent
was removed under vacuum to yield an orange viscous oil.  Purification by
chromatography on SiO2 (ethyl acetate) afforded 26 (163 mg, 82%) as a slightly yellow
20
oil:  Rf 0.5 (ethyl acetate).  This compound proved to be unstable and was therefore
used immediately after preparation.
N
H
O OH
OTBS
NHCO2Me
O
N
NHCO2Me
OTBSBurgess 
Reagent
THF
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Methyl 3-(4-(3-(t e r t-butyldimethylsilyloxy)propyl)-4,5-dihydrooxazol-2-
yl)prop-2-ynylcarbamate.  A solution of 26 (56.0 mg, 0.150 mmol, 1.0 equiv) in THF (5
mL) was treated with Burgess reagent (44.0 mg, 0.190 mmol, 1.3 equiv), refluxed for 5
h, cooled to rt and concentrated.  Purification of the residue by chromatography on SiO2
(5% to 10% MeOH/CH2Cl2) afforded methyl 3-(4-(3-(tert-butyldimethylsilyloxy)propyl)-
4,5-dihydrooxazol-2-yl)prop-2-ynylcarbamate (28.0 mg, 53%) as a clear, yellow oil that
was used without further purification. 1H NMR δ 4.95 (bs, 1 H), 4.37  (dd, 1 H, J = 9.6,
8.8 Hz), 4.21-4.13 (m, 3 H), 3.90 (app t, 1 H, J = 8.1 Hz), 3.69-3.59 (m, 2 H), 1.69-1.53
(m, 4 H), 0.88 (s, 9 H), 0.03 (s, 6 H).
1) Dess-Martin,
    CH2Cl2;
2) PPh3, (CBrCl2)2,
    2,6-di-t-butyl-
    4-methyl pyridine,
    DBU, CH2Cl2
N
H
O OH
OTBS
NHCO2Me
O
N
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26 34
(3-{4-[3-(tert-Butyldimethylsilyloxy)-propyl]-oxazol-2-yl}-prop-2-ynyl)-
carbamic acid methyl ester (34).  To a solution of 26 (75 mg, 0.20 mmol) in CH2Cl2 (5
mL) was added Dess-Martin periodinane (171 mg, 0.404 mmol).  The reaction mixture
was stirred for 1 h and purified by chromatography on SiO2 (60% ethyl
acetate/hexanes).  The resulting clear oil was immediately dissolved in CH2Cl2 (10 mL)
21
and treated with triphenylphosphine (165 mg, 0.629 mmol), 2,6-di-tert-butyl-4-
methylpyridine (332 mg, 1.617 mmol) and 1,2-dibromo-1,1,2,2-tetrachloroethane (204
mg, 0.626 mmol).  The reaction mixture was stirred for 10 h, treated with DBU (266 µL,
1.78 mmol) and stirred for an additional 6 h.  Purification by chromatography on SiO2
(30% ethyl acetate/hexanes) afforded 34 (23 mg, 32%) as a slightly yellow oil:  Rf 0.5
(40% ethyl acetate/hexanes); IR (neat) 2954, 2929, 2857, 2250, 1729, 1587, 1534,
1472, 1255, 1102, 837, 777 cm-1; 1H NMR δ 7.33 (s, 1 H), 5.11 (bs, 1 H), 4.22 (d, 2 H, J
= 5.5 Hz), 3.70 (bs, 3 H), 3.62 (t, 2 H, J = 6.1 Hz), 2.57 (t, 2 H, J = 7.6 Hz), 1.82 (tt, 2 H,
J = 7.2, 6.6 Hz), 0.87 (s, 9 H), 0.02 (s, 6 H); 13C NMR δ 156.7, 145.8, 142.1, 135.4, 87.9,
71.7, 62.2, 52.8, 31.5, 31.3, 26.1, 22.7, 18.5, -5.1; MS (EI) m/z (rel intensity) 337 ([M-
CH3]
+, 68), 295 (100), 263 (45), 238 (31), 98 (14), 89 (11), 75 (19), 73 (15), 59 (12); HRMS
m/z calcd for C13H19N2O4Si (M-C(CH3)3) 295.1114, found 295.1116.
1) H2, Lindlar, 
    quinoline, EtOAc;
2) TBAF, THF,
    60% (2 steps)
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{3-[4-(3-Hydroxypropyl)oxazol-2-yl]-allyl}-carbamic acid methyl ester (18).
To a solution of 34 (90 mg, 0.26 mmol) in ethyl acetate (30 mL) was added quinoline
(50 µL, 0.42 mmol) and Lindlar catalyst (90 mg).  The reaction mixture was stirred for 3
h at room temperature under hydrogen (1 atm) and filtered through Celite and the
resulting yellow-orange residue was dissolved in THF (20 mL).  Tetra-n-butyl-
ammonium fluoride (150 mg, 0.57 mmol) was added and the reaction mixture was
stirred at room temperature for 14 h.  The solvent was removed under vacuum and
22
purification of the the resulting red, oily residue by chromatography on SiO2 (ethyl
acetate) afforded 18 (36.4 mg, 60%) as a slightly yellow oil:  Rf 0.2 (ethyl acetate); 
1H
NMR δ 7.37 (s, 1 H), 6.29 (d, 1 H, J = 11.8 Hz), 6.08 (dt, 1 H, J = 11.7, 6.4 Hz), 5.50 (bs,
1 H), 4.35-4.25 (m, 2 H), 3.72 (t, 2 H, J = 6.1 Hz), 3.68 (s, 3 H), 2.66 (t, 2 H, J = 7.1 Hz),
2.25 (bs, 1 H), 1.90 (tt, 2 H, J = 6.8, 6.4 Hz); 13C NMR δ 160.2, 157.4, 141.7, 136.7,
134.0, 116.7, 62.3, 52.4, 39.7, 31.4, 23.0; IR (neat) 3327, 2925, 2851, 1704, 1523, 1264,
1055 cm-1; MS (EI) m/z (rel intensity) 240 (M+, 100), 222 (7), 208 (40), 195 (29), 181 (23),
163 (25), 151 (29), 136 (31), 47 (125), 81 (57), 66 (45), 54 (33); HRMS m/z calcd for
C11H16N2O4 240.1110, found 240.1119.
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MeO2CHN
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N
MeO2CHN
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pyr, NaHCO3,
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{3-[4-(3-Oxopropyl)-oxazol-2-yl]-allyl}-carbamic acid methyl ester.   To a
mixture of 18 (46.3 mg mg, 0.193 mmol, 1.0 equiv), NaHCO3 (50.0 mg, 0.595 mmol, 3.1
equiv) and pyridine (3 drops) in CH2Cl2 (2.5 mL) at rt was added Dess-Martin
periodinane (246.0 mg, 0.580 mmol, 3.0 equiv).  The reaction mixture was stirred for
1.5 h at rt, treated with 10% aqueous Na2S2O3 (5 mL) and saturated aqueous NaHCO3
(5 mL), diluted with CH2Cl2 (5 mL), stirred until both phases were clear (ca. 30 min) and
then extracted with CH2Cl2.  The combined organic layers were washed with 1.0 M
aqueous citric acid and brine and the combined aqueous washings were backwashed
with CH2Cl2.  The combined organic layers were dried (Na2SO4), filtered and
concentrated to a yellow oil.  Purification by chromatography on SiO2 (80% ethyl
acetate/hexanes) afforded {3-[4-(3-oxo-propyl)-oxazol-2-yl]-allyl}-carbamic acid methyl
23
ester (39.4 mg, 86%) as a clear, colorless oil that was used in the next step without
further purification:  Rf 0.43, (80% ethyl acetate/hexanes); 
1H NMR δ 9.84 (s, 1 H), 7.34
(s, 1 H), 6.27 (d, 1 H, J = 11.8 Hz), 6.09 (dt, 1 H, J = 12.0, 6.4 Hz), 5.51 (bs, 1 H), 4.30 (t,
2 H, J = 6.0 Hz), 3.68 (s, 3 H), 2.90-2.79 (m, 4 H).
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N
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MeO2CKHMDS,
18-C-6,
THF
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5-[2-(3-Methoxycarbonylaminopropenyl)-oxazol-4-yl]-pent-2-enoic acid
methyl ester (2).  A solution of 18-crown-6 (171.0 mg, 0.647 mmol, 5.7 equiv) and bis-
(2,2,2-trifluoroethyl)-(methoxycarbonylmethyl) phosphonate (45.0 µL, 0.213 mmol, 1.9
equiv) in THF (1.5 mL) was cooled to –78 °C and treated with a solution of potassium
hexamethyldisilazide (28.5 mg, 0.149 mmol, 1.3 equiv) in THF (0.57 mL) over 5 min.
The reaction mixture was stirred for an additional 10 min and then a solution of {3-[4-
(3-oxopropyl)-oxazol-2-yl]-allyl}-carbamic acid methyl ester (27.0 mg, 0.113 mmol, 1.0
equiv) in THF (2 mL + 2 mL rinse) was added dropwise with stirring.  After 5 h at –78
°C, the mixture was quenched with saturated aqueous NH4Cl (3.0 mL).  Upon warming
to room temperature, the mixture was diluted with water and extracted with CH2Cl2,
and the combined organic layers were dried (Na2SO4), filtered and concentrated to a
clear, colorless syrup.  Purification by chromatography on SiO2 (20% ethyl
acetate/CH2Cl2) afforded 2 (30.0 mg, 90%) as a clear, colorless wax:  Rf 0.4 (20% ethyl
acetate/CH2Cl2); IR (neat) 3348, 3136, 2993, 2951, 2923, 2852, 1721, 1521, 1252, 1198,
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1003 cm-1; 1H NMR δ 7.37 (s, 1 H); 6.23-6.31 (m, 2 H), 6.10 (dt, 1 H, J = 11.6, 6.4 Hz),
5.82 (dt, 1 H, J = 11.5, 1.6 Hz), 5.57 (bs, 1 H), 4.35-4.25 (m, 2 H), 3.71 (s, 3 H), 3.68 (s,
3 H), 3.01 (ddt, 2 H, J = 1.5, 7.3, 7.3 Hz), 2.70 (t, 2 H, J = 7.2 Hz); 1H NMR (C5D5N) δ
8.44 (bs, 1 H), 7.61 (s, 1 H); 6.38 (d, 1 H, J = 11.9 Hz), 6.32-6.22 (m, 2 H), 5.92 (d, 1 H, J
= 11.5 Hz), 4.80 (bt, 2 H, J = 5.4 Hz), 3.74 (s, 3 H), 3.63 (s, 3 H), 3.14 (dt, 2 H, J = 7.3,
7.3 Hz), 2.69 (t, 2 H, J = 7.4 Hz); 13C NMR δ 166.9, 160.2, 157.4, 149.1, 141.4, 136.4,
134.1, 120.4, 116.9, 52.4, 51.3, 39.5, 27.7, 25.8; 13C NMR (C5D5N) δ 166.6, 160.5,
158.1, 141.7, 138.6, 134.5, 120.4, 115.5, 51.9, 51.0, 40.8, 28.0, 25.9; MS (EI) m/z (rel
intensity) 294 (M+, 100), 263 (28), 233 (63), 206 (40), 195 (48), 160 (31), 114 (41), 91 (41);
HRMS m/z calcd for C14H18N2O5 294.1216, found 294.1220.
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2. Conjugate Additions to 2-Alkynyl Oxazoles and Oxazolines
2.1. Conjugate Additions Under Basic Conditions
2.1.1. Introduction
Oxazoles and oxazolines that are substituted at the 2- and the 4- positions are a
common structural component found in numerous biologically active natural
products.11,32  A subset of the 2,4-oxazole class are those containing a substituent at
the 2-position where the β-carbon is at the alcohol or ketone oxidation state (i.e. 36,
Figure 4).  Examples include the phorboxazoles,33 disorazoles34 and the streptogramin-
group A antibiotics (Virginiamycin,35 Madumycin II36 and Griseoviridin37).
The most developed route to access the motif 36 is the condensation of an
aldehyde with a 2-methyl oxazole anion (Figure 5, path A).  Numerous metals including
lithium diethylamide,38 zinc,39 chromium,40 samarium diiodide41 and sodium42 have been
employed for this transformation.  A less explored disconnection is at the Cβ/Cγ bond,
which requires the coupling of the C2-β-aldehyde with a suitable nucleophile (Figure 5,
path B).  The required aldehyde was envisioned to arise from a 2-ethynyl oxazole
(Figure 5, path C).  Alternatively, an internal alkyne could be converted to a C2-β-ketone
(Figure 5, path D).
26
Figure 4.  Natural products that contain 2,4-disubstituted oxazoles.
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Figure 5.  Routes to accessing C2-β-oxygen substituted oxazoles.
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Oxazoles containing a 2-alkynyl substituent are a relatively new structural class
that has recently become commonly reported in the chemical literature.  Many of the
methods for the synthesis of 2-alkynyl oxazoles were developed for the
leucascandrolide A side chain (Section 1.1.2).  As a result, several synthetic routes to
access 2-alkynyl oxazoles are described in the literature (Figure 6).  For example, an
appropriately functionalized aminoalcohol can be coupled to the alkynoic acid and
subsequently cyclized and oxidized to afford the oxazole (Figure 6, path A).19
Hydroxyamide 26  was oxidized and cyclized using Wipf’s modification of the
Robinson-Gabriel cyclization (Section 1.2.2.2, Scheme 8).10  Leighton’s route to the
leucascandrolide A side chain also utilized a cyclization-oxidation route (Section 1.1.2,
Scheme 2).18  A second method involves the condensation of an α-diazoketone with a
nitrile to give the oxazole (Figure 6, path B).14  Kozmin and coworkers demonstrated the
rhodium carbenoid-mediated formation of 2-alkynyl oxazole from alkynyl nitrile and 2-
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diazodimethylmalonate in their synthesis of the leucascandrolide A side chain (Section
1.1.2, Scheme 3).4  In a third method, a 2-trifluoromethylsulfonyl ester substituted
oxazole is cross-coupled with a terminal alkyne (Figure 6, path C).12  Panek and
coworkers demonstrated a cross-coupling under Sonogashira conditions to afford 2-
alkynyl oxazoles. (Section 1.1.2, Scheme 4).12
Figure 6.  Common disconnections for the synthesis of 2-alkynyl oxazoles.
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The first method (Figure 6, path A) was chosen to extend the scope of the
diethylaminosulfur trifluoride (DAST) mediated cyclization and BrCCl3/DBU oxidation
methodology.13  The advantages of the cyclization-oxidation approach are that the
required amino alcohols are commercially available, alkynes can be readily
carboxylated to give the alkynoic acids and expensive and potentially toxic transition
metal catalysts are not required.
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As part of a program directed towards the synthesis of natural products
containing oxazoles, the conversion of 2-alkynyl oxazoles into C2-β-heteroatom-
substituted oxazoles was investigated.43  The conjugate addition of nucleophiles into 2-
alkynyl oxazoles serves as a novel strategy for constructing C2-β-heteroatom
substituted oxazoles.  Similar conjugate additions can be conducted on oxazolines and
some evidence for a metal binding motif is presented.
2.1.2. Synthesis and Conjugate Addition Reactions of a 2-Ethynyl Oxazole.
2-Ethynyloxazole-4-carboxylic acid methyl ester (37) was selected for the model
studies (Figure 5, path C).  The 2-ethynyl oxazole 37 would arise via cyclization and
oxidation of hydroxyamide 38, which in turn would arise from the coupling of propiolic
acid and serine methyl ester hydrochloride (Figure 7).
Figure 7.  Retrosynthesis of 2-ethynyloxazole-4-carboxylic acid methyl ester.
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Attempts to couple propiolic acid to serine methyl ester resulted in
decomposition.44  The terminal alkyne was suspected to be the problematic
functionality, so several alkyne protecting groups were explored (Table 1).45
30
Condensation of the commercially available 3-trimethysilyl propiolic acid (39a) with
serine methyl ester hydrochloride using EDCI and HOBT afforded a low yield of the
hydroxyamide 40a (entry 1).46  Further experimentation with more sterically hindered
protecting groups identified PyBOP47 to be a superior coupling reagent.  The TES-
protected alkyne 39b afforded the hydroxyamide 40b in 70% yield (entry 2).48  The
TBS-protected propiolic acid 39c afforded the hydroxyamide 40c in 83% yield (entry
3).  Finally, the TIPS-protected propiolic acid 39d was coupled to serine methyl ester
hydrochloride using PyBOP in the presence of diisopropylethylamine and gave the
corresponding hydroxyamide 40d in quantitative yield (entry 4).  For large scale
preparations, a more cost-effective strategy involved converting 3 9 d  to the
triisopropylsilylpropynoyl chloride using oxalyl chloride and catalytic
dimethylformamide.49  The crude acid chloride was then coupled to serine methyl ester
hydrochloride in the presence of diisopropylethylamine and afforded the hydroxyamide
40d in 82% yield on a 22 mmol (5 g) scale (entry 5).
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Table 1.  Coupling propiolic acid derivatives to serine methyl ester.
  
R
O
HO
R
O
N
H
MeO2C
HOSer-OMe•HCl, 
conditions
0 °C to rt
DMF
39a-d 40a-d
Entry Acid R Conditions Yield of 40 (%)
1 39a TMS EDCI, HOBT, DIEA 22
2 39b TES PyBOP, DIEA 70
3 39c TBS PyBOP, DIEA 83
4 39d TIPS PyBOP, DIEA 100
5 39d TIPS oxalyl chloride, DMFa 82
a The acid choride was preformed and the crude material was used in the coupling with
CH2Cl2 as a cosolvent.
The hydroxyamides 40a-d were then subjected to the cyclization using
diethylaminosulfur trifluoride (DAST).  Both the TMS- and the TES-protected
hydroxyamides 40a and 40b afforded low yields (< 60%) of the oxazolines that were
mixtures of the trialkylsilyl-protected alkyne and the terminal alkyne.  The TBS and
TIPS-protected alkynes 40c and 40d proved to be more robust, and rapidly cyclized to
give the crude oxazolines which were oxidized with BrCCl3 and DBU to furnish the
oxazoles 41c and 41d in 76% and 74% yield, respectively, for the two steps (Scheme
9).  Removal of the triisopropylsilyl group from 41d with TBAF at ambient temperature
gave 37 in low yield.  Conducting the reaction at –78 °C afforded 37 in 99% yield.50
Similarly, the TBS-protected alkyne 41c afforded 37 in 96% yield.  The 2-ethynyl
oxazole 37 is a crystalline solid that can be stored for months at ambient temperature
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with no special precautions.51  In general, the TBS-protected alkyne gave similar results
to the TIPS protecting group while the only additional advantage of the TBS is that
hydroxyamide 40c and oxazole 41c proved to be crystalline solids rather than oils.
Scheme 9.  Synthesis of the 2-ethynyl oxazole.
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The ease of the TBAF deprotection of 41c/d and the 1H NMR data of 37 which
indicated the alkyne proton resonates at 3.29 ppm, suggest that the alkyne is
significantly polarized.  The alkyne 37 should therefore readily participate in conjugate
addition reactions.  Indeed, a variety of nucleophiles could be added to the alkyne in a
conjugate fashion (Table 2).  Both ethanethiol and thiophenol added in moderate to
good yield to afford 42a and 42b, respectively, and with good (Z)-selectivity (Table 2,
entries 1-3).52  2-Mercaptoethanol afforded only the thioenolether 42c and did not give
the thioxolane even after extended reaction time (Table 2, entry 4).  Benzyl alcohol
furnished adduct 42d with good (Z)-selectivity, demonstrating access to enol ethers
(Table 1, entry 5).53  Interestingly, secondary amines produced adducts 42e and 42f
with the (E)-configuration in excellent yields (Table 2, entry 6-7).54  The predominant (E)-
configuration of the enamine adducts is probably due to the reaction conditions
33
allowing for equilibration to the thermodynamically more stable product as well as an
avoidance of the excessive strain that would exist in the (Z)-configuration.
To gain access to the required C2-β-aldehyde, the deprotection of the
derivatives in Table 2 under a variety of standard conditions for the hydrolysis of enol
ethers, thioenol ethers and enamines was attempted, but resulted only in
decomposition.  Removing the conjugation with the oxazole ring was examined
(Scheme 10).  The addition of ethanedithiol to 37 resulted in bis-addition, giving the
1,3-dithiolane (43).52  Attempts to form the corresponding 1,3-dithiane by using 1,3-
propanedithiol under similar conditions resulted in an inseparable mixture of mono-
and bis-addition adducts in low yield.
Table 2.  Conjugate addition of nucleophiles to a 2-ethynyl oxazole.
N
O
MeO2C
H
N
O
MeO2C R
H
H
R-H
conditions
37 42a-f
Entry R-H Additive Time (h)a Product (Z/E)-ratio Yield (%)d
1 EtSH n-Bu3P 36 42a 10.5/ 1.0 70
2 EtSH K2CO3/18-C-6 1.5 42a 16.4/ 1.0 89
3 PhSH NMM 48 42b 1/ 0 97e
4 HOCH2CH2SH n-Bu3P 25
b 42c 6.4/ 1.0 68f
5 PhCH2OH n-Bu3P 0.5 42d 6.4/ 1.0 76
6 Et2NH - 20
c 42e 0/ 1 100
7 (i-Pr)2NH - 72 42f 0/ 1 100
a All reactions were conducted at ambient temperture unless noted otherwise.  b Reaction mixture
heated to 66 °C.  c Reaction mixture heated to 60 °C.  d Yields were determined after purification on SiO2
and refer to the major isomer, unless stated otherwise.  e Purification by recrystallization.  f Yield is for the
(Z/E)-mixture.
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Scheme 10.  Conjugate addition of ethanedithiol.
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Attempts to deprotect dithiolane 43 using Select-Fluor,55 PIFA56 or N -
bromosuccinimide57 resulted in decomposition (Table 3).  The use of HgCl2/HgO,
58
MeI/CaCO3
 59 or TBHP 60  resulted in recovered dithiolane.
Table 3.  Attempted conversion of the dithiolane to the aldehyde.
N
O
MeO2C
S
S N
O
MeO2C
O
H
conditions
43 44
Entry Conditions Result
1 Select-Fluor (2.4 equiv), CH3CN, rt decomp.
2 PhI(OCOCF3)2 (1.5 equiv), 10% aq. MeOH, rt decomp.
3 N-bromosuccinimide, 10% aq. acetone, 0 °C, 10 min decomp.
4 HgCl2 (2.2 equiv), HgO (2.2 equiv), 10% aq. MeOH, reflux, 6 h s.m.
5 MeI (2.0 equiv), CaCO3 (5.0 equiv),
10% aq. CH3CN, 50 °C, 18 h
s.m.
6 70% aq. TBHP (6.0 equiv.), MeOH, reflux, 6 h s.m.
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We speculated that aldehyde 44 was unstable to standard manipulations.61  To
gain insight into the properties of 44, the corresponding alcohol 48 was synthesized
(Scheme 11).  The known acid 4562 was coupled with serine methyl ester hydrochloride
to afford the hydroxyamide 46 in 99% yield.  Hydroxyamide 46 was cyclized and
oxidized to afford the oxazole 47 in 82% yield for the 2 steps.  The TBDPS group was
removed with TBAF in THF to afford alcohol 48 in 68% yield.
Scheme 11.  Synthesis of the C2-β-hydroxy substituted oxazole.
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Attempts to oxidize the primary alcohol 48 using Swern (oxalyl chloride, DMSO,
Et3N)
63,64 Dess-Martin periodinane17 (with and without the NaHCO3 buffer) or
TPAP/NMO65 conditions resulted in decomposition (Table 4).  Oxidation with the
NaOCl/TEMPO/KBr system66 did not afford the desired aldehyde, but led to an
unidentified product.
The ability of the C4-methyl ester group to remove electron density from the
oxazole ring of 48 was considered as a possible reason for the instability of the
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aldehyde product.  The reduced electron density in the oxazole could facilitate
enolization of the C2-β-aldehyde, and allow for decomposition to occur.  Reduction of
the ester to the alcohol would change the electronic nature of the compound and might
provide a more stable molecule.  Reduction of 47 with diisobutylaluminum hydride and
protection of the alcohol as the pivaloate followed by removal of the TBDPS group
afforded alcohol 49 in 75% over three steps (Scheme 12).  Unfortunately, attempts to
oxidize 49 with Dess-Martin periodinane17 under both buffered (NaHCO3) and non-
buffered conditions resulted in decomposition.
Table 4.  Attempts to oxidize the C2-β-alcohol to the C2-β-aldehyde.
N
O
MeO2C
O
H
N
O
MeO2C
OH
conditions
48 44
Entry Conditions Result
1 Oxalyl chloride, DMSO, CH2Cl2, -78 °C, 40 min;
then Et3N, -78 °C, 40 min
decomp.
2 Dess-Martin periodinane, CH2Cl2, rt decomp.
3 Dess-Martin periodinane, NaHCO3, CH2Cl2, 0 °C to rt decomp.
4 TPAP/NMO, 4 Å MS, CH2Cl2, rt decomp.
5 NaOCl, TEMPO, KBr, aq. carbonate buffer (pH 8.6),
CH2Cl2, 0 °C to rt, 2 h
unidentified product
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Scheme 12.  Reduction of the C4-methyl ester.
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A Fukuyama reduction67  of the corresponding thioethylester was considered as
a mild method to access the aldehyde.  A variation of a transformation developed by
Aggarwal and coworkers was employed to access the thioester from dithiolane 43.68  In
this transformation, a 1,3-dithiolanedioxide was rearranged under Pummerer
conditions and quenched with ethanethiol to give the thioethylester (Scheme 13).
Scheme 13.  Rearrangement of the 1,3-dithiolanedioxide.
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Oxidation of 43 under Trost’s conditions69 gave the 1,3-dithiolane dioxide 50 in
97% yield.  The hydrophilic nature of 50 required an anhydrous work-up that involved
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evaporating the reaction mixture onto a mixture of Florisil/Celite.  The crude product
was directly subjected to chromatography on silica gel.  The 1,3-dithiolane dioxide 50
was subjected to the Pummerer rearrangement and ethanethiol trapping to give
thioethylester 51 in 80% yield.
Reduction of 51 with Pd(OH)2
70 in dichloromethane gave a new compound by
TLC analysis, however, all attempts to isolate this compound failed.  The experiment
was repeated in dichlorodideuteromethane and the crude reaction mixture was filtered
and analyzed by 1H NMR, which revealed no aldehyde signal (Scheme 14).  Instead, a
pair of doublets was observed at 6.76 and 5.47 ppm with a 6.4 Hz coupling constant.
The 1H NMR data suggest that compound 44 exists exclusively in the tautomeric form
44a, which may be stabilized by hydrogen bonding to the oxazole nitrogen.71  The
compound decomposed in CD2Cl2 at room temperature over several hours into
multiple, unidentified compounds.  With the experimental evidence suggesting that 44
represented a synthetically challenging intermediate, the focus was shifted to internal
alkynes.72
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Scheme 14.  Fukuyama reduction of the thioester.
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2.1.3. Conjugate Additions to Internal Alkynes
Recognizing the limitations of a C2-β-aldehyde functionality, the potential to
access C2-β-ketones in a similar manner from conjugate additions to internal alkynes
was explored.  Two systems were chosen as model compounds to give a 4-hydroxy-1-
butynyl and a 3-hydroxy-1-propynyl substituted oxazole (Scheme 15).  The model
systems were selected because of the potential for accessing the 1,3-oxygen
substitution of the Streptogramin-Group A antibiotics.35,36,37
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Scheme 15.  Synthesis of internal alkynyl oxazoles.
N
O
MeO2C
Ser-OMe•HCl, 
PyBOP,
 DIEA or NMM,
DMF(CH2 )nOTBDPS
O
HO
O
N
H
MeO2C
HO
1) DAST, CH2Cl2,
    then K2CO3;
2) BrCCl3, DBU, 
    CH2Cl2
N
O
MeO2C
aq. HF,
 
CH3CN
53a, 31%
53b, 90%
54a,  41% (2-steps)
54b,  76% (2-steps)
55a, 95%
55b, 95%
52a, n = 1
52b, n = 2
(CH2 )nOH
(CH2 )nOTBDPS
(CH2 )nOTBDPS
The required 2-alkynyl oxazole was readily accessed starting from the
corresponding alkynoic acids 52a (n = 1)73 and 52b (n = 2) (Scheme 15).  Coupling the
carboxylic acids 52a and 52b with serine methyl ester hydrochloride in the presence of
PyBOP47 and an amine base afforded hydroxyamides 53a and 53b in 31% and 90%
yield, respectively.  The hydroxyamides rapidly cyclized in the presence of DAST and
oxidation of the crude oxazoline with BrCCl3 and DBU gave oxazoles 54a and 54b in
41% and 76% yield, respectively.  Removal of the TBDPS group with aqueous HF in
CH3CN afforded the model systems 55a and 55b in 95% yield.
The 2-alkynyloxazole 54b was found to readily accept ethanedithiol at the β-
position and gave the 1,3-dithiolane 56 in 94% yield (Scheme 16).  The TBDPS ether
can then be cleaved from 56 with buffered TBAF in THF to afford the primary alcohol
57.  Alternatively, 55b also accepts ethanedithiol to directly afford 57.
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Scheme 16.  Addition of ethanedithiol to internal alkynyl oxazoles.
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The dithiolane 56 was converted to the ketone 58 in 77% yield using N-
bromosuccinimide in 10% aqueous acetone (Table 5).57 Deprotection using a
combination of N-chlorosuccinimide and silver nitrate57 gave the corresponding
dichloroketone 59, suggesting that the α-methylene group may enolize under the
reaction conditions.  The purified ketone 58 is remarkably more stable than the
aldehyde, 44.  Other conditions including PIFA,56 Select-Fluor55 and Chloramine-T74
resulted in decomposition of the substrate.
The potential application of the conjugate-addition methodology to natural
product synthesis was demonstrated by the racemic synthesis of a protected segment
of virginiamycin M1
35 (Scheme 17).  Oxidation of 57 under Swern conditions41 afforded
aldehyde 60 in 81% yield.  Addition of 1-lithioproyne and protection of the resulting
alcohol as the TBDPS ether afforded 61 in 41% yield over the 2-steps.  The conjugate
addition methodology affords a 1,3,5-hydroxy-ketone-oxazole motif in a protected
form.  A potential application for 61 would be as a synthetic intermediate in the
synthesis of natural products such as virginiamycin M1.
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Table 5.  Unveiling the latent ketone via the dithiolane.
N
O
MeO2C
OTBDPS
O
58, R = H
59, R = Cl
R R
N
O
MeO2C
SS
OTBDPS
conditions
56
Entry Conditions Result
1 N-bromosuccinimide, 10% aq. acetone, 0 °C, 10 min 77% (R = H)
2 N-chlorosuccinimide, AgNO3, 20% aq. CH3CN, 0 °C to rt, 1 h 29% (R = Cl)
3 PhI(OCOCF3)2 (2.5 equiv), 10% aq. THF, 0 °C to rt, 30 min decomp.
4 Select-Fluor (2.5 equiv), 5% aq. CH3CN, 0 °C to rt, 2 h decomp.
5 Chloramine-T (4.2 equiv), 10% aq. MeOH, 0 °C to rt, 2 h decomp.
Scheme 17.  A potential application of the conjugate-addition methodology to the
synthesis of virginiamycin M1.
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A second example for a potential application for the conjugate-addition methodology
to natural product synthesis is 14,15-anhydropristinamycin IIB (Scheme 18).
75,76
Ethanedithiol readily added to alkyne 55a under the standard conditions to afford
dithiolane 62 in 91% yield.  The primary alcohol was oxidized under Swern conditions41
to afford aldehyde 63 in 93% yield.  The aldehyde was then homologated with the
Corey-Fuchs reagent77 to afford the dibromoolefin 64 in 86% yield.78  The product 64
represents the C14-C22 segment of 14,15-anhydropristinamycin IIB and is suitably
functionalized to serve as an advanced intermediate in convergent natural product
synthesis.79
Scheme 18.  A potential application of the conjugate-addition methodology to the
synthesis of 14,15-anhydropristinamycin IIB.
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2.1.4. Preliminary Metal Chelation Studies
Oxazoles with metal chelating substituents represent a privileged class of
ligands that are useful in metal mediated catalysis.80  To further expand the utility and
possible applications of the conjugate addition methodology, the potential of the
thioenol ether motif of 42a to bind metals was explored.81  The hypothesis was tested
by stirring a solution of 42a in CDCl3 with AgNO3 until TLC analysis indicated that 42a
was consumed and only baseline material remained.  The mixture was filtered and
analyzed by 1H NMR spectroscopy.  A similar experiment was conducted using
Zn(OTf)2 and the results are shown in Table 6.
Table 6.  Evidence for the chelation of Ag(I) and Zn(II) salts.
N
O
S
O
O 1
2
3
4
5
6
42a
Protons CDCl3
ppm
CDCl3 + AgNO3,
ppm (Δ ppm)
CDCl3 + Zn(OTf)2,
ppm (Δ ppm)
1 1.38 1.44 (+0.06) 1.41 (+0.03)
2 2.85 3.06 (+0.21) 2.92 (+0.07)
3 6.87 7.03 (+0.16) 7.26 (+0.39)
4 6.34 6.53 (+0.19) 6.93 (+0.59)
5 8.20 8.20 (0) 8.24 (+0.04)
6 3.90 3.92 (+0.02) 3.97 (+0.07)
Recovered (%) - 98 15a
a The low recovery is likely due to the voluminous precipitates that were removed by filtration during
NMR sample preparation.
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For silver (I), the results indicate a significant shift (+0.1-0.2 ppm) in the region of
the thioenol ether, as would be expected if the oxazole nitrogen and the sulfur atom
were forming a chelate to the metal atom.  Aqueous workup and extraction gave a
nearly quantitative recovery of 42a, whose spectral properties returned to the original
values listed in Table 6.  For Zn(II), a greater shift in the thioenol ether region (+0.4-0.6
ppm) was observed, also suggesting a similar metal chelate is being formed.  Again, an
aqueous workup returned material whose spectral data were unchanged from the
original.  Given the initial results and the ease with which the oxazole-thioenol ethers
such as 42a can be prepared, this general motif may be of broad utility in applications
where rapid and straightforward access to metal-binding ligands is required.
2.1.5. Conjugate Additions to Oxazolines
A related motif that has found utility in asymmetric synthesis is the thioether-
oxazoline ligand.81,82  Given the results for the thioether-oxazoles, the possibility of
accessing thioether-oxazolines by a similar conjugate addition to the corresponding 2-
ethynyl oxazoline was also examined.  The known oxazoline 6583 was prepared
analogously to the oxazoles (Scheme 19).  L-Phenylalanol and the TIPS-protected
alkynoic acid were condensed using PyBOP,47 affording the corresponding
hydroxyamide which was then cyclized using DAST and K2CO3 to provide the
oxazoline in 63% yield over the 2 steps.  The TIPS group was removed using TBAF
buffered with AcOH to afford 65 in 87% yield.
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Scheme 19.  Synthesis of a 2-ethynyl oxazoline.
N
O
H
TIPS
HO2C
Ph 1) L-Phenylalanol, 
     PyBOP, NMM, DMF;
 2) DAST, CH2Cl2 then K2CO3,
     61% (2 steps); 
 3) TBAF, AcOH, THF, 87%39d 65
The 2-ethynyl oxazoline 65 was found to participate in the conjugate addition reaction
with thiols (Scheme 20).  Ethanethiol and even the sterically hindered t-butyl thiol
formed adducts 66 and 67, respectively, in good to excellent yields and with good (Z)-
selectivity.  Interestingly, similar conditions using thiophenol gave the dithioacetal 68.
The results indicate that the conjugate addition methodology is equally effective for 2-
ethynyl oxazolines as it is for the corresponding oxazoles.  Along with varying the thiol
or the C4-substituent of the oxazoline, the conjugate addition methodology affords
adducts that offer potential for further modifications.  The mild conditions, good yields
and good (Z /E)-selectivity offer significant promise as a new method for easily
accessing many novel ligands for asymmetric catalysis.
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Scheme 20.  Conjugate additions to 2-ethynyl oxazolines.
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Ph
SEt
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SPh
SPh
EtSH, K2CO3, 
18-Crown-6, 
THF, rt, 4 h,
 89% (Z/E = 4:1)
t-BuSH, K2CO3, 
18-Crown-6, 
THF, rt, 12 h, 
97%
thiophenol, K2CO3, 
18-Crown-6, 
THF, rt, 12 h, 
82%
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2.1.6. Synthesis of a 2-Allenyl Oxazole
Allenes are important building blocks for organic synthesis.84  Many methods
exist for the synthesis of allenes; however, methods for the metal-free synthesis of
allenes are less common and include Mitsunobu85 and Wittig86 conditions.  A method
for the conversion of propargyl bromides into allenes was identified during studies to
prepare a  phosphonate reagent.
Attempts for obtaining phosphonate 70 were initially met with discouraging
results (Scheme 21).  Formation of the propargyl bromide 69 from the propargyl alcohol
55a occurred under standard condtions in 95% yield.  Condensation of the propargyl
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bromide 69 with the lithium anion of diethyl phosphite led to decomposition of the
starting material.  Milder conditions were explored due to the apparently sensitive
nature of the system.
Scheme 21.  Attempted synthesis of a phosphonate reagent.
N
O
MeO2C
OH
Br2, PPh3,
imidazole,
CH2Cl2, 95%
N
O
MeO2C
Br
N
O
MeO2CP-EtO
EtO
O
P
O
OEt
OEt
70
69
Li+
55a
In an effort to identify milder conditions, diethyl trimethylsilyl phosphite with
tetra-n-butylammonium iodide was stirred with propargyl bromide 69,87 however, no
reaction was evident by TLC analysis after 30 min at rt.  The addition of TBAF
unexpectedly afforded the allene 71 in excellent yield (Scheme 22).  The use of the less
expensive diethylphosphite under these conditions gave similar results, suggesting
that the TBAF was simply acting as a base.
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Scheme 22.  Initial synthesis of the 2-allenyl oxazole.
N
O
MeO2C
Br
N
O
MeO2C
•
H
H
H
(EtO)2POTMS,
n-Bu4N+I-, CH2Cl2,
then
 TBAF (1.0 M in THF),
rt, 1 h, 96% 7169
When 69 was stirred with diethylphosphite, potassium carbonate and 18-crown-
6, allene 71 rapidly formed (< 1 h), however, complete consumption of starting material
only occurred when additional water (ca. 5 equiv) was added.  The conditions were
further refined and allene 71 could be obtained in nearly quantitative yield (Scheme 23).
In contrast, subjecting the propargyl alcohol 55a to the optimized reaction conditions
did not afford the allene, even at elevated temperatures (60 °C, 2 h), suggesting that
the bromide is essential for the observed reactivity.  More control reactions and
additional substrates need to be studied to better understand the nature of the allene
formation.88  Expanding the initial studies may lead to a mild method of accessing
allenes without the use of metals.89
Scheme 23.  Optimized synthesis of the 2-allenyl oxazole.
N
O
MeO2C
Br
N
O
MeO2C
•
H
H
H
(EtO)2PHO,
K2CO3, 18-C-6, H2O,
 
THF, 98%
69 71
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2.2. Conjugate Additions Under Acidic Conditions
2.2.1. Introduction
Oxazoles that are substituted at the 2- and 4-positions are a common structural
element found in numerous biologically active natural products.11  A frequently
encountered subset of the 2,4-disubstituted oxazole class are those which contain an
unsaturated substituent at the 2-position.  Examples include the phorboxazoles,90
disorazoles91 and leucascandrolide1,2 (Figure 8).  A general method for the
stereospecific installation of either (E)- or (Z)-alkenyl oxazoles into more complex
molecules would be useful.  The utility of such a “bidirectional linchpin strategy” would
be enhanced if a common, advanced intermediate could give rise to either olefin
geometry.92  Consequently, the use of 2-alkynyl oxazoles as common intermediates in
the synthesis of oxazoles with geometrically-defined C2-unsaturated substituents was
explored.43
With numerous natural products containing 2-alkenyl substituted oxazoles,
significant research has been devoted towards installing this motif.  A common
disconnection involves the C1’ /C2’-bond (Figure 9, path A).  In the forward direction, the
condensation of phosphorous93 or silicon94 reagents with an aldehyde furnishes the
requisite 2-alkenyl oxazole.  The transformation usually gives good selectivity for the
formation of the (E)-olefin.
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Figure 8.  Disubstituted oxazoles containing an alkene at the C2-position.
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Figure 9.  Common retrosynthetic disconnections for 2-alkenyl oxazoles.
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More recently, the disconnection directly at the C2-carbon of the oxazole was
explored by Panek and others (Figure 9, path B).12,95  Several research groups used this
strategy to introduce the (Z )-alkene in the leucascandrolide A side chain by
Sonogashira coupling of the C2-triflate with a terminal alkyne followed by semi-
reduction with Lindlar catalyst (Section 1.1.2.3).6,12
For the present strategy, the less common disconnection at the C2’/C3’-carbons
was examined (Figure 9, path C).  An advantage to this approach is that the geometry
of the olefin can be set prior to installation of the oxazole segment and therefore avoids
the difficult separation of isomers.  In addition, accessing both (E)- and (Z)-isomers as
well as the 2-alkynyl oxazole from a common intermediate would allow for rapid access
to analogs for biological structure-activity studies (Figure 10).
Electron deficient alkynes are known to hydrohalogenate when exposed to HI or
HBr.96  Ma and coworkers97 demonstrated a more convenient approach involving the
lithium halide salt in the presence of acetic or trifluoroacetic acid to presumably
generate HI or HBr in situ.98  Various electron deficient alkynes hydrohalogenate under
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these conditions.  Similarly, the alkyne of 2-ethynyl oxazole was suspected to be
significantly polarized and would be an ideal candidate for hydrohalogenation.
Figure 10.  (E)- and (Z)-alkenyl oxazoles can be derived from a common intermediate.
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2.2.2. Hydrohalogenation of a 2-Ethynyl Oxazole
The conjugate addition studies under basic conditions suggested that the alkyne
of the 2-ethynyl oxazole retained the polarized character of the parent carboxylic acid
residue.  2-Alkynoates are known to undergo hydrohalogenation and afford the
corresponding vinyl halides.96,97,98  Gratifyingly, heating 37 in acetic acid in the presence
of sodium or lithium halides afforded good to moderate yields of the corresponding
vinyl halides (Table 7).  The formation of the vinyl bromide 73b with sodium bromide
occurred with a better (Z/E)-ratio than in the presence of lithium bromide (entries 2 vs
6), and generally there was some unreacted alkyne 37.  For the formation of the vinyl
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iodide 73c, the ratio of (Z/E)-isomers decreases with increasing quantities of sodium
iodide (entries 8, 10, 12) or increasing temperature (entry 10 vs 13).
Table 7.  Hydrohalogenation of 2-ethynyloxazole-4-carboxylic acid.
N
O
MeO2C
H
N
O
MeO2C
XMX,
AcOH (0.2 M),
95-100 °C
73a, X = Cl
73b, X = Br
73c, X = I
37
Entry MX (equiv) Time (h) (Z/E)-ratioa Yield % (Z/E)b
1 NaCl (1.5) 16 1.3 / 1.0 36 (Z), 26 (E)
2 LiBr (1.5) 16 4.0 / 1.0 71 (Z)
3 LiBr (1.0)/LiOAc (3.0) 16 9.1 / 1.0c 70 (Z)
4 LiBr (1.5)/LiOAc (4.5) 16 20 / 1.0d 87 (Z)
5 NaBr (1.0) 20 8.0 / 1.0c 70 (Z)
6 NaBr (1.5) 16 9.0 / 1.0c 68 (Z)
7 LiI (1.5) 12 5.6 / 1.0 77 (Z)
8 NaI (1.0) 12 10.7 / 1.0 90 (Z)
9 NaI (1.0)/NaOAc (3.0) 12 >50 / 1.0 92 (Z)
10 NaI (1.5) 12 4.2 / 1.0 75 (Z)
11 NaI (1.5)/NaOAc (1.5) 12 9.5 / 1.0 84 (Z)
12 NaI (3.0) 12 1.1 / 1.0 37 (Z), 33 (E)
13e NaI (1.5) 12 1.0 / 1.2 22 (Z), 28 (E)
a The (Z/E)-ratio was determined by 1H NMR analysis of the crude reaction product after aqueous
workup.  b The yield (%) refers to the major isomer and was determined after purification by
chromatography on SiO2.  
c The crude reaction product contained approximately 10% starting material
(alkyne).  d The crude reaction product contained approximately 3% starting material (alkyne).  e The
reaction was conducted in a sealed tube at an oil bath temperature of 150 °C.   
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To understand the background isomerization that may be occurring during the
reaction, the pure (Z)-isomers were re-subjected to the identical reaction conditions
and the olefin isomerized to afford mainly the (E)-isomers (Table 8).  The (Z/E)-ratios in
Table 8 (entries 2 and 3) initially appear to be in conflict with the (Z/E)-ratios in Table 7
(entries 10 and 12), with the only difference being the generation of one equivalent of
sodium acetate in the latter transformations.  To test the hypothesis that sodium
acetate was influencing the outcome of the reaction, the isomerization experiment was
conducted with additional sodium acetate and a dramatic decrease in the amount of
isomerization was observed (Table 8, entry 4).  In addition, sodium acetate inhibited the
isomerization of (E)-73c to (Z)-73c (Table 9).  The beneficial effects of acetate buffer
towards improving the (Z/E)-ratio are evident in the formation of both (Z)-73b (Table 7,
entries 2-4) and (Z)-73c (Table 7, entries 8 vs 9 and 10 vs 11).
Table 8.  Isomerization of (Z)-vinyl halides.
N
O
MeO2C
N
O
MeO2CMX,
AcOH (0.2 M),
95-100 °C X
X
(Z)-73b, X = Br
(Z)-73c, X = I
(E/Z)-73b
(E/Z)-73c
Entry X MX (equiv) Time (h) (Z/E)-ratioa Yield % (Z/E)b
1 Br NaBr (1.5) 16 1.0 / 5.9 74 (E)
2 I NaI (1.5) 12 1.0 / 6.7 83 (E)
3 I NaI (3.0) 12 1.0 / 7.8 86 (E)
4 I NaI (1.5) / NaOAc (4.5) 12 6.6 / 1.0 63 (Z)
a The (Z/E)-ratio was determined by 1H NMR analysis of the crude reaction product after aqueous
workup.  b The yield (%) refers to the major isomer and was determined after purification by
chromatography on SiO2.
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Table 9.  Isomerization of the (E)-vinyl iodide.
N
O
MeO2C
N
O
MeO2CNaI, NaOAc,
AcOH (0.2 M),
95-100 °C II
(E)-73c (Z/E)-73c
Entry NaI (equiv) NaOAc (equiv) Time (h) (Z/E)-ratioa Yield % (Z/E)b
1 1.5 0 12 1.0 / 8.1 84 (E)
2 1.5 4.5 12 0 / 1.0 73 (E)
a The (Z/E)-ratio was determined by 1H NMR analysis of the crude reaction product after aqueous
workup.  b The yield (%) refers to the major isomer and was determined after purification by
chromatography on SiO2.
With access to the required (E)- and (Z)-vinyl halides, the subsequent cross-
coupling reactions were studied.  (Z)-73c readily participated in the cross-coupling
reaction with trimethylsilyl acetylene under Sonogashira conditions99 to afford (Z)-73 in
89% yield (Figure 25).  It should be noted that (Z)-73 would be difficult to prepare using
either of the alternative methods in Figure 9.  The Wittig olefination normally favors the
(E)-isomer93 and Lindlar reduction of the diyne would require selectivity for one alkyne.
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Scheme 24.  Sonogashira cross-coupling of the (Z)-vinyl iodide.
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CuI, Pd(OAc)2, PPh3,
 i-Pr2NH, 89%
In a similar manner, (E )-73c also participated in the Sonogashira cross-
coupling99 reaction with trimethylsilylacetylene to afford (E)-74 in 90% yield (Scheme
25).
Scheme 25.  Sonogashira cross-coupling of the (E)-vinyl iodide.
(E)-73c (E)-74
N
O
MeO2CTMS-acetylene, 
CuI, Pd(OAc)2, PPh3,
 i-Pr2NH, 90%
TMS
N
O
MeO2C
I
2.2.3. Hydrohalogenation of 2-Allenyl Oxazole
Ma and coworkers also demonstrated that the hydrohalogenation of electron
deficient allenes affords the corresponding vinyl halides.100  In a similar manner, allene
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71  afforded vinyl iodide 75  in 37% yield when subjected to the standard
hydrohalogenatation conditions (Scheme 26).
Scheme 26.  Hydrohalogenation of a 2-allenyl oxazole.
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2.3. Summary and Conclusions
Significant structural variations can be obtained from 2-alkynyl oxazoles by
using different reaction conditions (Figure 11).  2-Alkynyl oxazoles and oxazolines are
easily synthesized from readily available starting materials and participate in conjugate
addition reactions.  Although the C2-β-aldehyde 44 could not be accessed, the
rearrangement of the 1,3-dithiolane adduct 43 afforded the ethylthioester 51, which
under Fukuyama reduction conditions, affords a glimpse of the unstable enol tautomer
44a.  The 1,3-dithiolane adduct 56 of the internal alkyne can be readily converted to
the C2-β-ketone 58 that is found in numerous biologically active natural products.
Internal alkynes can therefore act as a masked form of the C2-β-ketone that can be
unveiled under mild conditions.  Evidence that the ethylthioether oxazole adduct 42a
acts as a unique and readily accessible metal-binding motif was presented.  The
conjugate addition of thiols to the 2-ethynyl oxazoline 65 afforded unique, chiral
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thioether-oxazolines that could be used as ligands for asymmetric synthesis.  The
conjugate addition strategy offers a unique, mild and flexible method for the
construction of oxazole motifs found in many biologically active natural products.
Figure 11.  Summary of the numerous functionalities that are accessible from 2-alkynyl
oxazoles.
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The 2-ethynyl oxazole 37 participates in hydrohalogenation reactions to afford
predominantly the vinyl bromide and iodide in the (Z)-configuration.  The addition of an
acetate buffer to the reaction mixture improves the (Z/E)-ratio and the overall yield.
The (E)-vinyl halide can be obtained by re-subjecting the (Z)-isomer to the reaction
conditions.  Both (Z)-73c and (E)-73c readily participate in Pd-catalyzed cross-coupling
reactions to afford the corresponding C2-unsaturated oxazoles (E)-74 and (Z)-74. The
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2-allenyloxazole 71 also hydrohalogenated under similar conditions to afford the vinyl
iodide 75.  The conjugate addition and hydrohalogenation methodology uses a
common precursor to afford advanced oxazole intermediates that are suitably
functionalized for further derivatization.  The “linchpin strategy” offers a unique, mild
and flexible method for introducing oxazole segments into complex molecules.92
2.4.  Experimental Part
2.4.1. General
All moisture sensitive reactions were performed using syringe-septum
techniques under an N2 atmosphere and all glassware was dried in an oven at 140 °C
for more than 4 h prior to use.  Reactions at -78 °C employed a solid CO2-acetone
bath.  THF and ethyl ether were distilled from sodium/benzophenone ketyl.  Methylene
choride and toluene were filtered through activated alumina prior to use.  Reactions
were monitored by TLC analysis (pre-coated silica gel 60 F254 plates, 250 µm layer
thickness) and visualized using UV light (254 nm) or by staining with KMnO4 or
phosphomolybdic acid.  Flash chromatography on SiO2 was used to purify compounds
unless otherwise stated.  Concentration refers to removal of the solvent on a rotary
evaporator at water aspirator pressure.  Melting points are uncorrected.  Infrared
spectra were acquired using KBr pellets or thin films on NaCl plates (i.e. neat).
Chemical shifts were reported in parts per million and the residual solvent peak was
used as an internal reference.  1H NMR spectra were acquired in CDCl3 at a frequency
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of 300 MHz unless otherwise stated and are tabulated as follows: chemical shift
(multiplicity, number of protons, coupling constants).  13C NMR were acquired in CDCl3
at a frequency of 75 MHz using a proton decoupled pulse sequence unless otherwise
stated.  For acid sensitive samples, CDCl3 was filtered through activated basic alumina
(Brockmann I) immediately prior to sample preparation.  For optical rotations,
concentration (c) is reported in g/100 mL.
2.4.2. Experimental Procedures
2.4.2.1. Conjugate Additions Under Basic Conditions
H
TES
CO2H
TES
MeLi then CO2,
ethyl ether, THF
39b
3-(Triethylsilyl)propiolic acid (39b).  A solution of triethylsilylacetylene (1.00
mL, 5.602 mmol, 1.0 equiv) in THF (56.0 mL) was cooled under N2 to 0 °C.  A solution
of MeLi (1.5 M in ethyl ether, 5.22 mL, 7.83 mmol, 1.4 equiv) was added and the
mixture was stirred for 1 h, cooled to –78 °C and CO2 gas was bubbled into the
solution for 1 h.  The reaction mixture was quenched by the slow addition of 2.0 M
aqueous NaHSO4 (20 mL), warmed to rt and extracted with ethyl acetate.  The
combined organic layers were washed with brine, dried (Na2SO4), filtered and
concentrated to a yellow syrup that was diluted with toluene (50 mL), poured onto a
pad of SiO2 (40 mm x 40 mm) and eluted with ethyl acetate (5 X 20 mL).  The filtrate
was concentrated to afford a pale yellow oil.  Bulb to bulb distillation (118 °C/ 0.1 mm
Hg) afforded 39b (993.9 mg, 96%) as clear, colorless syrup: 1H NMR δ 10.18 (bs, 1 H),
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1.01 (t, 9 H, J = 7.9 Hz), 0.69 (q, 6 H, J = 7.9 Hz); 13C NMR δ 157.7, 95.7, 95.3, 7.4, 3.9;
IR (neat) 3115, 2858, 2915, 2878, 2628, 2174, 1686 cm-1; MS (EI) m/z (rel. intensity) 184
(M+, 6), 155 ([M-C2H5]
+, 100), 127 ([M-C4H9]
+, 34), 111 ([M-C2H5-CO2]
+, 17), 103 (69);
HRMS (EI) m/z calcd for C9H16O2Si 184.0920, found 184.0927.
H
TBS
CO2H
TBS
MeLi then CO2,
ethyl ether, THF
39c
3-(tert-Butyldimethylsilyl)propiolic acid (39c).  A solution of tert-
butyldimethylsilylacetylene (1.00 mL, 5.353 mmol, 1.0 equiv) in THF (50.0 mL) was
cooled under N2 to 0 °C.  A solution of MeLi (1.5 M in ethyl ether, 5.00 mL, 7.50 mmol,
1.4 equiv) was added and the mixture was stirred for 1 h, cooled to –78 °C and CO2
gas was bubbled into the solution for 1 h.  The reaction mixture was quenched by the
slow addition of 2.0 M aqueous NaHSO4 (20 mL), warmed to rt and extracted with ethyl
acetate.  The combined organic layers were washed with brine, dried (Na2SO4), filtered
and concentrated to a yellow syrup that was diluted with toluene (50 mL), poured onto
a pad of SiO2 (40 mm x 40 mm) and eluted with ethyl acetate (5 X 20 mL).  The filtrate
was concentrated to afford 39c (990.1 mg, 100%) as yellow syrup that crystallized to a
pale yellow solid under vacuum: Mp 38.4-40.0 °C (ethyl acetate/toluene); 1H NMR δ
10.3 (bs, 1 H), 0.97 (s, 9 H), 0.19 (s, 6 H); 13C NMR δ 157.6, 96.3, 94.9, 26.1, 16.7, -5.1;
IR (neat) 3104, 2955, 2931, 2889, 2860, 2624, 2175, 1693 cm-1; MS (EI) m/z (rel.
intensity) 184 (M+, 22), 169 ([M-CH3]
+, 19), 127  ([M-C4H9]
+, 45), 75 (100); HRMS (EI) m/z
calcd for C9H14O2Si 184.0920, found 184.0911.
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H
TIPS
CO2H
TIPS
MeLi then CO2,
ethyl ether, THF
39d
Triisopropylsilylpropiolic acid (39d).  A solution of triisopropylsilylacetylene
(1.00 mL, 4.46 mmol, 1.0 equiv) in THF (40 mL) was cooled under N2 to 0 °C.  A
solution of MeLi (0.9 M in ethyl ether, 7.00 mL, 6.30 mmol, 1.4 equiv) was added and
the mixture was stirred for 1 h, cooled to –78 °C and CO2 gas was bubbled into the
solution for 1 h.  The reaction mixture was quenched by the slow addition of 2.0 M
aqueous NaHSO4 (20 mL), warmed to rt, diluted with water (30 mL) and extracted with
ethyl acetate.  The combined organic layers were washed with brine, dried (Na2SO4),
filtered and concentrated to a yellow syrup that was diluted with toluene (50 mL),
poured onto a pad of SiO2 (40 mm x 40 mm) and eluted with ethyl acetate (5 X 20 mL).
The filtrate was concentrated to afford 39d (1.01 g, 100%) as yellow syrup that
crystallized to a pale yellow solid under vacuum:  Mp 60.5-62.5 °C (CH2Cl2); 
1H NMR δ
10.94 (bs, 1 H), 1.21-1.02 (m, 21 H); 13C NMR δ 157.7, 96.1, 95.1, 18.6, 11.1; IR (neat)
3068, 2947, 2892, 2868, 2634, 2503, 2185, 2162, 1683, 1460, 1407, 1266 cm-1; MS (EI)
m/z (rel. intensity) 226 (M+, 21), 183 ([M-C3H7]
+, 100), 155 ([M-C5H11]
+, 79), 139 ([M-
C6H15]
+, 79), 127 (100), 111 (80), 85 (78), 83 (87), 75 (84), 69 (70); HRMS (EI) m/z calcd
for C12H22O2Si 226.1389, found 226.1388.
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CO2H
TMS
TMS
O
N
H
OH
CO2Me
Ser-OMe•HCl,
EDCI, HOBT, DIEA,
DMF
40a39a
Methyl 3-hydroxy-2-(3-(trimethylsilyl)propiolamido)propanoate (40a).  A
suspension of 39a (513.0 mg, 3.607 mmol, 1.0 equiv), DL-serine methyl ester
hydrochloride (617.0 mg, 3.966 mmol, 1.1 equiv) and HOBT (540.0 mg, 3.996, 1.1
equiv) in DMF (3.0 mL) was cooled to 0 °C under argon and treated with EDCI (770.0
mg, 4.016 mmol, 1.1 equiv) and N,N-diisopropylethylamine (1.40 mL, 8.053 mmol, 2.2
equiv).  The cold bath was removed and the mixture was stirred at rt for 8.5 h, treated
with  saturated aqueous NaHCO3, diluted with water and extracted with ethyl acetate.
The combined organic extracts were washed with 1.0 M aqueous citric acid, water,
and 10% aqueous LiCl, dried (Na2SO4), filtered and concentrated to a pale yellow
syrup.  Purification by chromatography on SiO2 (60% ethyl acetate/hexanes) afforded
40a (195.7 mg, 22%) as a clear, colorless syrup:  1H NMR δ 7.08 (s, 1 H), 4.60 (dt, 1 H,
J = 7.9, 3.4 Hz), 3.95 (d of AB, 1 H, J = 11.3, 3.6 Hz), 3.83 (d of AB, 1 H, J = 11.3, 3.4
Hz), 3.72 (s, 3 H), 3.58 (bs, 1 H), 0.2 (s, 9 H); 13C NMR δ 170.4, 152.9, 96.9, 93.3, 62.5,
54.8, 52.9, -0.7; IR (neat) 3325, 2958, 2901, 2169, 1745, 1639, 1532 cm-1; MS (EI) m/z
(rel. intensity) 225 ([M-H2O]
+, 3.1), 213 (37), 184 (46), 125 (100); HRMS (EI) m/z calcd for
C10H15NO3Si (M-H2O) 225.0821, found 225.0825.
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Methyl 3-hydroxy-2-(3-(triethylsilyl)propiolamido)propanoate (40b).  A
suspension of  39b  (1.450 g, 7.867 mmol, 1.0 equiv), DL-serine methyl ester
hydrochloride (1.840 g, 11.83 mmol, 1.5 equiv) and PyBOP (4.500 g, 8.647 mmol, 1.1
equiv) in DMF (10.0 mL) at 0 °C under argon was treated with diisopropylethylamine
(5.00 mL, 28.8 mmol, 3.3 equiv) in one portion.  The cold bath was removed and the
mixture was stirred at rt for 40 h.  Saturated aqueous NaHCO3 was added and the
mixture was diluted with water and extracted with ethyl acetate.  The combined
organic extracts were washed with 1.0 M aqueous citric acid, water, and 10%
aqueous LiCl, dried (Na2SO4), filtered and concentrated to a yellow syrup.  Purification
by chromatography on SiO2 (40% to 60% ethyl acetate/hexanes) afforded 40b (1.574
g, 70%) as a clear, colorless syrup that crystallized to a solid on standing: Mp 76.2-
77.2 °C (ethyl acetate/hexanes); 1H NMR δ 6.81 (bd, 1 H, J = 7.3 Hz), 4.68 (app dt, 1 H,
J = 7.6, 3.4 Hz), 4.01 (dd of AB, 1 H, J = 11.2, 5.7, 3.6 Hz), 3.93 (dd of AB, 1 H, J =
11.3, 5.7, 3.4 Hz), 3.80 (s, 3 H), 2.64 (t, 1 H, J = 5.9 Hz), 1.00 (t, 9 H, J = 7.9 Hz), 0.66
(q, 6 H, J = 7.9 Hz); 13C NMR δ 170.5, 152.9, 98.1, 91.5, 63.1, 55.0, 53.1, 7.5, 4.0; IR
(neat) 3414, 3326, 3045, 2957, 2913, 2877, 2166, 1746, 1639, 1529 cm-1; MS (EI) m/z
(rel. intensity) 267 ([M-H2O]
+, 3.1), 255 (61), 226 (61), 208 (65), 204 (83), 167 (100);
HRMS (EI) m/z calcd for C13H21NO3Si (M-H2O) 267.1291, found 267.1291.
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Methyl 2-(3-(t e r t-butyldimethylsilyl)propiolamido)-3-hydroxypropanoate
(40c).  A solution of 39c (2.064 g, 11.12 mmol, 1.0 equiv) and serine methyl ester
hydrochloride (2.610 g, 16.78 mmol, 1.5 equiv) in DMF (20 mL) was cooled to 0 °C
under argon and treated with PyBOP (6.800 g, 13.07 mmol, 1.2 equiv) and
diisopropylethylamine (7.00 mL, 40.3 equiv, 3.6 mmol).  The cold bath was removed
after 10 min and the mixture was stirred at rt for 18 h, quenched with NaHCO3 (20 mL),
stirred for 1 h at rt and extracted with ethyl acetate.  The combined organic layers were
washed with 1.0 M aqueous citric acid (100 mL), water (50 mL), 10% aqueous LiCl (50
mL) and brine (25 mL).  The combined aqueous washings were backwashed with one
portion of ethyl acetate and the combined organic layers were dried (Na2SO4), filtered
and concentrated to a yellow syrup.  Purification by chromatography on SiO2 (40% to
60% ethyl acetate/hexanes) afforded 40c (2.639 g, 83%) as a clear, colorless syrup
that crystallized to a white solid on standing: Rf 0.50 (60% ethyl acetate/hexanes); Mp
65.3-66.3 °C (ethyl acetate/hexanes); 1H NMR δ 6.84 (d, 1 H, J = 7.3 Hz), 4.68 (app dt,
1 H, J = 7.2, 3.4 Hz), 4.02 (t of AB, 1 H, J = 11.4, 4.2 Hz), 3.93 (t of AB, 1 H, J = 10.5,
4.1 Hz), 3.80 (s, 3 H), 2.71 (t, 1 H, J = 4.9 Hz), 0.95 (s, 9 H), 0.16 (s, 6 H); 13C NMR δ
170.5, 152.9, 97.8, 92.1, 63.0, 55.0, 53.1, 26.2, 16.7, -4.9; IR (neat) 3414, 3325, 3047,
2954, 2931, 2887, 2859, 2168, 1746, 1639, 1530 cm-1; MS (EI) m/z (rel. intensity) 285
(M+, 0.5), 270 ([M-CH3]
+, 2.5), 267 ([M-H2O]
+, 2.3), 255 (22), 228 ([M-C4H9]
+, 20), 176
(100); HRMS (EI) m/z calcd for C12H20NO4Si (M-CH3) 270.1162, found 270.1165.
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3-Hydroxy-2-[3-(triisopropylsilyl)propynoylamino]propionic acid methyl
ester (40d).  To a suspension of  39d  (1.00 g, 4.45 mmol, 1.0 equiv) and DL-serine
methyl ester hydrochloride (1.04 g, 6.65 mmol, 1.5 equiv) in DMF (6.0 mL) at 0 °C under
argon was added diisopropylethylamine (2.70 mL, 15.5 mmol, 3.5 equiv) and PyBOP
(2.54 g, 4.88 mmol, 1.1 equiv) in one portion.  The cold bath was removed and the
mixture was stirred at rt for 15 h.  Saturated, aqueous NaHCO3 (6.0 mL) was added and
the mixture was stirred for 1 h at rt, diluted with water and extracted with ethyl acetate.
The combined organic extracts were washed with 1.0 M aqueous citric acid, water,
and 4.0 M aqueous LiCl, dried (Na2SO4), filtered and concentrated to a yellow syrup.
Purification by chromatography on SiO2 (40% to 50% ethyl acetate/hexanes) afforded
40d (1.45 g, 100%) as a clear, colorless syrup:  1H NMR δ 6.81 (d, 1 H, J = 7.3 Hz), 4.68
(app dt, 1 H, J = 7.2, 3.4 Hz), 4.02, 3.94 (d of AB, 2 H, J = 11.3, 3.4 Hz), 3.80 (s, 3 H),
1.07-1.11 (m, 21 H); 13C NMR δ 170.5, 153.0, 99.1, 90.7, 63.1, 55.1, 53.1, 18.7, 11.2; IR
(neat) 3421, 3328, 2945, 2892, 2867, 2166, 1747, 1640, 1526, 1463, 1438, 1218 cm-1;
MS (EI) m/z (rel. intensity) 327 (M+, 6), 309 ([M-H2O]
+, 10), 297 (16), 284 ([M-C3H7]
+, 38),
266 ([M-C3H7-H2O]
+, 77), 238 (16), 57 (100); HRMS (EI) m/z calcd for C16H29NO4Si
327.1866, found 327.1871.
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3-Hydroxy-2-[3-(triisopropylsilyl)propynoylamino]propionic acid methyl
ester (40d, scale-up protocol).  A solution of 39d (5.00 g, 22.1 mmol, 1.0 equiv) in
CH2Cl2 (10 mL) was cooled under N2 to –20 °C and treated with DMF (5 drops).  Oxalyl
chloride (2.90 mL, 33.24 mmol, 1.5 equiv) was slowly added.  The mixture was stirred
for 30 min while the bath temperature increased to –10 °C.  The cold bath was then
removed and the mixture was stirred at rt for 60 min and then concentrated under
vacuum, affording an orange-colored oil.  The oil was diluted with CH2Cl2 (5.0 mL + 5.0
mL rinse) and added via cannula to a stirred mixture of DL-serine methyl ester
hydrochloride (5.20 g, 33.4 mmol, 1.5 equiv) and diisopropylethylamine (12.0 mL, 69.0
mmol, 3.1 equiv) in DMF (10 mL) at 0 °C.  The mixture was stirred at 0 °C for 30 min,
then at rt for 20 h.  Saturated aqueous NaHCO3 (20 mL) was added and after stirring for
1 h at rt, the mixture was poured into water (20 mL) and extracted with ethyl acetate (3
x 50 mL).  The combined organic layers were washed with 1.0 M aqueous citric acid (2
x 100 mL), water (25 mL), and 4.0 M aqueous LiCl (25 mL), dried (Na2SO4), filtered and
concentrated to an amber syrup.  Purification by chromatography on SiO2 (40% to
60% ethyl acetate/hexanes) afforded 40d (5.90 g, 82%) as a pale yellow syrup.  The
spectral data were identical to material obtained from the PyBOP coupling.
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2-((tert-Butyldimethylsilyl)ethynyl)-4,5-dihydrooxazole-4-carboxylic acid
methyl ester.  A solution of 40c (2.630 g, 9.215 mmol, 1.0 equiv) in CH2Cl2 (40 mL) was
cooled to –78 °C under argon and treated with DAST (1.280 mL, 9.688 mmol, 1.05
equiv), stirred for 30 min and treated with anhydrous K2CO3 (1.910 g, 13.820 mmol, 1.5
equiv), warmed to 0 °C and stirred for 15 min.  Saturated aqueous NaHCO3 (10 mL)
was added and the mixture was warmed to rt, stirred for 2 h, diluted with H2O (10 mL)
and extracted with CH2Cl2.  The combined organic layers were washed with brine,
dried (Na2SO4), filtered and concentrated to an orange-colored oil.  Purification by
chromatography on SiO2 (20% to 40% ethyl ether/hexanes) afforded 2-((tert-
butyldimethylsilyl)ethynyl)-4,5-dihydrooxazole-4-carboxylic acid methyl ester (2.080 g,
84%) as a pale yellow oil:  Rf 0.53 (40% ethyl acetate/hexanes); 
1H NMR δ 4.81 (dd, 1
H, J = 10.8, 8.2 Hz), 4.54 (app t, 1 H, J = 8.5 Hz), 4.44 (dd, 1 H, J = 10.8, 8.8 Hz), 3.78
(s, 3 H), 0.94 (s, 9 H), 0.15 (s, 6 H); 13C NMR δ 170.8, 151.6, 97.9, 91.9, 69.4, 68.5, 53.0,
26.1, 16.7, -5.0; IR (neat) 2954, 2931, 2888, 2859, 2184, 1747, 1620 cm-1; MS (EI) m/z
(rel. intensity) 267 (M+, 13), 252 ([M-CH3]
+, 20), 211 (100), 210 ([M-C4H9]
+, 35), 208 ([M-
CO2CH3]
+, 56), 180 (16), 168 (46), 108 (70); HRMS (EI) m/z calcd for C13H21NO3Si
267.1291, found 267.1292.
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2-((tert-Butyldimethylsilyl)ethynyl)oxazole-4-carboxylic acid methyl ester
(41c).  A solution of 2-((tert-butyldimethylsilyl)ethynyl)-4,5-dihydrooxazole-4-carboxylic
acid methyl ester (2.080 g, 7.779 mmol, 1.0 equiv) in CH2Cl2 (40 mL) was cooled to 0
°C under argon and treated with BrCCl3 (0.815 mL, 8.27 mmol, 1.06 equiv) and DBU
(1.250 mL, 8.359 mmol, 1.07 equiv).  The mixture was stirred at 0 °C for 2 h and then
treated with saturated aqueous NaHCO3 (20 mL), stirred at rt for 30 min and extracted
with CH2Cl2.  The combined organic layers were washed with 1.0 M aqueous citric acid
(20 mL), water (20 mL) and brine (20 mL).  The combined aqueous washings were
backwashed with CH2Cl2 and the combined organic layers were dried (Na2SO4), filtered
and concentrated to a red syrup.  Purification by chromatography on SiO2 (10% to
20% ethyl ether/hexanes) afforded 41c (1.880 g, 91%) as a clear, colorless syrup that
crystallized to a white solid under vacuum:  Rf 0.55 (40% ethyl ether/hexanes); Mp
50.5-51.5 °C (ethyl ether/hexanes); 1H NMR δ 8.16 (s, 1 H), 3.91 (s, 3 H), 0.98 (s, 9 H),
0.20 (s, 6 H); 13C NMR δ 161.1, 146.8, 144.3, 134.1, 99.8, 90.9, 52.5, 26.1, 16.8, -5.0; IR
(neat) 3152, 2954, 2931, 2886, 2859, 2179, 1753, 1731, 1573, 1536 cm-1; MS (EI) m/z
(rel. intensity) 265 (M+, 16), 250 ([M-CH3]
+, 11), 234 ([M-OCH3]
+, 15), 208 ([M-C4H9]
+,
100), 194 (19), 176 (6), 149 (16); HRMS (EI) m/z calcd for C13H19NO3Si 265.1134, found
265.1134.
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2-[(Triisopropylsilyl)ethynyl]oxazole-4-carboxylic acid methyl ester (41d).  A
solution of 40d (5.90 g, 18.0 mmol, 1.0 equiv) in CH2Cl2 (100 mL) was cooled to –78 °C
under argon.  Diethylaminosulfurtrifluoride (DAST) (2.80 mL, 21.2 mmol, 1.2 equiv) was
added.  After 10 min at –78 °C, anhydrous K2CO3 (3.74 g, 27.06 mmol, 1.5 equiv) was
added and the mixture was stirred at –78 °C for 15 min, then at 0 °C for 1 h.  Saturated
aqueous NaHCO3 (100 mL) was slowly added (caution: vigorous evolution of gas) and
the cold bath was removed.  After stirring for 1 h at rt, the mixture was extracted with
CH2Cl2 (3 x 50 mL) and the combined organic layers were dried (Na2SO4), filtered and
concentrated to an amber oil, which was used without further purification.  For
analytical purposes, purification by chromatography on SiO2 (20% to 30% ethyl
ether/hexanes) afforded 2-[(triisopropylsilyl)ethynyl]-4,5-dihydrooxazole-4-carboxylic
acid methyl ester as a pale yellow syrup:  1H NMR δ 4.84 (dd, 1 H, J = 10.8, 8.4 Hz),
4.57 (app t, 1 H, J = 8.5 Hz), 4.46 (dd, 1 H, J = 10.8, 8.8 Hz), 3.80 (s, 3 H), 1.22-1.09 (m,
21 H); 13C NMR δ 170.8, 151.6, 96.4, 93.1, 69.2, 68.5, 53.0, 18.6, 11.1; IR (neat) 2946,
2893, 2867, 2180, 1747, 1619, 1464, 1437, 1349, 1271, 1221 cm-1; MS (EI) m/z (rel.
intensity) 309 (M+, 9), 266 ([M-C3H7]
+, 100), 250 ([M-CO2CH3]
+, 11), 238 (34); 224 (13),
196 (15); HRMS (EI) m/z calcd for C16H27NO3Si 309.1760, found 309.1760.
The crude oxazoline was azeotropically dried with toluene (2 x 25 mL) at
reduced pressure, diluted with CH2Cl2 (100 mL) and cooled to –15 °C under N2.  BrCCl3
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(2.13 mL, 21.61 mmol, 1.2 equiv) was added.  DBU (2.96 mL, 19.79 mmol, 1.1 equiv)
was added dropwise and the mixture was stirred for 1 h while the bath temperature
increased to –5 °C.  Ethyl ether (100 mL) was added and the mixture was filtered
through a pad of SiO2 (80 mm x 40 mm, prewetted with hexanes).  The pad was
washed with ethyl ether (150 mL) and the combined filtrate was concentrated to an
orange-colored oil.  Purification by chromatography on SiO2 (5% to 20% ethyl
ether/hexanes) afforded 41d (4.09 g, 74%) as a pale yellow syrup:  Rf 0.45 (20% ethyl
ether/hexanes); 1H NMR δ 8.17 (s, 1 H), 3.91 (s, 3 H), 1.18-1.07 (m, 21 H); 13C NMR δ
161.1, 146.9, 144.2, 134.0, 98.4, 92.1, 52.5, 18.6, 11.2; IR (neat) 3151, 2946, 2892,
2867, 1753, 1732, 1574, 1536, 1465, 1436 cm-1; MS (EI) m/z (rel. intensity) 307 (M+, 19),
292 ([M-CH3]
+, 5), 264 ([M-C3H7]
+, 100), 236 (34), 222  ([M-C6H13]
+, 8), 208 (32), 194 (16);
HRMS (EI) m/z calcd for C16H25NO3Si 307.1604, found 307.1609.
N
O
MeO2CN
O
MeO2C
TBS
TBAF, AcOH,
THF
41c 37
A solution of 41c (1.880 g, 7.084 mmol, 1.0 equiv) in THF (40 mL) was cooled to
–78 °C under argon.  A solution of TBAF (1.0 M in THF, 7.80 mL, 7.80 mmol, 1.1 equiv)
and glacial AcOH (450 µL, 7.86 mmol, 1.1 equiv) was added dropwise over 5 minutes.
The mixture was stirred for 30 min (total) at –78 °C and then treated with saturated
aqueous NaHCO3 (25 mL), warmed to rt, diluted with H2O (25 mL) and extracted with
ethyl ether.  The combined organic layers were washed with brine, dried (Na2SO4)  and
concentrated to an orange solid that was dissolved in ethyl acetate and filtered through
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a pad of SiO2 (ethyl acetate rinse).  The filtrate was concentrated to afford 37 (1.030 g,
96%) as a white, crystalline solid that was analytically identical to the material obtained
from the TIPS-protected alkyne.
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2-Ethynyloxazole-4-carboxylic acid methyl ester (37).  A solution of 41d (76.0
mg, 247 µmol, 1.0 equiv) in THF (2.5 mL) was cooled to –78 °C under argon.  A stock
solution of TBAF (0.50 mL of a 1.0 M solution on THF) and glacial acetic acid (50 µL)  in
THF (2.0 mL) was prepared and 1.25 mL was added dropwise over 5 min.  After an
additional 10 min, saturated, aqueous NH4Cl was added (3.0 mL) at –78 °C and the
mixture was warmed to rt, diluted with water and extracted with ethyl ether.  The
combined organic layers were washed with brine, dried (Na2SO4), filtered and
concentrated to afford 37 (36.9 mg, 99%) as a white, crystalline solid:  Mp 92.0-93.0 °C
(CH2Cl2); 
1H NMR δ 8.20 (s, 1 H), 3.92 (s, 3 H), 3.29 (s, 1 H); 13C NMR δ 160.9, 146.2,
144.7, 134.2, 81.4, 70.5, 52.6; IR (KBr) 3186, 3158, 3116, 2958, 2126, 1729, 1578,
1536, 1437 cm-1; MS (EI) m/z (rel. intensity) 151 (M+, 100), 123 (50), 120 ([M-OCH3]
+, 77),
100 (99), 93 ([M-CO2CH3+H]
+, 21), 84 (26), 69 (37), 64 (75), 53 (52); HRMS (EI) m/z calcd
for C7H5NO3 151.0269, found 151.0275.
74
N
O
MeO2C
H
N
O
MeO2CEtSH, (n-Bu)3P,
THF
SEt
37 42a
2-(2-Ethylsulfanylvinyl)oxazole-4-carboxylic acid methyl ester (42a).  To a
solution of 37 (11.0 mg, 73 µmol, 1.0 equiv) in THF (1.0 mL) at rt under N2, was added
ethanethiol (40.0 µl, 540 µmol, 7.4 equiv) and a solution of tri-n-butyl phosphine (0.20
mL of a 27 mg/mL solution in THF, 5.4 mg, 26 µmol, 0.4 equiv).  After stirring for 36 h
at rt under N2, the mixture was concentrated under vacuum.  
1H NMR analysis of the
residue indicated a (Z/E)-ratio of 10.5:1.  The residue was purified by chromatography
on SiO2 (30 to 50% ethyl ether/hexanes) to give 42a (10.9 mg, 70%) as a white solid
that contained 7.6% of the (E)-isomer.  (Z)-42a: Mp 61.9-63.5 °C (CH2Cl2); 
1H NMR δ
8.20 (s, 1 H), 6.87 (d, 1 H, J = 11.0 Hz), 6.34 (dd, 1 H, J = 11.0, 0.7 Hz), 3.90 (s, 3 H),
2.85 (dq, 2 H, J = 7.4, 0.7 Hz), 1.38 (dt, 3 H, J = 7.4, 0.9 Hz); 13C NMR δ 162.0, 161.9,
143.0, 140.3, 134.5, 109.0, 52.2, 29.8, 15.6; IR (KBr) 3124, 3076, 2979, 2953, 2929,
2870, 2851, 1737, 1611 cm-1; MS (EI) m/z (rel. intensity) 213 (M+, 41), 184 ([M-CH2CH3]
+,
6), 153 ([M-CH2CH3-OCH3]
+, 7), 86 (6), 84 (87), 66 (100); HRMS (EI) m/z calcd for
C9H11NO3S 213.0460, found 213.0459; Characteristic signals for the (E)-42a:  
1H NMR δ
8.10 (s, 1 H), 7.49 (d, 1 H, J = 15.6 Hz), 6.32 (d, 1 H, J = 15.6 Hz).
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37 42a
2-(2-Ethylsulfanylvinyl)oxazole-4-carboxylic acid methyl ester (42a).  To a
solution of 37 (20.0 mg, 132 µmol, 1.0 equiv) in THF (1.20 mL) at rt was added
thioethanol (75.0 µL, 1.0 mmol, 7.7 equiv) and anhydrous K2CO3 (20.0 mg, 145 µmol,
1.1 equiv).  18-Crown-6 was added and the reaction mixture turned pale yellow.  After
stirring at rt for 1.5 h, the mixture was diluted with ethyl ether (2.0 mL) and filtered
through a plug of Florisil/Celite (1:1, v/v).  The plug was washed with ethyl ether (3.0
mL) and the combined filtrate was concentrated to a clear, colorless oil.  1H NMR
analysis of the residue indicated a (Z/E)-ratio of 16.4:1.0.  The residue was purified by
chromatography on SiO2 (30% to 50% ethyl ether/hexanes) to afford 42a (25.2 mg,
89%) as a white solid that contained 3.5% of the (E)-isomer.  The analytical data were
identical to material obtained from the tri-n-butyl phosphine method.
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37 42b
2-(2-Phenylsulfanylvinyl)oxazole-4-carboxylic acid methyl ester (42b).  To a
solution of 37 (6.4 mg, 42 µmol, 1.0 equiv) in CH2Cl2 (1.0 mL) at rt under N2, was added
thiophenol (0.100 mL, 0.974 mmol, 23.2 equiv) and N-methyl morpholine (10 µL, 0.091
mmol, 2.1 equiv).  After stirring for 48 h at rt, the solvent was removed under vacuum
to give a pale yellow solid.  Recrystallization from ethyl acetate/hexanes afforded 42b
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(10.7 mg, 97%) as a white crystalline solid:  Mp 119.5-120.5 °C (CH2Cl2); 
1H NMR δ
8.22 (s, 1 H), 7.49-7.44 (m, 2 H), 7.37-7.28 (m, 3 H), 7.04 (d, 1 H, J = 11.0 Hz), 6.38 (d, 1
H, J = 11.0 Hz), 3.90 (s, 3 H); 13C NMR δ 161.8, 161.3, 143.1, 140.1, 135.4, 134.5,
131.1, 129.5, 128.3, 109.1, 52.2; IR (KBr) 3124, 3075, 2952, 2848, 1736, 1709, 1614
cm-1; MS (EI) m/z (rel. intensity) 261 (M+, 100),  230 ([M-OCH3]
+, 6), 202 ([M-OCOCH3]
+,
7), 184 ([M-C6H5]
+, 51), 172 (44), 147 (30), 77 (15); HRMS (EI) m/z calcd for C13H11NO3S
261.0460, found 261.0459.
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37 42c
2-[2-(2-Hydroxyethylsulfanyl)vinyl]oxazole-4-carboxylic acid methyl ester
(42c).  To a solution of 37 (50.0 mg, 331 µmol, 1.0 equiv) in THF (3.0 mL) at rt under N2
was added 2-mercaptoethanol (28.0 µL, 399 µmol, 1.2 equiv).  A solution of tri-n-
butylphosphine (100 mg/mL, 0.330 mL, 33 mg, 0.5 equiv) was added and the mixture
was stirred at rt for 1 h then heated to 60 °C for 6 h.  The mixture was then heated at
reflux for 18 h with no additional change occurring as indicated by TLC analysis.
Concentration under vacuum and purification by chromatography on SiO2 (60% ethyl
acetate/hexanes) afforded 42c (51.6 mg, 68%) in a (Z /E)-ratio of 6.4:1.0 as an
amorphous solid that crystallized on standing:  Rf 0.23 (60% ethyl acetate/hexanes);
Mp 95.2-97.2 °C (CH2Cl2); 
1H NMR δ 8.19 (s, 1 H), 6.89 (d, 1 H, J = 11.0 Hz), 6.34 (d, 1
H, J = 11.0 Hz),  3.90 (s, 3 H), 3.87 (t, 2 H, J = 6.0 Hz), 3.02 (t, 2 H, J = 6.0 Hz), 2.32 (bs,
1 H); 13C NMR δ 161.9, 161.6, 143.1, 140.3, 134.3, 109.4, 62.1, 52.4, 38.6; IR (KBr)
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3342, 3176, 3017, 2957, 2929, 1752, 1594, 1441 cm-1; MS (EI) m/z (rel. intensity) 229
(M+, 32), 211 ([M-H2O]
+, 37), 198 ([M-OCH3]
+, 25), 184 ([M-CH2CH2OH]
+, 100), 151 ([M-
HSCH2CH2OH]
+, 52), 139 ([M-CO2Me-CH2OH]
+, 42), 125 ([M-CO2CH3-CH2CH2OH]
+, 25),
110 (55); HRMS (EI) m / z calcd for C9H11NO4S 229.0409, found 229.0411.
Characteristic signals for the (E)-isomer: 1H NMR δ 8.09 (s, 1 H), 7.47 (d, 1 H, J = 15.7
Hz), 6.31 (d, 1 H, J = 15.7 Hz).
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37 42d
2-(2-Benzyloxyvinyl)oxazole-4-carboxylic acid methyl ester (42d).  To a
solution of 37 (10.0 mg, 66 µmol, 1.0 equiv)) and benzyl alcohol (20.0 µL, 193 µmol, 2.9
equiv) in CH2Cl2 (1.0 mL) was added a solution of tri-n-butylphosphine (13.4 mg, 66
µmol, 1.0 equiv) in CH2Cl2 (100 µL).  The mixture immediately turned yellow then slowly
became dark red over 30 min.  The mixture was filtered through a plug of SiO2 (2 cm in
a pasteur pipette) and the plug was washed with ethyl ether.  The combined filtrate
was concentrated under vacuum to a yellow oil.  1H NMR analysis of the oil indicated a
(Z/E )-ratio of 6.4:1.0  Purification by chromatography on SiO2 (25% ethyl
ether/hexanes) afforded 42d (13.0 mg, 76%) as a white, crystalline solid:  Rf 0.31 (60%
ethyl ether/hexanes); Mp 79.2-80.5 °C (CH2Cl2); 
1H NMR δ 8.06 (s, 1 H), 7.64 (d, 1 H, J
= 12.9 Hz), 7.45-7.31 (m, 5 H), 5.82 (d, 1 H, J = 12.9 Hz), 4.95 (s, 2 H), 3.90 (s, 3 H); 13C
NMR δ 162.0, 156.3, 142.4, 135.5, 133.8, 128.9, 128.8, 127.9, 93.8, 73.0, 52.3; IR (KBr)
3144, 3082, 3027, 2948, 2917, 1719, 1656, 1576, 1452, 1430 cm-1; MS (EI) m/z (rel.
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intensity) 259 (M+, 13), 91 (100), 65 (15); HRMS (EI) m/z calcd for C14H13NO4 259.0845,
found 259.0855.
N
O
MeO2C
H
N
O
MeO2Cdiethylamine
THF N(Et)2
37 42e
2-(2-Diethylaminovinyl)oxazole-4-carboxylic acid methyl ester (42e).  To a
solution of 37 (50.0 mg, 331 µmol, 1.0 equiv) in THF (2.0 mL) at rt under N2 was added
diethylamine (50 µL, 480 µmol, 1.5 equiv).  After 4 h at rt, additional diethylamine (50
µL, 480 µmol, 1.5 equiv) was added.  After 18 h (total reaction time) at rt, TLC analysis
indicated that starting alkyne remained, so additional diethylamine (100 µL, 970 µmol,
3.0 equiv) was added and the mixture was heated to 60 °C for 2 h, then cooled to rt.
The volatile components were removed under vacuum and the resulting residue was
purified by chromatography on SiO2 (40% ethyl ether/hexanes) to give 42e (74.4 mg,
100%) as a clear, colorless oil: Rf 0.23 (60% ethyl ether/hexanes); 
1H NMR δ 7.90 (s, 1
H), 7.32 (d, 1 H, J = 13.6 Hz), 4.93 (d, 1 H, J = 13.6 Hz), 3.83 (s, 3 H), 3.15 (q, 4 H, J =
7.1 Hz), 1.11 (t, 6 H, J = 7.1 Hz); 13C NMR δ 166.1, 162.6, 145.4, 140.6, 133.3, 80.1,
51.9, 46.1, 13.2; IR (neat) 3161, 3085, 2975, 2945, 2930, 2868, 1738, 1634, 1573, 1553
cm-1; MS (EI) m/z (rel. intensity) 224 (M+, 83), 209 ([M-CH3]
+, 21), 195 ([M-CH2CH3]
+, 44),
164 ([M-HOCOCH3]
+, 70), 163 (46), 135 (100), 109 (62), 181 (11); HRMS (EI) m/z calcd
for C11H16N2O3 224.1161, found 224.1158.
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O
MeO2C
H
N
O
MeO2Cdiisopropylamine
CH2Cl2 N(i-Pr)2
37 42f
2-(2-Diisopropylaminovinyl)oxazole-4-carboxylic acid methyl ester (42f).  To
a solution of 37 (10.0 mg, 66 µmol, 1.0 equiv) in CH2Cl2 (1.0 mL) at rt under N2 was
added diisopropylamine (20 µL, 143 µmol, 2.2 equiv).  After 24 h at rt, additional
diisopropylamine (100 µL, 714 µmol, 10.8 equiv) was added and the mixture was
stirred at rt for an additional 48 h (72 h total).  Volatile components were removed
under vacuum and the resulting residue was purified by chromatography on SiO2 (40%
ethyl ether/hexanes) to afford 42f (17.0 mg, 100%) as a clear, colorless oil:  1H NMR δ
7.94 (s, 1 H), 7.41 (d, 1 H, J = 13.7 Hz), 5.09 (d, 1 H, J = 13.7 Hz), 3.87 (s, 3 H), 3.66
(sept, 2 H, J = 6.7 Hz), 1.20 (d, 12 H, J = 6.7 Hz); 13C NMR δ 166.5, 162.8, 141.4, 140.6,
133.4, 80.6, 52.0, 47.8, 21.7; IR (neat) 3160, 3088, 2975, 2934, 2872, 1743, 1720, 1627,
1571, 1552, 1463, 1435 cm-1; MS (EI) m/z (rel. intensity) 252 (M+, 43), 237 ([M-CH3]
+,
34), 221 ([M-OCH3]
+, 8), 209 ([M-CH(CH3)2]
+, 100), 195 (36), 192 (16), 177 (38), 163 (62),
149 (31), 135 (27); HRMS (EI) m/z calcd for C13H20N2O3 252.1474, found 252.1473.
N
O
MeO2C
H
N
O
MeO2C
S
S
1,2-ethanedithiol,
K2CO3,
18-Crown-6,
THF
37 43
2-[1,3]-Dithiolan-2-ylmethyloxazole-4-carboxylic acid methyl ester (43).  To
a solution of 37 (342.5 mg, 2.266 mmol, 1.0 equiv) in THF (11.0 mL) at rt was added
anhydrous K2CO3 (150.0 mg, 1.085 mmol, 0.5 equiv) and 1,2-ethanedithiol (950 µL,
80
11.3 mmol, 5.0 equiv).  18-Crown-6 was added and the mixture became turbid and
pale yellow within 10 min.  The solution was stirred for 12 h at rt and then evaporated
onto a blend of Florisil/Celite (1:1 v/v).  The resulting solid was directly purified by
chromatography on SiO2 (30% to 60% ethyl ether/hexanes) to afford 43 (538.0 mg,
97%) as a white, crystalline solid:  Mp 84.0-85.0 °C (ethyl acetate/hexanes); 1H NMR δ
8.15 (s, 1 H), 4.93 (t, 1 H, J = 7.4 Hz), 3.87 (s, 3 H), 3.27 (d, 2 H, J = 7.4 Hz), 3.23, 3.24
(d of AB, 4 H, J = 6.3, 1.3 Hz); 13C NMR δ 162.8, 161.7, 144.1, 133.4, 52.3, 49.9, 39.0,
38.8; IR (KBr) 3165, 3118, 2956, 2919, 1726, 1583, 1437, 1423, 1320, 1159, 1110 cm-1;
MS (EI) m/z (rel. intensity) 245 (M+, 25), 217 ([M-C2H4]
+, 7), 186 ([M-CO2CH3]
+, 32), 154
([M-OCH3-SCH2CH2]
+, 11), 141 (19), 105 (100), 61 (13), 59 (9); HRMS (EI) m/z calcd for
C9H11NO3S2 245.0180, found 245.0173.
OTBDPS
O
N
H
HO
MeO2COTBDPS
O
HO
Ser-OMe•HCl,
PyBOP, NMM,
DMF
45 46
Methyl 2-(3-(tert-butyldiphenylsilyloxy)propanamido)-3-hydroxypropanoate
(46).  A mixture of  45 (4.113 g, 12.52 mmol, 1.0 equiv) and serine methyl ester
hydrochloride (2.920 g, 18.77 mmol, 1.5 equiv) in DMF (15.0 mL) was cooled to 0 °C
under N2 and treated with PyBOP (7.170 g, 13.78 mmol, 1.1 equiv) and N -
methylmorpholine (4.82 mL, 43.8 mmol, 3.5 equiv).  The mixture was stirred at 0 °C for
30 min, warmed to rt for 24 h, quenched with saturated aqueous NaHCO3 (50 mL),
poured into water (50 mL) and extracted with ethyl acetate.  The combined organic
layers were washed with 1.0 M aqueous citric acid (2 x 25 mL), water (25 mL) and 4.0
M aqueous LiCl (25 mL).  The combined aqueous washings were backwashed with
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ethyl acetate and the combined organic layers were dried (Na2SO4), filtered and
concentrated.  Purification by chromatography on SiO2 (60% to 100% ethyl
acetate/hexanes) afforded 46 (5.314 g, 99%) as a pale yellow syrup that crystallized to
a white solid on standing: Rf 0.40 (60% ethyl acetate/hexanes); Mp 77.4-79.4 °C (ethyl
acetate/hexanes); 1H NMR (acetone-d6) δ 7.76-7.71 (m, 4 H), 7.56-7.52 (m, 1 H), 7.48-
7.34 (m, 6 H), 4.63 (dt, 1 H, J = 8.2, 4.2 Hz), 4.26 (bt, 1 H, J = 5.3 Hz), 3.99 (t, 2 H, J =
6.2 Hz), 3.96-3.91 (m, 1 H), 3.84-3.76 (m, 1 H), 3.67 (s, 3 H), 2.59 (t, 2 H, J = 6.2 Hz),
1.04 (s, 9 H); 13C NMR (acetone-d6) δ 171.8, 171.6, 136.3, 134.4, 130.7, 128.7, 63.2,
61.4, 55.6, 52.4, 39.8, 27.2, 19.7; IR (neat) 3365, 3071, 3049, 2955, 2932, 2886, 2858,
1744, 1655, 1537 cm-1; MS (EI) m/z (rel. intensity) 414 ([M-CH3]
+, 0.2), 372 ([M-C4H9]
+,
54), 354 ([M-C4H9-H2O]
+, 100), 294 (11), 222 (26), 199 (44); HRMS (EI) m/z calcd for
C22H28NO5Si (M-CH3) 414.1737, found 414.1744.
N
O
MeO2C
OTBDPSOTBDPS
O
N
H
HO
MeO2C
1) DAST, K2CO3,
    CH2Cl2;
2) BrCCl3, DBU,
    CH2Cl2
46 47
2-(2-(tert-Butyldiphenylsilyloxy)ethyl)oxazole-4-carboxylic acid methyl ester
(47).  A solution of 46 (5.314 g, 12.37 mmol, 1.0 equiv) in CH2Cl2 (70.0 mL) was cooled
to –78 °C under N2, treated with DAST (1.80 mL, 13.62 mmol, 1.1 equiv), stirred at –78
°C for 50 min, treated with anhydrous K2CO3 (2.56 g, 18.5 mmol, 1.5 equiv), warmed to
0 °C for 15 min and then treated with NaHCO3 (10 mL).  The cold bath was removed
and the mixture was stirred at rt for 1 h and extracted with CH2Cl2.  The combined
organic layers were concentrated, diluted with a small portion of CH2Cl2 and poured
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onto a pad of SiO2 (40 mm x 10 cm).  Gradient elution (20% to 40% ethyl ether/CH2Cl2)
and concentration of the filtrate afforded the crude oxazoline (4.570 g, 90%) as an
orange-colored oil that was diluted with CH2Cl2 (60 mL), cooled to 0 °C and treated
with BrCCl3 (1.220 mL, 12.38 mmol, 1.1 equiv) and DBU (1.820 mL, 12.17 mmol, 1.1
equiv).  The cold bath was removed and the mixture was stirred at rt.  Additional
BrCCl3 (0.150 mL, 1.52 mmol, 0.14 equiv) and DBU (0.180 mL, 1.20 mmol, 0.11 equiv)
were added at 2 h and 6 h.  After 22 h, the mixture was poured onto a pad of SiO2 (40
mm x 10 cm) and eluted with 20% ethyl ether/hexanes (200 mL).  The filtrate was
concentrated to a pale yellow syrup.  Purification by chromatography on SiO2 (20 to
30% ethyl ether/hexanes) afforded 47 (3.726 g, 82%) as a clear, colorless syrup:  Rf
0.51 (60% ethyl ether/hexanes); 1H NMR δ 8.13 (s, 1 H), 7.62-7.59 (m, 4 H), 7.44-7.33
(m, 6 H), 4.06 (t, 2 H, J = 6.6 Hz), 3.91 (s, 3 H), 3.07 (t, 2 H, J = 6.6 Hz), 1.00 (s, 9 H); 13C
NMR δ 163.8, 161.9, 144.0, 135.7 (2 C), 133.4, 129.9, 127.9, 61.2, 52.2, 31.9, 26.9,
19.2; IR (neat) 3162, 3131, 3071, 3049, 2954, 2932, 2887, 2857, 1750, 1729, 1587 cm-1;
MS (EI) m/z (rel. intensity) 394 (M+, 0.4), 378 ([M-OCH3]
+, 1.8), 352 ([M-C4H9]
+, 100);
HRMS (EI) m/z calcd for C19H18NO4Si (M-C4H9) 352.1005, found 352.1009.
N
O
MeO2C
OH
N
O
MeO2C
OTBDPS
TBAF, AcOH,
THF
47 48
2-(2-Hydroxyethyl)oxazole-4-carboxylic acid methyl ester (48).  A solution of 47
(87.8 mg, 0.214 mmol, 1.0 equiv) in THF (1.0 mL) at rt was treated with glacial AcOH
(15 µL, 0.26 mmol, 1.2 equiv) and TBAF (1.0 M in THF, 0.24 mL, 0.24 mmol, 1.1 equiv),
stirred for 24 h, treated with additional TBAF (1.0 M in THF, 0.10 mL, 0.10 mmol, 0.5
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equiv) and stirred at rt for an additional 24 h.  The mixture was quenched with NaHCO3
and extracted with ethyl acetate.  The combined organic layers were dried (Na2SO4),
filtered and concentrated.  Purification by chromatography on SiO2 (90% ethyl
acetate/hexanes to 100% ethyl acetate) afforded 48 (24.7 mg, 68%) as a clear,
colorless syrup: Mp 62.9-63.7 °C (CH2Cl2); 
1H NMR δ 8.15 (s, 1 H), 4.04 (t, 2 H, J = 5.9
Hz), 3.88 (s, 3 H), 3.04 (t, 2 H, J = 5.9 Hz), 2.74 (bs, 1 H); 13C NMR δ 164.1, 161.8,
144.1, 133.2, 59.2, 52.3, 31.4; IR (neat) 3394, 2956, 2894, 1736, 1588 cm-1; MS (EI) m/z
(rel. intensity) 171 (M+, 0.3), 141 ([M-OCH2]
+, 6), 127 (12); HRMS (EI) m/z calcd for
C6H7NO3 (M-CH2O) 141.0426, found 141.0426.
N
O
MeO2C
OTBDPS
1) DiBAl-H, THF;
2) Piv-Cl, DMAP, 
    Et3N, THF;
3) TBAF, AcOH, THF
N
O OH
OPiv
47 49
(2-(2-Hydroxyethyl)oxazol-4-yl)methyl pivaloate (49).  A solution of 47 (418.0
mg, 1.021 mmol, 1.0 equiv) in THF (5.0 mL) was cooled under N2 to –20 °C, treated
with a solution of DiBAl-H (1.0 M in hexanes, 4.00 mL, 4.00 mmol, 3.9 equiv), slowly
warmed to 0 °C over 2 h and treated with 1.0 M aqueous L-tartaric acid (4.0 mL) and
brine (4.0 mL).  The resulting mixture was stirred at rt for 2 h and extracted with ethyl
ether.  The combined organic layers were washed with brine, dried (Na2SO4), filtered
and concentrated to a yellow oil that was azeotropically dried with toluene, diluted with
THF (5.0 mL), cooled to 0 °C and treated with DMAP (12.0 mg, 0.098 mmol, 0.1 equiv),
triethylamine (500 µL, 3.56 mmol, 3.5 equiv) and pivaloyl chloride (250 µL, 2.03 mmol,
2.0 equiv).  The mixture was stirred at rt for 12 h, treated with saturated, aqueous
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NaHCO3 and extracted with ethyl acetate.  The combined organic layers were washed
with brine, dried (Na2SO4), filtered and concentrated.  The residue was diluted with THF
(5.0 mL), cooled to 0 °C and treated with glacial acetic acid (60.0 µL, 1.05 mmol, 1.0
equiv) and TBAF (1.0 M in THF, 1.50 mL, 1.50 mmol, 1.5 equiv), stirred at rt for 18 h,
treated with saturated, aqueous NaHCO3 and extracted with ethyl acetate.  The
combined organic layers were washed with brine, dried (Na2SO4), filtered and
concentrated.  Purification by chromatography on SiO2 (40% ethyl acetate/hexanes)
afforded 49 (174.1 mg, 75%, 3 steps) as a clear, colorless syrup:  Rf 0.35 (60% ethyl
acetate/hexanes); 1H NMR δ 7.52 (s, 1 H,), 4.94 (s, 2 H), 3.96 (bs, 2 H), 3.52 (bs, 1 H),
2.95 (t, 2 H, J = 5.9 Hz), 1.15 (s, 9 H); 13C NMR δ 178.4, 163.5, 136.9, 136.1, 59.2, 58.1,
38.9, 31.2, 27.2; IR (neat) 3375, 3142, 2973, 2930, 2875, 1728, 1577 cm-1; MS (EI) m/z
(rel. intensity) 227 (M+, 2.8), 197 ([M-C2H6]
+, 2.0), 142 ([M-(CH3)3CCO]
+, 78), 126 ([M-
(CH3)3CCO2]
+, 32), 57 (C4H9, 100); HRMS (EI) m/z calcd for C11H17NO4 227.1158, found
227.1161.
N
O
MeO2C
O1) MCPBA, CH2Cl2;
2) TFAA, THF then
     EtSH, LiOH•H2O
SEt
N
O
MeO2C
S
S
43 51
2-Ethylsulfanylcarbonylmethyloxazole-4-carboxylic acid methyl ester (51).
A solution of 43 (620 mg, 2.53 mmol, 1.0 equiv) in CH2Cl2 (10.0 mL) was cooled under
N2 to –78 °C.  A suspension of MCPBA (920 mg, 5.33 mmol, 2.1 eqiv) in CH2Cl2 (5.0 mL
+ 5.0 mL rinse) was added.  After 20 min at –78 °C, Florisil/Celite (1:1 v/v) was added
and the mixture was warmed to rt and concentrated under vacuum.  The resulting
mixture was purified by chromatography on SiO2 (10% methanol/ethyl acetate)
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affording the dithiolanedioxide 50 (678 mg, 97%) as a white solid that was used
without further purification:  Rf 0.25 (10% methanol/ethyl acetate).
A suspension of 50 (62.0 mg, 224 µmol, 1.0 equiv) in THF (3.0 mL) was cooled to
0 °C under N2 and pyridine (43.0 µL, 530 µmol, 2.4 equiv) was added.  TFAA (44.0 µL,
312 µmol, 1.4 equiv) was added dropwise and the mixture was stirred for 30 min at 0
°C.  Additional TFAA (10.0 µL, 71 µmol, 0.3 equiv) was added and after an additional 15
min at 0 °C, ethanethiol (166 µL, 2.24 mmol, 10 equiv), water (100 µL, 5.56 mmol, 25
equiv) and LiOH•H2O (47.0 mg, 1.12 mmol, 5.0 equiv) were sequentially added.  After
stirring for 1 h at 0 °C, the mixture was poured into water and extracted with CH2Cl2.
The combined organic layers were washed with 1.0 M aqueous citric acid, water and
brine, dried (Na2SO4), filtered and concentrated to a pale yellow oil.  Purification by
chromatography on SiO2 (40% ethyl ether/hexanes) afforded 51 (41.0 mg, 80%) as a
clear, colorless syrup that contained some impurities as indicated by 1H NMR analysis:
Rf 0.20 (40% ethyl ether/hexanes); 
1H NMR δ 8.21 (s, 1 H), 4.06 (s, 2 H), 3.88 (s, 3 H),
2.90 (q, 2 H, J = 7.4 Hz), 1.23 (t, 3 H, J = 7.4 Hz); 13C NMR δ 192.0, 161.4, 158.1, 145.0,
133.8, 52.4, 42.9, 24.1, 14.5; IR (neat) 3160, 3124, 2954, 2933, 2868, 2848, 1739, 1688,
1583, 1438, 1323 cm-1; MS (EI) m/z (rel. intensity) 229 (M+, 12), 198 ([M-OCH3]
+, 9), 168
([M-SCH2CH3]
+, 27), 141 (100), 109 (72), 89 (37), 57 (43); HRMS (EI) m/z calcd for
C9H11NO4S 229.0409, found 229.0399.
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51 44a
2-(2-Hydroxyvinyl)oxazole-4-carboxylic acid methyl ester (44a).  To a
solution of 51 (11.0 mg, 48 µmol, 1.0 equiv) in CD2Cl2 (1.0 mL) was added Pd(OH)2 (wet
Degussa type E101 NE/W, 20% Pd content, 5.5 mg) and the flask was partially
evacuated and then flushed with N2 (2 cycles).  Et3SiH (50 µL, 310 µmol, 6.5 equiv) was
added and the mixture was stirred at rt.  After 7.5 h, additional Et3SiH (50 µL, 310 µmol,
6.5 equiv) was added and stirred for 1.5 h (9 h total).  The mixture was filtered rapidly
through a plug of Florisil/Celite (1:1 v/v) and the filtrate was carefully concentrated
under vacuum to approximately 0.5 mL, then transferred to an NMR tube.  1H NMR
analysis indicated a 44a/51 ratio of 2:1.  44a:  Rf 0.46 (60% ethyl ether/hexanes); 
1H
NMR (CD2Cl2) δ 8.13 (s, 1 H), 6.76 (d, 1 H, J = 6.4 Hz), 5.47 (d, 1 H, J = 6.4 Hz), 3.85 (s,
3 H).
N
H
O
MeO2C
HO
OTBDPS
O
HO OTBDPS
Ser-OMe•HCl, 
PyBOP, NMM, 
DMF
52a 53a
Methyl 2-(4-(tert-butyldiphenylsilyloxy)but-2-ynamido)-3-hydroxypropan-
oate (53a).  A mixture of 52a (4.84 g, 14.3 mmol, 1.0 equiv), serine methyl ester
hydrochloride (4.00 g, 25.7 mmol, 1.8 equiv) and PyBOP (7.50 g, 14.4 mmol, 1.0 equiv)
in DMF (10 mL) was cooled to 0 °C and treated with N-methyl morpholine (5.00 mL,
45.3 mmol, 3.2 equiv).  The mixture was stirred at rt for 20 h, quenched with saturated,
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aqueous NaHCO3, poured into water and extracted with ethyl acetate.  The combined
organic layers were washed with 1.0 M aqueous citric acid, water, 4.0 M aqueous LiCl,
dried (Na2SO4), filtered and concentrated.  Purification by chromatography on SiO2 (50%
to 70% ethyl acetate/hexanes) afforded 53a (1.964 g, 31%) as a pale yellow syrup that
was used without further purification.
N
H
O
CO2Me
OH
TBDPSO
TBDPSO
1) MeLi then CO2,
    ether, THF;
2) Ser-OMe•HCl,
    PyBOP, DIEA,
    DMF
H
53b
2-[5-(tert-Butyldiphenylsilyloxy)pent-2-ynoylamino]-3-hydroxy-propionic
acid methyl ester (53b).  A solution of 1-(tert-butyl)diphenylsiloxybut-3-yne (2.00 g,
6.48 mmol, 1.0 equiv) in THF (40 mL) was cooled to –78 °C under N2.  MeLi (1.5 M in
diethyl ether, 6.00 mL, 9.00 mmol, 1.4 equiv) was added and the mixture was stirred at
–78 °C for 1 h, warmed to 0 °C for 15 min and then cooled to –78 °C.  CO2 (gas from
dry ice, passed over anhydrous CaSO4) was bubbled into the reaction mixture.  After
10 min, the mixture was warmed to 0 °C, stirred for 20 min and slowly quenched by the
addition of 2.0 M aqueous NaHSO4 (20 mL).  The mixture was poured into brine (20
mL) and extracted with ethyl acetate.  The combined organic layers were dried
(Na2SO4), filtered and concentrated to afford 5-(tert-butyldiphenylsilyloxy)pent-2-ynoic
acid as a pale yellow syrup (2.48 g, quant.) that was used without further purification.
A mixture of the crude 5-(tert-butyldiphenylsilyloxy)pent-2-ynoic acid (2.48 g,
7.04 mmol, 1.0 equiv) and DL-serine methyl ester hydrochloride (1.64 g, 10.5 mmol, 1.5
equiv) was dissolved in DMF (10 mL) and cooled to 0 °C under N2.  PyBOP (4.10 g,
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7.88 mmol, 1.1 equiv) and diisopropylethylamine (4.30 mL, 24.7 mmol, 3.5 equiv) were
added and the cold bath was removed.  After stirring at rt for 36 h, saturated, aqueous
NaHCO3 (10 mL) was added and the mixture was stirred for 30 min, then poured into
water (50 mL) and extracted with ethyl acetate.  The combined organic layers were
washed with 1.0 M aqueous citric acid (50 mL), water (50 mL) and 4.0 M aqueous LiCl
(50 mL), dried (Na2SO4), filtered and concentrated.  Purification by chromatography on
SiO2 (50% ethyl acetate/hexanes) afforded 53b (2.63 g, 90% for 2 steps) as a clear,
colorless syrup:  Rf 0.40 (60% ethyl acetate/hexanes); 
1H NMR δ 7.68-7.66 (m, 4 H),
7.47-7.37 (m, 6 H), 6.67 (d, 1 H, J = 7.4 Hz), 4.67 (ddd, 1 H, J = 7.2, 7.2, 3.4 Hz), 3.99
(ddd, 1 H, J = 11.2, 5.5, 3.9 Hz), 3.90 (ddd, 1 H, J = 11.2, 5.3, 3.5 Hz), 3.81 (t, 2 H, J =
6.9 Hz), 3.78 (s, 3 H), 2.57 (t, 2 H, J = 6.9 Hz), 2.48 (t, 1 H, J = 5.8 Hz), 1.07 (s, 9 H); 13C
NMR δ 170.4, 153.4, 135.7, 133.4, 130.0, 128.0, 86.2, 76.0, 63.1, 61.6, 54.9, 53.1, 26.9,
22.9, 19.4; IR (neat) 3412, 3071, 3049, 2955, 2930, 2885, 2858, 2243, 1963, 1894,
1829, 1743, 1644, 1516, 1112 cm-1; MS (EI) m/z (rel. intensity) 438 ([M-OH]+, 22), 422
([M-CH3OH]
+, 47), 396 ([M-C4H9]
+, 100), 378 ([M-C4H9-H2O]
+, 26), 199 (30), 105 (36);
HRMS (EI) m/z calcd for C21H22NO5Si (M-C4H9) 396.1267, found 396.1279.
N
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1) DAST then
    K2CO3, CH2Cl2;
2) BrCCl3, DBU,
    CH2Cl2
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53a
54a
2-[4-(tert-Butyldiphenylsilyloxy)prop-1-ynyl]oxazole-4-carboxylic acid
methyl ester (54a).  A solution of 53a (1.964 g, 4.468 mmol, 1.0 equiv) in CH2Cl2 (25.0
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mL) was cooled under N2 to –78 °C, treated with DAST (620 µL, 4.692 mmol, 1.05
equiv), stirred for 15 min and treated with anhydrous K2CO3 (1.600 g, 11.58 mmol, 2.6
equiv), warmed to 0 °C and stirred for 1 h.  The mixture was treated with saturated,
aqueous NaHCO3 (25 mL), stirred at rt for 30 min and then extracted with CH2Cl2.  The
combined organic layers were dried (Na2SO4), filtered and concentrated.  The residue
was azeotropically dried with toluene (2 mL) at reduced pressure, diluted with CH2Cl2
(25.0 mL), cooled to 0 °C and treated with BrCCl3 (530 µL, 5.38 mmol, 1.2 equiv) and
DBU (735 µL, 4.92 mmol, 1.1 equiv).  After stirring for 40 min at 0 °C, the mixture was
diluted with ethyl ether (25.0 mL), poured onto a pad of SiO2 and the pad was washed
with ethyl ether (150 mL).  The combined filtrate was concentrated to a yellow syrup.
Purification by chromatography on SiO2 (20% ethyl ether/hexanes) afforded 54a (770.9
mg, 41%) as a yellow syrup and methyl 2-(4-(tert-butyldiphenylsilyloxy)but-2-
ynamido)acrylate (505.0 mg, 27%) as a yellow syrup.  54a:  Rf 0.35 (40% ethyl
ether/hexanes); 1H NMR δ 8.19 (s, 1 H), 7.71-7.69 (m, 4 H), 7.47-7.37 (m, 6 H), 4.51 (s,
2 H), 3.93 (s, 3 H), 1.07 (s, 9 H); 13C NMR δ 161.1, 146.8, 144.5, 135.8, 134.2, 132.6,
130.2, 128.1, 91.7, 72.1, 52.8, 52.5, 26.8, 19.4; IR (neat) 3157, 3072, 3049, 2954, 2932,
2894, 2858, 2254, 1752, 1726, 1573, 1548 cm-1; MS (EI) m/z (rel. intensity) 419 (M+, 10),
388 ([M-OCH3]
+, 9), 362 ([M-C4H9]
+, 100), 332 ([M-C4H9-OCH3]
+, 91); HRMS (EI) m/z
calcd for C24H25NO4Si 419.1553, found 419.1563.  Methyl 2-(4-(tert-
butyldiphenylsilyloxy)but-2-ynamido)acrylate:  Rf 0.49 (40% ethyl ether/hexanes); 
1H
NMR δ 7.90 (bs, 1 H), 7.72-7.69 (m, 4 H), 7.48-7.39 (m, 6 H), 6.58 (s, 1 H), 5.97 (d, 1 H,
J = 1.3 Hz), 4.43 (s, 2 H), 3.87 (s, 3 H), 1.08 (s, 9 H); 13C NMR δ 164.1, 150.8, 135.8,
90
132.6, 130.8, 130.3, 128.1, 110.7, 85.3, 79.1, 53.3, 52.5, 26.9, 19.4; IR (neat) 3389,
3071, 3049, 2956, 2932, 2894, 2858, 2235, 1724, 1676, 1509 cm-1; MS (EI) m/z (rel.
intensity) 364 ([M-C4H9]
+, 6), 295 (20), 267 (20), 199 (100); HRMS (EI) m/z calcd for
C20H18NO4Si (M-C4H9) 364.1005, found 364.0990.
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54b53b
2-[4-(tert-Butyldiphenylsilyloxy)but-1-ynyl]oxazole-4-carboxylic acid methyl
ester (54b).  A solution of 53b (2.63 g, 5.81 mmol, 1.0 equiv) in CH2Cl2 (30 mL) was
cooled to -78 °C under N2 and diethylaminosulfurtrifluoride (DAST) (810 µL, 6.13 mmol,
1.1 equiv) was added dropwise over 2 min.  The mixture was stirred for 10 min at -78
°C, then anhydrous K2CO3 (1.20 g, 8.68 mmol, 1.5 equiv) was added.  The -78 °C bath
was replaced with a 0 °C bath and, after 10 min, saturated, aqueous NaHCO3 (20 mL)
was carefully added (caution: vigorous evolution of gas).  The cold bath was removed
and the mixture was stirred at rt for 1 h, diluted with water and extracted with CH2Cl2.
The combined organic layers were washed with brine, dried (Na2SO4), filtered and
concentrated.  The resulting oil was azeotropically dried at reduced pressure from
toluene (10 mL), diluted with CH2Cl2 (30 mL) and cooled to 0 °C under N2.  BrCCl3 (630
µL, 6.39 mmol, 1.1 equiv) and DBU (950 µL, 6.35 mmol, 1.1 equiv) were added and the
mixture was stirred at 0 °C for 4 h.  Hexanes (50 mL) was added and the mixture was
poured onto a pad of SiO2 (40 mm x 40 mm) and eluted with 50% ethyl ether/hexanes.
The combined filtrate was concentrated to a yellow syrup which was purified by
chromatography on SiO2 (10% ethyl ether/hexanes) to afford 54b (1.91 g, 76%) as a
91
clear colorless, syrup:  Rf 0.37 (40% ethyl ether/hexanes); 
1H NMR δ 8.15 (s, 1 H), 7.69-
7.66 (m, 4 H), 7.47-7.36 (m, 6 H), 3.91 (s, 3 H), 3.86 (t, 2 H, J = 6.8 Hz), 2.69 (t, 2 H, J =
6.8 Hz), 1.06 (s, 9 H); 13C NMR δ 161.2, 147.3, 144.1, 135.7, 133.9, 133.4, 130.0, 128.0,
92.7, 69.3, 61.6, 52.5, 26.9, 23.5, 19.4; IR (neat) 3158, 3071, 2953, 2932, 2884, 2857,
2249, 1967, 1885, 1829, 1751, 1728, 1574, 1551, 1113 cm-1; MS (EI) m/z (rel. intensity)
432 ([M-H]+, 0.3), 418 ([M-CH3]
+, 0.5), 402 ([M-OCH3]
+, 3.3), 376 ([M-C4H9]
+, 91), 346
(100); HRMS (EI) m/z calcd for C25H27NO4Si (M-H) 432.1631, found 432.1625.
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54a 55a
2-(3-Hydroxyprop-1-ynyl)oxazole-4-carboxylic acid methyl ester (55a).  A
solution of 54a (275.4 mg, 0.656 mmol, 1.0 equiv) in CH3CN (10.0 mL) was cooled to 0
°C and treated with 48% aqueous HF (1.0 mL), warmed to rt and stirred for 36 h.  The
mixture was carefully added to a solution of saturated, aqueous NaHCO3 (75 mL).
Ethyl acetate (20 mL) was added and the mixture was stirred at rt for 1 h and extracted
with ethyl acetate.  The combined organic layers were washed with brine, dried
(Na2SO4), filtered and concentrated.  Purification by chromatography on SiO2 (50%
ethyl acetate/hexanes) afforded 55a (112.4 mg, 95%) as a crystalline, white solid:  Rf
0.19 (40% ethyl acetate/hexanes); Mp 100.1-101.1 °C (ethyl acetate/hexanes); 1H NMR
δ 8.16 (s, 1 H), 4.50 (s, 2 H), 4.33 (bs, 1 H), 3.85 (s, 3 H); 13C NMR δ 160.9, 146.8, 144.6,
133.6, 92.8, 71.6, 52.5, 50.6; IR (KBr) 3455, 3161, 3113, 3017, 2959, 2921, 2249, 2220,
1736, 1584, 1551 cm-1; MS (EI) m/z (rel. intensity) 181 (M+, 79), 152 (100), 150 (M-OCH3,
92
54), 120 (43), 100 (64), 83 (81); HRMS (EI) m/z calcd for C8H7NO4 (M
+) 181.0375, found
181.0379.
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54b 55b
2-(4-Hydroxybut-1-ynyl)oxazole-4-carboxylic acid methyl ester (55b).  A
solution of 54b (640.1 mg, 1.476 mmol, 1.0 equiv) in THF (5.0 mL) at rt was treated with
glacial AcOH (125 µL, 2.18 mmol, 1.5 equiv) and a solution of TBAF (1.0 M in THF, 2.20
mL, 2.20 mmol, 1.5 equiv).  The mixture was stirred at rt for 18 h, treated with
saturated, aqueous NH4Cl (5 mL), diluted with water (5 mL) and extracted with ethyl
acetate.  The combined organic layers were dried (Na2SO4), filtered and concentrated
to a pale yellow solid.  Purification by chromatography on SiO2 (60% ethyl
acetate/hexanes to 100% ethyl acetate) afforded 55b (266.3 mg, 92%) as a white solid:
Rf 0.18 (60% ethyl acetate/hexanes); Mp 99.5-100.0 °C (ethyl acetate); 
1H NMR δ 8.12
(s, 1 H), 3.85 (s, 3 H), 3.83 (t, 2 H, J = 6.4 Hz), 3.39 (bs, 1 H), 2.69 (t, 2 H, J = 6.4 Hz);
13C NMR δ 161.0, 147.1, 144.1, 133.6, 93.0, 69.2, 60.1, 52.4, 23.6; IR (KBr) 3483, 3160,
3111, 2235, 1724, 1583, 1551 cm-1; MS (EI) m/z (rel. intensity) 195 (M+, 50), 165 (100),
149  ([M-CH3-CH2OH]
+, 7), 133 ([M-OCH3-CH2OH]
+, 51); HRMS (EI) m/z calcd for
C9H9O4N 195.0532, found 195.0541.
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54b 56
2-{2-[2-(tert-Butyldiphenylsilyloxy)ethyl]-[1,3]dithiolan-2-ylmethyl}oxazole-
4-carboxylic acid methyl ester (56).  To a solution of 54b (101.5 mg, 234 µmol, 1.0
equiv) in THF (5.0 mL) at rt was added 1,2-ethanedithiol (100 µL, 1.19 mmol, 5.1 equiv)
and anhydrous K2CO3 (32.0 mg, 232 µmol, 1.0 equiv).  18-Crown-6 (24.0 mg, 91 µmol,
0.4 equiv) was added and the colorless solution immediately became pale yellow.  The
mixture was stirred for 4 h at rt, slowly becoming turbid, and was filtered through a
plug of Florisil/Celite (1:1 v/v).  The filtrate was concentrated and purified by
chromatography on SiO2 (30% ethyl ether/hexanes) to afford 54b (116.4 mg, 94%) as a
clear, colorless oil:  Rf 0.29 (40% ethyl ether/hexanes); 
1H NMR δ 8.15 (s, 1 H), 7.70-
7.66 (m, 4 H), 7.44-7.34 (m, 6 H), 3.96 (t, 2 H, J = 6.7 Hz), 3.90 (s, 3 H), 3.53 (s, 2 H),
3.22 (s, 4 H), 2.42 (t, 2 H, J = 6.7 Hz), 1.04 (s, 9 H); 13C NMR δ 162.2, 161.8, 144.2,
135.7, 133.6, 133.3, 129.8, 127.8, 66.5, 62.3, 52.2, 44.5, 43.2, 39.9, 26.9, 19.2; IR (neat)
3070, 3048, 2952, 2930, 2890, 2856, 1964, 1897, 1820, 1748, 1729, 1581, 1139 cm-1;
MS (EI) m/z (rel. intensity) 527 (M+, 0.04), 513 ([M-CH2]
+, 0.16), 499 ([M-C2H4]
+, 30), 470
([M-C4H9]
+, 51), 199(24), 131(32), 91(100); HRMS (EI) m/z calcd for C23H24NO4S2Si (M-
C4H9) 470.0916, found 470.0902.
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56 57
2-((2-(2-Hydroxyethyl)-1,3-dithiolan-2-yl)methyl)oxazole-4-carboxylic acid
methyl ester (57).  A solution of 56 (116.0 mg, 0.220 mmol, 1.0 equiv) in THF (2.0 mL)
at rt was treated with glacial AcOH (19.0 µL, 0.332 mmol, 1.5 equiv) and TBAF (1.0 M in
THF, 0.330 mL, 0.330 mmol, 1.5 equiv), stirred for 16 h at rt, treated with NaHCO3 (2
mL), diluted with H2O (10 mL) and extracted with ethyl acetate.  The combined organic
layers were washed with brine, dried (Na2SO4), filtered and concentrated.  Purification
by chromatography on SiO2 (60% ethyl acetate/hexanes) afforded 57 (57.8 mg, 91%)
as a clear, colorless syrup:  Rf 0.30 (60% ethyl acetate/hexanes); 
1H NMR δ 8.17 (s, 1
H), 3.91 (t, 2 H, J = 6.0 Hz), 3.86 (s, 3 H), 3.51 (s, 2 H), 3.37-3.24 (m, 4 H), 2.76 (bs, 1
H), 2.31 (t, 2 H, J = 6.0 Hz); 13C NMR δ 162.1, 161.6, 144.2, 133.3, 67.2, 60.8, 52.3,
44.0, 43.6, 40.1 (2 C); IR (neat) 3404, 3160, 2951, 2925, 1736, 1580, 1437 cm-1; MS (EI)
m/z (rel. intensity) 289 (M+, 6), 244 ([M-C2H4OH]
+, 6), 230 ([M-CO2CH3]
+, 76), 212 (15),
200 (38), 149 (100), 119 (61); HRMS (EI) m/z calcd for C11H15NO4S2 289.0443, found
289.0432.
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55b 57
2-((2-(2-Hydroxyethyl)-1,3-dithiolan-2-yl)methyl)oxazole-4-carboxylic acid
methyl ester (57).  A solution of 55b (93.5 mg, 0.479 mmol, 1.0 equiv) in THF (5.0 mL)
was treated at rt with ethanedithiol (200 µL, 2.384 mmol, 5.0 equiv), anhydrous K2CO3
95
(73.0 mg, 0.528 mmol, 1.1 equiv) and 18-crown-6 (38.0 mg, 0.144 mmol, 0.3 equiv),
stirred at rt for 6 h, diluted with ethyl ether (5 mL) and filtered through a plug of
Florisil/Celite (1:1 v/v).  The plug was rinsed with ethyl ether (5 mL) and the combined
filtrate was concentrated.  Purification by chromatography on SiO2 (50% ethyl
acetate/hexanes to 100% ethyl acetate) afforded 57 (121.5 mg, 88%) as a clear,
colorless syrup.  The spectral data were in agreement with the material obtained by
TBDPS deprotection.
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56 58
2-[4-(tert-Butyldiphenylsilyloxy)-2-oxobutyl]oxazole-4-carboxylic acid
methyl ester (58).  A solution of N-bromosuccinimide (52.0 mg, 292 µmol, 8.1 equiv) in
acetone/water (9:1 v/v; 1.0 mL) was cooled to 0 °C and a solution of 56 (19.0 mg, 36
µmol, 1.0 equiv) in acetone/water (9:1; 1.0 mL) was added dropwise.  The mixture
became yellow and after 10 min, saturated, aqueous NaHCO3 (1.0 mL) and saturated,
aqueous Na2S2O3 (1.0 mL) were added.  The mixture was diluted with water and
extracted with ethyl acetate.  The combined organic layers were dried (Na2SO4), filtered
and concentrated.  Purification of the mixture by chromatography on SiO2 (20% to
30% ethyl acetate/hexanes) afforded 58 (12.5 mg, 77%) as a clear, colorless wax:  Rf
0.43 (40% ethyl acetate/hexanes); 1H NMR δ 8.21 (s, 1 H), 7.66-7.63 (m, 4 H), 7.46-7.36
(m, 6 H), 4.03 (s, 2 H), 3.93 (app q, 2 H, J = 6.1 Hz), 3.92 (s, 3 H), 2.73 (app t, 2 H, J =
6.1 Hz), 1.03 (s, 9 H); 13C NMR δ 201.7, 161.6, 159.1, 145.0, 135.7, 133.8, 133.3, 130.0,
128.0, 59.5, 52.4, 45.4, 43.3, 27.0, 19.3 ; IR (neat) 3163, 3071, 3049, 2954, 2931, 2888,
96
2857, 1964, 1893, 1830, 1729, 1587, 1428, 1112 cm-1; MS (EI) m/z (rel. intensity) 420
([M-OCH3]
+, 1.3), 394 ([M-C(CH3)3]
+, 57), 362 ([M-C(CH3)3-OCH3]
+, 16), 316 ([M-C(CH3)3-
C6H6]
+, 29), 199 (100), 105 (44), 77 (32); HRMS (EI) m/z calcd for C24H26NO4Si (M-OCH3)
420.1631, found 420.1631.
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56 59
2-[4-(tert-Butyldiphenylsilyloxy)-1,1-dichloro-2-oxobutyl]-oxazole-4-
carboxylic acid methyl ester (59).  A solution of N-chlorosuccinimide (46.5 mg, 348
µmol, 4.0 equiv) and AgNO3 (66.5 mg, 391 µmol, 4.5 equiv) in 80% (v/v) aqueous
acetonitrile (1.0 mL) was cooled to 0 °C.  A solution of 56 (24.2 mg, 87 µmol, 1.0 equiv)
in 80% (v/v) aqueous acetonitrile (0.5 mL+ 0.5 mL rinse) was added via syringe.  The
cold bath was removed and a white precipitate formed.  After 30 min, additional N-
chlorosuccinimide (26.0 mg, 195 µmol, 2.2 equiv) was added in one portion.  After an
additional 30 min at rt, the mixture was diluted with ethyl ether (5.0 mL) and filtered
through a plug of Florisil/Celite (1:1 v/v).  The filtrate was diluted with ethyl acetate (10
mL) and washed with saturated, aqueous Na2S2O3 (5 mL) and brine (5 mL), dried
(Na2SO4), filtered and concentrated.  Purification by chromatography on SiO2 (20%
ethyl ether/hexanes) afforded 59 (12.9 mg, 29%) as a clear, colorless oil:  Rf 0.43 (40%
ethyl ether/hexanes); 1H NMR δ 8.30 (s, 1 H), 7.67-7.64 (m, 4 H), 7.46-7.37 (m, 6 H),
4.01 (t, 2 H, J = 6.1 Hz), 3.93 (s, 3 H), 3.18 (t, 2 H, J = 6.1 Hz), 1.02 (s, 9 H); 13C NMR δ
191.6, 160.9, 158.4, 146.3, 135.8, 134.4, 133.3, 130.0, 128.0, 78.8, 59.1, 52.7, 38.7,
97
26.9, 19.3; IR (neat) 3162, 3071, 3050, 2954, 2931, 2888, 2857, 1959, 1897, 1825,
1752, 1578, 1112 cm-1; MS (EI) m/z (rel. intensity) 462 ([M-C4H9]
+, 11), 426 ([M-C2H5S2]
+,
32), 384 (64), 350 (23), 217 (32), 199 (100), 135(32); HRMS (EI) m/z  calcd for
C21H18NO5SiCl2 (M-C4H9) 462.0331, found 462.0312.
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57 60
2-((2-(2-Oxoethyl)-1,3-dithiolan-2-yl)methyl)oxazole-4-carboxylic acid
methyl ester (60).  A solution of trifluoroacetic anhydride (30.0 µL, 0.212 mmol, 1.5
equiv) in CH2Cl2 (1.0 mL) was cooled to –78 °C under N2, treated with DMSO (30.0 µL,
0.423 mmol, 3.0 equiv), stirred for 30 min and treated via cannula with a solution of 57
(41.4 mg, 0.143 mmol, 1.0 equiv) in CH2Cl2 (0.5 mL + 0.5 mL rinse).  The mixture was
stirred at –78 °C for 30 min, treated with triethylamine (60.0 µL, 0.428 mmol, 3.0 equiv),
stirred for an additional 30 min at –78 °C, treated with saturated, aqueous NH4Cl (1.0
mL), warmed to rt, diluted with H2O (10 mL) and extracted with CH2Cl2.  The combined
organic layers were dried (Na2SO4), filtered and concentrated.  Purification by
chromatography on SiO2 (30% to 40% ethyl acetate/hexanes) afforded 60 (33.3 mg,
81%) as a clear, colorless syrup:  Rf 0.24 (40% ethyl acetate/hexanes); 
1H NMR δ 9.77
(t, 1 H, J = 1.5 Hz), 8.18 (s, 1 H), 3.89 (s, 3 H), 3.58 (s, 2 H), 3.36 (s, 4 H), 3.23 (d, 2 H, J
= 1.5 Hz); 13C NMR δ 199.6, 161.6 (2 C), 144.3, 133.6, 63.0, 53.3, 52.4, 43.8, 40.4 (2 C);
IR (neat) 3158, 3117, 2952, 2926, 2844, 2740, 1720, 1581, 1437 cm-1; MS (EI) m/z (rel.
intensity) 287 (M+, 12), 244 ([M-CH2CHO]
+, 5), 228 ([M-CO2CH3]
+, 100), 200 (24), 147
(86), 119 (76); HRMS (EI) m/z calcd for C11H13NO4S2 287.0286, found 287.0282.
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60 61
2-((2-(2-(tert-Butyldiphenylsilyloxy)pent-3-ynyl)-1,3-dithiolan-2-yl)methyl)-
oxazole-4-carboxylic acid methyl ester (61).  Propyne (0.5 mL) was condensed into a
flask at –78 °C, diluted with THF (1.0 mL) and treated with n-BuLi (1.8 M in hexanes,
0.190 mL, 0.342 mmol, 1.1 equiv).  The mixture was stirred at –78 °C for 1.5 h, treated
via cannula with a solution of the aldehyde (87.3 mg, 0.304 mmol, 1.0 equiv) in THF
(1.0 mL + 1.0 mL rinse), stirred at –78 °C for 1.75 h, warmed to 0 °C and quenched
with saturated, aqueous NH4Cl.  The mixture was diluted with water and extracted with
ethyl acetate.  The combined organic layers were dried (Na2SO4), filtered and
concentrated.  Purification by chromatography on SiO2 (30% acetone/hexanes)
afforded methyl 2-((2-(2-hydroxypent-3-ynyl)-1,3-dithiolan-2-yl)methyl)oxazole-4-
carboxylate (40.3 mg, 41%) as a clear, colorless oil.  This oil (22.3 mg, 0.068 mmol, 1.0
equiv) was diluted in DMF (0.5 mL) and treated with imidazole (14.0 mg, 0.206 mmol,
3.0 equiv), stirred at rt for 3 d, treated with saturated, aqueous NH4
+Cl- (3.0 mL), poured
into H2O (10 mL) and extracted with ethyl acetate.  The combined organic layers were
washed with 4.0 M aqueous LiCl (5.0 mL), dried (Na2SO4), filtered and concentrated to
a yellow oil.  Purification by chromatography on SiO2 (20% ethyl acetate/hexanes)
afforded 61  (34.4 mg, 89%) as a clear, colorless oil:  Rf 0.20 (20% ethyl
acetate/hexanes); 1H NMR δ 8.13 (s, 1 H), 7.78-7.71 (m, 4 H), 7.44-7.33 (m, 6 H), 4.72-
4.66 (m, 1 H), 3.90 (s, 3 H), 3.61 (s, 2 H), 3.19-3.08 (m, 4 H), 2.65 (d of AB, 1 H, J =
14.5, 6.2 Hz), 2.61 (d of AB, 1 H, J = 14.5, 6.4 Hz), 1.50 (d, 3 H, J = 2.1 Hz), 1.05 (s, 9
99
H); 13C NMR δ 162.5, 161.9, 144.2, 136.3, 136.1, 134.2, 133.8, 133.4, 129.8, 129.5,
127.7, 127.3, 84.0, 80.5, 66.2, 63.1, 52.3, 51.3, 42.4, 39.8, 39.7, 27.2, 19.4, 3.6; IR
(neat) 3071, 3047, 2953, 2930, 2887, 2856, 1749, 1729, 1581 cm-1; MS (EI) m/z (rel.
intensity) 565 (M+, 0.1), 508 ([M-C4H9]
+, 81), 440 (57), 199 (64), 135 (74), 121 (100);
HRMS (ESI) m/z calcd for C30H35NO4SiS2Na (M+Na) 588.1675, found 588.1699.
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55a 62
2-((2-(Hydroxymethyl)-1,3-dithiolan-2-yl)methyl)oxazole-4-carboxylic acid
methyl ester (62).  A solution of 55a (48.0 mg, 0.265 mmol, 1.0 equiv) in THF (2.0 mL)
at rt was treated with 1,2-ethanedithiol (110 µL, 1.31 mmol, 4.9 equiv), K2CO3 (40.3 mg,
0.292 mmol, 1.1 equiv) and 18-crown-6 (14.0 mg, 0.053 mmol, 0.2 equiv).  The
resulting yellow, turbid mixture was stirred at rt for 30 min, diluted with ethyl ether (2.0
mL) and filtered through a plug of Florisil/Celite (1:1).  The plug was rinsed with ethyl
ether (3.0 mL) and the combined filtrate was concentrated.  Purification by
chromatography on SiO2 (60% ethyl acetate/hexanes) afforded 62 (66.4 mg, 91%) as a
clear, colorless syrup:  Rf 0.18 (50% ethyl acetate/hexanes); 
1H NMR δ 8.17 (s, 1 H),
3.85 (s, 3 H), 3.75 (d, 2 H, J = 6.7 Hz), 3.55 (s, 2 H), 3.30-3.23 (m, 5 H); 13C NMR δ
162.2, 161.6, 144.3, 133.3, 69.8, 69.4, 52.2, 39.6, 38.3; IR (neat) 3419, 3159, 2951,
2926, 2852, 1732, 1582, 1437 cm-1; MS (EI) m/z (rel. intensity) 275 (M+, 1.0), 257 ([M-
H2O]
+, 12), 245 (100), 244 (M-OCH3, 88), 216 ([M-CO2CH3]
+, 36), 184 (19), 141 (68), 135
(79); HRMS (EI) m/z calcd for C10H13NO4S2 275.0286, found 275.0278.
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62 63
2-((2-Formyl-1,3-dithiolan-2-yl)methyl)oxazole-4-carboxylic acid methyl
ester (63).  A solution of TFAA (50.0 µL, 0.354 mmol, 1.5 equiv) in CH2Cl2 (0.5 mL) was
cooled to –78 °C under N2 and treated with a solution of DMSO (50 µL, 0.704mmol, 3.0
equiv) in CH2Cl2 (0.5 mL + 0.5 mL rinse).  The mixture was stirred for 20 min, treated
with a solution of 62 (64.7 mg, 0.235 mmol, 1.0 equiv), stirred for 20 min and treated
with triethylamine (100 µL, 0.715 mmol, 3.0 equiv).  The mixture was stirred for 90 min
at –78 °C, treated with water (1.0 mL), warmed to rt, diluted with water (5.0 mL) and
extracted with CH2Cl2.  The combine organic layers were dried (Na2SO4), filtered and
concentrated.  Purification by chromatography on SiO2 (40% ethyl acetate/hexanes)
afforded 63 (59.4 mg, 93%) as a clear, colorless syrup:  Rf 0.31 (50% ethyl
acetate/hexanes); 1H NMR δ 9.12 (s, 1 H), 8.16 (s, 1 H), 3.87 (s, 3 H), 3.62 (s, 2 H), 3.33
(s, 4 H); 13C NMR δ 187.5, 161.7, 161.5, 144.3, 133.5, 69.2, 52.3, 41.1, 34.5; IR (neat)
3158, 2952, 2844, 1712, 1582, 1437 cm-1; MS (EI) m/z (rel. intensity) 273 (M+, 0.1), 244
([M-CHO]+, 100), 217 (13), 212 (22), 184 (20), 156 (10), 141 (53); HRMS (EI) m/z calcd for
C10H11O4S2 273.0130, found 273.0119.
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63 64
2-((2-(2,2-Dibromovinyl)-1,3-dithiolan-2-yl)methyl)oxazole-4-carboxylic acid
methyl ester (64).  A solution of PPh3 (100.0 mg, 0.381 mmol, 4.1 equiv) in CH2Cl2 (1.0
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mL) at 0 °C was treated with CBr4 (62.0 mg, 0.187 mmol, 2.0 equiv), stirred for 20 min,
treated with triethylamine (130 µL, 0.927 mmol, 10.0 equiv), stirred for 10 min and
treated with a solution of 63 (25.4 mg, 0.093 mmol, 1.0 equiv).  The mixture was
allowed to warm to rt over 2 h and then was treated with additional PPh3 (50.0 mg,
0.191 mmol, 2.0 equiv) and CBr4 (31.0 mg, 0.093 mmol, 1.0 equiv).  The mixture was
stirred for 22 h (overnight), diluted with ethyl ether (5 mL) and poured onto a pad of
SiO2.  The pad was washed with ethyl ether (100 mL) and the combined filtrate was
concentrated to a yellow wax.  Purification by chromatography on SiO2 (30% to 40%
ethyl acetate/hexanes) afforded 64 (34.2 mg, 86%) as a pale yellow wax:  Rf 0.51 (50%
ethyl acetate/hexanes); 1H NMR δ 8.21 (s, 1 H), 7.14 (s, 1 H), 3.90 (s, 3 H), 3.80 (s, 2 H),
3.45-3.28 (m, 4 H); 13C NMR δ 161.7, 161.3, 144.5, 141.4, 133.5, 93.5, 66.6, 52.4, 42.4,
40.6 (2 C); IR (neat) 3159, 3021, 2950, 2923, 2846, 1742, 1579 cm-1; MS (EI) m/z (rel.
intensity) 426 (M+, 0.1), 398 ([M-C2H4]
+, 33), 370 (20), 350 (17), 289 (100), 229 (27);
HRMS (EI) m/z calcd for C11H11NO3S2Br2 426.8547, found 426.8529.
N
O
H
Ph
65
CO2H
TIPS
1) (L)-phenylalaninol,
    PyBOP, NMM, DMF;
2) DAST, CH2Cl2,
    then K2CO3;
3) TBAF, AcOH, THF39d
(4S)-4-Benzyl-2-ethynyl-4,5-dihydrooxazole (65).  A mixture of 39d (354.0 mg,
1.56 mmol, 1.0 equiv), L-phenylalaninol (354.0 mg, 2.34 mmol, 1.5 equiv) and PyBOP
(900.0, 1.73 mmol, 1.1 equiv) in DMF (3.0 mL) was cooled to 0° C and N-
methylmorpholine (400 µL, 3.94 mmol, 2.5 equiv) was added.  The mixture was allowed
to warm to rt, stirred for 20 h, poured into saturated aqueous NaHCO3 (10 mL), diluted
with water (10 mL) and extracted with ethyl acetate.  The combined organic extracts
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were washed with 1.0 M aqueous citric acid (10 mL), water (10 mL) and 4.0 M aqueous
LiCl (10 mL), dried (Na2SO4), filtered and concentrated.  Purification by chromatography
on SiO2 (30% to 40% ethyl acetate/hexanes) afforded (1S)-3-(triisopropylsilyl)propiolic
acid (1-benzyl-2-hydroxyethyl)amide (580.9 mg, quant.) as a clear, colorless syrup that
was used without further purification:  Rf 0.33 (40% ethyl acetate/hexanes), 
1H NMR δ
7.34-7.19 (m, 5 H), 6.08 (bd, 1 H, J = 7.3 Hz), 4.25-4.08 (m, 1 H), 3.69 (d of AB, 1 H, J =
11.1, 3.4 Hz), 3.62 (d of AB, 1 H, J = 11.1, 4.4 Hz), 2.37 (bs, 1 H), 1.05-1.08 (m, 21 H),
2.95-2.90 (m, 2 H).
A solution of the hydroxyamide (580.0 mg, 1.61 mmol, 1.0 equiv) in CH2Cl2 (10.0
mL) was cooled to –78 °C under N2.  Diethylaminosulfurtrifluoride (DAST) (240 µL, 1.82
mmol, 1.1 equiv) was added and, after 10 min, TLC analysis indicated that the
hydroxyamide was consumed.  Solid anhydrous K2CO3 (340.0 mg, 2.46 mmol, 1.5
equiv) was added and the mixture was stirred at –78 °C for 20 min, then at 0 °C for 20
min.  Saturated aqueous NaHCO3 (5 mL) was carefully added (caution: vigorous
evolution of gas) and the mixture was stirred for 1 h while warming to rt and then
extracted with CH2Cl2.  The combined organic extracts were dried (Na2SO4), filtered
and concentrated.  Purification by chromatography on SiO2 (10% ethyl ether/hexanes)
afforded (4S)-4-benzyl-2-[(triisopropylsilyl)ethynyl]-4,5-dihydrooxazole (338.3 mg, 63%,
2 steps) as a clear, colorless oil that was used without further purification. 1H NMR δ
7.33-7.19 (m, 5 H), 4.48 (app dq, 1 H, J = 5.2, 9.0 Hz), 4.22 (t, 1 H, J = 9.0 Hz), 4.00 (t, 1
H, J = 8.2 Hz), 3.18 (dd, 1 H, J = 13.8, 5.2 Hz), 2.67 (dd, 1 H, J = 13.8, 8.9 Hz), 1.10-
1.11 (m, 21 H).
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A solution of (4S ) -4-benzyl-2-[(triisopropylsilyl)ethynyl]-4,5-dihydrooxazole
(338.0 mg, 0.990 mmol, 1.0 equiv) in THF (10.0 mL) was cooled under N2 to –78 °C.
Glacial acetic acid (65 µL, 1.1 mmol, 1.1 equiv) and TBAF (1.0 M in THF, 1.10 mL, 1.1
equiv) were added.  After 30 min at –78 °C, saturated aqueous NaHCO3 was added
and the mixture was warmed to rt, diluted with water and extracted with ethyl acetate.
The combined organic layers were dried (Na2SO4), filtered and concentrated.
Purification by chromatography on SiO2 (10% to 20% ethyl acetate/hexanes) afforded
65 (158.5 mg, 87%) as a clear colorless syrup.  The spectral data were in agreement
with the literature values: [α]D -32.8 (c 0.85, CHCl3, 22 °C), lit. [α]D -62.5 (c 1.58, CHCl3,
23 °C). 83
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65 66
Ph
(4S)-4-Benzyl-2-(2-ethylsulfanylvinyl)-4,5-dihydro-oxazole (66).  To a solution
of 65 (12.2 mg, 66 µmol, 1.0 equiv) in THF (0.5 mL) at rt was added ethanethiol (25 µL,
338 µmol, 5.1 equiv) and anhydrous K2CO3 (10.2 mg, 74 µmol, 1.1 equiv).  18-Crown-6
(5.0 mg, 19 µmol, 0.3 equiv) was added and the mixture was vigorously stirred for 4 h
at rt, diluted with ethyl ether (1.0 mL) and filtered through a plug of Florisil/Celite (1:1
v/v).  The plug was washed with ethyl ether (3.0 mL) and the combined filtrate was
concentrated to a pale yellow oil.  Purification by chromatography on SiO2 (20% ethyl
acetate/hexanes) afforded 66 (14.5 mg, 89%) as a clear colorless oil that was a 4:1
(Z/E) mixture:  Rf 0.40 (40% ethyl acetate/hexanes); 
1H NMR δ 7.32-7.19 (m, 5 H), 6.82
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(d, 1 H, J = 10.8 Hz), 5.89 (d, 1 H, J = 10.8 Hz), 4.51 (dddd, 1 H, J = 9.1, 9.1, 7.3, 5.1
Hz), 4.19 (app t, 1 H, J = 8.9 Hz), 4.00 (dd, 1 H, J = 8.3, 7.3 Hz), 3.21 (dd, 1 H, J = 13.7,
5.0 Hz), 2.79 (q, 2 H, J = 7.4 Hz), 2.66 (dd, 1 H, J = 13.7, 9.0 Hz), 1.36 (t, 3 H, J = 7.4
Hz); 13C NMR δ 163.4, 142.7, 138.4, 129.4, 128.7, 126.6, 110.6, 71.4, 68.0, 42.1, 29.8,
15.6; IR (neat) 3060, 3026, 2967, 2925, 1635, 1585, 1493, 1453, 1183 cm-1; MS (EI) m/z
(rel. intensity) 247 (M+, 35), 218 ([M-C2H5]
+, 25), 156 ([M-C7H7]
+, 100), 128 (58), 91 (57);
HRMS (EI) m/z calcd for C14H17NOS 247.1031, found 247.1043; Characteristic signals
for the (E)-isomer:  1H NMR δ 5.94 (d, 1 H, J = 15.5 Hz), 4.21 (t, 1 H, J = 8.5 Hz), 3.12
(dd, 1 H, J = 13.8, 5.4 Hz), 1.35 (t, 3 H, J = 7.4 Hz).
N
O
H
Ph
N
O
Ph
S
t-BuSH, K2CO3,
18-crown-6,
THF
65 67
(4S)-4-Benzyl-2-(2-tert-butylsulfanylvinyl)-4,5-dihydrooxazole (67).  To a
solution of 65 (26.3 mg, 142 µmol, 1.0 equiv) in THF (1.0 mL) at rt was added t-
butylmercaptane (80 µL, 710 µmol, 5.0 equiv) and anhydrous K2CO3 (22.0 mg, 159
µmol, 1.1 equiv).  18-Crown-6 (12.0 mg, 45 µmol, 0.3 equiv) was added and the
mixture was stirred for 12 h at rt, diluted with ethyl ether (3.0 mL) and filtered through a
plug of Florisil/Celite (1:1 v/v).  The plug was washed with ethyl ether (3.0 mL) and the
combined filtrate was concentrated to give a pale yellow oil.  Purification by
chromatography on SiO2 (10% acetone/hexanes) afforded 67 (38.6 mg, 97%) as a clear
colorless oil:  Rf 0.27 (10% acetone/hexanes, twofold developed); [α]D +3.6 (c 1.34,
CHCl3, 22 °C); 
1H NMR δ 7.31-7.18 (m, 5 H), 6.98 (d, 1 H, J = 11.2 Hz), 5.90 (d, 1 H, J =
11.2 Hz), 4.56-4.46 (m, 1 H), 4.17 (app t, 1 H, J = 8.8 Hz), 3.99 (app t, 1 H, J = 7.8 Hz),
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3.22 (dd, 1 H, J = 13.6, 4.9 Hz), 2.64 (dd, 1 H, J = 13.6, 9.2 Hz), 1.42 (s, 9 H); 13C NMR
δ 163.3, 138.7, 138.4, 129.4, 128.6, 126.5, 110.0, 71.4, 68.1, 44.4, 42.1, 30.9; IR (neat)
3083, 3060, 3026, 2961, 2940, 2926, 2898, 2864, 1950, 1875, 1803, 1637, 1582, 1378,
1366, 1184, 1167 cm-1; MS (EI) m/z (rel. intensity) 218 ([M-C4H9]
+, 100), 184 ([M-C7H7]
+,
22), 128 (81), 117 (53), 100 (22), 91 (53), 57 (37); HRMS (EI) m/z calcd for C12H12NOS
(M-C4H9) 218.0640, found 218.0636.
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thiophenol, 
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65 68
(4S)-4-Benzyl-2-(2,2-bisphenylsulfanylethyl)-4,5-dihydrooxazole (68).  To a
mixture of the oxazoline 65 (29.4 mg, 0.159 mmol, 1.0 equiv) and thiophenol (80 µL,
780 µmol, 4.9 equiv) in THF (1.0 mL) at rt was added anhydrous K2CO3 (24.0 mg, 174
µmol, 1.1 equiv) and 18-crown-6 (12.0 mg, 45 µmol, 0.3 equiv).  After stirring for 12 h at
rt, the mixture was diluted with ethyl ether (3.0 mL) and filtered through a plug of
Florisil/Celite (1:1 v/v).  The plug was washed with ethyl ether (3.0 mL) and the
combined filtrate was concentrated.  Purification of the residue by chromatography on
SiO2 (10% acetone/hexanes) afforded 68 (53.1 mg, 82%) as a clear colorless oil:  Rf
0.27 (10% acetone/hexanes, twofold developed); [α]D –14.7 (c 1.31, CHCl3, 22 °C); 
1H
NMR δ 7.54-7.50 (m, 4 H), 7.37-7.19 (m, 11 H), 4.80 (t, 1 H, J = 7.5 Hz), 4.43-4.33 (m, 1
H), 4.13 (app t, 1 H, J = 8.9 Hz), 3.94 (dd, 1 H, J = 8.4, 7.2 Hz), 3.11 (dd, 1 H, J = 13.7,
5.6 Hz), 2.81 (dd, 2 H, J = 7.6, 0.8 Hz), 2.65 (dd, 1 H, J = 13.7, 8.5 Hz); 13C NMR δ
164.4, 138.1, 133.6, 133.4, 133.2, 129.4, 129.1, 128.7, 128.3, 128.2, 126.6, 72.0, 67.6,
106
54.3, 41.9, 35.3; IR (neat) 3058, 3026, 3002, 2960, 2919, 2898, 1951, 1882, 1807, 1669,
1603, 1582 cm-1; MS (EI) m/z (rel. intensity) 405 (M+, 8), 296 ([M-C6H5S]
+, 67), 204 ([M-
C7H7-C6H5SH]
+, 100), 190 (22), 105 (66), 91 (54), 77 (36), 65 (21); HRMS (EI) m/z calcd
for C24H23NOS2 405.1221, found 405.1221.
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55a 69
2-(3-Bromoprop-1-ynyl)oxazole-4-carboxylic acid methyl ester (69).  A
solution of PPh3 (51.0 mg, 0.194 mmol, 1.4 equiv) in CH2Cl2 (0.5 mL) at rt was treated
with Br2 (10.0 µL, 0.195 mmol, 1.4 equiv).  A precipitate formed, and after 20 min the
mixture was treated with imidazole (12.0 mg, 0.176 mmol, 1.3 equiv).  The precipitate
dissolved to afford a clear, yellow solution, which was cooled to 0 °C and treated with
a solution 55a (25.0 mg, 0.138 mmol, 1.0 equiv) in CH2Cl2 (0.5 mL + 0.5 mL rinse).  The
mixture was stirred at 0 °C for 20 min, diluted with hexanes, warmed to rt, stirred for 5
min and then filtered through a plug of Florisil/Celite (1:1 v/v).  The plug was rinsed with
ethyl ether (5.0 mL) and the combined filtrate was concentrated to a clear, colorless oil
that solidified to a white solid under vacuum.  Purification by chromatography on SiO2
(20% ethyl acetate/hexanes) afforded 69 (32.1 mg, 95%) as a white, crystalline solid:
Rf 0.50 (40% ethyl acetate/hexanes); Mp 82.0-83.0 °C (CH2Cl2); 
1H NMR δ 8.21 (s, 1 H),
4.08 (s, 2 H), 3.92 (s, 3 H); 13C NMR δ 160.9, 146.2, 144.8, 134.4, 88.1, 73.0, 52.6, 12.3;
IR (KBr) 3157, 3093, 3003, 2952, 2240, 1744, 1553 cm-1; MS (EI) m/z (rel. intensity) 242
(M+, 9), 212 (4), 164 ([M-Br]+, 100); HRMS (EI) m/z calcd for C8H6NO3Br 242.9531, found
242.9524.
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69 71
2-(Propa-1,2-dienyl)oxazole-4-carboxylic acid methyl ester (71).  A mixture
of 69 (50.0 mg, 0.205 mmol, 1.0 equiv), K2CO3 (31.0 mg, 0.224 mmol, 1.1 equiv) and
18-crown-6 (5.4 mg, 0.02 mmol, 0.1 equiv) was suspended in THF (1.0 mL) at rt and
treated with diethyl phosphate (50.0 µL, 0.388 mmol, 1.9 equiv) and water (18.0 µL,
1.00 mmol, 4.9 equiv).  The mixture was vigorously stirred at rt for 2 h and then diluted
with ethyl ether (2.0 mL) and filtered through a plug of Florisil/Celite (1:1 v/v).  The plug
was rinsed with ethyl ether (5.0 mL) and the combined filtrate was concentrated to an
oily, white solid.  Purification by chromatography on SiO2 (20% to 40% ethyl
acetate/hexanes) afforded 71 (33.2 mg, 98%) as a white, crystalline solid: Rf 0.39 (40%
ethyl acetate/hexanes); Mp 114.1-115.4 °C (toluene); 1H NMR δ 8.16 (s, 1 H), 6.25 (t, 1
H, J = 6.8 Hz), 5.36 (d, 2 H, J = 6.8 Hz), 3.91 (s, 3 H); 13C NMR δ 213.2, 161.7, 158.9,
144.0, 134.5, 83.3, 81.1, 52.4; IR (KBr) 3409, 3140, 3077, 3022, 2993, 1963, 1929,
1713, 1578 cm-1; MS (EI) m/z (rel. intensity) 165 (M+, 47), 134 ([M-OCH3]
+, 32), 133 ([M-
HOCH3]
+, 100); HRMS (EI) m/z calcd for C8H7NO3 165.0426, found 165.0423.
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2.4.2.2. Conjugate Additions Under Acidic Conditions
N
O
MeO2C
H
N
O
MeO2C Cl N
O
MeO2C
Cl
LiCl
AcOH
+
37 (Z)-73a (E)-73a
(Z)-2-(2-Chlorovinyl)oxazole-4-carboxylic acid methyl ester [(Z)-73a] and 2-
(E)-(2-chlorovinyl)oxazole-4-carboxylic acid methyl ester [(E)-73a].  A mixture of 37
(25.0 mg, 165 µmol, 1.0 equiv) and lithium chloride (10.5 mg, 248 µmol, 1.5 equiv) in
glacial acetic acid (0.75 mL) was heated under N2 to 100 °C for 16 h, cooled to rt and
diluted with water.  The mixture was extracted with ethyl ether and the combined
organic layers were washed with 2.0 M aqueous NaOH until the washings had a pH>9,
washed with brine, dried (Na2SO4), filtered and concentrated.  
1H NMR analysis of the
residue indicated a (Z/E)-ratio of 1.3:1.0.  The residue was purified by chromatography
on SiO2 (5 to 10% acetone/hexanes) to afford (Z)-73a (11.2 mg, 36%) and (E)-73a (8.0
mg, 26%) as white solids.  (Z)-73a: Rf 0.40 (20% acetone/hexanes, twofold developed);
Mp 86.3-87.0 °C (CH2Cl2); 
1H NMR δ 8.27 (s, 1 H), 6.72, 6.67 (AB, 2 H, J = 8.4 Hz), 3.93
(s, 3 H); 13C NMR δ 161.6, 159.0, 143.9, 134.3, 127.0, 116.5, 52.5; IR (KBr) 3165, 3105,
3088, 3038, 2956, 2853, 1744, 1658, 1626, 1564, 1513, 1445 cm-1; MS (EI) m/z (rel.
intensity) 187 (M+, 60), 156 ([M-OCH3]
+, 33), 100 (100), 89 (34), 69 (39); HRMS (EI) m/z
calcd for C7H6NO3Cl 187.0036, found 187.0036; (E )-73a : Rf 0.50 (20%
acetone/hexanes, twofold developed); Mp 87.5-88.3 °C (CH2Cl2); 
1H NMR δ 8.17 (s, 1
H), 7.28 (d, 1 H, J = 13.7 Hz), 6.74 (d, 1 H, J = 13.7 Hz), 3.92 (s, 3 H); 13C NMR δ 161.5,
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159.2, 143.8, 134.5, 130.4, 119.4, 52.5; IR (KBr) 3152, 3113, 3086, 2961, 1731, 1716,
1619, 1573, 1556 cm-1; MS (EI) m/z (rel. intensity) 187 (M+, 63), 156 ([M-OCH3]
+, 36),
100 (100); HRMS (EI) m/z calcd for C7H6NO3Cl 187.0036, found 187.0023.
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37 (Z)-73b
(Z)-2-(2-Bromovinyl)oxazole-4-carboxylic acid methyl ester [(Z)-73b].  A
mixture of 37 (15.0 mg, 99 µmol, 1.0 equiv), lithium bromide (13.0 mg, 150 µmol, 1.5
equiv) and lithium acetate (29.5 mg, 447 mmol, 4.5 equiv) in glacial acetic acid (0.45
mL) was heated under N2 to 100 °C for 16 h, cooled to rt and diluted with ethyl acetate
(10 mL).  The mixture was washed with 2.0 M aqueous NaOH until the washings had a
pH>9, washed with saturated aqueous Na2S2O3 (5 mL) and brine (5 mL) and then dried
(Na2SO4), filtered and concentrated.  
1H NMR analysis of the residue indicated a
(Z/E/starting material)-ratio of 32:1.6:1.0.  The residue was purified by chromatography
on SiO2 (5 to 10% acetone/hexanes) to afford (Z)-73b (19.9 mg, 87%) as a white solid:
Rf 0.25 (10% acetone/hexanes, twofold developed); Mp 90.1-91.1 °C (CH2Cl2); 
1H NMR
δ 8.27 (s, 1 H), 7.14 (d, 1 H, J = 8.7 Hz), 6.89 (d, 1 H, J = 8.7 Hz), 3.90 (s, 3 H); 13C NMR
δ 161.5, 159.5, 143.7, 134.3, 119.7, 115.4, 52.5; IR (KBr) 3157, 3100, 3083, 3026, 2939,
1744, 1648  cm-1; MS (EI) m/z (rel. intensity) 233 (M+, 54), 231 (M+, 53), 202 ([M-OCH3]
+,
20), 200 ([M-OCH3]
+, 19), 174 ([M-OCOCH3]
+, 7), 172 ([M-OCOCH3]
+, 6), 146 (13), 144
(14), 135 (21), 133 (26), 100 (100), 69 (45), 64 (21), 59 (11); HRMS (EI) m/z calcd for
C7H6NO3Br 230.9531, found 230.9513.
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 2-(E)-(2-Bromovinyl)oxazole-4-carboxylic acid methyl ester [(E)-73b] .  A
mixture of (Z)-73b (20.0 mg, 86 µmol, 1.0 equiv) and sodium bromide (13.3 mg, 129
µmol, 1.5 equiv) in glacial acetic acid (0.37 mL) was heated under N2 to 100 °C for 16 h,
cooled to rt and diluted with ethyl acetate (10 mL).  The mixture was washed with 2.0
M aqueous NaOH until the washings had a pH>9, washed with saturated aqueous
Na2S2O3 (5 mL) and brine (5 mL) and then dried (Na2SO4), filtered and concentrated.  
1H
NMR analysis of the residue indicated a (Z/E)-ratio of 1.0:5.9.  The residue was purified
by chromatography on SiO2 (5% acetone/hexanes) affording (E)-73b (14.8 mg, 74%) as
a white solid: Rf 0.34 (10% acetone/hexanes, twofold developed); Mp 118.2-119.2 °C
(CH2Cl2); 
1H NMR δ 8.18 (s, 1 H), 7.48 (d, 1 H, J = 14.2 Hz),  7.02 (d, 1 H, J = 14.2 Hz),
3.93 (s, 3 H); 13C NMR δ 161.5, 159.9, 143.8, 134.5, 123.1, 118.8, 52.6; IR (KBr) 3152,
3113, 3084, 3012, 2960, 1728, 1710, 1608, 1572, 1556 cm-1; MS (EI) m/z (rel. intensity)
233 (M+, 8), 231 (M+, 8), 202 ([M-OCH3]
+, 10), 168 (100), 137 ([M-CH3-Br]
+, 34), 110 (84),
109 (37), 67 (57); HRMS (EI) m/z calcd for C7H6NO3Br 230.9531, found 230.9531.
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37 (Z)-73c
(Z)-2-(2-Iodovinyl)oxazole-4-carboxylic acid methyl ester [(Z) -73c] .  A
mixture of 37 (25.0 mg, 165 µmol, 1.0 equiv), sodium iodide (24.7 mg, 165 µmol, 1.0
equiv) and sodium acetate (40.7 mg, 496 µmol, 3.0 equiv) in glacial acetic acid (0.75
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mL) was heated under N2 to 100 °C for 12 h, then cooled to rt and diluted with ethyl
acetate (10 mL).  The organic layer was washed with 2.0 M aqueous NaOH until the
washings had a pH>9, washed with saturated Na2S2O3 (5.0 mL) and brine (5.0 mL).
The combined aqueous washings were backwashed with ethyl acetate (3.0 mL) and
the combined organic extracts were dried (Na2SO4), filtered and concentrated.  
1H NMR
analysis of the residue indicated a (Z/E)-ratio of >50:1.  Purification by chromatography
on SiO2 (5% to 10% acetone/hexanes) afforded (Z)-73c (42.2 mg, 92%) as a white
solid:  Rf 0.23 (10% acetone/hexanes, twofold developed); Mp 88.2-89.2 °C (CH2Cl2);
1H NMR δ 8.30 (s, 1 H), 7.54 (d, 1 H, J = 9.5 Hz), 7.24 (d, 1 H, J = 9.5 Hz), 3.93 (s, 3 H);
13C NMR δ 161.2, 160.2, 143.5, 134.3, 125.9, 87.1, 52.5; IR (KBr) 3161, 3121, 3061,
3008, 2956, 2911, 2845, 1741, 1719, 1629, 1575 cm-1; MS (EI) m/z (rel. intensity) 279
(M+, 100), 248 ([M-OCH3]
+, 14), 220 ([M-OCOCH3]
+, 4), 192 (10), 181 (24), 100 (37);
HRMS (EI) m/z calcd for C7H6NO3I 278.9392, found 278.9392.
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2-(2-(E)-Iodovinyl)oxazole-4-carboxylic acid methyl ester [(E)-73c] .  A
mixture of (Z)-73c (41.2 mg, 148 µmol, 1.0 equiv) and sodium iodide (66.6 mg, 444
µmol, 3.0 equiv) in glacial acetic acid (0.75 mL) was heated under N2 to 100 °C for 12 h,
then cooled to rt and diluted with ethyl acetate (10 mL).  The organic layer was washed
with 2.0 M aqueous NaOH until the washings had a pH>9, washed with saturated
Na2S2O3 (5.0 mL) and brine (5.0 mL).  The combined aqueous washings were
backwashed with ethyl acetate (3.0 mL) and the combined organic extracts were dried
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(Na2SO4), filtered and concentrated.  
1H NMR analysis of the residue indicated an (E/Z)-
ratio of 7.8:1.0.  Purification by chromatography on SiO2 (5% acetone/hexanes)
afforded (Z)-73c (2.6 mg, 6%) and (E)-73c (35.3 mg, 86%) as white solids.  (E)-73c: Rf
0.30 (10% acetone/hexanes, twofold developed); Mp 141.1-142.1 °C (CH2Cl2); 
1H NMR
δ 8.18 (s, 1 H), 7.68 (d, 1 H, J = 15.2 Hz), 7.33 (d, 1 H, J = 15.2 Hz), 3.92 (s, 3 H); 13C
NMR δ 161.5, 160.9, 143.9, 134.3, 130.3, 89.9, 52.5; IR (KBr) 3149, 3108, 3069, 3007,
2955, 1724, 1705, 1570, 1552 cm-1; MS (EI) m/z (rel. intensity) 279 (M+, 100), 248 ([M-
OCH3]
+, 20), 220 ([M-OCOCH3]
+, 6), 207 (21), 181 (24), 137 ([M-CH3I]
+, 48), 136 (66), 135
(74), 121 ([M-OCH3-I]
+, 22); HRMS (EI) m/z  calcd for C7H6NO3I 278.9392, found
278.9393.
(Z)-73c
TMS-acetylene,
CuI, Pd(OAc)2, PPh3,
i-Pr2NH
N
O
MeO2C
I
N
O
MeO2C
TMS
(Z)-74
(Z)-2-[4-(Trimethylsilyl)but-1-en-3-ynyl]oxazole-4-carboxylic acid methyl
ester [(Z)-74].  A mixture of (Z)-73c (20.0 mg, 72 µmol, 1.0 equiv), CuI (4.0 mg, 22
µmol, 0.3 equiv), Pd(OAc)2 (2.0 mg, 8 µmol, 0.1 equiv) and PPh3 (8.0 mg, 30 µmol, 0.4
equiv) was dissolved in i- P r2NH (0.5 mL) and cooled to 0 °C under N2.
Trimethylsilylacetylene (16.0 µL, 0.11 mmol, 1.6 equiv) was added.  The reaction
mixture was allowed to warm to room temperature and after 30 min, ethyl ether (2.0
mL) and water (2.0 mL) were added.  The mixture was poured into water (5.0 mL) and
extracted with ethyl ether.  The combined organic layers were washed with 1.0 M
aqueous citric acid (5.0 mL), water (5 mL) and brine (5 mL), dried (Na2SO4), filtered and
113
concentrated.  Purification of the residue by chromatography on SiO2 (10%
acetone/hexanes) afforded (Z)-74 (19.1 mg, 89%) as a white crystalline solid:  Rf 0.21
(20% ethyl ether/hexanes); Mp 51.2-51.9 °C (CH2Cl2); 
1H NMR δ 8.23 (s, 1 H), 6.63,
6.06 (AB, 2 H, J = 12.0 Hz), 3.93 (s, 3 H), 9.08 (s, 9 H); 13C NMR δ 161.7, 160.8, 143.6,
134.5, 124.0, 116.2, 106.9, 101.4, 52.5, -0.2; IR (KBr) 3178, 3040, 2959, 2900, 2142,
1721, 1616, 1577 cm-1; MS (EI) m/z (rel. intensity) 249 (M+, 27), 234 ([M-CH3]
+, 56), 204
([M-C3H9]
+, 67), 190 ([M-O2CCH3]
+, 100); HRMS (EI) m/z  calcd for C12H15NO3Si
249.0821, found 249.0812.
(E)-73c (E)-74
N
O
MeO2CTMS-acetylene,
CuI, Pd(OAc)2, PPh3,
i-Pr2NH
TMS
N
O
MeO2C
I
(E)-2-[4-(Trimethylsilyl)but-1-en-3-ynyl]oxazole-4-carboxylic acid methyl
ester [(E)-74].  A mixture of (E)-73c (10.0 mg, 36 µmol, 1.0 equiv), CuI (2.0 mg, 11
µmol, 0.3 equiv), Pd(OAc)2 (1.0 mg, 4 µmol, 0.1 equiv) and PPh3 (4.0 mg, 15 µmol, 0.4
equiv) was dissolved in i- P r2NH (0.5 mL) and cooled to 0 °C under N2.
Trimethylsilylacetylene (10.0 µL, 70 µmol, 2.0 equiv) was added.  The mixture was
allowed to warm to rt and after 30 min, ethyl ether (2.0 mL) and water (2.0 mL) were
added.  The mixture was poured into water (5.0 mL) and extracted with ethyl ether.
The combined organic layers were washed with 1.0 M aqueous citric acid (5.0 mL),
water (5 mL) and brine (5 mL), dried (Na2SO4), filtered and concentrated.  Purification of
the residue by chromatography on SiO2 (10% to 20% ethyl ether/hexanes) afforded (E)-
74 (8.1 mg, 90%) as a white crystalline solid:  Rf 0.25 (20% ethyl ether/hexanes); Mp
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109.1-109.9 °C (CH2Cl2); 
1H NMR δ 8.17 (s, 1 H), 6.75, 6.66 (AB, 2 H, J = 16.3 Hz), 3.92
(s, 3 H), 0.22 (s, 9 H); 13C NMR δ 161.6, 161.0, 144.0, 134.9, 125.8, 118.4, 104.0, 102.0,
52.5, -0.1; IR (KBr) 3156, 3110, 3055, 2957, 2177, 2127, 1713, 1567 cm-1; MS (EI) m/z
(rel. intensity) 249 (M+, 50), 234 ([M-CH3]
+, 100), 218 ([M-CH3O]
+, 17), 190 ([M-O2CCH3]
+,
27), 204 ([M-C3H9]
+, 20); HRMS (EI) m/z  calcd for C12H15NO3Si 249.0821, found
249.0822.
N
O
MeO2C
•
H
H
H
N
O
MeO2C
I
NaI, NaOAc,
AcOH
71 75
2-(2-Iodoallyl)oxazole-4-carboxylic acid methyl ester (75).  A mixture of 71
(14.2 mg, 0.086 mmol, 1.0 equiv), sodium iodide (13.0 mg, 0.087 mmol, 1.0 equiv) and
sodium acetate (23.0 mg, 0.280 mmol, 3.3 equiv) was dissolved in glacial AcOH (0.45
mL) and heated under N2 to 100 °C (oil bath temp) for 12 h, cooled to rt and diluted
with ethyl acetate (10 mL).  The mixture was washed with 2.0 N NaOH until the
washings were pH>9, and then with saturated aqueous Na2S2O3.  The combined
organic layers were backwashed with ethyl acetate and the combined organic layers
were dried (Na2SO4), filtered and concentrated to an orange-colored oil.  Purification by
chromatography on SiO2 (10% to 40% ethyl acetate/hexanes) afforded 75 (9.4 mg,
37%) as a clear, colorless oil:  Rf 0.40 (40% ethyl acetate/hexanes); 
1H NMR δ 8.22 (s, 1
H), 6.23 (d, 1 H, J = 1.7 Hz), 5.93 (d, 1 H, J = 1.8 Hz), 4.05 (s, 2 H), 3.92 (s, 3 H); 13C
NMR δ 161.7, 144.7, 133.8, 130.1, 98.9, 77.4, 52.5, 44.5; IR (neat) 3159, 3001, 2952,
2848, 1747, 1622, 1583 cm-1; MS (EI) m/z (rel. intensity) 293 (M+, 62), 262 ([M-OCH3]
+,
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14), 182 (34), 166 ([M-I]+, 79), 134 (100); HRMS (EI) m/z calcd for C8H8NO3I 292.9549,
found 292.9543.
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3. Synthesis of Disorazoles C1 and Analogs
3.1. Introduction
3.1.1. The Biology of the Disorazoles
The disorazoles are a group of 29 related macrodiolides isolated in 1994 by
Jansen and coworkers from the fermentation broth of the gliding bacterium Sorangium
cellulosum (strain So Ce 12).34  Common to all disorazoles is the dimeric or pseudo-
dimeric structure contained within a 30-membered macrodiolide, conjugated polyenes
that may be interrupted by oxiranes or diols, and a 1-hydroxy-2-butenyl side chain that
is linked through a gem-dimethyl unit (Figure 12).  The initial report only detailed the
connectivity of the atoms as determined by spectroscopic analysis.34  The relative and
absolute stereochemistry of disorazole A1 was assigned after degradation and
fragment synthesis studies.101  Figure 12 shows the structures of the eight most
abundant disorazoles and their abundance (%) relative to all disorazoles.  The eight
most common disorazoles comprise 92% by weight of all known disorazoles.  Notably,
disorazole A1 comprises 71% by weight of all disorazoles and was isolated in
multigram quantities from the fermentation broth.  The remaining 21 disorazoles were
isolated in less than 1% each.
117
Figure 12.  The structures of the eight most abundant disorazoles.
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Along with the disorazoles, several other compounds were isolated from
Sorangium cellulosum strain So Ce 12, including chivosazoles (anti-fungal),102
sorangiolid (bacteriacidal)103 and sorangicins (eubacterial RNA polymerase inhibitors)104
(Figure 13).105  The varied structures and biological activity demonstrate the diversity of
the secondary metabolites that the myxobacteria are capable of producing; in this
case, within just one strain of Sorangium cellulosum.  Notable are the disorazoles and
chivosazoles which incorporate serine residues in the form of oxazoles suggesting a
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combined biosynthesis by polyketide synthase (PKS) and non-ribosomal peptide
synthetases (NRPS).106  Additionally, the chivosazoles incorporate an appended sugar
moiety.  Sorangicin and sorangiolide are of purely polyketide origin.
Figure 13.  Compound classes isolated from Sorangium cellulosum Strain So ce 12.
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Sorangium cellulosum is a member of the myxobacteria.  The myxobacteria are
prolific producers of secondary metabolites that have a wide range of biological
acitvity.107  A small subset of these secondary metabolites, including the epothilones,108
tubulysins109 and disorazoles,34 are highly cytotoxic and are known to perturb
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microtubules (Figure 14).  Epothilones stabilize microtubules in a manner similar to
taxol and will displace taxol from the binding site on microtubules.110  In contrast,
tubulysins and disorazoles inhibit tubulin polymerization and therefore have a chemical
phenotype more closely related to the vinca alkaloids.111,112  Both tubulysins and
disorazoles are more potent inhibitors of cell proliferation than the epothilones, taxol
and vinblastin.109,111
Figure 14.  Myxobacterium metabolites that affect tubulin polymerization.
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Initial studies indicated that disorazole A1 demonstrates potent cell growth
inhibition with an IC50 value of 3 pg/mL in L-929 mouse fibroblasts.
34b  Additional
studies suggest that disorazole A1 initiates the decay of microtubules, causes G2/M
cell cycle arrest and competes in vitro with vinblastin for the tubulin binding site.113  The
extreme potency of the disorazoles has attracted the interest of researchers who are
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working to understand how the disorazoles disrupt cellular networks.  No synthetic
route to the disorazoles existed until 2004,114 so the biological studies focused on the
major metabolite, disorazole A1, which is available in multigram quantities by
fermentation.34
Recently, Sasse and coworkers reported the results of their biological studies
with disorazole A1.
111  The antiproliferative effects of disorazole across a variety of
animal and human cell lines ranged from 2 to 42 pM.  This antiproliferative activity
corresponds to 10 to 1000 times greater potency than epothilone B or vinblastin.
Disorazole A1 caused G2/M-phase cell cycle arrest and induced nuclei enlargement as
well as multinucleation and increased the population of hyperploid cells.  Interestingly,
while signs of apoptosis where evident, many cells maintained full metabolic activity for
extended periods of time.  Importantly, disorazole A1 was also found to be a poor
substrate for multi-drug resistant cells expressing high levels of P-glycoprotein (PGP).
MDR1 PGP is responsible for pumping toxins out of cells and leads to decreased
efficacy of anti-cancer pharmaceuticals.115  There was a discrepancy between the in
vitro tubulin polymerization experiments, where disorazole A1 was comparable to
vinblastin and whole-cell assays, where disorazole A1 demonstrated three orders of
magnitude higher efficacy.  In addition, even short treatments (5 h) led to irreversible
effects.  The discrepancy between the in vitro and whole-cell assays may suggest that
disorazole A1 is being accumulated and strongly bound within the cell, a result that has
important therapeutic consequences.111
Two groups have focused on understanding the genetic control of disorazole
biosynthesis.116,117  Both groups presented a similar model for the biosynthesis of the
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disorazoles and the hypothesis of Müller and coworkers116 will be discussed with some
additional information from the work of Julien and coworkers.117  Transposon libraries
were used to identify the gene clusters that govern the biosynthesis of the disorazoles
(Figure 15).  Four genes, Dis A through Dis D, were found.  Three of the genes, Dis A,
Dis B and Dis C, are responsible for ten polyketide synthase (PKS) modules and one
non-ribosomal peptide synthetase (NRPS) module.  Modules 1 through 7 and the
NRPS module assemble the seven acetate and one serine residues that constitute the
disorazole monomer.118  Module 1 is responsible for the loading and construction of the
2-butenoyl ACP1 thioester.  A loading domain for Dis A could not be identified, so some
details of module 1 are still unknown.116  Julien and coworkers suggested that the
module 1 KS could be directly loaded by acetyl-CoA, module 1 could be loaded by a
process termed “backloading” or module 1 could be loaded by an ACP that is outside
of the 10 kb areas on each side of the PKS genes that were sequenced.117  Module 2
contains the keto-reductase that is responsible for the C16-stereocenter and the S-
adenosylmethionine (SAM)-dependent methyl transferase (MT3) that introduces the
gem-dimethyl substitution at C15 of the disorazole monomer.  The presence of two MT
domains in module 2 indicates that the gem-dimethyl groups are introduced under a
different mechanism from the gem-dimethyls in the epothilones.117,119  In addition,
ACP2b is likely to be inactive due to an absence of a critical serine residue.
117  Module 3
is a standard acetate extension module and is the final complete PKS module encoded
by the Dis A gene.  Module 4 is split between Dis A and Dis B and constructs a second
unit of unsaturation in the disorazole monomer.  Modules 5 through 7 are similar to
module 4 and result in the completed tetraene bound to ACP7.  Müller and coworkers
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suggest that the incorporation of the unusual (Z)-olefins in the tetraene results from the
elimination of an L-configured alcohol.116  Conserved domains found in KR2, KR4, KR5
and KR7 are believed to be responsible for the incorporation of L-configured alcohols
during biosynthesis.  The product of module 7 is then transferred via module 8 to the
NRPS, a process that is governed by the Dis C gene.  The HC1a and HC1b domains of
the NRPS module are responsible for the introduction and cyclization of a serine
residue.  Oxidation of the oxazoline to the oxazole is performed by the Ox1 domain of
the NRPS module and affords the completed disorazole monomer bound to PCP1.  Dis
C also encodes modules 9 and 10, both of which Müller and coworkers suggest are
inactive.116  Dis D encodes the only acyl transferase (AT) domain as well as an
oxidoreductase (Or) domain.  The exact function of Dis D in the synthesis of the
disorazoles is not known.
Julien and coworkers speculated on the functions of modules 8, 9 and 10.117,120
The non-extending modules may transfer the polyketide chains between proteins or
function in other protein-protein interactions.  An alternative explanation for the non-
extending modules is to mediate the polyketide transfer between the NRPS and a PKS
module and may be related to the incorporation of the serine residue.  The steps that
lead to the macrocyclic structure of the disorazoles could not be identified from the
analysis of the regions bordering the Dis A to Dis D.116,117  Julien and coworkers
suggest that vicinal thioesterase (TE) and carrier protein (CP) domains in the non-
extending modules cooperate to afford the completed dimer (Figure 16).117  The
hypothesis encompasses the formation of the “ring-expanded” disorazoles (G1, G2,
G3)
34 by acylation of the C16/C16’ hydroxyls instead of the C14/C14’ positions.
117
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An interesting proposal concerning the formation of pseudodimers such as
disorazole A1 was put forth by Julien and coworkers (Figure 16).
117  The β -
hydroxydehydratase (DH) domain of module 7 may function with 50% efficiency,
leading to monomer units containing a C6-hydroxyl substituent rather than the (Z)-
alkene.  Subsequent C14/C14’ acylation reactions afford the pseudodimer.  Alternatively,
the synthesis of a common dimer that is modified by unknown processes to afford the
pseudo-dimers could not be ruled out.  Subsequent methylation of the C6-hydroxyl
affords the southern segment of disorazole A1.
The steps that lead to the 29 disorazole derivatives could not be accounted for
by Müller’s or Julien’s genetic analyses.  The introduction of oxirane, hydroxyl and
methoxy substituents found in many of the disorazoles is believed to occur after the
PKS/NRPS assembly, but any genes responsible for these transformations were not
identified by either group.  Further refinement in the genetic analysis will be required to
attain a complete understanding of the biosynthetic pathways that are responsible for
the  formation of the disorazoles.
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Figure 15.  Müller’s model for the biosynthesis of the disorazoles.116
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Figure 16.  Julien's hypothesis for the dimerization of the disorazole monomers.117
xCP
O
S
N
O
OH
OHOH
Me Me
Me
TE
O
O
N
O
Me Me
OHOH
Me
xCP
HS
TE
O
O
N
O
Me Me
OOH
Me
O N
O
HO
OH
Me Me
OH
Me
post-NRPS
modules
post-NRPS
modules
disorazole A1
Me
HO O
Me Me
OMe
O
NO
N
O
O O
O
OH
Me
MeMe
Me
HO O
Me Me
OH
O
NO
N
O
O
O
OH
Me
MeMe
disorazole F2
post-PKS
modifications
14'16'
14'16'
1416
1614
6
6
126
3.1.2. Disorazole C1: An Important Minor Metabolite
Disorazole C1 (76) is a minor metabolite but it is interesting from a synthetic
stand point because it is a dimer, and thus the synthesis of a monomer leads to a
convergent synthesis of the final compound (Figure 17).  In addition, the monomer unit
of disorazole C1 is found in 17 of the 29 disorazoles, so a successful synthesis of
disorazole C1 can be extended to the synthesis of other disorazoles.  Disorazole C1
lacks the potentially labile divinyl oxiranes and tetraenes that are common in the more
abundant members of the family, allowing for a more facile synthesis and improving its
potential for therapeutic uses.  It could be suggested, however, that the extreme
potency of the disorazoles is dependent on the divinyl oxiranes found in the more
abundant members of the family (Figure 12).  A hypothesis linking the activity to the
divinyl oxiranes can be tested by making a disorazole that lacks the oxirane and
evaluating its biological activity.121
Figure 17.  The structure of the minor metabolite, disorazole C1.
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3.1.3. Prior Synthetic Efforts
3.1.3.1. Meyers’ Approach to Disorazole C1
The Meyers group was first to attempt a synthesis of any member of the
disorazole class.122  Disorazole C1 was chosen as a target because it lacks the
potentially labile divinyl oxirane and tetraene moities and has a monomer unit that is
common in 17 of the 29 disorazole (Figure 18).  Only the gross structure of the
disorazoles was known when the Meyers group began their studies, so a successful
total synthesis would also define the relative and absolute stereochemistry.  The
configurations at the C6/C6’, C14/C14’ and C16/C16’ stereogenic centers were arbitrarily
chosen at the outset.  Retrosynthetically, Meyers and coworkers took advantage of the
dimeric structure of disorazole C1, separating at the oxazole esters to afford the
monomer methyl ester 77.  Disconnection between the C10-C11 bond afforded
fragments 78 and 79.  A Stille reaction between 78 and 79 was envisioned to afford the
potentially labile triene in a highly convergent strategy.
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Figure 18.  Meyers’ original retrosynthetic analysis of disorazole C1.
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Meyers and coworkers proceeded to synthesize 78 and 79  (vide infra) .122
Subsequent Stille cross-coupling using catalytic Pd(CH3CN)2Cl2 in DMF afforded 76%
yield of a material which 1H NMR analysis revealed to be similar to the natural product
76, however, the triene tended to isomerize even during storage at –20 °C.  Attempts to
form the dimer by double lactonization were unsuccessful.  The sensitivity of the triene
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unit towards isomerization required the development of a revised strategy involving a
masked triene unit.
The revised strategy for the synthesis of disorazole C1 incorporated an alkyne to
mask the C11-C12 (Z )-alkene (Figure 19).
123  Late stage reduction of the alkyne to the
alkene would afford the sensitive triene.  The incorporation of the alkyne allows for a
disconnection at the C10-C12 bond, affording oxazole fragment 79 and alkyne fragment
81.  A Sonogashira cross-coupling99 reaction between 79 and 81 was envisioned to
afford the masked triene in a highly convergent strategy.
The synthesis of the oxazole fragment 79 began with the L-malic acid derivative
8 2  (Scheme 27).  The condensation of 82  and L-serine methyl ester using
carbodiimidazole afforded the hydroxyamide in 67% yield.  The hydroxyamide was
cyclized with DAST and oxidized to afford oxazole 83 in 79% yield for the 2 steps.
Protecting group manipulations were then required to selectively install the methyl
ether.  Consequently, removal of the acetal from 83 under acidic conditions afforded
the diol in greater than 95% yield.  Selective protection of the primary hydroxyl as the
TIPS ether afforded 84 in 76% yield and the secondary hydroxyl was transformed to
the methyl ether in 71% yield using MeI and silver(I) oxide.  Removal of the TIPS group
afforded 85 in 89% yield.  The primary hydroxyl of 85 was then transformed in 45%
yield into the dienal by oxidation to the aldehyde and Wittig homologation.  A second
homologation under the Stork-Zhao conditions124 afforded the dienyliodide 79 in 76%
yield.  The oxazole segment 79 was completed in 10 steps and 8% overall yield.
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Figure 19.  Meyers’ revised retrosynthetic analysis of disorazole C1.
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Scheme 27.  Meyers’ synthesis of the oxazole segment.
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Attention was then turned towards the alkyne 81, beginning with Kiyooka’s
modification of the Mukaiyama aldol reaction (Scheme 28).125  Condensation of meth-
acrolein (86) and silylenol ether 87 under the influence of the catalyst generated in situ
from N-tosyl-L-valine and borane•THF complex afforded the aldol product 88 in 85%
yield and 92% ee.  Subjecting the mixed acetal 88 to Horner-Wadsworth-Emmons
conditions triggered the silyl migration that unveiled the latent aldehyde which
subsequently condensed with the diethyl phosphonoacetate ethyl ester to afford 89 in
72% yield.  Meyers and Hillier found in a separate study that unsaturated aldehydes
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and the gem-dimethyl substitution are required for this interesting tandem reaction to
proceed.126
Diisobutylaluminum hydride reduction of the α,β-unsaturated ester 89 afforded
the allylic alcohol in 85% yield.  The second required stereocenter (C14) was set in 94%
yield and a diastereomeric ratio of 14:1 by Sharpless asymmetric epoxidation of the
allylic alcohol to afford 90.  The oxirane was reduced with Red-Al in 77% yield to afford
the 1,3-diol as a single diastereomer, which was subsequently protected as the p-
methoxyphenyl acetal 91 in greater than 95% yield.  Selective opening to the acetal
using diisobutylaluminum hydride afforded the primary alcohol in 90% yield and
oxidation to aldehyde 92 with Dess-Martin periodinane17 occurred in 90% yield.  One
carbon homologation using the Stork-Zhao conditions124 and DDQ removal of the PMB
ether afforded in 78% and 86% yield, respectively, the vinyl iodide 93.127  Elimination of
the vinyl iodide using NaHMDS afforded the homopropargylic alcohol 81 in 93% yield.
Interestingly, the elimination only occurred in the presence of the hydroxyl group and
did not occur with the PMB-protected precursor.  The alkyne 81 was constructed in 11
steps and 18% overall yield.
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Scheme 28.  Meyers’ synthesis of the diol segment.
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Meyers and coworkers attempted to form the macrocycle using a potentially
efficient dimerization of two monomer units constructed from the oxazole fragment 79
and the alkyne fragment 81 (Scheme 29).  Sonogashira cross-coupling99 of 79 and 81
afforded the masked monomer unit 94 in 87% yield.  Saponification with LiOH and
subsequent cyclization of the hydroxyacid with dipyridylthionocarbonate (DPTC) and
134
catalytic DMAP afforded the cyclomonomer 95 in 46% with no amounts of the dimer
being isolated.  Deprotection of 95 with HF•pyr afforded a 3:1 mixture of 96 and the
acyl transfer (ring expanded) product from which the major product 96 was crystallized
in 45% yield.
Scheme 29.  Attempted dimerization of the monomer.
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The attempt to efficiently form the dimer from the monomer hydroxyacid was
unsuccessful, so an alternative strategy involving a stepwise construction of the
macrocycle was pursued (Scheme 30).  Protection of the C14-hydroxyl as the TES-ether
135
occurred in 69% yield.  Saponification and condensation with 94 using DPTC and
DMAP afforded the protected seco-acid methyl ester 97 in 65% yield for the two steps.
Removal of the TES group under acidic conditions and saponification of the methyl
ester afforded the seco-acid which was cyclized under Yamaguchi conditions128 to
afford the macrocyclic dimer 80 in 24% yield.  The formation of 80 was accompanied
by significant transesterification as indicated by the isolation of the cyclomonomer 95
in 76% yield.  Attempts to install the triene unit by reduction of the triple bonds in 80 to
afford the trienes were unsuccessful.
Meyers and coworkers pioneered the synthesis of disorazole C1, and although
they were unsuccessful in completing the task, significant knowledge concerning the
idiosyncrasies of the disorazoles was gained and documented.  Several points are
noteworthy.  First, the triene unit of the monomer was found to be unstable and placing
the alkyne at the C11-12-position of the monomer prevented isomerization of the
remaining diene.  Second, cyclomonomer formation was a significant side reaction.
Third, late stage intermediates appeared to be unstable towards strongly acidic or
basic conditions.  Fourth, silyl and acyl transfers between the C14- and C16-oxygens
occurred with various intermediates.  All of these findings were considered when the
synthesis of disorazole C1 was devised (Section 3.2.1).
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Scheme 30.  Stepwise synthesis of the dimer.
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3.1.3.2. Hoffmann’s Approach to Disorazole C1
Hoffmann and coworkers, incorporating the findings of Meyers and coworkers,
also utilized an alkyne to mask one of the (Z)-alkenes of the triene unit (Figure 20).129
Preliminary computational estimates suggested that masking the C9-10-alkene would
inhibit the formation of the cyclomonomer that was observed by Meyers.  Hoffmann
also disconnected at the oxazole esters to afford monomer 98.  The monomer was
further disconnected at the alkene and alkyne to afford fragments 99 and 100.
Hoffmann and coworkers had the additional advantage of knowing the relative and
absolute stereochemical configurations of the disorazoles, based on degradation
studies performed by Höfle.101
Synthesis of the oxazole fragment 99 began with the Keck allylation130 of
aldehyde 101 to afford homoallylic alcohol 102 in 84% yield and greater than 94% ee.
The hydroxyl was converted to the methyl ether in 94% yield.  Ozonolysis of the alkene
and subsequent oxidation to the carboxylic acid 103 occurred in 86% and 98% yield,
respectively.  Acid 103 was then coupled to serine methyl ester using the mixed
anhydride method to afford the hydroxy amide in 71% yield.  Cyclization of the
hydroxyamide using DAST and oxidation to the oxazole using BrCCl3 and DBU
occurred in 79% yield for the two steps.13  The benzyl ether was cleaved by
hydrogenation in 97% yield and the resulting primary alcohol was oxidized to the
aldehyde 105 in 75% yields.  The enyne was installed by Wittig olefination in 49% yield
and modest (E/Z)-selectivity.  Finally, removal of the trimethylsilyl group with basic
methanol afforded the terminal alkyne 100 as an inseparable mixture of (E/Z)-isomers.
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The oxazole segment was completed in 11 steps and 10% yield and was used as a
mixture of (E/Z)-isomers.
Figure 20.  Hoffmann's retrosynthetic analysis of the masked monomer unit.
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Scheme 31.  Hoffmann's synthesis of the oxazole segment.
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The synthesis of the diol segment was initiated in a similar manner to Meyers’
synthesis, relying on Kiyooka’s Mukaiyama aldol methodology125 to convert aldehyde
106 to 108 in 96% yield and 88% ee. TBS-protection of 108 was nearly quantitative.
Reduction of the ester to the alcohol with DiBAl-H and oxidation using Dess-Martin
periodinane17 afforded the aldehyde 109.  Addition of trans-propenyl lithium to 109
afforded a nearly quantitative yield of 110a and 110b in nearly equivalent amounts.
The 1,3-anti-diastereomer 110a was then protected as the SEM ether and the PMB
group was removed with DDQ to afford 111 in 98% yield for the two steps.  Finally,
Parikh-Doering oxidation131 and homologation using the Stork-Zhao conditions124
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afforded the completed diol segment 99.  This segment was completed in a total of 9
steps and 22% overall yield.
Scheme 32.  Hoffmann's synthesis of the diol segment.
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Construction of monomer 98 was accomplished using Sonogashira conditions99
to couple 99 and 100 in 58% yield (Scheme 33).  A significant amount of the vinyl
iodide 99 was recovered.  Efforts concerning the further conversion of 98 to the dimer
have not been reported.
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Scheme 33.  Completion of the masked monomer unit.
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In a later publication, Hoffmann and coworkers detailed their efforts towards
setting the C16-stereocenter
132 of 110 by reduction of the corresponding ketone 112
(Table 10).133  Luche conditions using LiBH4 and CeCl3•7 H2O afforded a 58% yield of a
mixture of the allylic alcohols, favoring the undesired syn-diastereomer (entry 1).  The
product of a 1,4-reduction was also isolated in 24% yield.  The application of the chiral
(R)-methyl-CBS-oxazaborolidine134 reagent afforded the allylic alcohols in 78% yield
and favored the undesired syn-diastereomer by greater than 10:1 (entry 2).  The
product of 1,4-reduction was isolated in 17% yield.  Interestingly, the (S)-methyl-CBS-
oxazaborolidine reagent134 afforded only 1,4-reduction product.  Reduction using the
Terashima reagent135 afforded only the product of 1,4-reduction in 84% yield.  Other
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reagents including L-Selectride, lithium aluminum hydride, lithium triethyl borohydride
and zinc borohydride/CeCl3•7 H2O afforded 1,4-reduction products.
Table 10.  Diastereoselective reduction of the (S)-enantiomer.
OTBS
Me Me
OH
Me OPMB
OTBS
Me Me
O
OPMBMe
conditions
112 110
Entry Reducing Conditionsa syn/anti Yield (%) Comment
1 LiBH4, CeCl3•7 H2O, MeOH 1.6 / 1.0 58% 24%, 1,4-reduction
2 (S)-Me-CBS (2.1 equiv),
BH3•DMS (5.0 equiv)
10.8 / 1.0 78% 17%, 1,4-reduction
3 Terashima reagent - - 84%, 1,4-reduction
a L-Selectride, LiAlH4, LiHBEt3, Zn(BH4)2/CeCl3•7 H2O and (R)-Me-CBS afforded the 1,4-reduction
product.
The odd behavior of the CBS-oxazaborolidine was further explored using the
opposite enantiomer ent-112 (Scheme 34).  Reduction of ent-112 using (S)-methyl-
CBS-oxazaborolidine134 afforded 72% of the allylic alcohol ent-110 favoring the 1,3-
anti-isomer.  The 1,4-reduction product was isolated in 18% yield.  The results suggest
that significant match-mismatch pairing may be occurring in the transitions state
leading to the allylic alcohols.
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Scheme 34.  Diastereoselective reduction of the (R)-enantiomer.
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Reduction of the propargyl ketone 114 was explored as an alternative to the
reductions outlined above.  The addition of propynyl magnesium bromide to aldehyde
113 afforded the propargylic alcohol in 99% yield with no syn/anti-selectivity (Scheme
35).  Oxidation of the mixture afforded the ketone 114 in 99% yield.
Scheme 35.  Propynyl magnesium bromide addition to the C16-aldehyde.
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A variety of conditions were screened for the diastereoselective reduction of the
propargylic ketone 114 (Table 11).  Luche reduction afforded the propargylic alcohol
115 in 94% yield, but the selectivity was poor (entry 1).  Reduction with (S)-Me-CBS-
oxazaborolidine134 and borane-dimethylsulfide complex afforded a moderate yield of
115, favoring the undesired 1,3-syn-relationship and a significant amount of 114 was
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recovered (entry 2).  Similar conditions using catecholborane as the stoichiometric
reductant again favored the undesired syn-diastereomer to a lesser extent with slightly
increased yield and significant amounts of recovered 114 (entry 3).  Likewise, the
Terashima reagent135 afforded the undesired syn-diastereomer in 82% yield.
Table 11.  Diastereoselective reductions of the propargylic ketone.
OTBS
Me Me
O
OBn
Me
OTBS
Me Me
OH
OBn
Me
conditions
114 115
Entry Reducing Conditions Yield (%) syn/antia
1 LiBH4, CeCl3•7 H2O
b 94 1.0 / 1.5
2 (S)-Me-CBS (0.5 equiv), BH3•DMS (1.0 equiv) 58
b 5.3 / 1.0
3 (S)-Me-CBS (1.0 equiv), catechol borane (2.0 equiv) 66c 1.7 / 1.0
4 Terashima reagent (2.1 equiv) 82 2.0 / 1.0
a Determined by 1H NMR analysis.  b Starting material recovered (35%).  c Starting material recovered
(28%).
Unfortunately, attempts to reduce the propargyl alcohol anti-115 to the allylic
alcohol 116 using lithium aluminum hydride or Red-Al were unsuccessful (Scheme 36).
Scheme 36.  Attempted alkyne reduction.
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Following on the findings of Meyers and coworkers, Hoffmann and coworkers
demonstrated an alternative strategy for the synthesis of a masked monomer unit of
disorazole C1.  Importantly, masking of the C9-10-(Z )-alkene as an alkyne was
demonstrated to be a viable route to the monomer unit although the potential of the
alkyne to inhibit cyclomonomer formation was not demonstrated.  Additionally, the
challenges of stereoselectively installing the propenyl side-chain were demonstrated.
In common with the Meyers route, Hoffmann used the masked triene unit as an
important disconnection point, allowing for a convergent synthesis.
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3.2. Synthesis of Disorazole C1
3.2.1. Retrosynthetic Analysis
Disorazole C1 (76) was chosen as a target for the reasons mentioned earlier
(Section 3.1.2).  In addition, the pioneering work of Meyers and Hoffmann offered
insight into the challenges that exist in executing a synthesis of this complex molecule.
A highly convergent route to disorazole C1 was developed with special consideration
given to the known sensitivity of the late stage intermediates (Figure 20).114
Retrosynthetically, the dimer was separated into four segments that could be
assembled under mild reaction conditions with minimal protecting group
manipulations.  An obvious disconnection is at the oxazole esters and in the synthetic
direction would allow the macrocycle to be formed via a Yamaguchi
macrolactonization.128  Given the known sensitivity of the triene unit of the monomer
towards isomerization, one of the (Z)-alkenes of the triene unit was masked as an
alkyne (117) and the complete triene would only be revealed once the dimer was
formed.  The required dienyne (117) offered an opportunity to disconnect between the
alkene and the alkyne, leading to the advanced intermediates 118 and 119, which in
the synthetic direction would be connected with a mild Sonogashira cross-coupling.99
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Figure 21.  Retrosynthetic analysis of disorazole C1.
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3.2.2. Synthesis of the Diol Segment
3.2.2.1. Preliminary Attempts at Setting the C16-Stereocenter
While the successful synthesis of disorazole C1 involved an entry into the
enantiomeric series by setting the C14-stereocenter
132 with an asymmetric allylation,
preliminary synthetic studies explored setting the C16-stereocenter by using an
asymmetric vinyl zinc addition (Figure 22).136  Retrosynthetically, the diol fragment 118
is derived from allylic alcohol 120 which is derived from vinyl zinc 121 and aldehyde
122.
Figure 22.  Initial retrosynthesis of the diol segment.
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Model systems were constructed to evaluate the efficiency of the vinyl zinc
additions (Scheme 37).  Synthesis of the known aldehydes 122a137 and 122b138
commenced with the monoprotection of 2,2-dimethylpropane-1,3-diol to afford the
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known protected diols 124a137 and 124b138 in 81% and 78% yield, respectively.
Oxidation with NaOCl and catalytic TEMPO66 afforded the corresponding aldehydes
122a in 88% yield and 122b in 71% yield.
Scheme 37.  Synthesis of the model systems for the vinyl zinc additions.
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Table 12.  Model study for setting the C16-stereocenter.
OR
Me Me
O
H
OR
Me Me
OH
Me
Me ZnMe
Me
Cp2ZrHCl,
CH2Cl2,
then
Me2Zn
SH
Me
NMe2
122a, R = PMB
122b, R = TBDPS
124a, R = PMB
124b, R = TBDPS
123
toluene
16
Entry Aldehyde Ligand 123 (equiv) Temp/ Time Yield 124 (%) ee (%)
1 122a - 0 °C, 1 h; rt, 3 h 76 0
2 122a 0.25 -14 °C, 18 h 19a 24
3 122b 0.20 0 °C, 6.5 h 87 33
4 122b 0.20 -14 °C, 18 h 75 32
a Aldehyde recovered in 49% yield.
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Initial studies focused on the model system containing the p-methoxy-
benzylether (122a) (Table 12).  Hydrozirconation of a solution of propyne gas in CH2Cl2
followed by a solvent exchange to toluene and addition of the aldehyde afforded the
corresponding racemic allylic alcohol 124a in 76% yield.  The standard asymmetric
conditions employing ligand 123 afforded the allylic alcohol 124a in 19% yield and
24% ee with 49% of the aldehyde recovered.  Performing the asymmetric reaction at
higher temperatures could improve the conversion; however, the enantioselectivity was
not expected to improve.  The PMB protecting group was suspected to be problematic
due to the ability of this group to form chelates.  The model system containing the
TBDPS ether (122b) afforded the corresponding allylic alcohol 124b in 87% yield with a
marginal improvement in the enantioselectivity (Table 4, entry 3).  Performing the
reaction at lower temperatures afforded 124b  in decreased yield and similar
enantioselectivity.  Based on the model studies, the asymmetric vinyl zinc addition
proved to be inadequate for the present application, so the focus was shifted towards
the introduction of the C14-stereocenter.
3.2.2.2. Successful Synthesis of the Diol Segment
The focus of gaining access to the required enantiomeric series shifted to the
possibility of setting the C14-stereocenter, thus rendering the bond forming event at the
C16-stereocenter diastereoselective (Scheme 38).  The homoallylic alcohol 125 was
obtained in 91% yield and 92% ee using Carreira’s methodology139 for the addition of
allyltrimethylsilane to the corresponding aldehyde under the influence of the catalyst
formed in situ from TiF4 and (S)-BINOL.  The terminal olefin of 125 was then converted
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to the alcohol in 88% yield by cleavage with ozone using Sudan III140 as an indicator,
followed by in situ reduction with NaBH4.
141  The resulting 1,3-diol was converted to the
acetonide in 97% yield by exposure to 2,2-dimethoxypropane and PPTS in THF.  The
naphthoyl group was removed with aqueous LiOH to afford the protected triol 126 in
82% yield.  Oxidation of 126 under Swern conditions63 afforded the known aldehyde
127,142 which was treated with 1-lithiopropyne and dimethylaluminum chloride to afford
a mixture of diastereomers 128a and 128b in 56% and 29% yield, respectively, after
separation by chromatography on triethylamine-deactivated silica gel.  Reduction of
128a using Red-Al in THF initially gave the corresponding allylic alcohol 129a in 68%
yield.  The yield of the alkyne reduction was improved to 83% by rigorously degassing
the THF, prior to the introduction of Red-Al.143  Alternatively, propenyl lithium can be
added to aldehyde 127 to directly afford a mixture of 129a and 129b.  The propenyl
lithium addition directly affords the desired allylic alcohol, however, the separation of
the diastereomers was more difficult due to the poorer resolution during silica gel
chromatography.  Further efforts towards improving the diastereoselectivity of the
addition to aldehyde 127 will be discussed in Section 3.2.2.4.
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Scheme 38.  Synthesis of the diol segment.
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The relative stereochemistry of 128a and 128b was determined by 13C NMR
analysis of the frame-shifted acetonides (Scheme 39).144  Acetonides 128a and 128b
were converted to the corresponding triols under acidic conditions.  The resulting triols
were selectively acylated on the primary alcohol and converted to 130a and 130b in
64% and 45% yield, respectively, over three steps.  The relative stereochemistry of
each 1,3-dioxolane was subsequently determined by 13C NMR analysis to give the
assignments shown in Scheme 39.144  The acetonide 130a  has both C2-methyl
substituents (acetonide numbering) resonating near 25 ppm and a C2-quaternary
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carbon resonating at greater than 100 ppm.  According to the studies of Rychnovsky
and Evans,144 these characteristics correspond to the acetonide of a 1,3-anti-diol.
Acetonide 130b has one C2-methyl substituent resonating at less than 20 ppm and the
other C2-methyl substituent resonating near 30 ppm.  In addition, the C2-quaternary
carbon resonates at less than 100 ppm.  According to the studies of Rychnovsky and
Evans,144 these characteristics correspond to the acetonide of a 1,3-syn-diol.  Both
stereocenters of the diol fragment were installed and assigned.  The remaining steps
were directed towards installing the enyne.
Scheme 39.  Determination of the relative stereochemistry of the diol segment.
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With the stereocenters installed, standard manipulations afforded the completed
diol segment.  The allylic alcohol 129a was converted to the diol 131a by first
protecting the allylic hydroxyl as the p-methoxybenzyl ether using freshly distilled p-
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methoxybenzyl bromide145 with triethylamine and KHMDS in THF,146  followed by
removal of the acetonide with aqueous acetic acid in THF to afford 131a in 84% yield
for the two steps.  Similarly, the 3,4-dimethoxybenzyl ether derivative 131b was
obtained in 99% yield under analogous conditions using freshly prepared 3,4-
dimethoxybenzyl bromide,147 followed by removal of the acetonide.  Diols 131a and
131b are considered to be key intermediates, because the primary hydroxyl group
allows for a variety of transformations to be considered for the installation of the C11-12-
(Z)-alkene.  For the present synthesis, a Peterson olefination using Corey’s 1,3-bis-
(triisopropylsilyl)propyne148 was utilized.  The (Z)-enyne functionality was appended
using a four step sequence involving protection of both hydroxyl groups as triethylsilyl
ethers followed by selective oxidation under Swern conditions149 to afford the aldehyde
132a in 75% yield and aldehyde 132b in 86% yield for the two steps.  The resulting
aldehydes were converted to the enynes by exposure to lithiated 1,3-bis-
(triisopropyl)propyne148 followed by removal of the triethylsilyl ether with chloroacetic
acid in methanol.150  The (E/Z )-isomers were readily separated by column
chromatography on silica gel, affording (Z)-133a in 55% yield and (E)-133a in 7%
yield.151  The 3,4-dimethoxybenzyl derivative 132b afforded (Z)-133b and (E)-133b in
57% and 10% yield respectively.  Deprotection of (Z)-133a and (Z)-133b using TBAF in
THF afforded the completed diol fragments 118a and 118b in 94% and 85% yield,
respectively.
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Scheme 40.  Completion of the diol segment.
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3.2.2.3. A Comment on the C16-Hydroxyl Protecting Group
The choice of a PMB/DMB protecting group for the C16-hydroxyl at first seems
risky because of the propensity of allylic alcohol systems to undergo over-oxidation
during deprotection (Figure 23).152  In addition, the behavior of the conjugated dienyne
156
and the C6-allylic methoxy during the removal of a methoxybenzyl ether could not be
predicted.
Figure 23.  Deprotection of allylic PMB ethers can lead to over-oxidation.
PMBO
Me Me
Me
HO
Me Me
Me
DDQ
"deprotection"
O
Me Me
Me
DDQ
"over-oxidation"
Despite these potential complications, several additional considerations factored
into the choice of methoxybenzyl ethers as suitable protecting groups for the C16-
hydroxyl.  First, Meyers and coworkers suggested that late stage intermediates are
potentially labile under acidic or basic conditions.123  The C16-hydroxyl would be
deprotected late in the synthesis, so the required protecting group would need to be
removed under nearly neutral conditions.  The buffered (pH ≈ 7 ) conditions used
during DDQ mediated methoxybenzyl ether cleavage were appealing.  Second, the
sterically hindered environment of the alcohol must be considered for the deprotection.
During model studies, the environment around the C14-C16 diol system was found to be
sterically encumbered.  The aromatic system of the methoxybenzylether would be
expected to extend away from the system and therefore, the methoxybenzylether
would not suffer from an attenuation of reactivity induced by steric congestion.  Third,
Meyers and coworkers took advantage of the propensity for silyl groups to transfer
within the C14-C16 diol system during their studies (Scheme 28).
123,126  The propensity for
the oxygen to oxygen migration to occur unexpectedly during a synthetic sequence
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could not be predicted, so silyl groups were avoided.  Likewise, there is the potential
for acyl transfer to occur in the C14-C16 diol system.  Several “macrocycle expanded”
disorazoles are known, so the energetics of such a reaction may be favorable under the
correct conditions.  The complication of acyl transfer would most likely occur under
any strongly basic or acidic conditions used to deprotect the C16-hydroxyl.
153  Again,
DDQ under buffered conditions offered a mild and therefore attractive method for
deprotecting the C16-hydroxyl group.
3.2.2.4. Diastereoselective Additions to the C16-Aldehyde
Efforts towards improving the diastereoselectivity of the propynyl lithium
addition to the C16-aldehyde focused initially on additives (Table 13).  The addition of
trimethylaluminum154 to the lithium acetylide followed by introduction of aldehyde 126
led to a slight increase in the undesired diastereomer 128b relative to the desired
diastereomer 128a (entry 2) when performed with THF as a solvent.  Switching the
solvent to toluene afforded only the product of methyl addition (entry 3) while the
addition in toluene without any additive favored the formation of 128b (entry 4).  The
addition of ZnCl2 in THF resulted in decomposition (entry 5) and TMEDA favored the
formation of 128b (entry 6).  The organocerium reagent also favored 128b and the
conversion and yield were also poor (entry 7).  The use of diethylaluminum chloride and
dimethylaluminum chloride in ethyl ether afforded the only examples that were
selective for the diastereomer 128a (entries 9-14).  The dialkylaluminum chloride
reactions appeared to stall at –78 °C and warming to 0 °C or rt was required to
consume the aldehyde.  Extended reaction time (22h) at –55 °C using
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dimethylaluminum chloride gave a similar (128a/128b)-ratio and failed to completely
consume the aldehyde.  The reaction with dimethylaluminum chloride was quenched
after 6 h and 1H NMR analysis of the crude reaction product indicated 70% conversion
with a (128a/128b)-ratio of 2.3/1.0 (entry 15).  The results from entries 14 and 15
suggest that the reaction slows and becomes less selective over time, but further
experiments are required to elucidate the factors that influence rate and selectivity.
Diisobutylaluminum chloride afforded no selectivity (entry 16).
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Table 13.  Diastereoselective propynyl lithium additions to the C16-aldehyde.
OH
Me Me
O O
Me Me
Me
OH
Me Me
O O
Me Me
Me
O
Me Me
O O
Me Me
propyne, R-M
conditions
127 128a 128b
H
Entry R-M Solvent Additive Temp, Time Ratioa
128a/ b
Yield (%)b
128a, b
1 n-BuLi THF - -78 to 0 °C, 1.5 h 1.0/ 1.1 41, 44
2 MeLi THF Me3Al -78 to 0 °C, 3 h 1.0/ 1.5 34, 52
3 n-BuLi toluene Me3Al -78 °C to rt, 1.5 h - -
c
4 n-BuLi toluene - -78 to 0 °C, 1.5 h 1.0/ 1.4 35, 51
5 n-BuLi THF ZnCl2 -78 °C to rt, 12 h - -
d
6 n-BuLi THF TMEDA -78 to 0 °C, 1 h 1.0/1.2 30, 45
7 n-BuLi THF CeCl3 -78 °C to rt, 12 h 1.0/ 1.4
e 13, 15
8 MeLi ether - -78 to 0 °C, 3 h 1.0/ 1.3 38, 46
9f MeLi ether Et2AlCl
g -78 to 0 °C, 3.5 h 1.3/ 1.0h 50, 30
10i MeLi ether Et2AlCl
g -78 to 0 °C, 3 h 1.4/ 1.0 52, 36
11i MeLi THF Et2AlCl
g -78 °C to rt, 3.5 h 1.0/ 1.0 41, 37
12i MeLi ether EtAlCl2
j -78 to 0 °C, 3 h 1.3/ 1.0 22, 14
13i MeLi ether Me2AlCl
k -78 to 0 °C, 1.5 h 1.8/ 1.0 56, 29
14i MeLi ether Me2AlCl
k -55 °C, 22 h 1.6/ 1.0l 49, 26
15i MeLi ether Me2AlCl
k -55 °C, 6 h 2.3/ 1.0m 38, 16
16i MeLi ether (i-Bu)2AlCl -78 to 0 °C, 2.5 h 1.0/ 1.0 25, 26
a Product ratio determined by 1H NMR (C6D6) analysis of the crude reaction product.  
b Isolated yields
determined after purification by chromatography on SiO2 (4% acetone, 1% Et3N/hexanes).  
c Methyl
adduct was the predominant product.  d Decomposition.  e Aldehyde (16%) present in the crude reaction
product.  f Ratio of aldehyde/Et2AlCl/propynyl lithium = 1:2.5:5. 
g Et2AlCl was a commercially available
solution (1.8 M) in toluene.  h Aldehyde (7%) present in the crude reaction product.  i Ratio of
aldehyde/R2AlCl/propynyl lithium = 1:5:5. 
j EtAlCl2 was a commercially available solution (1.0 M) in
hexanes.  k Me2AlCl was a commercially available solution (1.0 M) in hexanes.  
l Trace of the aldehyde
present in the crude reaction product.  m Aldehyde (30%) present in the crude reaction product.
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The initial studies focused on the addition of propyne to aldehyde 126 because
the diastereomers could be readily separated by chromatography on SiO2.  Later, the
chromatography conditions were refined so that diastereomers resulting from the
propenyl additions to the aldehyde could also be separated, although with poorer
resolution.  As a result, the diastereoselectivity of the propenyl metal additions was
explored with the knowledge that material obtained in these studies could be carried
forward in the synthesis (Table 14).  Propenyl lithium was generated from isomerically
pure propenyl bromide via a metal-halogen exchange using t-butyl lithium.  The
addition in THF favored allylic alcohol 129b (entry 1).  Conducting the reaction in ethyl
ether reduced the preference for 129b relative to 129a and increased the yield (entry 2).
The addition of CeCl3 prior to addition of the aldehyde afforded equal amounts of each
diastereomer; however, the yield was poor and the conversion was not complete.
Performing the reaction in ethyl ether with MgBr2 gave a (129a/129b)-ratio similar to the
absence of MgBr2; however the yield was improved (entry 4).  A variety of copper salts
were also explored.  The complex formed in situ from CuI and tri-n-butylphosphine155
as well as the commercially available Li2CuCl4 complex
156 favored the undesired
diastereomer 129b  with similar overall yields (entries 5 and 6).  The use of the
sterically-hindered complex formed in situ from CuI and tricyclohexylphosphine as well
as the CuBr-dimethylsulfide complex afforded no addition product (entries 7 and 8).157
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Table 14.  Diastereoselective propenyl lithium additions to the C16-aldehyde.
O
H
OO
Me Me
Me Me
OH OO
Me Me
Me Me
Me
OH OO
Me Me
Me Me
Me
Me Li
conditions
t-BuLi
Me Br
+
127 129a 129b
Entry Solvent Additive Temp, Time Ratioa
129a/ b
Combined
Yield (%)b
1 THF - -78 °C, 1 h 1.0/ 1.8 72
2 ethyl ether - -78 °C, 1 h 1.0/ 1.3 82
3 THF CeCl3 -78 °C, 30 min;
0 °C, 30 min
1.0/ 1.0 36 +
(7% s.m.)
4 ethyl ether MgBr2 -78 °C to 0 °C,
30 min
1.0/ 1.2 97
5 THF CuI•PBu3 -78 °C, 1 h;
0 °C, 1 h
1.0/ 1.4 82
6 THF Li2CuCl4 -78 °C, 30 min 1.0/ 1.8 83
7 THF CuI•P(C6H11)3 -78 °C, 1 h;
0 °C, 30 min
-c -
8 THF CuBr•DMS -78 °C, 1 h;
0 °C, 30 min
-c -
a Product ratio determined by 1H NMR (acetone-d6) analysis of the crude reaction product.  b Combined
yield for both diastereomers after purification by chromatography on SiO2.  
c No reaction at –78 °C (TLC
analysis) and the Cu species likely decomposed upon warming to 0 °C as indicated by a color change
from yellow to black.
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An attempt to add a propenyl zinc to aldehyde 127 failed to afford the allylic
alcohol adducts 129a/b.158  The propenyl zinc was formed by hydrozirconation of
propyne, followed by transmetallation to zinc.  Only starting aldehyde and some traces
of olefinic material were present in the 1H NMR spectrum of the crude mixture.
Scheme 41.  Attempted addition of a propenyl zinc.
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H
OO
Me Me
Me Me
OH OO
Me Me
Me Me
Me
Me ZnMe
toluene
0 °C to rt, 12 h
Cp2ZrHCl, CH2Cl2
then Me2Zn, toluene
Me
127 129a/b
Similar to the results for the propynyl additions, the propenyl additions also
indicate a slight preference for the 1,3-syn-diastereomer 129b.  The failure to
significantly influence the diastereoselectivity of the propynyl or propenyl lithium
additions to the C16-aldehyde led to the exploration of alternate routes involving
oxidation-reduction sequences.
3.2.2.5. Oxidation and Diastereoselective Reduction Sequence
The most extensive studies on the oxidation-reduction sequence involve the
reduction of ketone 134 which was prepared by oxidizing the undesired diastereomer
128b with  Dess-Martin periodinane17 (Scheme 42).
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Scheme 42.  Oxidation of the propargyl alcohol to the ketone.
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Conditions for the diastereoselective reduction of ketone 134 were screened
(Table 15).  Luche conditions afforded equal amounts of diastereomers 128a and 128b
in a 97% combined yield (entry 1).  Borane reductions catalyzed by (R )-CBS-
oxazaborolidine134 afforded only 128a in moderate yield, however the product was
contaminated by inseparable impurities (entries 2 and 3).  Reduction with L-Selectride
afforded the product of 1,4-reduction (entry 4).  Aluminum-based reagents were
explored next.  Diisobutylaluminum hydride afforded the desired diastereomer 128a
and the solvent was also found to be important (entries 5-8).  Dichloromethane was
superior to THF or toluene and afforded a greater than a 3:1 ratio favoring 128a in 89%
combined yield (entry 7).  Interestingly, lithium aluminum hydride, LiAlH4/LiI
159 and Red-
Al favored the undesired diastereomer 128b (entries 9-11).  Very sterically hindered
reagents such as triisobutylaluminum,160 DiBAl-H/BHT complex161 and DIP-Cl162 as well
as the Noyori transfer-hydrogenation catalyst163 afforded none of the desired reduction
product.  The results from Table 15 suggest that influencing the diastereomeric ratio
during the reduction of ketone 134 is challenging.  The results also indicate that a
sterically encumbered reagent such as diisobutylaluminum hydride will favor the
desired diastereomer 128a, while non-sterically encumbered reagents such as LiAlH4
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favor the undesired diastereomer 128b.  Very sterically encumbered reagents will not
give the reduction product.  Presently, diisobutylaluminum hydride in dichloromethane
at low temperature (entry 7) is used to reduce the ketone and allows for the recycling of
the undesired C16-epimer, 128b.
Recycling of the undesired allylic alcohol diastereomer 129b was also briefly
explored.  Oxidation of the allylic alcohol 129b with Dess-Martin periodinane17 or
Swern conditions afforded ketone 135 in 84% and 80% yield, respectively.  The use of
MnO2 in dichloromethane afforded 135 in only 36% yield.
Reduction of ketone 135 using the best conditions for the propargylic ketone
(Table 15, entry 7) afforded a 2:1 ratio favoring the desired diastereomer 129a and a
combined yield of 56% (Table 17, entry 1).  Luche conditions afforded a 1:1 mixture of
129a and 129b in 78% combined yield (entry 2).
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Table 15.  Diastereoselective reductions at the C16-ketone.
MeMe
O O O
Me Me
Me MeMe
OH O O
Me Me
Me
conditions
134 128a
MeMe
OH O O
Me Me
Me
128b
Entry Reagent Temp, Time  Ratioa
128a/ b
 Yield (%)b
128a, 128b
1 NaBH4, CeCl3•7 H2O 0 °C, 2 h 1.0/ 1.0 48, 49
2 (R)-CBS, BH3•DMS, THF -10 °C to rt, 3 h 1/ 0 73, 0
 d
3 (R)-CBS, BH3•DMS, toluene 0 °C to +10 °C, 1 h 1/ 0 54, 0
 d
4 L-Selectride, THF -78 °C, 2 h - -e
5 DiBAl-H, THF -78 °C, 3.5 h 1.1/ 1.0 n. d.f
6 DiBAl-H, toluene -78 °C, 45 min 2.2/ 1.0 64, 28
7 DiBAl-H, CH2Cl2 -78 °C, 75 min 3.3/ 1.0 76, 23
8 DiBAl-H, CH2Cl2 -95 to -78 °C, 1.5 h 3.5/ 1.0 63, 14
9 LiAlH4, ethyl ether -78 °C, 1 h 1.0/ 2.3 25, 71
10 LiAlH4, LiI, ethyl ether -78 °C, 75 min 1.0/ 1.6 27, 49
11 Red-Al -78 °C, 1.5 h 1.0/ 1.4 n.d.f
12 (i-Bu)3Al -78 °C, 75 min - - 
c
13 (i-Bu)3Al -78 °C to 0 °C, 30 min - - 
g
14 DiBAl-H, BHT, toluene -78 °C, 1 h - - h
15 (+)-DIP-Cl, ethyl ether rt, 22 h - (76%) c
16 (-)-DIP-Cl, ethyl ether rt, 48 h - (75%) c
17 RuCl2(η
6-cymene), (R,R-
TsDPEA), KOH
rt, 2 h;
65°, 18 h
- (99%) c
a Product ratio determined by 1H NMR (C6D6) analysis of the crude reaction product.  
b Isolated yields
determined after purification by chromatography on SiO2 (4% acetone, 1% Et3N/hexanes).  
c Ketone
recovered (%).  d Isolated material contains inseparable impurities.  e Isolated material was the product of
1,4-reduction.  f The yield was not determined.  g Decomposed on warming to 0 °C.  h TLC indicated
ketone, no reduction occurred.
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Table 16.  Oxidation of the undesired allylic alcohol to the ketone.
HO O
Me Me
O
MeMe
Me
O O
Me Me
O
MeMe
Me
conditions
129b 135
Entry Reagent Solvent Temp, Time Yield (%)a
1 Dess-Martin periodinane, NaHCO3 CH2Cl2 0 °C to rt, 1 h 84
2 oxalyl-chloride, DMSO; Et3N CH2Cl2 -78 °C to rt, 25 min 80
3 MnO2, CH2Cl2 CH2Cl2 rt, 20 h 36
a Combined yield determined after purification by chromatography on SiO2.
Table 17.  Reduction of the α,β-unsaturated ketone to the allylic alcohol.
HO O
Me Me
O
MeMe
Me
O O
Me Me
O
MeMe
Me
conditions
135 129a
HO O
Me Me
O
MeMe
Me
129b
Entry Reagent Solvent Temp, Time Ratioa
129a/ b
Combined
Yield (%)b
1 DiBAl-H CH2Cl2 -78 °C, 1 h 2.0/ 1.0 56
2 CeCl3•7 H2O MeOH 0 °C to rt, 2 h 1.0/ 1.0 78
a Product ratio determined by 1H NMR (acetone-d6) analysis of the crude reaction product.  b Combined
yield for the mixture of diastereomers determined after purification by chromatography on SiO2
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3.2.2.6. A Comment on the Diastereoselectivity at the C16-Stereocenter
Diastereoselective additions to the C16-aldehyde or reductions of the C16-ketone
remain as one of the challenges of the current synthetic sequence.  Some general
comments can be made about the data given in Table 13, Table 14 and Table 15.
Aluminum-based propynyl and hydride reagents demonstrated a unique ability to
influence the diastereoselectivity at the C16-stereocenter.  Additions of organometallics
(propynyl and propenyl) to the aldehyde 127 slightly favor the undesired 1,3-syn-
epimer but dimethylaluminum chloride afforded the desired 1,3-anti-epimer for addition
of the propynyl group.  Second, reduction of the C16-ketone with diisobutylaluminum
hydride is 1,3-anti-selective while reduction with LiAlH4 is slightly 1,3-syn-selective.
The results do suggest that the diastereoselectivity can be influenced by different
conditions but the selectivity is only modest.  Further investigation into conditions that
affect the facial selectivity of organometallic and hydride additions at the C16-aldehyde
and ketones is required.
3.2.3. Synthesis of the Oxazole Segment
Synthesis of the oxazole fragment commenced with the protection of
commercially available 3-hydroxypropionitrile (136) as the triisopropylsilyl ether under
standard conditions followed by reduction of the nitrile with diisobutylaluminum
hydride to afford the known aldehyde 137164 in 78% yield for the two steps (Scheme
43).  The transformation of 137 to the propargylic alcohol 138 utilized the methodology
of Pu and coworkers.165  According to this protocol, the alkynyl zinc formed from
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trimethylsilylacetylene and diethylzinc was added to 137 under the influence of the
catalyst formed in situ from Ti(i-OPr)4 and (S)-BINOL and afforded 138
166 in 66% yield.
For the determination of the enantioselectivity of the transformation, 138 was
converted to benzoate 139 by acylating with benzoyl chloride in pyridine followed by
HF-promoted silyl ether cleavage in 93% yield.  Chiral HPLC analysis of 139 indicated
the enantiomeric excess to be 92%.167  Dimethylsulfate under phase-transfer
conditions was used to convert 138 to the methyl ether 140 in 95% yield with
concomitant loss of the trimethylsilyl group.  The silyl ether of 140 was converted to the
known carboxylic acid 141168 in a highly efficient manner by removal of the
triisopropylsilyl group with aqueous HF in acetonitrile, neutralization with aqueous
NaOH and oxidation of the resulting mixture using the Merck protocol.169
Scheme 43.  Synthesis of the carboxylic acid for the oxazole segment.
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Conversion of 141 to the oxazole was accomplished in three steps by first
coupling with DL-serine methyl ester hydrochloride, using EDC and HOBT with N-
methylmorpholine to afford the hydroxyamide 142 in 55% yield (Scheme 44).
Cyclodehydration of the 142 was accomplished using diethylaminosulfurtriflouride
(DAST) and K2CO3 and the crude oxazoline was oxidized with BrCCl3 and DBU
13 to
afford the oxazoles 143 and 144 in 37% and 31% yield, respectively, after tedious
separation by chromatography on silica gel.  The incorporation of bromine in 144 was
an unexpected outcome, but allowed for an efficient conversion to the required vinyl
iodide by using palladium-catalyzed hydrostannylation and iodination to afford 119 in
92% yield.170  The remaining alkynyl oxazole 143 was converted to 144 in moderate
yield, using silver nitrate and N-bromosuccinimide.  Finally, 119 was converted to the
carboxylic acid 145 in 90% yield by saponification with aqueous LiOH in THF.
Scheme 44.  Completion of the oxazole segment.
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The sequence for the oxazole synthesis as shown in Scheme 44 afforded the
bromoalkynyl oxazole 144 in 28% yield (4 steps) after conversion of the terminal alkyne
143 to 144.  Improvements to the sequence were made based on two considerations.
First, hydroxyamide 142  has limited solubility in dichloromethane, chloroform and ethyl
acetate/hexanes mixtures.  DMF was added to the coupling reaction to improve the
homogeneity of the reaction mixture.  In addition, a screening of solvent systems
identified acetone as a more suitable solvent and thus acetone or mixtures of
acetone/hexanes were used for chromatographic purifications and other pertinent
manipulations throughout the sequence.  The yield of oxazoline 146 was improved to
77% over the two steps (Scheme 45).  Second, the separation of the bromoalkyne and
the terminal alkyne was tedious and not amenable to large scale synthesis.  The
solution to the problem was to directly subject the mixture of 143 and 144 to the
bromination conditions using DMF as a solvent to afford the bromoalkyne 144 in 70%
yield for the two steps.  The improved sequence afforded 144 in 54% yield over the 4-
step sequence.
Scheme 45.  Improved synthesis of the oxazole segment.
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3.2.4. Completion of Disorazole C1
With access to 118a/b, 119 and 145 the convergent construction of the
macrocycle was initiated (Scheme 46).  Sonogashira cross-coupling99 of 118a/b and
119 afforded the protected monomers 147a and 147b  in 94% and 87% yield,
respectively.  Acylation of 147a/b using DCC and DMAP with an excess of 145,
afforded 148a and 148b.  A second Sonogashira cross-coupling99 between 148a/b and
118a/b afforded the seco-acid methyl esters 149a and 149b in 75% and 61% yield,
respectively.  Selective saponification of the methyl esters with aqueous lithium
hydroxide in THF afforded the crude seco-acids which were subjected to Yamaguchi
lactonization conditions128 affording the macrocycles 150a and 150b in 77% and 76%
yield, respectively.
The macrocyclic dimer 150a was also formed by a direct dimerization of the
monomer hydroxy acid (Scheme 47).  Saponification of methyl ester 147a with
aqueous LiOH and subsequent dimerization under Yamaguchi conditions128 afforded
the macrocyclic dimer 150a in 59% yield.
The synthesis of the diol segment afforded material with the C16-hydroxyl
masked as a 4-methoxybenzyl or a 3,4-dimethoxybenzyl ether (Scheme 48).  The initial
studies used the PMB group for the C16-hydroxyl protection.  Deprotection of 150a
using DDQ afforded 151 in 61% yield.  However, TLC analysis suggested that over-
oxidation was occurring, as indicated by the formation of less-polar material.  The 3,4-
dimethoxybenzyl ethers, which are more reactive to DDQ due to the increased electron
density of the aromatic ring, allowed the reaction to be more easily controlled and
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improved the yield of 151 to 77%.  In addition, no over-oxidation was observed by TLC
analysis during the deprotection of the 3,4-dimethoxybenzyl ethers.  Finally, 151 was
reduced using Lindlar catalyst in the presence of excess quinoline to afford the crude
76 which was purified by HPLC  to afford 76 in 57% yield.
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Scheme 46.  Stepwise synthesis of the macrocycle.
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Scheme 47.  Synthesis of the macrocycle by direct dimerization.
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Scheme 48.  Completion of (-)-disorazole C1.
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3.2.5. Biological Activities for Disorazole C1 and the Synthetic Intermediates
∗
The ultimate reason for the synthesis of disorazole C1 was to obtain material for
biological testing.  Specifically, the hypothesis that the significant biological activity of
disorazole A1 results from the presence of the divinyl oxirane could now be tested.  In
addition, testing the synthetic intermediates allows for the evaluation of structure-
activity relationships.171  Disorazole C1 and seven synthetic intermediates were tested
in cellular anti-mitotic assays (Figure 24).172  Only the synthetic disorazole C1 (76) and
the direct alkyne precursor (151) had significant biological activity (Table 18).173  All
other synthetic intermediates were inactive at concentrations less than 5 µM.  The data
suggest that disorazole C1 (76) may have a mechanism of action that is closely related
to the vinca alkaloids and distinct from paclitaxel.  The results suggest that the
macrocyclic structures of 76 and 151 are important for biological activity because all
other compounds were inactive.  In addition, the difference in activity between the
alkyne precursor and synthetic disorazole C1 suggests that the conformation of the
macrocycle is important for the biological activity.
∗
 Biological evaluations were performed by Dr. Alexander P. Ducruet and Rachel P. Sikorski under the
supervision of Dr. John S. Lazo and Dr. Andreas Vogt.
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Figure 24.  Biological evaluation of synthetic (-)-disorazole C1 and intermediates.
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Table 18.  High-content analysis of mitotic arrest in HeLa cells treated with antimitotic
agents.∗
Sample Cell
Density
Nuclear
Condensation
Mitotic
Indexb
Tubulin Mass G2/M
Arrest
EC50 (nM) MEC
c (nM)
vincristine 6.9
± 1.7 (3)
18.0
± 9.8 (3)
9.8
± 6.4 (3)
4.1
± 1.9 (3)
7.3
± 5.0 (3)
76 14.6
± 3.8 (3)
19.7
± 6.6 (3)
5.8
± 2.4 (3)
7.6
± 3.6 (3)
9.1
± 6.0 (3)
151 3912
± 1143 (3)
>5000 (3) 4401
± 848 (3)
3733
± 1186 (3)
5000
± 0 (3)
vinblastine 0.3
± 0.2 (3)
1.0
± 0.9 (3)
0.6
± 0.3 (3)
0.2
± 0.1 (3)
0.8
± 0.7 (3)
colchicine 23.9
± 0.6 (3)
22.2
± 3.3 (3)
12.2
± 0.6 (3)
11.9
± 1.4 (3)
17.7
± 6.5 (3)
paclitaxel 6.7
± 4.7 (2)
14.2
± 16.2 (2)
4.3
± 1.8 (2)
3.7
± 1.9 (2)
1.4
± 0.2 (2)
a average of (n) independent experiments ± SD; b percentage of phospho-H3 positive cells; c Minimal
Effective Concentration
∗ Biological evaluations were performed by Dr. Alexander P. Ducruet and Rachel P. Sikorski under the
supervision of Dr. John S. Lazo and Dr. Andreas Vogt.
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3.3. Synthesis of Disorazole C1 Analogs
3.3.1. Synthesis of the C14-tert-Butyl Analog
The initial goal for the synthesis of analogs focused on simplifying the structure
while still maintaining the biological activity.  The current synthesis of disorazole C1
requires significant synthetic steps to install the but-2-en-1-ol side chain.  Replacing
the side chain with a methyl group would give the simpler C14-tert-butyl analog 152
which retains the C14-stereocenter and some of the steric properties found in the
parent molecule (Figure 25).  The t-butyl analog has the additional advantage of a
significantly shorter synthesis and obviates the tedious chromatographic separations of
the C16-diastereomers (Sections 3.2.2.4 and 3.2.2.5).
Figure 25.  The C14-t-butyl analog of (-)-disorazole C1.
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Synthesis of the t-butyl analog 152 required the synthesis of fragment 153 and
followed a similar route as the synthesis of the disorazole C1 diol fragment (Scheme
180
49).  Pivaldehyde (154) was subjected to the allylation conditions as reported by
Carreira to afford the crude homoallylic alcohol in 56% yield.174,175  The crude alcohol
was then treated with TBS-Cl and imidazole in DMF at elevated temperature to afford
the known homoallylic silyl ether 155 in nearly quantitative yield.176  A comparison with
literature [α]D values indicated that the enantiopurity of 155 was 91% ee.
176  A three-
step sequence involving ozonolysis and reductive workup gave the aldehyde which
was condensed with 1,3-bis(triisopropylsilyl)propynyl lithium to afford the enyne.
Cleavage of the TBS ether with aqueous HF in acetonitrile afforded (Z)-156 and (E)-156
in 43% and 10% yield, respectively.  As before, enynes (Z)-156 and (E)-156 were
readily separable by column chromatography on silica gel.  The triisopropylsilyl group
of (Z)-156 was removed using TBAF buffered with acetic acid to afford enyne 153 in
76% yield.  Cross-coupling 153 with vinyl iodide 119 under Sonagashira conditions99
afforded the t-butyl monomer methyl ester 157 in 94% yield.
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Scheme 49.  Synthesis of the C14-t-butyl analog monomer unit.
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The dimer 158 was constructed from the monomer hydroxyacid under
Yamaguchi conditions128 (Scheme 50).  Saponification of methyl ester 157 afforded the
crude monomer hydroxyacid in 97% yield.  The hydroxyacid was subjected to the
Yamaguchi conditions128 to afford the dimer 158 in 26% yield.  The cyclomonomers
159 and 160 were each isolated in 8% yield after separation by HPLC.
 The t-butyl analog 152 was completed by reduction of 158 using Pd/BaSO4
poisoned with quinoline in 43% yield after purification by HPLC (Scheme 51).
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Scheme 50.  Synthesis of the C14-t-butyl analog macrocycle.
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Scheme 51.  Alkyne reduction to afford the t-butyl analog.
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3.3.2. Synthesis of the C17-18-Cyclopropyl Analog
The next analog that was chosen as a synthetic target was the C17-18-cyclopropyl
analog 161 (Figure 26).  Cyclopropanes are often used as alkene isosteres177 or to
modify biologically active compounds.178  The t-butyl analog proved to be biologically
inactive (Section 3.3.5), so the cyclopropyl analog was chosen to better understand
how the alkene contributes to the activity of disorazole C1.  An advantage of the
cyclopropyl analog is that it is expected to maintain similar geometrical properties of
the alkene.  Access to the cyclopropyl target required the modified diol segment 162
(Figure 26).
Figure 26.  The C17-18-cyclopropyl analog of (-)-disorazole C1.
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The synthesis of the cyclopropane modified diol segment began with the allylic
alcohol 129a  which was subjected to a Furukawa-modified Simmons-Smith
cyclopropanation179 to afford the cyclopropane adduct 163 in 98% yield and excellent
diastereoselectivity.  Crystals suitable for x-ray diffractions were prepared by low-
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temperature crystallization from hexanes and confirmed the relative stereochemistry of
163 (Appendix Section 4.2).  The alcohol was protected as the 3,4-dimethoxybenzyl
ether and the acetonide was removed to afford diol 164 in 84% yield for the two steps.
Protection of the diol as the bis-triethylsilylether and selective oxidation under Swern
conditions afforded aldehyde 165.  Condensation of 165 with 1,3-bis(triisopropylsilyl)-
propynyl lithium and removal of the remaining triethylsilylether under mildly acidic
conditions afforded (Z)-166 and (E)-166 in 32% and 12% yield after separation by
chromatography on silica gel.  The triisopropylsilyl group was removed from (Z)-166
with TBAF in THF to afford the completed cyclopropane diol segment 162 in 89%
yield.
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Scheme 52.  Synthesis of the C17-18-cyclopropane enyne.
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The cyclopropyl analog was completed using a similar route to that used for
disorazole C1 (Scheme 53).  Cross-coupling the enyne 162 and vinyl iodide 119 under
Sonogashira conditions99 afforded the monomer methyl ester 167 in 94% yield.
Saponification of the methyl ester afforded the crude hydroxyacid that was
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immediatedly subjected to the Yamaguchi conditions128 to afford the dimer 168 in 27%
yield after purification by HPLC.  A mixture of cyclomonomers 169 and 170 was also
isolated in 12% yield.  The 3,4-dimethoxybenzyl protecting groups were then removed
with DDQ under buffered conditions to afford the diol in 91% yield.  The yield for the
alcohol deprotection is higher than for the deprotection of the parent allylic alcohol
system of disorazole C1.  In addition, no overoxidation to the ketone was observed,
and this represents a synthetic advantage to replacing the (E)-alkene with the
cyclopropane.  Finally, reduction of the alkynes using hydrogen and quinoline-
poisoned Pd on BaSO4 afforded the completed C17-18-cyclopropyl analog of (-)-
disorazole C1 (161) in 22% yield after purification by HPLC.
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Scheme 53.  Completion of the C17-18-cyclopropane analog
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3.3.3. Attempted Synthesis of the C6-Desmethoxy Analog
Concurrent with the goals of simplifying the structure of disorazole C1 while
maintaining the biological activity, a third analog was selected which lacks the C6-
methoxy substituents, 172 (Figure 27).  The advantage of the desmethoxy compound is
the shortened synthetic sequence.  Additionally, the potential for using the methoxy
substituent as an anchor point for affinity labels if it proves to the inconsequential to
the biological activity could also be evaluated.  The disadvantage of removing the
allylic methoxy substituent is the potential disruption of the macrocycle conformation
or the destabilization of the sensitive triene unit.
Figure 27.  The C6-desmethoxy analog of (-)-disorazole C1.
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The synthesis of the desmethoxy analog 172 involved a modification of the
oxazole segment and began with the coupling of commercially available 4-pentynoic
acid (174) to serine methyl ester in 34% yield (Scheme 54).  Cyclization of
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hydroxyamide 175 with DAST and oxidation of the resulting oxazoline to the oxazole
using BrCCl3 and DBU
13 afforded a mixture of the terminal alkyne and the
bromoalkyne.  The mixture was treated with N-bromosuccinimide and silver nitrate in
DMF to afford the bromoalkyne 176 in 51% yield over the three steps.  The
bromoalkyne 176 was converted to the vinyl iodide 173 in 90% yield by the efficient
one-pot palladium-catalyzed hydrostannylation-iodination sequence.  Sonogashira
cross-coupling99 of 173 with enyne 118a afforded the C6-desmethoxymonomer methyl
ester 177 in 56% yield.
Scheme 54.  Synthesis of the desmethoxy monomer.
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Direct formation of the C6-desmethoxy dimer by saponification of the monomer
177 and dimerization under Yamaguchi conditions128 afforded a low yield of the dimer
178 (Scheme 55).  The reason for the low yield of 178 was unknown, so a longer, step-
wise approach towards the dimer was explored next.
Scheme 55.  Direct synthesis of the desmethoxy dimer.
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The step-wise approach to the synthesis of the desmethoxy analog was
analogous to the synthesis of disorazole C1 and began with the acylation of monomer
177 with the oxazole acid 179 using DCC and DMAP to afford the ester in 37% yield.
Cross-coupling with enyne 118a afforded the seco-acid methyl ester 180 in 82% yield.
Selective saponification and cyclization of the crude hydroxyacid afforded the dimer
178 in 20% yield.180  The low yields for the sequence were accompanied by the inability
191
to obtain material that was pure by 1H NMR.  For these reasons, further attempts to
complete the C6-desmethoxy analog of disorazole C1 (172) were abandoned.
181
Scheme 56.  Stepwise synthesis of the desmethoxy dimer.
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3.3.4. Additional Analogs
3.3.4.1. Hydrogenated Disorazole C1
The semi-hydrogenation of bis-alkyne 151 to afford disorazole C1 (76) (Scheme
48) was accompanied by a variety of byproducts that had a similar structure and may
result from olefin isomerization or olefin saturation.  The byproducts converged to 181
upon exposure to hydrogen and palladium on carbon (Scheme 57).  The saturated
analog 181 was submitted for biological testing (Section 3.3.5).
Scheme 57.  Saturation of the disorazole C1 olefins.
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3.3.4.2. Synthesis of C16-Didehydrodisorazole C1
A hypothesis concerning the activity of disorazole C1 is that the allylic alcohol
side chains of disorazole C1 undergo oxidations in vivo, affording an α,β-unsaturated
ketone.  The oxidized disorazole C1 could then cause a disruption in the cellular
network by irreversibly binding to a protein via the conjugate addition of an amino acid
residue to the α,β-unsaturated ketone.  This hypothesis was tested by oxidizing the
193
bis-alkyne 151 and disorazole C1 (76) to the corresponding α,β-unsaturated ketones
182  and 183 in 89% and 91% yields, respectively, using buffered Dess-Martin
periodinane.17  The resulting ketone analogs 182 and 183 were subjected to biological
testing (Section 3.3.5).
Scheme 58.  α,β-Unsaturated ketone analogs of disorazole C1 and the alkyne
precursor.
Dess-Martin
periodinane,
NaHCO3,
CH2Cl2 (wet),
89%
Me
O
Me Me
MeO O
N
Me
O
MeMe
OMeO
N
O
O
151
O
O
Dess-Martin
periodinane,
NaHCO3,
CH2Cl2 (wet),
91%
76 Me
O
Me Me
O
N
Me
O
MeMe
O
N
O
O
MeO
OMe
O
O
182
183
194
3.3.5. Biological Activities for the Disorazole C1 Analogs
The analogs of disorazole C1 that were submitted for biological evaluation are
summarized in Figure 28.  The initial biological evaluation of disorazole C1 and the
synthetic intermediates indicated that only disorazole C1 (76) and the alkyne precursor
151 had biological activity (Section 3.2.5).  The t-butyl analogs 152 and 158 and the
cyclomonomers 159 and 160 were not active at concentrations less than 5 µM.
Likewise, the saturated analog 181 was also not active.  The hypothesis concerning an
in vivo oxidation of the allylic alcohol to an α,β-unsaturated ketone that could act as an
alkylating reagent can also be discounted because enones 182 and 183 were not
active.  Finally, the cyclopropyl analogs 171 and 161 were also not active.
The results from the biological evaluation of the disorazole C1 analogs indicate
that the 2-butene-1-ol side chain is essential for activity.  The energy minimized
conformations of the analogs were evaluated to understand how this group influences
the conformations of the macrocycle.182  The mimimized structures are shown in
Appendix Section 4.3.  The conformation of disorazole C1 (7 6) indicates a twisted
structure that places the side chains in close proximity (Figure 30).  The bis-alkyne
(151) adopts a less-twisted conformation that places one of the methoxy groups on the
concave face of the macrocycle (Figure 31).173  The t-butyl analog 152 indicates a
flattened structure with the t-butyl groups on opposite sides of the molecule and
suggests that the side chains can have a significant impact on the overall conformation
of the molecule (Figure 32).  The cyclopropyl analog 161 adopts a similar conformation
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to disorazole C1 (7 6) (Figure 33).  The diketone analog 182 is flattened relative to
disorazole C1 (76) (Figure 34).  Finally, disorazole A1 adopts a conformation similar to
disorazole C1 (76) (Figure 35).  These results suggest that subtle changes in structure
can lead to a significant change in the conformation of the macrocycle.  The possibility
that the natural product is binding in a different conformation still exists and a more
definite SAR model can only be developed by testing additional analogs.183
196
Figure 28.  Analogs of disorazole C1 that were submitted for biological evaluation.
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Table 19.  Summary of the high-content analysis of mitotic arrest in HeLa cells treated
with disorazole C1 and analogs.
∗
Sample Cell
Density
Nuclear
Condensation
Mitotic Indexb Tubulin Mass G2/M
Arrest
EC50 (nM) MEC
c (nM)
76 14.6
± 3.8
19.7
± 6.6
5.8
± 2.4
7.6
± 3.6
9.1
± 6.0
151 3912
± 1143
>5000 4401
± 848
3733
± 1186
5000
± 0
147a >5000 >5000 >5000 >5000 >5000
147c >5000 >5000 >5000 >5000 >5000
148a >5000 >5000 >5000 >5000 >5000
149a >5000 >5000 >5000 >5000 >5000
149c >5000 >5000 >5000 >5000 >5000
150a >5000 >5000 >5000 >5000 >5000
152 >5000 >5000 >5000 >5000 >5000
158 >5000 >5000 >5000 >5000 >5000
159 >5000 >5000 >5000 >5000 >5000
160 >5000 >5000 >5000 >5000 >5000
161 >5000 >5000 >5000 >5000 >5000
171 >5000 >5000 >5000 >5000 >5000
181 >5000 >5000 >5000 >5000 >5000
182 >5000 >5000 >5000 >5000 >5000
183 >5000 >5000 >5000 >5000 >5000
a average of (n = 3) independent experiments ± SD; b percentage of phospho-H3 positive cells;  c Minimal
Effective Concentration.  For positive controls, refer to Table 18.
∗
 Biological evaluations were performed by Dr. Alexander P. Ducruet and Rachel P. Sikorski under the
supervision of Dr. John S. Lazo and Dr. Andreas Vogt.
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3.4. Summary and Conclusions
A highly convergent and stereoselective synthesis of disorazole C1 (76) was
completed.  Notable features include the installation of the absolute configurations of
each fragment by titanium (IV)/BINOL mediated additions of allyl trimethylsilane139 or
zinc acetylides165 to aldehydes.  The oxazole was installed using the DAST mediated
cyclodehydration and the BrCCl3/DBU oxidation methodology
13 to afford bromoalkyne
144 which was transformed to the vinyl iodide using a highly efficient hydro-
stannylation/iodination sequence.170  The macrocycle was constructed with minimal
protecting group manipulations, using mild esterification and Sonogashira cross-
coupling reactions.  Finally, the C16-hydroxyl protecting group was removed under mild
conditions and reduction of the alkyne afforded disorazole C1 (76).
The convergent synthesis of disorazole C1 allowed for the synthesis of additional
analogs.  These analogs include the C14-t-butyl analog 152 and the C17-18-cyclopropyl
analog 161.  Attempts to prepare the C6-desmethoxy analog failed due to low yields.
Additional derivatives include the diketones 181 and 182 and the fully reduced
derivative 181.  Only synthetic disorazole C1 (76) and the alkyne precursor 151
demonstrated anti-proliferative activity in cellular assays.  All other analogs and
derivatives proved to be inactive at less than 5 µM in biological assays.172,183
We initially embarked on the synthesis of (-)-disorazole C1 with the idea that a
convergent synthesis would allow other members of the disorazole family to be
prepared.  The biological profile of disorazole C1 or any of the other minor metabolites
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in the disorazole family had not been reported.  Gratifyingly, our synthesis and
biological evaluation proved that the synthetically challenging divinyl oxirane and
tetraene segments found in the more abundant disorazoles were not required for
potent biological activity.121  Our initial SAR studies also proved that the activity is
strongly dependant on the structure of the natural product.  Even minor changes, such
as cyclopropanation of the C17-18-olefin or oxidation of the C16-alcohol, led to
significantly lower activities in biological assays.183  In addition, we currently believe
that the C6-methoxy is important for the stability of the natural product because our
attempts to prepare the C6-desmethoxy analog failed.  The preparation of more
analogs will be required to further probe the correlation between the structural features
of the molecule and the biological activity and molecular stability profiles.  The
preparation of other members of the disorazole family would allow for a direct
comparison of activities in biological assays and lead to an improved understanding of
the SAR.
The potent antiproliferative activity and extraordinary SAR profile suggest that
disorazole C1 participates in a very specific interaction within the cellular network and
is therefore a promising candidate for anti-cancer therapies.  The apparent
irreversibility of the cellular response to the disorazoles is another interesting property
of the disorazoles.111,183  The exact cellular target of the disorazoles remains to be
unequivocally elucidated and will require the synthesis of labeled natural product.  The
current synthetic route to disorazole C1 is convergent and allows for numerous
opportunties to prepare labeled material.  Finally, the current synthetic route has the
potential to afford significant quantities of disorazole C1 and analogs for in vivo testing.
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3.5. Experimental Part
3.5.1. General
All moisture sensitive reactions were performed using syringe-septum
techniques under an N2 atmosphere and all glassware was dried in an oven at 140 °C
for more than 4 h prior to use.  Reactions at -78 °C employed a solid CO2-acetone
bath.  THF and ethyl ether were distilled from sodium/benzophenone ketyl.  Methylene
choride and toluene were filtered through activated alumina prior to use.  Reactions
were monitored by TLC analysis (pre-coated silica gel 60 F254 plates, 250 µm layer
thickness) and visualized using UV light (254 nm) or by staining with KMnO4 or
phosphomolybdic acid.  Flash chromatography on SiO2 was used to purify compounds
unless otherwise stated.  Concentration refers to removal of the solvent on a rotary
evaporator at water aspirator pressure.  Melting points are uncorrected.  Infrared
spectra were acquired using KBr pellets or thin films on NaCl plates (i.e. neat).
Chemical shifts were reported in parts per million and the residual solvent peak was
used as an internal reference.  1H NMR spectra were acquired in CDCl3 at a frequency
of 300 MHz unless stated otherwise and are tabulated as follows: chemical shift
(multiplicity, number of protons, coupling constants).  13C NMR were acquired in CDCl3
at a frequency of 75 MHz using a proton decoupled pulse sequence unless stated
otherwise.  For acid sensitive samples, CDCl3 was filtered through activated basic
alumina (Brockmann I) immediately prior to sample preparation.  For optical rotations,
concentration (c) is reported in g/100 mL.  Semi-preparative HPLC was performed
using a 10 mm x 25 mm SiO2 column.
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3.5.2. Experimental Procedures
3.5.2.1. Synthesis of Disorazole C1
OPMB
Me Me
O
H
OPMB
Me Me
OH
Me
propyne,
Cp2ZrHCl, CH2Cl2,
then
Me2Zn,
SH
Me
NMe2
123
toluene
122a 124a
(S ,E )-1-(4-Methoxybenzyloxy)-2,2-dimethylhex-4-en-3-ol (124a).  A
suspension of Cp2ZrHCl (70.0 mg, 0.271 mmol, 1.2 equiv) in CH2Cl2 (4.0 mL) was
stirred at rt while gaseous propyne was bubbled into the solution for 30 min.  The
solvent was removed in vacuo and toluene (2.0 mL) was added.  The mixture was
cooled to –78 °C and treated with Me2Zn (2.0 M in toluene, 0.112 mL, 0.225 mmol, 1.0
equiv) and ligand 123 (10.0 mg, 0.055 mmol, 0.25 equiv), warmed to –15 °C for 1 h,
treated with a solution of 122a (50.0 mg, 0.225 mmol, 1.0 equiv) in toluene (2.0 mL) and
stirred under argon for 20 h at –15 °C.  A small amount of saturated aqueous NaHCO3
was added and the mixture was filtered through a pad of Florisil/Celite (1:1).  The
filtrate was washed with brine, dried (Na2SO4), filtered and concentrated to a pale
yellow oil.  Purification by chromatography on SiO2 (10% to 20% ethyl ether/hexanes)
afforded recovered aldehyde 122a (29.3 mg, 49%) and 124a (11.0 mg, 19%) as a clear,
colorless oil.  Analysis by analytical HPLC (Chiralcel-OD, 0.46 cm x 25 cm, 1%
isopropanol/hexanes, 1.0 mL/min, 254 nm) indicated 24% ee [Rt(major)= 14.09 min,
Rt(minor)= 16.17 min)]:  
1H NMR δ 7.24 (dt, 2 H, J = 8.6, 1.8 Hz), 6.88 (dt, 2 H, J = 8.6,
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1.9 Hz), 5.65 (q of AB, 1 H, J = 15.2, 6.4 Hz), 5.47 (dq of AB, 1 H, J = 15.2, 7.3, 1.4 Hz),
4.43 (s, 2 H), 3.86 (dd, 1 H, J = 7.1, 4.2 Hz), 3.80 (s, 3 H), 3.36 (d, 1 H, J = 4.3 Hz), 3.36,
3.24 (AB, 2 H, J = 8.8 Hz), 1.69 (d, 3 H, J = 6.4 Hz), 0.89 (s, 3 H), 0.87 (s, 3 H); 13C NMR
δ 159.4, 130.6, 130.1, 129.4, 128.2, 113.9, 80.2, 79.2, 73.4, 55.4, 38.4, 23.0, 20.1, 18.0;
IR (neat) 3476, 2960, 2935, 2910, 2856, 1612, 1586, 1514 cm-1; MS (EI) m/z (rel.
intensity) 264 (M+, 3.8), 191 ([M-CH3(CH2)2CHOH]
+, 3.7), 138 (54), 121 (100); HRMS (EI)
m/z calcd for C16H24O3  264.1725, found 264.1723.
OTBDPS
Me Me
O
H
OTBDPS
Me Me
OH
Me
propyne,
Cp2ZrHCl, CH2Cl2,
then
Me2Zn,
SH
Me
NMe2
123
toluene
122b 124b
(S,E)-1-(tert-Butyldiphenylsilyloxy)-2,2-dimethylhex-4-en-3-ol (122b).  A
suspension of Cp2ZrHCl (150.0 mg, 0.582 mmol, 1.9 equiv) in CH2Cl2 (4.0 mL) was
stirred at rt while gaseous propyne was bubbled into the solution for 10 min.  The
solvent was removed in vacuo and toluene (1.0 mL) was added.  The mixture was
cooled to –78 °C and treated with Me2Zn (2.0 M in toluene, 0.270 mL, 0.540 mmol, 1.8
equiv) and ligand 123 (11.0 mg, 0.061 mmol, 0.2 equiv), warmed to 0 °C for 30 min,
treated with a solution of 122b (101.7 mg, 0.297 mmol, 1.0 equiv) in toluene (0.4 mL +
0.4 mL rinse) and stirred under argon for 6.5 h at 0 °C.  The mixture was treated with a
small amount of water (0.2 mL), followed by anhydrous Na2SO4, stirred for 10 min and
filtered through a pad of Florisil/Celite (1:1).  The filtrate was concentrated to a clear,
colorless syrup.  Purification by chromatography on SiO2 (5% ethyl ether/hexanes)
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afforded 124b (98.8 mg, 87%) as a clear, colorless oil.  Analysis by analytical HPLC
(Chiralcel-OD, 0.46 cm x 25 cm, 2% isopropanol/hexanes, 0.5 mL/min, 254 nm)
indicated 33% ee [Rt(major)= 9.00 min, Rt(minor)= 9.98 min)]:  
1H NMR δ 7.73-7.69 (m,
4 H), 7.49-7.39 (m, 6 H), 5.75 (q of AB, 1 H, J = 15.2, 6.4 Hz), 5.58 (dq of AB, 1 H, J =
15.2, 7.2, 1.4 Hz), 4.04 (dd, 1 H, J = 6.8, 3.5 Hz), 3.57, 3.48 (AB, 2 H, J = 9.8 Hz), 3.39
(d, 1 H, J = 3.9 Hz), 1.74 (dd, 3 H, J = 6.3, 0.7 Hz), 1.10 (s, 9 H), 0.92 (s, 3 H), 0.88 (s, 3
H); 13C NMR δ 135.9, 133.0, 130.7, 130.0, 128.3, 127.9, 80.0, 73.0, 39.1, 27.0, 22.4,
19.7, 19.4, 18.1; IR (neat) 3480, 3071, 3049, 2960, 2931, 2858, 1959, 1890, 1824, 1670,
1590, 1472, 1428 cm-1; MS (EI) m/z (rel. intensity) 325 ([M-C4H9]
+, 15), 307 ([M-C4H9-
H2O]
+, 18), 269 (10), 229 (35), 199 (100); HRMS (EI) m/z calcd for C20H25O2Si (M-C4H9)
325.1624, found 325.1618.
O
Me Me
O
O
MeMe
O
OH
Me Me
O
O
1) O3/O2, Sudan III,
    MeOH, CH2Cl2, 
    then NaBH4;
2) 2,2-dimethoxy-
    propane, THF
125
Naphthalene-2-carboxylic acid 2-[(4S)-2,2-dimethyl-[1,3]dioxan-4-yl]-2-
methylpropyl ester.  A solution of 125 (9.46 g, 31.7 mmol, 1.0 equiv) in methanol (100
mL) and CH2Cl2 (50 mL) containing Sudan III (1.0 mg) was cooled to –78 °C.  O3/O2 was
bubbled through the mixture for approximately 40 min until the color changed to a pale
yellow.  NaBH4 (1.80 g, 47.6 mmol, 1.5 equiv) was added in one portion and the
reaction mixture was stirred at –78 °C for 10 min and then warmed to 0 °C for 1 h.
Additional NaBH4 (1.80 g, 47.6 mmol, 1.5 equiv) was added and the cold bath was
removed.  After stirring for 1 h at rt, 1.0 M aqueous citric acid (100 mL) and brine (100
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mL) were added and the mixture was stirred for 10 min and extracted with ethyl
acetate.  The combined organic layers were washed with brine, dried (Na2SO4), filtered
and concentrated to a yellow syrup.  Purification by chromatography on SiO2 (30% to
80% ethyl acetate/hexanes) afforded (3S )-naphthalene-2-carboxylic acid 3,5-
dihydroxy-2,2-dimethylpentyl ester (8.420 g, 88%) as a pale yellow glass that was used
without further purification: Rf = 0.38 (60% ethyl acetate/hexanes).  A solution of this
ester (8.35 g, 27.6 mmol, 1.0 equiv) in THF (100 mL) was cooled to 0 °C, and PPTS
(500 mg, 2.00 mmol, 0.1 equiv) and then 2,2-dimethoxypropane (20.0 mL, 163 mmol,
5.9 equiv) was added.  The cold bath was removed and the mixture was stirred at rt for
48 h, quenched with saturated aqueous NaHCO3 solution and extracted with ethyl
acetate.  The combined organic layers were washed with brine, dried (Na2SO4), filtered
and concentrated.  Purification by chromatography on SiO2 (3% ethyl acetate, 1%
triethylamine/hexanes, then 100% ethyl acetate) afforded the acetonide and a small
amount of starting diol which was re-subjected and purified as above.  The two
batches were combined to afford naphthalene-2-carboxylic acid 2-[(4S)-2,2-dimethyl-
[1,3]dioxan-4-yl]-2-methylpropyl ester (9.140 g, 97%) as a clear, colorless syrup:  [α]D
+27.4 (c 1.40, CHCl3, 22 °C); 
1H NMR δ 8.60 (s, 1 H), 8.06 (dd, 1 H, J = 8.6, 1.0 Hz),
7.97 (d, 1 H, J = 7.5 Hz), 7.89 (d, 2 H, J = 8.7 Hz), 7.62-7.52 (m, 2 H), 4.31, 4.16 (AB, 2
H, J = 10.7 Hz), 3.99 (dd, 1 H, J = 11.7, 2.8 Hz), 3.95-3.86 (m, 2 H), 1.78 (app dq, 1 H, J
= 12.1, 5.6 Hz), 1.44-1.40 (m, 1 H), 1.41 (s, 3 H), 1.36 (s, 3 H), 1.04 (s, 6 H); 13C NMR δ
166.8, 135.7, 132.7, 131.1, 129.5, 128.4, 128.0, 126.9, 125.3, 98.6, 72.5, 70.5, 60.4,
37.8, 30.0, 25.4, 21.5, 19.5, 19.3; IR (neat) 3060, 2991, 2966, 2940, 2874, 1717, 1631,
1603 cm-1; MS (EI) m/z (rel. intensity) 342 (M+, 24), 327 ([M-CH3]
+, 35), 284 ([M-C4H10]
+,
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15), 211 (6), 172 (42), 155 (100), 115 (66); HRMS (EI) m/z calcd for C21H26O4 342.1831,
found 342.1835.
O
Me Me
O
O
MeMe
O O
Me Me
O
MeMe
OHaq. LiOH,
THF, MeOH
126
2-{(4S)-2,2-Dimethyl-[1,3]dioxan-4-yl}-2-methyl-propan-1-ol (126).  A
solution of naphthalene-2-carboxylic acid 2-[(4S)-2,2-dimethyl-[1,3]dioxan-4-yl]-2-
methylpropyl ester (1.59 g, 4.64 mmol, 1.0 equiv) in THF (20 mL) and MeOH (5 mL) was
cooled to 0 °C and treated with 1.0 M aqueous LiOH (5.00 mL, 5.00 mmol, 1.1 equiv).
The reaction mixture was allowed to warm to rt and after 20 h, diluted with ethyl ether
(20 mL) and washed with water (20 mL) and brine (20 mL).  The combined aqueous
layers were backwashed with ethyl ether (5 mL) and the combined organic extracts
were dried (Na2SO4), filtered and concentrated.  Purification by chromatography on
SiO2 (40% ethyl ether/hexanes) afforded 126 (720.0 mg, 82%) as a pale yellow oil:  Rf
0.20 (40% ethyl ether/hexanes); [α]D +13.3 (c 1.50, CHCl3, 22 °C); 
1H NMR δ 3.94 (app
dt, 1 H, J = 11.8, 2.8 Hz), 3.86 (ddd, 1 H, J = 11.7, 5.7, 1.8 Hz), 3.78 (dd, 1 H, J = 11.9,
2.5 Hz), 3.53 (dd, 1 H, J = 10.9, 5.9 Hz), 3.35 (dd, 1 H, J = 10.9, 5.3 Hz), 3.00 (app t, 1
H, J = 5.7 Hz), 1.75 (app dq, 1 H, J = 12.4, 5.7 Hz), 1.44 (s, 3 H), 1.38-1.31 (m, 1 H),
1.36 (s, 3 H), 0.88 (s, 3 H), 0.86 (s, 3 H); 13C NMR δ 98.7, 77.4, 71.7, 60.3, 37.8, 30.1,
25.7, 22.2, 19.4, 19.2; IR (neat) 3441, 2991, 2963, 2873, 1475, 1460 cm-1; MS (EI) m/z
(rel. intensity) 173 ([M-CH3]
+, 48), 115 (12), 88 (21), 73 (76), 61 (100); HRMS (EI) m/z
calcd for C9H17O3 (M-CH3) 173.1178, found 173.1180.
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CH2Cl2
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O
Me Me
O
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(S)-2-(2,2-Dimethyl-1,3-dioxan-4-yl)-2-methylpropanal (127).142  A solution of
oxalyl chloride (3.30 mL, 37.8 mmol, 1.5 equiv) in CH2Cl2 (250 mL) was cooled under N2
to –78 °C and treated via cannula with a solution of CH2Cl2 (5.0 mL+5.0 mL rinse).  The
reaction mixture was stirred for 20 min, treated via cannula with a solution of 126 (4.70
g, 25.0 mmol, 1.0 equiv) in CH2Cl2 (5.0 mL+5.0 mL rinse), stirred at –78 °C for an
additional 30 min, and treated with triethylamine (15.00 mL, 106.9 mmol, 4.3 equiv).
The solution was stirred at –78 °C for 2 h, treated with water (50 mL), warmed to rt,
poured into water (50 mL) and extracted with CH2Cl2.  The combined organic layers
were dried (Na2SO4), filtered and concentrated.  The residue was diluted with
anhydrous ethyl ether and filtered through a plug of SiO2.  The plug was rinsed with
ethyl ether and the filtrate was concentrated to give 127 as a yellow oil that was used
in the following transformation without further purification:  Rf 0.50 (40% ethyl
ether/hexanes).
O
Me Me
O
MeMe
O HO O
Me Me
O
MeMepropyne, 
MeLi,
Me2AlCl,
ethyl ether Me
HO O
Me Me
O
MeMe
Me
+
128a 128b127
H
(3S)-2-{(4S)-2,2-Dimethyl-[1,3]-dioxan-4-yl}-2-methylhex-4-yn-3-ol (128a)
and (3R )-2-{(4S)-2,2-dimethyl-[1,3]-dioxan-4-yl}-2-methylhex-4-yn-3-ol (128b).
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Propyne (ca. 1 mL) was condensed into a flask at –78 °C, diluted with ethyl ether (5.0
mL) and treated with MeLi (1.5 M in ethyl ether, 2.80 mL, 4.20 mmol, 5.1 equiv).
Additional ethyl ether (5.0 mL) was added and the reaction mixture was warmed to 0
°C for 30 min, cooled to –78 °C and treated with Me2AlCl (1.0 M in hexanes, 4.20 mL,
4.20 mmol, 5.1 equiv) and a solution of the aldehyde (153.4 mg, 0.824 mmol, 1.0 equiv)
in ethyl ether (1.0 mL + 1.0 mL rinse).  After 1 h at –78 °C and then 30 min at 0 °C, the
mixture was treated with 1.0 M aqueous sodium tartrate (10 mL) and brine (10 mL),
stirred until the organic phase was clear (ca. 1 h) and extracted with ethyl ether.  The
combined organic layers were dried (Na2SO4), filtered and concentrated.  Purification
by chromatography on SiO2 (4% acetone, 1% triethylamine/hexanes) afforded 128a
(103.9 mg, 56%) and 128b (53.5 mg, 29%) as clear, colorless syrups.  128a: Rf 0.34
(10% acetone/hexanes, twofold developed); [α]D +39.5 (c 1.11, CHCl3, 22 °C); 
1H NMR
δ 4.29 (dd, 1 H, J = 11.9, 2.4 Hz), 4.07 (dq, 1 H, J = 9.4, 2.1 Hz), 3.99 (dd, 1 H, J = 11.9,
2.8 Hz), 3.89 (ddd, 1 H, J = 11.7, 5.4, 1.8 Hz), 3.83 (d, 1 H, J = 8.8 Hz), 1.87 (d, 3 H, J =
2.2 Hz), 1.78 (app dq, 1 H, J = 12.4, 5.4 Hz), 1.52 (s, 3 H), 1.38 (s, 3 H), 1.32 (app dq, 1
H, J = 12.9, 2.3 Hz), 1.04 (s, 3 H), 0.88 (s, 3 H); 1H NMR (C6D6) δ 4.32 (dq, 1 H, J = 8.2,
2.2 Hz), 4.13 (dd, 1 H, J = 11.9, 2.4 Hz), 3.62-3.52 (m, 2 H), 3.33 (d, 1 H, J = 8.2 Hz),
1.54 (d, 3 H, J = 2.2 Hz), 1.52-1.46 (m, 1 H), 1.33 (s, 6 H), 1.08 (s, 3 H), 0.82 (s, 3 H),
0.77 (ddd, 1 H, J = 12.7, 4.8, 2.5 Hz); 13C NMR δ 98.8, 81.8, 78.9, 75.1, 72.2, 60.5, 40.6,
30.0, 25.5, 21.8, 19.3, 19.0, 3.8; IR (neat) 3458, 2991, 2969, 2938, 2876, 2224, 1468,
1427 cm-1; MS (EI) m/z (rel. intensity) 211 ([M-CH3]
+, 16), 187 ([M-C3H3]
+, 7), 161 (49),
115 (86), 69 (73), 59 (100); HRMS (EI) m/z calcd for C12H19O3 (M-CH3) 211.1334, found
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211.1330; 128b: Rf 0.26 (10% acetone/hexanes, twofold developed); [α]D +31.1 (c 1.36,
CHCl3, 22 °C); 
1H NMR δ 4.31 (s, 1 H), 3.96 (app dt, 1 H, J = 11.8, 2.8 Hz), 3.93-3.83
(m, 2 H), 3.19 (bs, 1 H), 1.86 (d, 3 H, J = 2.2 Hz), 1.82-1.72 (m, 1 H), 1.46 (s, 3 H), 1.41-
1.34 (m, 1 H), 1.36 (s, 3 H), 1.02 (s, 3 H), 0.87 (s, 3 H); 1H NMR (C6D6) δ 4.42 (d, 1 H, J =
2.0 Hz), 3.81 (dd, 1 H, J = 11.8, 2.5 Hz), 3.62 (td, 1 H, J = 5.8, 2.1 Hz), 3.59 (td, 1 H, J =
11.5, 2.8 Hz), 2.20 (bs, 1 H), 1.66-1.52 (m, 1 H), 1.51 (d, 3 H, J = 2.2 Hz), 1.40 (s, 3 H),
1.29 (s, 3 H), 1.18 (s, 3 H), 0.91 (s, 3 H), 0.95-0.88 (m, 1 H); 13C NMR δ 98.7, 81.7, 78.5,
76.3, 71.1, 60.4, 41.4, 30.0, 25.8, 20.4, 19.4, 15.9, 3.8; IR (neat) 3441, 2969, 2935,
2877, 2243, 1468, 1381 cm-1; MS (EI) m/z (rel. intensity) 211 ([M-CH3]
+, 22), 197 (6), 171
(6), 151 (29), 129 (80), 115 (100), 83 (96), 59 (77); HRMS (EI) m/z calcd for C12H19O3
211.1334, found 211.1340.
HO O
Me Me
O
MeMe
Red-Al,
THF
HO O
Me Me
O
MeMe
Me
Me
128a 129a
2-[(4S)-2,2-Dimethyl-[1,3]dioxan-4-yl]-2-methyl-hex-4-en-3-ol (129a).  A
solution of 128a (2.315 g, 10.23 mmol, 1.0 equiv) in THF (50 mL) was degassed (freeze-
pump-thaw, 3 cycles), flushed with argon and slowly treated with Red-Al (65% w/w in
toluene, 9.00 mL, 30.0 mmol, 2.9 equiv).  After the evolution of gas ceased (ca. 15 min),
the reaction mixture was heated to 70-75 °C (oil bath temperature) under argon for 25
h, cooled to 0 °C and treated with i-PrOH (5 mL).  When the evolution of gas ceased,
Na2SO4•10 H2O (11.00 g) was added and the mixture was vigorously stirred at 0 °C for
1 h and filtered through a pad of Florisil/Celite (1:1 v/v).  The pad was rinsed with ethyl
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ether and the combined filtrates were concentrated to give a yellow oil.  Purification by
chromatography on SiO2 (1% triethylamine/hexanes to 5% acetone, 1%
triethylamine/hexanes) afforded 129a (1.940 g, 83%) as a yellow syrup.  A white
crystalline solid resulted upon storage at –35 °C for >1 month:  Rf 0.50 (10%
acetone/hexanes, three-fold developed); Mp 34.9-36.9 °C (acetone, hexanes,
triethylamine); [α]D -0.26 (c 1.56, CHCl3, 22 °C); 
1H NMR δ 5.67 (dq, 1 H, J = 15.0, 6.3
Hz), 5.51 (ddd, 1 H, J = 15.2, 6.8, 1.2 Hz), 3.94 (app dt, 1 H, J = 11.8, 2.7 Hz), 3.89-3.84
(m, 3 H), 3.71 (d, 1 H, J = 6.0 Hz), 1.80 (app dq, 1 H, J = 12.1, 5.6 Hz), 1.71 (d, 3 H, J =
6.3 Hz), 1.44 (s, 3 H), 1.37 (s, 3 H), 1.31 (app dq, 1 H, J = 15.3, 2.1 Hz), 0.91 (s, 3 H),
0.82 (s, 3 H); 13C NMR δ 130.5, 127.9, 98.7, 79.8, 76.2, 60.5, 39.9, 30.1, 25.4, 21.1,
20.7, 19.2, 18.1; IR (neat) 3485, 2987, 2967, 2938, 2875, 1671, 1470, 1412 cm-1.
HO O
Me Me
O
MeMe
Me
O
Me Me
O
MeMe
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O
MeMe
MeH
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127 129a 129b
(E)-propenyl-
bromide, t-BuLi,
ethyl ether
(S,E)-2-((S)-2,2-Dimethyl-1,3-dioxan-4-yl)-2-methylhex-4-en-3-ol (129a) and
(R,E)-2-((S)-2,2-dimethyl-1,3-dioxan-4-yl)-2-methylhex-4-en-3-ol (129b).  A solution
of (E)-bromopropene (50.0 µL, 0.582 mmol, 2.5 equiv) in ethyl ether (0.5 mL) at – 78 °C
was treated with a solution of t-BuLi (1.7 M in pentane, 0.685 mL, 1.165 mmol, 5.0
equiv), warmed to 0 °C for 10 min, cooled to –78 °C and treated with a solution of 127
(43.4 mg, 0.233 mmol, 1.0 equiv) in ethyl ether (0.5 mL + 0.5 mL rinse) via cannula.
The mixture was stirred for 1 h at –78 °C, treated with saturated aqueous NH4Cl (1.0
mL) and water (1.0 mL), warmed to rt, diluted with water (10 mL) and extracted with
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ethyl ether.  The combined organic layers were dried (Na2SO4), filtered and
concentrated.  1H NMR indicated a diastereomeric ratio of 1.0:1.3 (129a/129b).
Purification by chromatography on SiO2 (4% acetone, 1% triethylamine/hexanes)
afforded the diastereomeric mixture of 129a and 129b (43.5 mg, 82%) as a clear,
colorless oil.  The diastereomers can be separated by chromatography on SiO2 using
the same solvent system, however, this usually required several columns (2-3) and was
therefore only performed on larger quantities of material.  129b: Rf 0.42 (10%
acetone/hexanes, three-fold developed); [α]D +41.7 (c 1.46, CHCl3, 22 °C); 
1H NMR δ
5.61 (q of AB, 1 H, J = 15.2, 6.3 Hz), 5.47 (dd of AB, 1 H, J = 15.2, 7.6, 1.4 Hz), 3.91 (d,
1 H, J = 8.3 Hz), 3.98-3.78 (m, 3 H), 3.39 (s, 1 H),1.72 (app dq, 1 H, J = 12.6, 5.6 Hz),
1.68 (d, 3 H, J = 6.3 Hz), 1.44 (s, 3 H), 1.35 (s, 3 H), 1.37-1.31 (m, 1 H), 0.90 (s, 3 H),
0.67 (s, 3 H); 13C NMR δ 130.4, 128.7, 98.6, 80.8, 77.2, 60.4, 40.4, 30.0, 25.6, 20.7,
19.5, 18.0, 15.2; IR (neat) 3465, 2990, 2965, 2937, 2876, 1672 cm-1.
HO O
Me Me
O
MeMe
Me
O O
Me MeMe
OPiv
Me Me1) p-TsOH•H2O,
    MeOH, H2O;
2) Piv-Cl, pyr, Et3N, 
    CH2Cl2;
3) 2,2-dimethoxypropane, 
    p-TsOH•H2O, THF128a 130a
2,2-Dimethylpropionic acid 2-[(4S ,6S)-(2,2,5,5-tetramethyl-6-prop-1-
ynyl[1,3]dioxan-4-yl)]ethyl ester (130a).  A solution of 128a (39.0 mg, 172 µmol, 1.0
equiv) was treated at rt with water (50 µL) and p-TsOH•H2O (10.0 mg, 53.0 µmol, 0.3
equiv).  After 12 h at rt, triethylamine (0.1 mL) was added and the mixture was
concentrated.  Purification of the residue by chromatography on SiO2 (3% to 5%
MeOH/CH2Cl2) afforded a white solid [Rf 0.34 (5% MeOH/CH2Cl2)] that was dissolved in
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CH2Cl2 (1.0 mL) and treated with triethylamine (100 µL), pyridine (10 µL) and pivaloyl
chloride (75 µL).  After 12 h at rt, the reaction mixture was poured into 1.0 M aqueous
citric acid and extracted with ethyl acetate.  The combined organic layers were dried
(Na2SO4), filtered and concentrated.  The residue was dried azeotropically with toluene,
diluted with THF (1.0 mL) and treated with p-TsOH•H2O (10 mg) and 2,2-dimethoxy-
propane (1.0 mL).  After 4 h at rt, triethylamine (0.1 mL) was added and the mixture was
concentrated onto Florisil/Celite (1:1, v/v) and purified by chromatography on SiO2 (5%
ethyl ether/hexanes) to afford 130a (34.2 mg, 64%, 3 steps) as a clear, colorless syrup:
Rf 0.30 (10% ethyl ether/hexanes); [α]D –35.0 (c 1.59, CHCl3, 22 °C); 
1H NMR δ 4.22-
4.15 (m, 1 H), 4.17 (dd, 1 H, J = 4.5, 2.2 Hz), 4.07 (app dt, 1 H, J = 9.8, 5.0 Hz), 3.67
(dd, 1 H, J = 10.9, 1.9 Hz), 1.85 (d, 3 H, J = 2.3 Hz), 1.82-1.69 (m, 1 H), 1.65-1.51 (m, 1
H), 1.41 (s, 3 H), 1.35 (s, 3 H), 1.18 (s, 9 H), 0.92 (s, 3 H), 0.89 (s, 3 H); 13C NMR δ 178.6,
101.4, 83.7, 76.0, 71.4, 70.1, 61.3, 38.9, 38.8, 28.6, 27.4, 26.0, 23.7, 21.6, 19.5, 3.9; IR
(neat) 2969, 2937, 2873, 2240, 1730, 1481, 1464 cm-1; MS (EI) m/z (rel. intensity) 295
([M-CH3]
+, 24), 184 (7), 159 (14), 151 (12), 133 (19), 94 (42), 82 (100); HRMS (EI) m/z
calcd for C17H27O4 (M-CH3) 295.1909, found 295.1901.
1) p-TsOH•H2O,
    MeOH, H2O;
2) Piv-Cl, pyr, Et3N, 
    CH2Cl2;
3) 2,2-dimethoxypropane, 
    p-TsOH•H2O, THF
HO O
Me Me
O
MeMe
Me
O O
Me MeMe
OPiv
Me Me
128b 130b
2,2-Dimethylpropionic acid 2-[(4S ,6R)-(2,2,5,5-tetramethyl-6-prop-1-
ynyl[1,3]dioxan-4-yl)]ethyl ester (130b).  Using the same procedure as for 130a, 128b
(50.0 mg, 221 µmol) afforded 130b (31.0 mg, 45%) as a clear, colorless syrup:  Rf 0.23
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(10% ethyl ether/hexanes); [α]D –26.1 (c 1.53, CHCl3, 22 °C); 
1H NMR δ 4.32 (d, 1 H, J =
2.1 Hz), 4.18-4.03 (m, 2 H), 3.58 (dd, 1 H, J = 10.4, 1.5 Hz), 1.86 (d, 3 H, J = 2.1 Hz),
1.84-1.75 (m, 1 H), 1.64-1.54 (m, 1 H), 1.41 (s, 6 H), 1.18 (s, 9 H), 1.03 (s, 3 H), 0.84 (s,
3 H); 13C NMR δ 178.6, 99.4, 82.4, 75.7, 74.0, 71.4, 61.4, 38.9, 36.6, 30.1, 29.0, 27.4,
21.3, 19.1, 13.9, 3.9; IR (neat) 2971, 2937, 2874, 2239, 1729, 1481, 1465 cm-1; MS (EI)
m/z (rel. intensity) 295 ([M-CH3]
+, 96), 271 (6), 201 (14), 187 (39), 159 (72), 151 (50), 133
(100), 73 (128); HRMS (EI) m/z calcd for C17H27O4 (M-CH3) 295.1909, found 295.1907.
PMBO OH
Me Me
Me OH
HO O
Me Me
Me
O
MeMe 1) PMB-Br, Et3N,
    KHMDS, THF;
2) AcOH, H2O, THF
131a129a
(3S,5S)-5-(4-Methoxybenzyloxy)-4,4-dimethyl-oct-6-ene-1,3-diol (131a). To a
solution of freshly distilled p-methoxybenzylbromide184 (5.20 mL, 31.0 mmol, 3.6 equiv)
in THF (40 mL) at rt was added triethylamine (7.20 mL, 51.3 mmol, 6.0 equiv) under N2.
The mixture became turbid and 129a (1.94 g, 8.50 mmol, 1.0 equiv) in THF (5 mL + 5
mL rinse) was added via cannula. The mixture was cooled to –78 °C and KHMDS was
added as a solid in one portion, followed by THF (10 mL).  The reaction mixture was
stirred at –78 °C for 1 h, then at rt for 2 h, treated with saturated aqueous NH4Cl (20
mL) and H2O (20 mL) and extracted with ethyl ether.  The combined organic layers
were washed with brine, dried (Na2SO4), filtered and concentrated to give a yellow oil
that was diluted with a mixture of glacial acetic acid (26 mL), THF (7 mL) and water (7
mL), heated at 60 °C for 12 h, poured into water (40 mL) and extracted with ethyl
acetate.  The combined organic layers were washed with 2.0 N NaOH until the
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washings had a pH > 9, extracted with brine, dried (Na2SO4), filtered and concentrated.
Purification by chromatography on SiO2 (40% to 80% ethyl acetate/hexanes) afforded
131a (2.20 g, 84%) as a pale yellow syrup:  Rf 0.24 (60% ethyl acetate/hexanes); [α]D
+22.9 (c 1.33, CHCl3, 22 °C); 
1H NMR δ 7.21 (dt, 2 H, J = 8.7, 2.4 Hz), 6.87 (dt, 2 H, J =
8.7, 2.4 Hz), 5.68 (dq, 1 H, J = 15.4, 6.4 Hz), 5.48 (ddq, 1 H, J = 15.4, 8.5, 1.5 Hz), 4.51
(d, 1 H, J = 11.2 Hz), 4.19 (d, 1 H, J = 11.2 Hz), 3.88-3.77 (m, 2 H), 3.80 (s, 3 H), 3.75
(dd, 1 H, J = 9.2, 3.8 Hz), 3.62 (d, 1 H, J = 8.5 Hz), 3.53 (bs, 2 H), 1.80 (dd, 3 H, J = 6.3,
1.4 Hz), 1.68-1.53 (m, 2 H), 0.88 (s, 3 H), 0.83 (s, 3 H); 13C NMR δ 159.5, 131.9, 130.0,
129.8, 127.5, 114.1, 88.1, 79.0, 70.1, 63.0, 55.5, 40.8, 33.0, 21.9, 21.3, 18.1; IR (neat)
3423, 2964, 2934, 2876, 1612, 1586, 1514 cm-1; HRMS (ESI) m/z calcd for C18H28O4Na
(M+Na) 331.1885, found 331.1884.
3,4-DMBO OH
Me Me
Me OH
HO O
Me Me
Me
O
MeMe 1) 3,4-DMB-Br, Et3N,
    KHMDS, THF;
2) AcOH, H2O, THF
129a 131b
(3S,5S,6E)-5-(3,4-Dimethoxybenzyloxy)-4,4-dimethyloct-6-ene-1,3-diol
(131b).  A solution of 3,4-dimethoxybenzyl bromide (1.310g, 5.669 mmol, 3.0 equiv) in
THF (10.0 mL) at rt under N2 was treated with triethylamine (1.60 mL, 11.4 mmol, 6.1
equiv).  After 2 min, a white precipitate formed and 129a (429.6 mg, 1.881 mmol, 1.0
equiv) in THF (2.5 mL + 2.5 mL rinse) was added via cannula.  The mixture was cooled
to –78 °C and treated with a solution of KHMDS (1.20 g, 5.72 mmol, 3.0 equiv) in THF
(5.0 mL).  The white precipitate dissolved and the mixture became bright yellow in
color.  After stirring for 10 min at –78 °C, the mixture was warmed to 0 °C for 10 min
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and the yellow color dissipated and a white precipitate formed.  The resulting turbid
mixture was stirred at rt for 30 min, treated with saturated aqueous NH4Cl (10 mL),
poured into water (10 mL) and extracted with ethyl ether.  The combined organic layers
were dried (Na2SO4), filtered and concentrated to a yellow syrup that was diluted with a
mixture of THF (4.0 mL), glacial acetic acid (4.0 mL) and water (4.0 mL), stirred at rt for
18 h, diluted with ethyl acetate (100 mL) and washed with 2.0 aqueous N NaOH until
the washings were pH>9.  The aqueous washings were backwashed with ethyl acetate
(3x) and the combined organic layers were dried (Na2SO4), filtered and concentrated to
a yellow syrup.  Purification by chromatography on SiO2 (70% ethyl acetate/hexanes to
100% ethyl acetate) afforded 131b (632.4 mg, 99%) as a clear, pale yellow syrup:  Rf
0.24 (80% ethyl acetate/hexanes); [α]D +28.2 (c 1.24, CHCl3, 22 °C); 
1H NMR δ 6.81-
6.80 (m, 3 H), 5.65 (dq, 1 H, J = 15.2, 6.3 Hz), 5.47 (ddd, 1 H, J = 15.3, 8.6, 1.4 Hz),
4.50, 4.18 (AB, 2 H, J = 11.4 Hz), 4.20-4.16 (m, 1 H), 3.86 (s, 3 H), 3.85 (s, 3 H), 3.86-
3.72 (m, 3 H), 3.61 (d, 1 H, J = 8.6 Hz), 3.34 (bs, 1 H), 1.78 (dd, 3 H, J = 6.3, 1.3 Hz),
1.67-1.52 (m, 2 H), 0.86 (s, 3 H), 0.82 (s, 3 H); 13C NMR δ 149.3, 148.9, 131.9, 130.5,
127.5, 120.8, 111.6, 111.3, 87.9, 78.7, 70.3, 62.8, 56.1, 56.0, 40.8, 33.1, 21.7, 21.2,
18.0; IR (neat) 3448, 2963, 2939, 2876, 1667, 1607, 1593, 1517 cm-1; HRMS (ESI) m/z
calcd for C19H30O5Na (M+Na) 361.1991, found 361.1988.
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PMBO OH
Me Me
Me
TIPS
PMBO OH
Me Me
Me OH
1) TES-OTf, 2,6-lutidine, CH2Cl2;
2) oxalyl chloride, DMSO,
    Et3N, CH2Cl2;
3) 1,3-bis(triisopropylsilyl)-
    propyne, n-BuLi, THF;
4) chloroacetic acid, MeOH, CH2Cl2131a (Z)-133a / (E)-133a
(3Z,6S,8S,9E)-8-(4-Methoxybenzyloxy)-7,7-dimethyl-1-(triisopropylsilyl)-
undeca-3,9-dien-1-yn-6-ol [(Z)-133a] and (3E,6S,8S,9E)-8-(4-methoxybenzyloxy)-
7,7-dimethyl-1-(triisopropyl-silyl)-undeca-3,9-dien-1-yn-6-ol [(E)-133a].  A solution
of 131a (149.4 mg, 484.0 µmol, 1.0 equiv) in CH2Cl2 (2.5 mL) was cooled to 0 °C and
treated with 2,6-lutidine (330 µL, 2.83 mmol, 5.9 equiv) and triethylsilyl triflate (320 µL,
1.42 mmol, 2.9 equiv).  The reaction mixture was stirred at 0 °C for 30 min, treated with
saturated aqueous NaHCO3, poured into water and extracted with CH2Cl2.  The
combined organic layers were dried (Na2SO4), filtered and concentrated.  Purification
by chromatography on SiO2 (1% triethylamine/hexanes) afforded a clear, colorless oil
(343.8 mg) that was used without further purification:  Rf 0.27 (2.5% ethyl
ether/hexanes).  Characteristic signals:  1H NMR δ 7.23 (d, 2 H, J = 8.7 Hz), 6.85 (app
dt, 2 H, J = 8.7, 2.5 Hz), 5.61 (dq, 1 H, J = 15.3, 6.3 Hz), 5.39 (ddq, 1 H, J = 15.3, 8.7,
1.5 Hz), 4.48 (d, 1 H, J = 11.5 Hz), 4.16 (d, 1 H, J = 11.5 Hz), 3.80 (s, 3 H), 3.70 (dt, 1 H,
J = 9.4, 5.0 Hz), 3.63 (d, 1 H, J = 8.7 Hz), 3.60-3.52 (m, 1 H), 1.75 (dd, 3 H, J = 6.3, 1.5
Hz), 0.85 (s, 3 H), 0.79 (s, 3 H).
A solution of  oxalyl chloride (225 µL, 2.58 mmol, 4.0 equiv) in CH2Cl2 (4.0 mL)
was cooled to –78 °C and treated with a solution of dimethylsulfoxide (362 µL, 5.10
mmol, 8.0 equiv) in CH2Cl2 (1.0 mL).  After 15 min, a solution of the bis(triethylsilyl)ether
(343.0 mg, 639.0 µmol, 1.0 equiv) in CH2Cl2 (1.5 mL + 1.5 mL rinse) was added via
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cannula.  The reaction mixture was stirred at –78 °C for 20 min and at -40 °C for 20
min, then cooled to –78 °C and treated with triethylamine (1.34 mL, 9.55 mmol, 14.9
equiv).  After 15 min, the solution was warmed to rt, poured into water (10 mL) and
extracted with CH2Cl2.  The combined organic layers were dried (Na2SO4), filtered and
concentrated.  Purification by chromatography on SiO2 (5% ethyl ether/hexanes)
afforded 132a (152.0 mg, 75% for 2 steps) as a clear colorless oil that was used
without further purification.  Characteristic signals:  1H NMR δ 9.77 (dd, 1 H, J = 2.9,
1.5 Hz), 7.22 (d, 2 H, J = 8.5 Hz), 6.86 (d, 2 H, J = 8.6 Hz), 5.61 (dq, 1 H, J = 15.4, 6.4
Hz), 5.44 (ddd, 1 H, J = 15.3, 8.9, 1.5 Hz), 4.48 (d, 1 H, J = 11.4 Hz), 4.35 (dd, 1 H, J =
6.5, 4.4 Hz), 4.12 (d, 1 H, J = 11.4 Hz), 3.80 (s, 3 H), 3.60 (d, 1 H, J = 8.9 Hz), 2.64 (dd
of AB, 1 H, J = 16.7, 4.4, 1.5 Hz), 2.48 (dd of AB, 1 H, J = 16.7, 6.5, 2.9 Hz), 1.76 (dd, 3
H, J = 6.3, 1.4 Hz), 0.93 (t, 9 H, J = 7.8 Hz), 0.85 (s, 3 H), 0.80 (s, 3 H), 0.58 (q, 6 H, J =
7.8 Hz).
1,3-Bis(triisopropylsilyl)propyne (255.0 mg, 723.0 µmol, 2.0 equiv) was
azeotropically dried with hexanes (2 x 1 mL) at reduced pressure, diluted with THF (1.0
mL) and cooled to 0 °C under N2.  A solution of n-BuLi (1.5 M in hexanes, 480 µL, 720
µmol, 2.0 equiv) was added and the mixture was stirred for 1 h, affording a pale yellow
solution that was cooled to –78 °C and treated via cannula with a solution of 132a
(152.0 mg, 361.0 µmol, 1.0 equiv) in THF (1.0 + 1.0 mL rinse).  After 30 min at –78 °C,
saturated aqueous NH4Cl solution (3.0 mL) was added and the reaction mixture was
warmed to rt, poured into water (5.0 mL) and extracted with ethyl ether.  The combined
organic layers were washed with brine, dried (Na2SO4), filtered and concentrated to
give a pale yellow oil.  Polar impurities were removed by chromatography on SiO2 (2%
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ethyl ether/hexanes), affording a pale yellow oil [Rf 0.30 (2.5% ethyl ether/hexanes)]
that was diluted with MeOH (7.5 mL) and CH2Cl2 (2.5 mL), treated with chloroacetic
acid (100.0 mg, 106.0 µmol, 2.9 equiv), stirred for 14 h at rt and concentrated.  The
residue was purified by chromatography on SiO2 (10% ethyl ether/hexanes) to afford
(Z)-133a (96.8 mg, 55%) and (E)-133a (13.0 mg, 7%).  (Z)-133a: Rf 0.16 (10% ethyl
ether/hexanes); [α]D –28.2 (c 1.12, CHCl3, 22 °C); 
1H NMR δ 7.20, 6.85 (app t of AB, 4
H, J = 8.7, 2.8 Hz), 6.20 (ddd, 1 H, J = 10.9, 8.1, 6.0 Hz), 5.67 (dq, 1 H, J = 15.3, 6.3
Hz), 5.59 (app dt, 1 H, J = 10.9, 1.5 Hz), 5.48 (ddq, 1 H, J = 15.3, 8.5, 1.5 Hz), 4.51,
4.18 (AB, 2 H, J =11.3 Hz), 3.80 (s, 3 H), 3.62 (d, 1 H, J = 8.7 Hz), 3.63-3.55 (m, 1 H),
2.64 (dddd, 1 H, J = 14.6, 8.1, 2.6, 1.4 Hz), 2.25 (dddd, 1 H, J = 14.6, 10.2, 6.0, 1.6 Hz),
1.79 (dd, 3 H, J = 6.3, 1.4 Hz), 1.64-1.05 (m, 21 H), 0.90 (s, 3 H), 0.85 (s, 3 H); 13C NMR
δ 159.4, 143.5, 131.7, 130.3, 129.6, 127.7, 114.0, 110.4, 104.2, 95.1, 88.2, 77.0, 70.1,
55.5, 41.1, 33.3, 22.0, 20.9, 18.9, 18.1, 11.5; IR (neat) 3492, 2942, 2865, 2145, 1668,
1613, 1586 cm-1; HRMS (ESI) m/z calcd for C30H48O3SiNa (M+Na) 507.3270, found
507.3270;  (E)-133a:  Rf 0.29 (10% ethyl ether/hexanes); [α]D –14.7 (c 0.95, CHCl3, 22
°C); 1H NMR δ 7.20 (d, 2 H, J = 8.5 Hz), 6.86 (d, 2 H, J = 8.5 Hz), 6.33 (app dt, 1 H, J =
15.8, 7.2 Hz), 5.67 (dq, 1 H, J = 15.3, 6.4 Hz), 5.56 (d, 1 H, J = 15.9 Hz), 5.47 (ddd, 1 H,
J = 15.4, 8.5, 1.4 Hz), 4.51 (d, 1 H, J = 11.3 Hz), 4.17 (d, 1 H, J = 11.3 Hz), 3.80 (bs, 3
H), 3.79 (s, 1 H), 3.59 (d, 1 H, J = 8.5 Hz), 3.58-3.53 (m, 1 H), 2.21 (dd, 1 H, J = 14.4,
7.4 Hz), 2.04 (dddd, 1 H, J = 14.3, 10.0, 7.0, 1.2 Hz), 1.79 (dd, 3 H, J = 6.3, 1.2 Hz),
1.08-1.06 (m, 21 H), 0.86 (s, 3 H), 0.84 (s, 3 H); 13C NMR δ 159.4, 144.1, 131.8, 130.2,
129.8, 127.6, 114.0, 111.5, 106.1, 89.0, 87.7, 76.9, 70.0, 55.5, 41.0, 35.9, 22.0, 21.0,
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18.8, 18.1, 11.5; IR (neat) 3490, 2960, 2942, 2891, 2865, 2171, 2131, 1613, 1586, 1514,
1464 cm-1; HRMS (ESI) m/z calcd for C30H48O3SiNa (M+Na) 507.3270, found 507.3294.
3,4-DMBO OH
Me Me
Me
3,4-DMBO OTES
CHO
Me Me
MeOH
1) TES-OTf, 2,6-lutidine,
    CH2Cl2;
2) oxalyl chloride,
    DMSO, CH2Cl2
131b 132b
(3S,5S,6E)-5-(3,4-Dimethoxybenzyloxy)-4,4-dimethyl-3-(triethylsilyloxy)oct-
6-enal  (132b).  A solution of 131b (632.4 mg, 1.869 mmol, 1.0 equiv) in CH2Cl2 (20.0
mL) was cooled under N2 to 0 °C and treated with 2,6-lutidine (1.40 mL, 12.0 mmol, 6.4
equiv) and triethylsilyltriflate (1.35 mL, 5.97 mmol, 3.2 equiv).  The mixture was stirred
at 0 °C for 45 min and quenched with saturated aqueous NH4Cl (20 mL) and water (10
mL), stirred for 30 min at rt and then extracted with CH2Cl2.  The combined organic
layers were washed with 1.0 M aqueous citric acid (50 mL) and brine, dried (Na2SO4),
filtered and concentrated to a turbid, pale yellow oil which was diluted with ethyl ether
and filtered through a plug of Florisil/Celite (1:1 v/v).  The plug was rinsed with ethyl
ether and the combined filtrate was concentrated to a clear, pale yellow oil that was
used without further purification.
A solution of oxalyl chloride (650 µL, 7.45 mmol, 4.0 equiv) in CH2Cl2 (20.0 mL)
was cooled under N2 to –78 °C and treated with a solution of DMSO (1.10 mL, 15.5
mmol, 8.3 equiv) in CH2Cl2 (1.0 mL + 1.0 mL rinse).  The mixture was aged at –78 °C for
15 min and then treated with a solution of the crude bis(triethysilyl)ether in CH2Cl2 (5.0
mL + 5.0 mL rinse).  The mixture was stirred for 25 min at –78 °C, 20 min at –40 °C , 15
min at –78 °C, treated with triethylamine (4.00 mL, 28.5 mmol, 15.2 mmol), stirred for
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10 min at –78 °C, warmed to rt over 25 min and then treated with water (20 mL).  The
mixture was extracted with CH2Cl2 and the combined organic layers were washed with
brine, dried (Na2SO4), filtered and concentrated.  Purification by chromatography on
SiO2 (10% to 20% ethyl ether/hexanes) afforded 132b (720.3 mg, 86%) as a clear,
colorless oil:  Rf 0.41 (40% ethyl ether/hexanes); [α]D +0.101 (c 1.49, CHCl3, 22 °C); 
1H
NMR (C6D6) δ 9.54 (app t, 1 H, J = 1.0 Hz), 6.94-6.92 (m, 2 H), 6.64 (d, 1 H, J = 7.8 Hz),
5.58-5.40 (m, 2 H), 4.60 (d, 1 H, J = 11.4 Hz), 4.52 (dd, 1 H, J = 6.4, 4.2 Hz), 4.22 (d, 1
H, J = 11.4 Hz), 3.69 (d, 1 H, J = 8.0 Hz), 3.54 (s, 3 H), 3.41 (s, 3 H), 2.44 (dd of AB, 1 H,
J = 17.1, 4.2, 1.0 Hz), 2.34 (dd of AB, 1 H, J = 17.1, 6.5, 2.3 Hz), 1.58 (d, 3 H, J = 5.1
Hz), 1.02 (s, 3 H), 0.99 (s, 3 H), 0.95 (t, 9 H, J = 6.4 Hz), 0.68-0.60 (m, 6 H); 13C NMR
(C6D6) δ 200.6, 150.8, 150.1, 132.7, 131.2, 129.7, 120.5, 112.9 (2 C), 85.0, 72.1, 70.5,
56.2 (2 C), 49.2, 43.4, 20.8, 19.4, 18.1, 7.6, 6.2; IR (neat) 2955, 2912, 2876, 2834, 2723,
1725, 1609, 1593, 1517, 1465 cm-1; HRMS (ESI) m/z calcd for C25H42O5SiNa (M+Na)
473.2699, found 473.2666.
3,4-DMBO OH
Me Me
Me
TIPS
3,4-DMBO OTES
CHO
Me Me
Me
1) 1,3-bis(triisopropylsilyl)-
     propyne, n-BuLi, THF;
2) chloroacetic acid, 
    MeOH, CH2Cl2
132b (Z)-133b / (E)-133b
(3Z,6S,8S,9E)-8-(3,4-Dimethoxybenzyloxy)-7,7-dimethyl-1-(triisopropylsilyl)-
undeca-3,9-dien-1-yn-6-ol [(Z)-133b] and (3E,6S,8S,9E)-8-(3,4-dimethoxybenzyl-
oxy)-7,7-dimethyl-1-(triisopropyl-silyl)-undeca-3,9-dien-1-yn-6-ol [(E )-133b].   A
solution of 1,3-bis(triisopropylsilyl)propyne (1.130 g, 3.203 mmol, 2.0 equiv) was
azeotropically dried with hexanes at reduced pressure, diluted with THF (10.0 mL),
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cooled to 0 °C under N2 and treated with a solution of n-BuLi (1.5 M in hexanes, 2.15
mL, 3.23 mmol, 2.0 equiv).  The mixture was warmed to rt and stirred for 1.5 h, cooled
to –78 °C and treated via cannula with a solution of 132b (720.0 mg, 1.600 mmol, 1.0
equiv) in THF (1.0 mL + 1.0 mL rinse).  The mixture was stirred for 3 h at –78 °C and
treated with saturated aqueous NH4Cl (10 mL), warmed to rt, diluted with H2O (10 mL)
and extracted with ethyl ether.  The combined organic layers were dried (Na2SO4),
filtered and concentrated, diluted with CH2Cl2 (5.0 mL) and MeOH (15.0 mL) and
treated with chloroacetic acid (200.0 mg, 2.116 mmol, 1.3 equiv).  The mixture was
stirred at rt for 20 h, treated with additional chloroacetic acid (200.0 mg, 2.116 mmol,
1.3 equiv), stirred for an additional 28 h (48 h total), concentrated, diluted with ethyl
ether (20 mL) and washed with saturated aqueous NaHCO3, dried (Na2SO4), filtered and
concentrated.  Purification by chromatography on SiO2 (20% to 40% ethyl
ether/hexanes) afforded (E)-133b (84.6 mg, 10%) and (Z)-133b (467.6 mg, 57%):  (Z)-
133b:  Rf 0.26 (40% ethyl ether/hexanes); [α]D –17.8 (c 1.14, CHCl3, 22 °C); 
1H NMR δ
6.83 (m, 3 H), 6.19 (ddd, 1 H, J = 10.8, 7.9, 6.6 Hz), 5.66 (dq, 1 H, J = 15.2, 6.3 Hz),
5.59 (d, 1 H, J = 10.9 Hz), 5.48 (dd, 1 H, J = 15.3, 8.5 Hz), 4.51 (d, 1 H, J = 11.4 Hz),
4.19 (d, 1 H, J = 11.4 Hz), 3.87 (s, 3 H), 3.87 (s, 3 H), 3.73 (d, 1 H, J = 4.2 Hz), 3.63 (d, 1
H, J = 8.6 Hz), 3.64-3.59 (m, 1 H), 2.65 (dd, 1 H, J = 13.6, 7.1 Hz), 2.28 (ddd, 1 H, J =
15.6, 10.2, 6.1 Hz), 1.79 (d, 3 H, J = 6.3 Hz), 1.11-1.07 (m, 21 H), 0.90 (s, 3 H), 0.86 (s, 3
H); 13C NMR δ 149.2, 148.8, 143.5, 131.7, 130.7, 127.7, 120.6, 111.4, 111.1, 110.4,
104.2, 95.2, 88.1, 77.0, 70.3, 56.1, 56.0, 41.1, 33.3, 21.9, 20.9, 18.9, 18.1, 11.5; IR
(neat) 3493, 2942, 2865, 2144, 1898, 1611, 1593, 1516 cm-1; HRMS (ESI) m/z calcd for
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C31H50O4SiNa (M+Na) 537.3376, found 537.3398.  (E)-133b:  Rf 0.47 (40% ethyl
ether/hexanes); [α]D -15.1 (c 1.64, CHCl3, 22 °C); 
1H NMR δ 6.82-6.81 (m, 3 H), 6.33
(app dt, 1 H, J = 15.9, 7.0 Hz), 5.67 (dq, 1 H, J = 15.3, 6.4 Hz), 5.57 (d, 1 H, J = 15.9
Hz), 5.47 (dd, 1 H, J = 15.3, 8.6 Hz), 4.51 (d, 1 H, J = 11.5 Hz), 4.18 (d, 1 H, J = 11.5
Hz), 3.87 (s, 6 H), 3.72 (d, 1 H, J = 4.4 Hz), 3.60 (d, 1 H, J = 8.5 Hz), 3.65-3.55 (m, 1 H),
2.23 (dd, 1 H, J = 14.2, 7.3 Hz), 2.12-2.02 (m, 1 H), 1.79 (d, 3 H, J = 6.3 Hz), 1.06-1.04
(m, 21 H), 0.86 (s, 3 H), 0.85 (s, 3 H); 13C NMR δ 149.2, 148.9, 144.0, 131.8, 130.6,
127.6, 120.7, 111.6, 111.5, 111.1, 106.1, 89.0, 87.6, 76.9, 70.2, 56.1, 56.0, 41.0, 35.9,
21.9, 21.0, 18.8, 18.1, 11.5; IR (neat) 3491, 2942, 2865, 2170, 2130, 1593, 1516, 1464,
1418 cm-1; HRMS (ESI) m/z calcd for C31H50O4SiNa (M+Na) 537.3376, found 537.3394.
PMBO OH
Me Me
Me
TIPS
PMBO OH
Me Me
Me
TBAF
THF
H
(Z)-133a 118a
(6S,8S)-8-(4-Methoxybenzyloxy)-7,7-dimethylundeca-3,9-dien-1-yn-6-ol
(118a).  A solution of (Z)-133a (99.7 mg, 206 µmol, 1.0 equiv) in THF (2.0 mL) was
cooled to 0 °C and a solution of TBAF (1.0 M in THF, 250 µL, 250 µmol, 1.2 equiv) was
added.  The reaction mixture was allowed to warm to rt and stirred for 14 h.  Saturated
aqueous NaHCO3 solution (5.0 mL) was added and the mixture was poured into water
and extracted with ethyl ether.  The combined organic layers were dried (Na2SO4),
filtered and concentrated.  Purification by chromatography on SiO2 (10% ethyl
ether/hexanes) afforded 118a (63.9 mg, 94%) as a clear, colorless syrup:  Rf 0.26 (20%
ethyl ether/hexanes); [α]D –9.05 (c 1.48, CHCl3, 22 °C); 
1H NMR δ 7.21 (app dt, 2 H, J =
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8.7, 2.8 Hz), 6.86 (app dt , 2 H, J = 8.7, 2.8 Hz), 6.24 (app dtd, 1 H, J = 10.9, 7.2, 0.7
Hz), 5.69 (dq, 1 H, J = 15.3, 6.3 Hz), 5.55-5.44 (m, 2 H), 4.51(d, 1 H, J = 11.2 Hz), 4.19
(d, 1 H, J = 11.2 Hz), 3.79 (app s, 4 H), 3.65 (d, 1 H, J = 8.5 Hz), 3.58 (ddd, 1 H, J =
10.0, 4.7, 2.5 Hz), 3.07 (d, 1 H, J = 1.6 Hz), 2.55 (bdd, 1 H, J = 14.4, 7.7 Hz), 2.28
(dddd, 1 H, J = 14.5, 10.1, 6.7, 1.2 Hz), 1.79 (dd, 3 H, J = 6.3, 1.5 Hz), 0.90 (s, 3 H),
0.89 (s, 3 H); 13C NMR δ 159.4, 144.6, 131.7, 130.2, 129.7, 127.6, 114.0, 109.0, 87.9,
81.6, 80.9, 77.3, 70.0, 55.4, 41.0, 33.2, 21.9, 21.2, 18.1; IR (neat) 3482, 3290, 3031,
2965, 2937, 2913, 2874, 2837, 2095, 1613, 1586, 1514 cm-1; MS (EI) m/z (rel. intensity)
328 (M+, 0.3), 258 (1.3), 163 (1.4), 121 (100), 96 (26); HRMS (EI) m/z calcd for C21H28O3
328.2038, found 328.2040.
3,4-DMBO OH
Me Me
Me
TIPS
3,4-DMBO OH
Me Me
Me
TBAF
THF
H
(Z)-133b 118b
(3Z,6S,8S,9E)-8-(3,4-Dimethoxybenzyloxy)-7,7-dimethylundeca-3,9-dien-1-
yn-6-ol (118b).  A solution of (Z)-133b (275.6 mg, 535.3 µmol, 1.0 equiv) in THF (2.0
mL) was treated with a solution of TBAF (1.0 M in THF, 700 µL, 700 µmol, 1.3 equiv)
and stirred at rt for 8 h.  Saturated aqueous NaHCO3 solution (5.0 mL) was added and
the mixture was poured into water (10 mL) and extracted with ethyl ether.  The
combined organic layers were dried (Na2SO4), filtered and concentrated.  Purification
by chromatography on SiO2 (20% to 40% ethyl ether/hexanes) afforded 118b (162.7
mg, 85%) as a clear, colorless syrup:  Rf 0.31 (20% acetone/hexanes); [α]D –1.81 (c
0.83, CHCl3, 22 °C); 
1H NMR δ 6.84-6.81 (m, 3 H), 6.24 (ddd, 1 H, J = 10.8, 7.5, 6.9 Hz),
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5.68 (dq, 1 H, J = 15.3, 6.4 Hz), 5.55-5.44 (m, 2 H), 4.51 (d, 1 H, J = 11.4 Hz), 4.20 (d, 1
H, J = 11.4 Hz), 3.87 (s, 6 H), 3.77 (d, 1 H, J = 5.0 Hz), 3.66 (d, 1 H, J = 8.6 Hz), 3.61-
3.55 (m, 1 H), 3.07 (d, 1 H, J = 2.2 Hz), 2.56 (dd, 1 H, J = 14.4, 7.7 Hz), 2.30 (ddd, 1 H,
J = 15.4, 9.3, 6.9 Hz), 1.80 (dd, 3 H, J = 6.3, 1.1 Hz), 0.90 (s, 3 H), 0.90 (s, 3 H); 13C
NMR δ 149.2, 148.8, 144.6, 131.8, 130.6, 127.6, 120.7, 111.5, 111.1, 109.1, 87.8, 81.7,
80.9, 77.4, 70.2, 56.1, 56.0, 41.1, 33.3, 21.8, 21.3, 18.1; IR (neat) 3482, 3286, 2964,
2937, 2905, 2875, 2833, 2094, 1667, 1608, 1593, 1516 cm-1; HRMS (ESI) m/z calcd for
C22H30O4Na (M+Na) 381.2042, found 381.2055.
HO O
Me Me
O
MeMe
Me
128b
O
Me Me
O
MeMe
Me
O
Dess-Martin
Periodinane,
NaHCO3,
CH2Cl2
134
(S)-2-(2,2-Dimethyl-1,3-dioxan-4-yl)-2-methylhex-4-yn-3-one (134).  A
solution of 128b (106.0 mg, 0.468 mmol, 1.0 equiv) in CH2Cl2 (5.0 mL) was treated at rt
with NaHCO3 (150.0, 1.786 mmol, 3.8 equiv) and Dess-Martin periodinane (485.0 mg,
1.143 mmol, 2.4 equiv) and stirred at rt for 1 h.  Analysis by TLC indicated that the
reaction was sluggish, so water (1.0 µL, 55 µmol, 0.12 equiv) was added.  After 1.5 h,
saturated aqueous NaHCO3 (4.5 mL) and saturated aqueous Na2S2O3 (4.5 mL) were
carefully added.  The mixture was extracted with CH2Cl2 and the combined organic
layers were dried (Na2SO4), filtered and concentrated.  Purification by chromatography
on SiO2 (4% acetone, 1% triethylamine/hexanes) afforded 134 (95.0 mg, 90%) as a
white, crystalline solid:  Rf 0.41 (30% acetone/hexanes); Mp 71.6-73.6 °C
(hexanes/acetone/triethylamine); [α]D +31.9 (c 1.13, CHCl3, 22 °C); 
1H NMR δ 4.29 (dd,
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1 H, J = 11.7, 2.4 Hz), 3.97 (dt, 1 H, J = 11.8, 2.8 Hz), 3.84 (ddd, 1 H, J = 11.6, 5.3, 1.6
Hz), 2.01 (s, 3 H), 1.63 (app dq, 1 H, J = 5.4, 12.2 Hz), 1.41 (s, 3 H), 1.34 (dd, 1 H, J =
4.5, 2.1 Hz), 1.29 (s, 3 H), 1.12 (s, 3 H), 1.06 (s, 3 H); 13C NMR δ 192.6, 98.7, 90.9, 78.7,
72.9, 60.1, 51.6, 29.8, 25.4, 20.4, 19.1, 18.1, 4.2; IR (KBr) 3328, 2979, 2948, 2884,
2289, 2217, 1670 cm-1; MS (EI) m/z (rel. intensity) 224 (M+, 1.0), 209 ([M-CH3]
+, 100),
166 (16), 149 (69), 115 (31); HRMS (EI) m/z calcd for C12H17O3 (M-CH3) 209.1178, found
209.1181.
O
Me Me
O
MeMe
Me
O HO O
Me Me
O
MeMe
Me
HO O
Me Me
O
MeMe
Me
+
128a 128b
DiBAl-H
CH2Cl2
134
(3S)-2-{(4S)-2,2-Dimethyl-[1,3]-dioxan-4-yl}-2-methylhex-4-yn-3-ol (128a)
and (3R)-2-{(4S)-2,2-dimethyl-[1,3]-dioxan-4-yl}-2-methylhex-4-yn-3-ol (128b).  A
solution of 134 (1.102 g, 4.915 mmol, 1.0 equiv) in CH2Cl2 (20.0 mL) was cooled to –78
°C under N2, treated with a solution DiBAl-H (1.0 M in hexanes, 5.50 mL, 5.50 mmol,
1.1 equiv) over 5 min, stirred for 45 min at –78 °C, treated with acetone (1.0 mL), stirred
for 15 min, treated with 1.0 M aqueous sodium tartrate (10 mL), warmed to rt and
vigorously stirred until the layers separated (ca. 2 h).  The mixture was extracted with
ethyl ether and the combined organic layers were dried (Na2SO4), filtered and
concentrated to a clear, pale yellow syrup.  1H NMR (benzene-d6) analysis indicated a
ratio 128a/128b = 2.9/1.0.  Purification by chromatography on SiO2 (4% acetone, 1%
triethylamine/hexanes to 20% acetone, 1% triethylamine/hexanes) afforded 128a
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(827.8 mg, 74%) and 128b (242.9 mg, 22%) and a mixture of diastereomers 128a/128b
= 1.0/1.0 (34.0 mg, 3%).
HO O
Me Me
O
MeMe
Me
O O
Me Me
O
MeMe
Me
Dess-Martin
periodinane,
NaHCO3,
CH2Cl2
129b 135
(S,E)-2-(2,2-Dimethyl-1,3-dioxan-4-yl)-2-methylhex-4-en-3-one (135).  A
solution of 129b (27.8 mg, 0.122 mmol, 1.0 equiv) in CH2Cl2 (2.0 mL) was cooled to 0
°C and treated with NaHCO3 (51.0 mg, 0.607 mmol, 5.0 equiv) and Dess-Martin
periodinane (85.0 mg, 0.200 mmol, 1.6 equiv), warmed to rt and stirred for 1 h and
treated with saturated aqueous NaHCO3 (2.0 mL) and saturated aqueous Na2S2O3 (2.0
mL).  The mixture was diluted with CH2Cl2 (5 mL) and water (5 mL), stirred until both
phases were clear (ca. 1 h) and extracted with CH2Cl2.  The combined organic layers
were dried (Na2SO4), filtered and concentrated.  Purification by chromatography on
SiO2 (4% acetone, 1% triethylamine/hexanes) afforded 135 (23.3 mg, 84%) as a clear,
colorless oil that crystallized to a white solid on standing:  Rf 0.34 (10%
acetone/hexanes); Mp 52.2-54.0 °C (CH2Cl2); [α]D -1.76 (c 1.70, CHCl3, 22 °C); 
1H NMR
δ 6.83 (dq, 1 H, J = 15.1, 6.9 Hz), 6.51 (dq, 1 H, J = 15.1, 1.5 Hz), 4.01 (dd, 1 H, J =
11.7, 2.5 Hz), 3.90 (td, 1 H, J = 11.9, 2.8 Hz), 3.79 (ddd, 1 H, J = 11.7, 5.4, 1.9 Hz), 1.83
(dd, 3 H, J = 6.9, 1.6 Hz), 1.56 (app dq, 1 H, J = 12.0, 5.5 Hz), 1.37 (s, 3 H), 1.30-1.28
(m, 1 H), 1.28 (s, 3 H), 1.08 (s, 3 H), 1.04 (s, 3 H); 13C NMR δ 203.0, 142.1, 127.3, 98.5,
73.4, 60.1, 49.7, 29.8, 25.7, 20.3, 19.8, 19.1, 18.4; IR (KBr) 2999, 2991, 2982, 2970,
2942, 2916, 2901, 2877, 2723, 1690, 1625 cm-1; MS (EI) m/z (rel. intensity) 211 ([M-15]+,
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1.8), 168 ([M-CO(CH3)2]
+, 3.0), 151 (1.4), 115 (4.2), 59 (100); HRMS (EI) m/z calcd for
C12H19O3 (M-CH3) 211.1334, found 211.1309.
HO CN TIPSO
1) TIPS-Cl, imidazole, DMF;
2) DiBAl-H, CH2Cl2
O
H
136 137
3-(Triisopropylsilyloxy)propionaldehyde (137).164  A mixture of 136 (2.00 mL,
29.3 mmol, 1.0 equiv) and imidazole (4.00 mL, 58.7 mmol, 2.0 equiv) in DMF (3.0 mL)
was treated at rt with TIPS-Cl (6.90 mL, 32.2 mmol, 1.1 equiv).  After a brief exothermic
period, the mixture was stirred at rt for 16 h, quenched with saturated aqueous NH4Cl
solution, diluted with water and extracted with ethyl ether.  The combined organic
layers were washed with 4.0 M aqueous LiCl, dried (Na2SO4), filtered and concentrated.
Bulb to bulb distillation (88 °C/0.1 mm Hg) afforded 3-triisopropylsilyloxypropionitrile
(6.77 g, quant) as a clear colorless oil that was used without further purification:  Rf
0.57 (20% acetone/hexanes, twofold developed).
A solution of 3-triisopropylsilyloxypropionitrile (7.21 g, 31.7 mmol, 1.0 equiv) in
CH2Cl2 (100 mL) was cooled to -10 °C under N2.  The flask was partially evacuated and
flushed with N2 (2 cycles), DiBAl-H (1.0 M in hexanes, 45.0 mL, 45.0 mmol, 1.4 equiv)
was added and the reaction mixture was stirred at -10 °C for 50 min and then added
via cannula to a mixture of 1.0 M aqueous L-tartaric acid (100 mL) and brine (100 mL).
The solution was vigorously stirred until both phases were clear and the aqueous layer
was extracted with CH2Cl2 (2 x 100 mL).  The combined organic layers were dried
(Na2SO4), filtered and concentrated to give an orange-colored oil that was poured onto
a pad of SiO2 (wetted with ethyl ether).  The pad was washed with ethyl ether (250 mL)
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and the combined filtrates were concentrated to a yellow oil.  Bulb to bulb distillation
(75 °C/0.1 mm Hg) afforded 137 as a clear colorless oil (4.83 g, 66%) that was used
without further purification.  For analytical purposes, a sample was purified by
chromatography on SiO2 (5% ethyl acetate/hexanes) to afford 137 as a clear, colorless
oil:  Rf 0.69 (20% acetone/hexanes, twofold developed); 
1H NMR δ 9.80 (t, 1 H, J = 2.1
Hz), 4.05 (t, 2 H, J = 6.0 Hz), 2.58 (dt, 2 H, J = 6.0, 2.1 Hz), 1.15-0.99 (m, 21 H); 13C
NMR δ 202.1, 58.1, 46.9, 18.1, 12.1; IR (neat) 2944, 2892, 2867, 2726, 1730, 1464,
1389, 1111 cm-1; MS (EI) m/z (rel. intensity) 187 ([M-C3H7]
+, 41), 157 (41), 145 (100), 129
(59), 117 (60), 101 (58), 87 (46); HRMS (EI) m/z calcd for C9H19O2Si (M-C3H7) 187.1154,
found 187.1158.
TIPSO
O
H TIPSO
OH
TMS
TMS-acetylene, Et2Zn,
(S)-BINOL, Ti(i-PrO)4,
toluene, Et2O
137 138
(3R)-5-(Triisopropylsilyloxy)-1-(trimethylsilyl)pent-1-yn-3-ol (138).185  A
solution of trimethylsilylacetylene (245 µL, 1.73 mmol, 4.0 equiv) and diethylzinc (175
µL, 1.71 mmol, 4.0 equiv) in toluene (2.0 mL) was heated at reflux under N2 for 1 h. A
voluminous precipitate formed, and the reaction mixture was cooled to rt and slowly
treated with (S)-BINOL (62.0 mg, 220  µmol, 0.5 equiv).  After addition of ethyl ether
(8.0 mL) and Ti(i-OPr)4 (130 µL, 440 µmol, 1.0 equiv), the mixture turned red-orange and
was stirred at rt for 1 h before addition of 137 (100.0 mg, 434 µmol, 1.0 equiv).  After 20
h at rt, 1.0 M aqueous L-tartaric acid (3 mL) and brine (3 mL) were added and the
reaction mixture was vigorously stirred for 1 h and extracted with ethyl ether.  The
combined organic layers were washed with brine, dried (Na2SO4), filtered and
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concentrated.  Purification by chromatography on SiO2 (5% to 20% ethyl
ether/hexanes) afforded 138 (93.8 mg, 66%) as a clear, colorless oil:  Rf 0.18 (5% ethyl
ether/hexanes); [α]D +21.0 (c 1.42, CHCl3, 22 °C); 4.63 (dd, 1 H, J = 10.0, 5.7 Hz), 4.16
(ddd, 1 H, J = 10.0, 8.2, 3.7 Hz), 3.91 (ddd, 1 H, J = 10.0, 5.8, 4.2 Hz), 3.66 (d, 1 H, J =
5.9 Hz), 2.02 (app ddt, 1 H, J = 14.2, 8.2, 4.2 Hz), 1.85 (app dtd, 1 H, J = 14.2, 6.1, 3.7
Hz), 1.14-1.03 (m, 21 H), 0.16 (s, 9 H); 13C NMR δ 106.4, 89.4, 62.8, 61.9, 38.5, 18.1,
11.9, 0.1;  IR (neat) 3418, 2958, 2944, 2894, 2867, 2172, 1464 cm-1; MS (EI) m/z (rel.
intensity) 285 ([M-C3H7]
+, 12), 177 (14), 145 (18), 131 (51), 119 (100), 103 (32), 75 (35);
HRMS (EI) m/z calcd for C14H29O2Si2 (M-C3H7) 285.1706, found 285.1701.
TIPSO
OH
TMS
HO
OBz
TMS
1) Bz-Cl, DMAP, pyr;
2) aq. HF, CH3CN
138 139
(3R)-3-Benzoyloxy-5-trimethylsilylpent-4-yn-1-ol (139).  A solution of 138
(32.0 mg, 97 µmol, 1.0 equiv) in pyridine (1.0 mL) was treated with 4-
dimethylaminopyridine (1.0 mg, 8.0 µmol, 0.1 equiv) and benzoyl chloride (50.0 µL, 430
µmol, 4.4 equiv) and stirred at rt for 4 h, treated with saturated aqueous NaHCO3
solution and stirred for an additional 30 min at rt.  The mixture was extracted with ethyl
ether and the combined organic layers were dried (Na2SO4), filtered and concentrated.
Purification by chromatography on SiO2 (0% to 2.5% ethyl ether/hexanes) afforded
(3R)-3-benzoyloxy-1-triisopropylsilyloxy-5-trimethylsilylpent-4-yne (41.8 mg, 100%) as
a clear, colorless oil.  A portion of this oil (25.0 mg, 58.0 µmol, 1.0 equiv) was dissolved
in CH3CN (2.0 mL), treated with 48% aqueous HF (0.1 mL), stirred for 12 h at rt, poured
into saturated aqueous NaHCO3 solution and extracted with ethyl ether.  The combined
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organic layers were dried (Na2SO4), filtered and concentrated.  Purification by
chromatography on SiO2 (30% to 40% ethyl ether/hexanes) afforded 139 (14.9 mg,
93%) as a clear colorless oil:  Rf 0.35 (40% ethyl ether/hexanes); [α]D +22.5 (c 0.89,
CHCl3, 22 °C); 
1H NMR δ 8.09-8.06 (m, 2 H), 7.61-7.56 (m, 1 H), 7.48-7.44 (m, 2 H), 5.85
(t, 1 H, J = 6.5 Hz), 3.90-3.74 (m, 2 H), 2.16 (app dt, 2 H, J = 6.1, 6.1 Hz), 2.00 (bs, 1 H),
0.18 (s, 9 H); 13C NMR δ 165.9, 133.5, 130.1, 130.0, 128.6, 102.4, 91.7, 62.6, 58.9, 38.3,
0.0; IR (neat) 3434, 3064, 2960, 2929, 2898, 2179, 1725, 1602, 1585, 1452 cm-1; HRMS
(ESI) m/z calcd for C15H20O3SiNa (M+Na) 299.1079, found 299.1066.  The enantiomeric
excess was determined to be 92% by analytical HPLC (Chiralcel-OD, 0.46 cm x 25 cm,
4% isopropanol/hexanes, 1 mL/min, UV detection at 254 nm, Rt (major) = 7.85 min,  Rt
(minor) = 11.08 min.
TIPSO
OH
TMS
TIPSO
OMe
Me2SO4,
n-Bu4NHSO4,
aq. NaOH (50% w/w),
toluene138 139
 (3S)-1-Triisopropylsilyloxy-3-methoxypent-4-yne (139).  A solution of 138
(4.764 g, 14.50 mmol, 1.0 equiv) in toluene (15 mL) was cooled to 0 °C and treated with
50% (w/w) aqueous NaOH (15 mL), n-Bu4NHSO4 (1.710 g, 5.040 mmol, 0.35 equiv) and
dimethylsulfate (6.90 mL, 72.9 mmol, 5.0 equiv).  The reaction mixture was vigorously
stirred for 1 h at 0 °C, then for an additional 2.5 h at rt, cooled to 0 °C and treated with
methanol (3.0 mL, 74 mmol, 5 equiv), stirred for 15 min and warmed to rt.  The resulting
gel was dissolved with water (30 mL) and ethyl ether (10 mL) and extracted with ethyl
ether.  The combined organic layers were washed with brine, dried (Na2SO4), filtered
and concentrated.  Purification by chromatography on SiO2 (0% to 5% ethyl
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ether/hexanes) afforded 139 (3.730 g, 95%) as a clear, colorless oil:  Rf 0.23 (2.5%
ethyl ether/hexanes); 1H NMR δ 4.19 (ddd, 1 H, J = 7.8, 7.8, 1.9 Hz), 3.91-3.77 (m, 2 H),
3.42 (s, 3 H), 2.43 (d, 1 H, J = 2.0 Hz), 2.03-1.84 (m, 2 H), 1.12-1.01 (m, 21 H); 13C NMR
δ 83.0, 73.9, 68.0, 59.3, 56.8, 39.1, 18.2, 12.2; IR (neat) 3311, 2943, 2892, 2867, 2823,
2108, 1464, 1111 cm-1; MS (EI) m/z (rel. intensity)  227 ([M-C3H7]
+, 7), 175 (7), 145 (84),
133 (100), 117 (28), 75 (38); HRMS (EI) m/z calcd for C12H23O2Si (M-C3H7) 227.1467,
found 227.1465.
OMeO
HOTIPSO
OMe 1) aq. HF, CH3CN;
2) NaClO2, NaOCl,
    TEMPO, buffer, 
    CH3CN140 141
(3R)-3-Methoxypent-4-ynoic acid (141).168 A solution of 140 in acetonitrile (20
mL) in a polypropylene reaction vessel was treated at 0 °C with 48% aqueous HF (2.00
mL, 55.2 mmol, 4.1 equiv) and stirred at rt for 24 h.  The reaction mixture was cooled to
0 °C and treated with a solution of NaOH (2.00 g, 50.0 mmol, 3.7 equiv) in water (5 mL),
warmed to rt, poured into 1.3 M phosphate buffer (pH 6.7, 50 mL) and diluted with
acetonitrile (30 mL).  TEMPO (2.00 g, 1.28 mmol, 0.1 equiv), NaClO2 (3.00 g, 33.3
mmol, 2.5 equiv) and NaOCl solution (0.5 mL) were added.  The mixture turned dark
purple and was heated to 45 °C (oil bath temperature).  After 4 h, additional NaClO2
(3.00 g, 33.3 mmol, 2.5 equiv) was added.  After a total of 18 h, methanol (10 mL) was
added and the color changed to yellow.  The mixture was poured into 2.0 N HCl (100
mL) and extracted with ethyl acetate.  The combined organic layers were dried
(Na2SO4), filtered and concentrated to give a pale yellow oil that was treated with 2.0 N
aqueous NaOH solution (20 mL) and water (20 mL).  The resulting mixture was washed
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with ethyl ether (2 x 35 mL), acidified with 2.0 N aqueous NaHSO4 (40 mL) and
extracted with ethyl acetate.  The combined ethyl acetate layers were washed with
brine, dried (Na2SO4), filtered and concentrated to afford 141 as a pale yellow oil (1.701
g, 99%) that was used without further purification:  Rf 0.50 (60% ethyl
acetate/hexanes); [α]D +64.1 (c 1.25, CHCl3, 22 °C); 
1H NMR δ 9.84 (bs, 1 H), 4.39 (ddd,
1 H, J = 7.8, 5.3, 2.0 Hz), 3.42 (s, 3 H), 2.79 (d of AB, 1 H, J = 16.1, 8.1 Hz), 2.76 (d of
AB, 1 H, J = 16.0, 5.3 Hz), 2.50 (d, 1 H, J = 2.0 Hz); 13C NMR δ 175.9, 80.8, 74.9, 67.0,
57.0, 40.9; IR (neat) 3452, 3290, 2997, 2830, 2622, 2117, 1717, 1404 cm-1; MS (EI) m/z
(rel. intensity) 128 (M+, 0.4), 127 ([M-H]+, 3.7), 113 ([M-CH3]
+, 8), 98 (7), 82 (7), 70 (26), 69
(100); HRMS (EI) m/z calcd for C6H7O3 (M-H) 127.0395, found 127.0395.
N
O
MeO2C OMe
R
OMeO
HO
144, R = Br
143, R = H
1) Ser-OMe•HCl, EDC, 
    HOBT, NMM, CH2Cl2;
2) DAST, CH2Cl2 then K2CO3;
3) BrCCl3, DBU, CH2Cl2141
2-[(2R)-4-Bromo-2-methoxybut-3-ynyl]oxazole-4-carboxylic acid methyl
ester (144) and 2-[(2R)-2-methoxybut-3-ynyl]oxazole-4-carboxylic acid methyl
ester (143).  A mixture of 141 (384.0 mg, 2.997 mmol, 1.0 equiv), serine methyl ester
hydrochloride (700.0 mg, 4.499 mmol, 1.5 equiv) and 1-hydroxybenzotriazole (400.0
mg, 2.960 mmol, 1.0 equiv) was suspended in CH2Cl2 (7.5 mL), cooled to 0 °C and
treated with EDC (640.0 mg, 3.339 mmol, 1.1 equiv) and N-methylmorpholine (830.0
µL, 7.5 mmol, 2.5 equiv).  The reaction mixture was stirred at rt for 16 h and then
treated with saturated aqueous NaHCO3 (10 mL), stirred for 1 h, diluted with water (10
mL), and extracted with ethyl acetate.  The combined organic layers were washed with
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1.0 M aqueous citric acid (10 mL), water (10 mL) and brine (10 mL), dried (Na2SO4),
filtered and concentrated.  Purification by chromatography on SiO2 (80 to 100% ethyl
acetate/hexanes) afforded 142 (379.5 mg, 55%) as a clear, colorless syrup that was
used without further purification:  Rf 0.39 (ethyl acetate).
A solution of 142 (379.5 mg, 1.655 mmol, 1.0 equiv) in CH2Cl2 (20 mL) was
cooled to –78 °C and treated with diethylaminosulfurtrifluoride (DAST) (250.0 µL, 1.9
mmol, 1.1 equiv), stirred at –78 °C for 1 h and then treated with anhydrous K2CO3
(580.0 mg, 4.20 mmol, 2.5 equiv).  After 20 min, the reaction mixture was warmed to 0
°C, stirred for 20 min, carefully quenched by addition of NaHCO3 solution (10 mL) and
stirred for 1 h while warming to rt.  The mixture was extracted with CH2Cl2 and the
combined organic layers were dried (Na2SO4), filtered and concentrated to give an
orange-colored oil that was azeotropically dried at reduced pressure with toluene (3
mL) and diluted with CH2Cl2 (10 mL).  The solution was cooled to 0 °C and treated with
BrCCl3 (340.0 µL, 3.5 mmol, 2.1 equiv) and DBU (450.0 µL, 3.0 mmol, 1.8 equiv), stirred
for 20 h at +4 °C and then diluted with ethyl ether (10 mL).  The mixture was poured
onto a pad of SiO2 (40 mm x 40 mm, prewetted with ethyl ether) and the pad was
washed with ethyl ether (200 mL).  The combined filtrates were concentrated and
purified by chromatography on SiO2 (4% to 10% ethyl acetate/CH2Cl2) to afford 144
(176.1 mg, 37%) as a white solid and 143 (106.3 mg, 31%) as a clear, colorless oil.
144 :  Rf 0.63 (2.5% ethyl acetate/CH2Cl2, twofold developed); Mp 80.4-81.4 °C
(CH2Cl2); [α]D +21.3 (c 1.25, CHCl3, 22 °C); 
1H NMR δ 8.17 (s, 1 H), 4.50 (dd, 1 H, J =
7.5, 6.1 Hz), 3.90 (s, 3 H), 3.39 (s, 3 H), 3.23 (d of AB, 1 H, J = 15.0, 7.8 Hz), 3.21 (d of
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AB, 1 H, J = 15.0, 6.0 Hz); 13C NMR δ 161.8, 161.7, 144.4, 133.7, 77.3, 69.5, 57.0, 52.4,
47.8, 35.0; IR (neat) 3169, 3119, 2998, 2954, 2885, 2834, 2198, 1724, 1586 cm-1; MS
(EI) m/z (rel. intensity) 288 (M+, 10), 272 ([M-CH3]
+, 16), 258 (8), 208 ([M-Br]+, 8), 203 (16),
178 ([M-Br-OCH3]
+, 10), 147 ([M-C6H6O3N]
+, 100); HRMS (EI) m/z calcd for C10H10O4NBr
286.9793, found 286.9788;  143:  Rf 0.49 (2.5% ethyl acetate/CH2Cl2, twofold
developed); [α]D +23.3 (c 1.15, CHCl3, 22 °C); 
1H NMR δ 8.16 (s, 1 H), 4.47 (ddd, 1 H, J
= 8.0, 6.1, 2.0 Hz), 3.89 (s, 3 H), 3.39 (s, 3 H), 3.24 (d of AB, 1 H, J = 15.0, 7.7 Hz), 3.21
(d of AB, 1 H, J = 15.0, 6.1 Hz), 2.48 (d, 1 H, J = 2.0 Hz); 13C NMR δ 161.8, 144.3,
133.6, 80.6, 75.4, 68.5, 56.8, 52.3, 35.0; IR (neat) 3265, 3161, 3121, 2996, 2952, 2850,
2828, 2114, 1743, 1586 cm-1; MS (EI) m/z (rel. intensity) 210 ([M+H]+, 11), 194 ([M-
CH3]
+, 6), 178 ([M-OCH3]
+, 14), 151 (88), 149 (100); HRMS (EI) m/z calcd for C9H8NO4
(M-CH3) 194.0453, found 194.0450.
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143 144
2-[(2R)-4-Bromo-2-methoxybut-3-ynyl]oxazole-4-carboxylic acid methyl
ester (17).  A solution of 143 (25.0 mg, 120 µmol, 1.0 equiv) in acetone (1.0 mL) was
treated at rt with AgNO3 (2.0 mg, 12 µmol, 0.1 equiv) and N-bromosuccinimide (23.5
mg, 132 µmol, 1.1 equiv).  After 1 h, hexanes (3.0 mL) were added, and the mixture
was filtered through a plug of Florisil/Celite (1:1, v/v).  The plug was rinsed with ethyl
ether (3.0 mL) and the combined filtrates were concentrated.  Purification by
chromatography on SiO2 (20% to 30% ethyl acetate/hexanes) afforded 144 (18.5 mg,
54%) as a clear, colorless glass that crystallized to a white solid under vaccum.
234
N
O
MeO2C OMe
Br
OMeO
HO
1) Ser-OMe•HCl, EDC, HOBT,
    NMM, CH2Cl2, DMF;
2) DAST, CH2Cl2 then K2CO3;
3) BrCCl3, DBU, CH2Cl2;
4) AgNO3, NBS, DMF;141 144
Improved sequence for the synthesis of 144:  A suspension of 141 (700.0 mg,
5.464 mmol, 1.0 equiv), serine methyl ester hydrochloride (1.300g, 8.356 mmol, 1.5
equiv) and HOBT (100.0 mg, 0.740 mmol, 0.14 equiv) in CH2Cl2 (5.0 mL) and DMF (1.0
mL) was treated with EDC (1.600g, 8.346 mmol, 1.5 equiv) cooled to 0 °C and treated
with N-methylmorpholine (1.510 mL, 13.69 mmol, 2.5 equiv) and stirred at 0 °C for 30
min, warmed to rt and stirred for 20 h.  The mixture was diluted with ethyl acetate (10
mL) and poured into 1.0 M aqueous citric acid (25 mL) and separated.  The organic
layer was washed with 4.0 M aqueous LiCl (10 mL) and the LiCl wash was added to the
aqueous portion.  The resulting aqueous mixture was extracted with ethyl acetate (10 x
50 mL) until TLC analysis indicated that no more product remained in the aqueous.  All
of the organic layers were combined, dried (Na2SO4), filtered and concentrated to a
yellow syrup.  Purification by chromatography on SiO2 (50% acetone/hexanes to 100%
acetone) afforded 142 (2.049 g) as a pale yellow syrup that was contaminated with
DMF (1H NMR) and was used without further purification.
The hydroxyamide 142 was suspended in hot CH2Cl2 (40 mL), cooled to –78 °C
under N2, treated with DAST (1.550 mL, 11.73 mmol, 2.1 equiv), stirred for 20 min at
–78 °C, treated with anhydrous K2CO3 (3.00 g, 21.7 mmol, 4.0 equiv), stirred for 20 min
at –78 °C, quenched with saturated aqueous NaHCO3 (10 mL) and water (20 mL),
warmed to rt, stirred for 45 min and extracted with CH2Cl2.  The combined organic
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were dried (Na2SO4), filtered and concentrated to a dark red oil.  Purification by
chromatography on SiO2 (30% to 50% acetone/hexanes) afforded the oxazoline (885.8
mg, 77%, 2 steps) as a red-brown oil that was used without further purification.  Rf
0.33 (40% acetone/hexanes).
The oxazoline (885.8 mg, 4.191 mmol, 1.0 equiv) in CH2Cl2 (10 mL) was cooled
to 0 °C and treated with BrCCl3 (1.30 mL, 13.2 mmol, 3.1 equiv) and DBU (1.30 mL,
8.69, 2.1 equiv) and allowed to slowly warm to rt.  After 8 h, the mixture was diluted
with hexanes (10 mL) and poured onto a pad of SiO2.  The pad was washed with 50%
acetone/hexanes and the combined filtrate was concentrated to a red oil.  Purification
by chromatography on SiO2 (20% to 40% acetone/hexanes) afforded the mixture of
143 and 144 as a pale yellow oil (839.5 mg) that crystallized on standing and was used
without further purification.
A solution of the oxazoles 143 and 144 (839.5 mg, 4.013 mmol, 1.0 equiv) in
DMF (10 mL) at 0 °C was treated with N-bromosuccinimide (785.0 mg, 4.410 mmol, 1.1
equiv) and AgNO3 (68.0 mg, 0.40 mmol, 0.1 equiv), warmed to rt, stirred for 2 h and
diluted with ethyl acetate (50 mL).  The mixture was washed with water and brine, dried
(Na2SO4), filtered and concentrated to a yellow, crystalline solid.  Purification by
chromatography on SiO2 (20% to 40% acetone/hexanes) afforded 144 (846.9 mg,
70%, 2 steps) as a white, crystalline solid.
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2-[(2R)-4-Iodo-2-methoxybut-3-enyl]oxazole-4-carboxylic acid methyl ester
(119).  A solution of 144 (241.4 mg,  838.0 µmol, 1.0 equiv) and PdCl2(PPh3)3 (5.0 mg,
7.0 µmol, 0.01 equiv) in THF (3.0 mL) was cooled under N2 to –78 °C.  The flask was
evacuated, flushed with N2 and n-Bu3SnH (450 µL, 1670 µmol, 2.0 equiv) was added in
one portion.  The reaction mixture was stirred at –78 °C for 105 min then at 0 °C for
105 min, and treated with a solution of I2 (250 mg, 985 µmol, 1.2 equiv) over 30 min,
such that a dark brown color persisted.  The mixture was quenched with saturated
aqueous NaHCO3 (3.0 mL) and saturated aqueous Na2S2O3 (10 mL) solutions.  Ethyl
acetate (10 mL) was added and the mixture was stirred for 30 min at rt and extracted
with ethyl acetate.  The combined organic layers were dried (Na2SO4), filtered and
concentrated.  Purification by chromatography on SiO2 (30% ethyl acetate/hexanes)
afforded 119 (259.0 mg, 92%) as a clear, colorless syrup:  Rf 0.40 (20% ethyl
acetate/hexanes); [α]D –0.74 (c 10.8, CHCl3, 22 °C); 
1H NMR δ 8.15 (s, 1 H), 6.44 (dd, 1
H, J = 14.5, 5.8 Hz), 6.43 (d, 1 H, J = 14.4 Hz), 4.13-4.06 (m, 1 H), 3.90 (s, 3 H), 3.26 (s,
3 H), 3.07 (dd, 1 H, J = 15.0, 7.5 Hz), 2.99 (dd, 1 H, J = 15.0, 5.8 Hz); 13C NMR δ 162.3,
161.7, 144.6, 144.3, 144.2, 133.6, 81.3, 80.2, 57.1, 52.3, 34.1; IR (neat) 3159, 2989,
2950, 2826, 1743, 1585, 1437 cm-1; HRMS (ESI) m/z calcd for C10H12NO4INa (M+Na)
359.9709, found 359.9702.
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2-[(2R)-4-Iodo-2-methoxybut-3-enyl]oxazole-4-carboxylic acid (145).  To a
solution of 119 (166.0 mg, 492.0 µmol, 1.0 equiv) in THF (5.0 mL) was added at rt 1.0 M
LiOH (1.10 mL, 1.10 mmol, 2.2 equiv).  After stirring for 12 h at rt, the mixture was
poured in water (20 mL) and washed with ethyl acetate (10 mL), and the organic
washing was discarded.  The aqueous layer was acidified with 2.0 M NaHSO4 and
extracted with ethyl acetate.  The combined organic layers were dried (Na2SO4), filtered
and concentrated to afford 145 (154.4 mg, 97%) as a beige, crystalline solid that was
used without further purification:  Mp 117.0-119.0 °C (ethyl acetate); [α]D +5.9 (c 1.36,
MeOH, 22 °C); 1H NMR (acetone-d6) δ 8.46 (s, 1 H), 6.64 (d, 1 H, J = 14.6 Hz), 6.60 (dd,
1 H, J = 14.6, 6.8 Hz), 4.17 (app q, 1 H, J = 6.8 Hz), 3.25 (s, 3 H), 3.12-3.03 (m, 2 H); 13C
NMR (acetone-d6) δ 163.0, 162.2, 146.0, 145.6, 134.4, 81.7, 80.7, 56.9, 34.3; IR (neat)
3142, 3040, 2988, 2927, 2822, 2578, 1678, 1597 cm-1; HRMS (ESI) m/z calcd for
C9H10NO4INa (M+Na) 345.9552, found 345.9555.
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2-{(2R,10S,12S)-[10-Hydroxy-2-methoxy-12-(4-methoxybenzyloxy)-11,11-
dimethylpentadeca-3,7,13-trien-5-ynyl]}-oxazole-4-carboxylic acid methyl ester
(147a).  A mixture of 119 (11.3 mg, 34.0 µmol, 1.0 equiv) and 118a (12.0 mg, 37.0
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µmol, 1.1 equiv) was azeotropically dried at reduced pressure with toluene (1.0 mL) and
then hexanes (1.0 mL), and dissolved in CH3CN (0.5 mL).  The solution was degassed
by freeze-pump-thaw (2 cycles).  PdCl2(PPh3)2 (1.0 mg, 1.0 µmol, 0.04 equiv) and CuI
(2.0 mg, 11 µmol, 0.3 equiv were added and the mixture was degassed by freeze-
pump-thaw (1 cycle), placed in a –20 °C bath under N2, and treated with triethylamine
(30 µL, 21 µmol, 6 equiv).  The yellow mixture became almost colorless before turning
to a dark red-brown color.  After 15 min, the cold bath was removed and the reaction
mixture was stirred at rt for 60 min, quenched with 0.05 M phosphate buffer (pH 7, 3.0
mL), poured into water (5.0 mL) and extracted with ethyl acetate.  The combined
organic layers were dried (Na2SO4), filtered and concentrated.  Purification by
chromatography on SiO2 (20% to 40% ethyl acetate/hexanes) afforded 147a (16.8 mg,
94%) as a pale yellow syrup: Rf 0.31 (40% ethyl acetate/hexanes), [α]D –25.2 (c 0.99,
CHCl3, 22 °C); 
1H NMR δ 8.14 (s, 1 H), 7.21 (d, 2 H, J = 8.6 Hz), 6.85 (d, 2 H, J = 8.6
Hz), 6.17 (dt, 1 H, J = 10.8, 7.2 Hz), 5.92 (dd, 1 H, J = 15.9, 7.0 Hz), 5.84 (dd, 1 H, J =
15.9, 2.0 Hz), 5.67 (dd, 1 H, J = 15.4, 6.3 Hz), 5.64 (dd, 1 H, J = 10.6, 1.8 Hz), 5.48
(ddd, 1 H, J = 15.3, 8.5, 1.5 Hz), 4.50 (d, 1 H, J = 11.2 Hz), 4.18 (d, 1 H, J = 11.2 Hz),
4.16 (ddd, 1 H, J = 13.1, 7.4, 5.8 Hz), 3.90 (s, 3 H), 3.79 (app s, 4 H), 3.64 (d, 1 H, J =
8.5 Hz), 3.61-3.54 (m, 1 H), 3.25 (s, 3 H), 3.08 (dd, 1 H, J = 15.0, 7.8 Hz), 2.96 (dd, 1 H,
J = 15.0, 5.7 Hz), 2.53 (dd, 1 H, J = 14.1, 7.6 Hz), 2.26 (dddd, 1 H, J = 14.3, 10.0, 6.8,
1.0 Hz), 1.79 (dd, 3 H, J = 6.3, 1.4 Hz), 0.90 (s, 3 H), 0.88 (s, 3 H); 13C NMR δ 162.6,
161.8, 159.4, 144.2, 143.4, 140.3, 133.6, 131.8, 130.2, 129.7, 127.6, 114.0, 109.8, 91.1,
89.0, 88.5, 87.9, 79.4, 77.4, 70.1, 57.0, 55.5, 52.3, 41.1, 34.8, 33.4, 21.9, 21.2, 18.1; IR
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(neat) 3477, 3160, 3027, 2937, 2873, 2832, 2182, 1747, 1612, 1585, 1514 cm-1; HRMS
(ESI) m/z calcd for C31H39NO7Na (M+Na) 560.2624, found 560.2648.
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2-{(2R,10S,12S)-[10-Hydroxy-2-methoxy-12-(3,4-dimethoxybenzyloxy)-
11,11-dimethylpentadeca-3,7,13-trien-5-ynyl]}-oxazole-4-carboxylic acid methyl
ester (147b).  A mixture of 119 (93.7 mg, 0.278 mmol, 1.0 equiv) and 118b (110.2 mg,
0.307 mmol, 1.1 equiv) was azeotropically dried at reduced pressure with toluene (1.0
mL) and then hexanes (1.0 mL), and dissolved in CH3CN (3.0 mL).  The solution was
degassed by freeze-pump-thaw (2 cycles).  PdCl2(PPh3)2 (10.0 mg, 14 µmol, 0.05 equiv)
and CuI (11.0 mg, 58 µmol, 0.2 equiv) were added and the mixture was degassed by
freeze-pump-thaw (1 cycle), placed in a 0 °C bath under N2, and treated with
triethylamine (235 µL, 1.68 mmol, 6 equiv).  The yellow mixture became almost
colorless before turning to a dark red-brown color.  The reaction mixture was stirred at
0 °C for 1 h then warmed to rt over 10 min, quenched with 0.05 M phosphate buffer
(pH 7, 3.0 mL), poured into water (10.0 mL) and extracted with ethyl acetate.  The
combined organic layers were dried (Na2SO4), filtered and concentrated.  Purification
by chromatography on SiO2 (40% to 60% ethyl acetate/hexanes) afforded 147b (138.0
mg, 87%) as a pale yellow wax:  Rf 0.27 (50% ethyl acetate/hexanes); [α]D –25.2 (c
1.34, CHCl3, 22 °C); 
1H NMR δ 8.14 (s, 1 H), 6.84-6.81 (m, 3 H), 6.18 (app dt, 1 H, J =
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10.7, 7.2 Hz), 5.93 (dd, 1 H, J = 15.9, 7.0 Hz), 5.84 (dd, 1 H, J = 15.9, 1.8 Hz), 5.77-5.58
(m, 2 H), 5.48 (ddd, 1 H, J = 15.3, 8.5, 1.5 Hz), 4.50 (d, 1 H, J = 11.3 Hz), 4.19 (d, 1 H, J
= 11.3 Hz), 4.15 (app dt, 1 H, J = 13.2, 7.3 Hz), 3.90 (s, 3 H), 3.86 (s, 3 H), 3.86 (s, 3 H),
3.76 (d, 1 H, J = 4.8 Hz), 3.65 (d, 1 H, J = 8.6 Hz), 3.62-3.56 (m, 1 H), 3.24 (s, 3 H), 3.07
(dd, 1 H, J = 15.0, 7.7 Hz), 2.95 (dd, 1 H, J = 15.0, 5.7 Hz), 2.54 (dd, 1 H, J = 14.1, 7.5
Hz), 2.28 (ddd, 1 H, J = 16.0, 9.3, 7.0 Hz), 1.80 (d, 3 H, J = 6.3 Hz), 0.91 (s, 3 H), 0.89
(s, 3 H); 13C NMR δ 162.6, 161.8, 149.2, 148.8, 144.2, 143.3, 140.3, 133.5, 131.9, 130.6,
127.6, 120.7, 114.0, 111.4, 111.0, 109.8, 91.2, 88.4, 87.8, 79.4, 77.5, 70.3, 57.0, 56.1,
56.0, 52.3, 41.1, 34.7, 33.4, 21.8, 21.2, 18.1; IR (neat) 3480, 3158, 2937, 2871, 2833,
2186, 1747, 1587, 1517 cm-1; HRMS (ESI) m/z  calcd for C32H41NO8Na (M+Na)
590.2730, found 590.2724.
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2-[(2R,10S,12S)-10-{2-[(2R)-4-Iodo-2-methoxybut-3-enyl]oxazol-4-oyloxy}-
2-methoxy-12-(4-methoxybenzyloxy)-11,11-dimethylpentadeca-3,7,13-trien-5-
ynyl]-oxazole-4-carboxylic acid methyl ester (148a).  A solution of 145 (154.4 mg,
478.0 µmol, 1.9 equiv), 147a (134.8 mg, 251.0 µmol, 1.0 equiv) and DMAP (31.0 mg,
254 µmol, 1.0 equiv) in CH2Cl2 (2.25 mL) was cooled to 0 °C under N2 and
dicyclohexylcarbodiimide (260.0 mg, 1260 µmol, 5.0 equiv) was added in one portion.
The reaction mixture was stirred at 0 °C for 10 min then at rt for 14 h, diluted with
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hexanes (5 mL) and filtered through a plug Florisil/Celite (1:1, v/v).  The plug was rinsed
with ethyl ether (5 mL) and the combined filtrates were concentrated.  Purification by
chromatography on SiO2 (30% to 50% ethyl acetate/hexanes) afforded 148a (169.0
mg, 80%) as a pale yellow syrup that was used without further purification.  For
analytical purposes, a sample was further purified by chromatography on SiO2 (30% to
50% ethyl acetate/hexanes) to afford 148a as a clear, colorless wax:  Rf 0.23 (40%
ethyl acetate/hexanes); [α]D +50.5 (c 1.26, CHCl3, 22 °C); 
1H NMR δ 8.16 (s, 1 H), 7.96
(s, 1 H), 7.24 (d, 2 H, J = 8.5 Hz), 6.82 (d, 2 H, J = 8.6 Hz), 6.46 (d of AB, 1 H, J = 14.5,
6.2 Hz), 6.44 (AB, 1 H, J = 14.5 Hz), 5.97 (dd, 2 H, J = 15.9, 7.1 Hz), 5.85 (dd, 1 H, J =
16.0, 1.8 Hz), 5.65 (dq, 1 H, J = 15.1, 6.4 Hz), 5.56 (d, 1 H, J = 10.8 Hz), 5.46 (dd, 1 H, J
= 8.5, 1.3 Hz), 5.40 (dd, 1 H, J = 9.2, 3.7 Hz), 4.36 (d, 1 H, J = 10.8 Hz), 4.08 (d, 1 H, J =
10.8 Hz), 4.20-4.01 (m, 2 H), 3.90 (s, 3 H), 3.78 (s, 3 H), 3.47 (d, 1 H, J = 8.5 Hz), 3.28
(s, 3 H), 3.27 (s, 3 H), 3.14-2.95 (m, 4 H), 2.75-2.57 (m, 2 H), 1.76 (dd, 3 H, J = 6.1, 1.0
Hz), 0.97 (s, 3 H), 0.95 (s, 3 H); 13C NMR δ 162.6, 162.1, 161.8, 160.8, 159.2, 144.7,
144.2, 143.7, 140.7 (2 C), 133.8, 133.6, 131.2, 129.8, 128.2, 113.8, 111.2, 91.5, 88.2,
84.4, 81.3, 80.1, 79.4, 77.4, 77.1, 70.1, 57.1, 55.4, 52.3, 42.1, 34.8, 34.1, 31.6, 25.2,
19.8, 19.6, 18.0; IR (neat) 3160, 2976, 2936, 2879, 1739, 1611, 1585, 1514 cm-1; HRMS
(ESI) m/z calcd for C40H47N2O10INa (M+Na) 865.2173, found 865.2209.
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(2E,4S,6S,8Z,12E,14R)-14-Methoxy-4-(4-methoxybenzyloxy)-15-(4-
(methoxycarbonyl)oxazol-2-yl)-5,5-dimethylpentadeca-2,8,12-trien-10-yn-6-yl 2-
((2R,3E,7Z,10S,12S,13E)-10-hydroxy-2-methoxy-12-(4-methoxybenzyloxy)-11,11-
dimethylpentadeca-3,7,13-trien-5-ynyl)oxazole-4-carboxylate (149a).  A mixture of
148a (100.5 mg, 119.0 µmol, 1.0 equiv) and 118a (74.4 mg, 227 µmol, 1.9 equiv) was
azeotropically dried at reduced pressure with hexanes (0.5 mL) and dissolved in
CH3CN (2.0 mL).  The solution was degassed by freeze-pump-thaw (2 cycles).
PdCl2(PPh3)2 (4.0 mg, 6.0 µmol, 0.05 equiv) and CuI (4.0 mg, 21 µmol, 0.2 equiv) were
added and the mixture was degassed by freeze-pump-thaw (1 cycle) and placed in a
–20 °C bath under N2.  Triethylamine (110 µL, 784 µmol, 7 equiv) was added and the
yellow solution became almost colorless before changing to a dark red-brown color.
After 25 min, the cold bath was removed and the reaction mixture was stirred at rt for
50 min, quenched with 0.05 M phosphate buffer (pH 7, 5.0 mL) and ethyl acetate (5.0
mL), stirred at rt for 20 min, poured into brine and extracted with ethyl acetate.  The
combined organic layers were dried (Na2SO4), filtered and concentrated.  Purification
by chromatography on SiO2 (40% to 60% ethyl acetate/hexanes) afforded 149a (116.6
mg, 94%) as a yellow wax:  Rf 0.18 (40% ethyl acetate/hexanes); [α]D +29.5 (c 1.01,
CHCl3, 22 °C); 
1H NMR δ 8.16 (s, 1 H), 7.95 (s, 1 H), 7.22 (app t, 4 H, J = 9.1 Hz), 6.83
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(app t, 4 H, J = 8.8 Hz), 6.17 (app dt, 1 H, J = 10.7, 7.2 Hz), 6.00-5.82 (m, 5 H), 5.74-
5.61 (m, 3 H), 5.56 (d, 1 H, J = 10.8 Hz), 5.52-5.37 (m, 3 H), 4.50 (d, 1 H, J = 11.2 Hz),
4.36 (d, 1 H, J = 10.8 Hz), 4.18 (d, 1 H, J = 11.4 Hz), 4.16 (app t, 2 H, J = 6.6 Hz), 4.08
(d, 1 H, J = 10.8 Hz), 3.90 (s, 3 H), 3.78 (s, 3 H), 3.77 (s, 3 H), 3.64 (d, 1 H, J = 8.5 Hz),
3.63-3.54 (m, 1 H), 3.47 (d, 1 H, J = 8.5 Hz), 3.27 (s, 3 H), 3.25 (s, 3 H), 3.10 (dd, 1 H, J
= 14.9, 7.6 Hz), 2.94 (dd, 1 H, J = 14.9, 5.3 Hz), 3.10-3.00 (m, 2 H), 2.74-2.59 (m, 2 H),
2.53 (dd, 1 H, J = 14.1, 7.7 Hz), 2.26 (ddd, 1 H, J = 15.8, 9.2, 6.9 Hz), 1.78 (d, 3 H, J =
6.4 Hz), 1.76 (d, 3 H, J = 6.3 Hz), 1.70 (bs, 1 H), 0.97 (s, 3 H), 0.94 (s, 3 H), 0.90 (s, 3 H),
0.88 (s, 3 H); 13C NMR δ 162.6, 162.5, 161.8, 160.8, 159.5, 159.1, 144.2, 143.7, 143.3,
140.7, 140.5, 133.7, 133.6, 131.7, 131.2, 130.3, 129.8, 129.7, 128.1, 127.7, 114.0,
113.9, 113.8, 91.5, 91.2, 88.4, 88.2, 88.0, 84.3, 79.4, 70.1, 70.0, 57.0, 55.5, 52.3, 42.1,
41.2, 34.8, 33.4, 31.6, 21.9, 21.1, 19.7, 19.6, 18.1; IR (neat) 3479, 2968, 2935, 2187,
1740, 1612, 1585, 1514 cm-1; HRMS (ESI) m/z  calcd for C61H74N2O13Na (M+Na)
1065.5089, found 1065.5087.
1) 145, DCC, 
    DMAP, CH2Cl2;
2) 118b, PdCl2(PPh3)2,
    CuI, Et3N, CH3CN
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(2E,4S,6S,8Z,12E,14R)-4-(3,4-Dimethoxybenzyloxy)-14-methoxy-15-(4-
(methoxycarbonyl)oxazol-2-yl)-5,5-dimethylpentadeca-2,8,12-trien-10-yn-6-yl 2-
((2R,3E,7Z,10S,12S,13E)-12-(3,4-dimethoxybenzyloxy)-10-hydroxy-2-methoxy-
11,11-dimethylpentadeca-3,7,13-trien-5-ynyl)oxazole-4-carboxylate (149b).  A
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mixture of 147b (85.0 mg, 0.149 mmol, 1.0 equiv), 145 (80.0 mg, 0.248 mmol, 1.7
equiv) and DMAP (20.0 mg, 0.164 mmol, 1.1 equiv)  in CH2Cl2 (2.0 mL) was cooled to 0
°C and treated with DCC (160.0 mg, 0.775 mmol, 5.2 equiv).  The mixture was stirred at
0 °C for 15 min then rt overnight (18 h).  The mixture was diluted with hexanes (5 mL)
and filtered through a plug of Florisil/Celite (1:1 v/v).  The plug was rinsed with ethyl
acetate and the combined filtrate was concentrated.  Purification by chromatography
on SiO2 (50% ethyl acetate/hexanes) afforded a pale yellow, oily solid that was used
without further purification.
A mixture of the oily solid and 118b (65.9 mg, 0.184 mmol, 1.2 equiv) in CH3CN
(2.0 mL) was degassed by freeze-pump-thaw (2 cycles).  PdCl2(PPh3)2 (5.0 mg, 7.0
µmol, 0.05 equiv) and CuI (6.0 mg, 32 µmol, 0.2 equiv) were added and the mixture
was degassed by freeze-pump-thaw (1 cycle) and placed in a 0 °C bath under N2.
Triethylamine (125 µL, 891 µmol, 6.0 equiv) was added and the yellow solution became
almost colorless before changing to a dark red-brown color.  The reaction mixture was
stirred at 0 °C for 2 h then warmed to rt for 30 min, quenched with phosphate buffer
(0.5 M NaH2PO4, 0.5 M Na2HPO4, 3.0 mL), poured into water (10 mL) and extracted
with ethyl acetate.  The combined organic layers were dried (Na2SO4), filtered and
concentrated.  Purification by chromatography on SiO2 (50% to 80% ethyl
acetate/hexanes) afforded 149b (99.7 mg, 61%, 2 steps) as a pale, yellow wax:  Rf 0.26
(60% ethyl acetate/hexanes); [α]D +17.1 (c 1.57, CHCl3, 22 °C); 
1H NMR δ 8.16 (s, 1 H),
7.98 (s, 1 H), 6.94-6.76 (m, 6 H), 6.18 (app dt, 1 H, J = 10.6, 7.4 Hz), 6.00-5.91 (m, 3 H),
5.85 (app dt, 2 H, J = 15.9, 2.5 Hz), 5.74-5.40 (m, 8 H), 4.51 (d, 1 H, J = 11.3 Hz), 4.35
(d, 1 H, J = 10.9 Hz), 4.20 (d, 1 H, J = 11.6 Hz), 4.19-4.13 (m, 2 H), 4.08 (d, 1 H, J =
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10.8 Hz),  3.90 (s, 3 H), 3.89 (s, 3 H), 3.86 (s, 3 H), 3.86 (s, 3 H), 3.85 (s, 2 H), 3.76 (d, 1
H, J = 4.8 Hz), 3.65 (d, 1 H, J = 8.5 Hz), 3.61-3.57 (m, 1 H), 3.49 (d, 1 H, J = 8.6 Hz),
3.26 (s, 3 H), 3.24 (s, 3 H), 3.08 (app dt, 2 H, J = 15.0, 7.7 Hz), 2.96 (app dt, 2 H, J =
14.9, 5.5 Hz), 2.70-2.63 (m, 2 H), 2.54 (dd, 1 H, J = 14.1, 7.0 Hz), 2.28 (ddd, 1 H, J =
15.4, 9.6, 7.0 Hz), 1.79 (d, 3 H, J = 10.0 Hz), 1.78 (d, 3 H, J = 9.7 Hz), 0.98 (s, 3 H), 0.95
(s, 3 H), 0.91 (s, 3 H), 0.89 (s, 3 H); 13C NMR δ 162.5 (2 C), 161.8, 160.8, 149.1, 148.9,
148.9, 148.8, 148.4, 144.4, 144.2, 143.8, 143.3, 141.4, 140.7, 140.5, 133.63, 133.5,
131.8, 131.5, 131.4, 130.6, 128.0, 127.5, 120.6, 120.5, 113.9, 113.7, 111.8, 111.4,
111.2, 111.0, 110.8, 110.5, 109.8, 91.5, 91.2, 88.4, 88.1, 87.8, 84.3, 79.3 (2 C), 77.4,
70.3 (2 C), 57.0, 56.9, 56.1, 56.0 (2 C), 42.0, 41.1, 34.7, 33.3, 31.5, 21.8, 21.2, 19.6,
19.4, 18.1 (2 C), 15.4; IR (neat) 3481, 2969, 2937, 2877, 2834, 2251, 2184, 1739, 1585,
1517 cm-1; HRMS (ESI) m/z calcd for C63H78N2O15Na (M+Na) 1125.5300, found
1125.5270.
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2) 2,4,6-TCBC, 
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(16,16’)-Bis(4-methoxybenzyloxy)-(9,9’,10,10’)-didehydrodisorazole C1
(150a).  A solution of 149a (33.4 mg, 32.0 µmol, 1.0 equiv) in THF (1.0 mL) was treated
at rt with 1.0 M aqueous LiOH solution (65 µL, 65 µmol, 2.0 equiv).  After 13.5 h, the
reaction mixture was diluted with water (5 mL), poured into 2.0 M aqueous NaHSO4 (5
mL) and extracted with ethyl acetate.  The combined organic layers were dried
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(Na2SO4), filtered and concentrated to afford the seco-acid (32.2 mg, 98%) as a yellow
wax that was used without further purification.  Characteristic signals for the seco-acid:
1H NMR δ 8.22 (s, 1 H), 7.96 (s, 1 H), 7.22 (app t, 4 H, J = 8.8 Hz), 6.83 (app t, 4 H, J =
9.0 Hz), 6.17 (app dt, 1 H, J = 10.7, 7.2 Hz), 6.02-5.81 (m, 5 H), 5.75-5.39 (m, 7 H), 4.51
(d, 1 H, J = 11.2 Hz), 4.36 (d, 1 H, J = 10.8 Hz), 4.19 (d, 1 H, J = 11.2 Hz), 4.21-4.13 (m,
2 H), 4.08 (d, 1 H, J = 10.9 Hz), 3.79 (s, 3 H), 3.78 (s, 3 H), 3.65 (d, 1 H, J = 8.7 Hz), 3.61
(dd, 1 H, J = 10.3, 2.6 Hz), 3.48 (d, 1 H, J = 8.5 Hz), 3.29 (s, 3 H), 3.26 (s, 3 H), 3.18-
2.94 (m, 4 H), 2.75-2.65 (m, 2 H), 2.57-2.50 (m, 1 H), 2.33-2.22 (m, 1 H), 1.79 (d, 3 H, J
= 6.2 Hz), 1.76 (d, 3 H, J = 6.1 Hz), 0.97 (s, 3 H), 0.95 (s, 3 H), 0.91 (s, 3 H), 0.87 (s, 3
H).
The crude seco-acid (32.2 mg, 31.3 µmol, 1.0 equiv) was azeotropically dried at
reduced pressure with benzene (1 mL) and then THF (2 x 1 mL), diluted with THF (2.5
mL) and treated at rt with triethylamine (90 µL, 640 µmol, 20 equiv) and 2,4,6-
trichlorobenzoyl chloride (50 µL, 320 µmol, 10 equiv).  After 2 h, the turbid reaction
mixture was diluted with toluene (1.5 mL) and added dropwise via syringe pump (4
mL/h) to a stirred solution of DMAP (154.0 mg, 1260 µmol, 40 equiv) in toluene (45 mL)
at rt.  After the addition was complete, the syringe was rinsed with toluene (2 x 1.0 mL)
and the rinse was added to the reaction mixture.  After stirring at rt for an additional 12
h (16 h total), the solution was treated with saturated aqueous NH4Cl (10 mL) and water
(10 mL) and the mixture was stirred for 30 min and then extracted with ethyl acetate.
The combined organic layers were washed with 1.0 M aqueous citric acid (10 mL) and
brine (10 mL), dried (Na2SO4), filtered and concentrated.  Purification by
chromatography on SiO2 (30% to 40% ethyl acetate/hexanes) afforded 150a (25.2 mg,
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79%) as a clear, colorless wax:  Rf 0.30 (40% ethyl acetate/hexanes); [α]D +150.5 (c
0.82, CHCl3, 22 °C); 
1H NMR δ 7.97 (s, 2 H), 7.27 (d, 4 H, J = 8.4 Hz), 6.83 (d, 4 H, J =
8.5 Hz), 6.00-5.92 (m, 4 H), 5.71-5.58 (m, 4 H), 5.52-5.41 (m, 6 H), 4.37 (d, 2 H, J = 10.7
Hz), 4.11 (d, 2 H, J = 10.7 Hz), 4.17-4.11 (m, 2 H), 3.79 (s, 6 H), 3.46 (d, 2 H, J = 8.4
Hz), 3.36 (s, 6 H), 3.32 (dd, 2 H, J = 16.2, 4.0 Hz), 2.99 (dd, 2 H, J = 14.2, 9.9 Hz), 2.95
(dt, 2 H, J = 13.8, 10.9 Hz), 2.36 (bd, 2 H, J = 13.8 Hz), 1.77 (d, 6 H, J = 6.1 Hz), 0.98 (s,
12 H); 13C NMR δ 161.8, 160.7, 159.2, 143.5, 141.4, 140.7, 134.0, 131.3, 131.2, 129.9,
128.2, 113.8 (2 C), 112.1, 91.1, 88.0, 84.4, 79.9, 76.4, 70.2, 57.0, 55.5, 41.9, 34.7, 31.7,
19.7, 19.6, 18.0; IR (neat) 2971, 2935, 2877, 2853, 2190, 1737, 1612, 1585, 1514 cm-1;
HRMS (ESI) m/z calcd for C60H70N2O12Na (M+Na) 1033.4826, found 1033.4838.
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(16,16’)-Bis(3,4-dimethoxybenzyloxy)-(9,9’,10,10’)-didehydrodisorazole C1
(150b).  A solution of 149b (68.0 mg, 61.6 µmol, 1.0 equiv) in THF (2.0 mL) and water
(0.1 mL) was treated at rt with 1.0 M aqueous LiOH solution (137 µL, 137 µmol, 2.2
equiv).  After 12 h, the reaction mixture was poured into 2.0 M aqueous NaHSO4 (10
mL) and extracted with ethyl acetate.  The combined organic layers were dried
(Na2SO4), filtered and concentrated to afford the seco-acid as yellow syrup that was
azeotropically dried with toluene at reduced pressure, diluted with THF (2.0 mL) and
treated with triethylamine (175.0 µL, 1.247 mmol, 20 equiv) and 2,4,6-trichlorobenzoyl
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chloride (96.0 µL, 0.614 mmol, 10 equiv).  The mixture was stirred at rt for 2.5 h and
diluted with toluene to give a solution (10 mL) that was added via syringe pump (2.4
mL/h) to a solution of DMAP (380 mg, 3.11 mmol, 50 equiv) in toluene (100 mL) at rt.
The mixture was stirred at rt for 12 h, treated with 1.0 M aqueous citric acid (50 mL)
and extracted with ethyl acetate.  The combined organic layers were washed with
water, saturated aqueous NaHCO3 and brine, dried (Na2SO4), filtered and concentrated.
Purification by chromatography on SiO2 (40% to 50% ethyl acetate/hexanes) afforded
150b (49.8 mg, 76%) as a clear, colorless syrup:  Rf 0.26 (50% ethyl acetate/hexanes);
[α]D +120.4 (c 1.08, CHCl3, 22 °C); 
1H NMR δ 7.99 (s, 2 H), 6.94 (d, 2 H, J = 1.8 Hz),
6.87 (dd, 2 H, J = 8.2, 1.8 Hz), 6.79 (d, 2 H, J = 8.2 Hz), 5.96 (dd, 2 H, J = 15.9, 7.6 Hz),
6.00-5.92 (m, 2 H), 5.62 (dd, 2 H, J = 15.8, 1.7 Hz), 5.71-5.59 (m, 2 H), 5.54-5.42 (m, 8
H), 4.36 (d, 2 H, J = 10.7 Hz), 4.13-4.09 (m, 2 H), 4.11 (d, 2 H, J = 10.7 Hz), 3.89 (s, 6
H), 3.86 (s, 6 H), 3.47 (d, 2 H, J = 8.5 Hz), 3.36-3.28 (m, 2 H), 3.35 (s, 6 H), 2.98 (dd, 2
H, J = 14.0, 10.0 Hz), 2.36 (bd, 2 H, J = 14.0 Hz), 1.77 (dd, 6 H, J = 6.2, 1.0 Hz), 0.99 (s,
6 H), 0.99 (s, 6 H); 13C NMR δ 161.8, 160.7, 148.9, 148.4, 143.5, 141.3, 140.6, 133.8,
131.6, 131.4, 128.0, 120.6, 113.8, 112.1, 111.9, 110.9, 91.0, 88.0, 84.3, 79.8, 76.2,
70.4, 57.0, 56.0 (2 C), 41.8, 34.5, 31.5, 19.6, 19.4, 18.1; IR (neat) 2971, 2937, 2878,
2833, 1738, 1585, 1517 cm-1; HRMS (ESI) m/z calcd for C62H74N2O4Na (M+Na)
1093.5038, found 1093.4962.
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(16,16’)-Bis(4-methoxybenzyloxy)-(9,9’,10,10’)-didehydrodisorazole C1
(150a).  A solution of 147a (16.1 mg, 30 µmol, 1.0 equiv) in THF (1.0 mL) was treated
with 1.0 M aqueous LiOH (65 µL, 65 µmol, 2.2 equiv), stirred at rt for 18 h, poured in
2.0 M aqueous NaHSO4 (5.0 mL) and extracted with ethyl acetate.  The combined
organic layers were dried (Na2SO4), filtered and concentrated to a pale yellow wax (17.6
mg, quant.) that was used without further purification.  Characteristic signals:  1H NMR
δ 8.22 (s, 1 H), 7.21 (d, 2 H, J = 8.7 Hz), 6.85 (d, 2 H, J = 8.6 Hz), 6.18 (app td, 1 H, J =
10.7, 7.3 Hz), 5.94 (d of AB, 1 H, J = 15.8, 6.9 Hz), 5.87 (d of AB, 1 H, J = 15.9, 1.7 Hz),
5.75-5.63 (m, 2 H), 5.49 (ddd, 1 H, J = 15.4, 8.5, 1.4 Hz), 4.51 (d, 1 H, J = 11.2 Hz),
4.21-4.13 (m, 1 H), 4.19 (d, 1 H, J = 11.2 Hz), 3.79 (s, 3 H), 3.65 (d, 1 H, J = 8.6 Hz),
3.61 (dd, 1 H, J = 10.1, 2.6 Hz), 3.26 (s, 3 H), 3.09 (d of AB, 1 H, J =15.1, 7.7 Hz), 3.01
(d of AB, 1 H, J = 15.1, 5.6 Hz), 2.54 (dd, 1 H, J = 13.5, 7.7 Hz), 2.27 (ddd, 1 H, J =
16.7, 9.9, 6.7 Hz), 1.79 (dd, 3 H, J = 6.3, 1.3 Hz), 0.91 (s, 3 H), 0.86 (s, 3 H).  The crude
hydroxyacid (17.6 mg) was azeotropically dried with toluene (1.0 mL) at reduced
pressure, dissolved in THF (1.0 mL) and treated with triethylamine (85.0 µL, 0.606
mmol, 20.2 equiv) and 2,4,6-trichlorobenzoylchloride (47.0 µL, 0.301 mmol, 10.0 equiv)
at rt.  After stirring for 2 h at rt, the turbid mixture was diluted with toluene to give a 4.0
mL solution that was added via syringe pump (1.0 mL/h) to a stirred solution of DMAP
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(150 mg, 1.31 mmol, 44 equiv) in toluene (50 mL).  After stirring for 12 h, the syringe
was rinsed with toluene (0.5 mL x 3) and the rinse was added to the reaction mixture
which was stirred for an additional 6 h, treated with saturated aqueous NH4Cl (10 mL),
diluted with water (10 mL) and extracted with ethyl acetate.  The combined organic
layers were sequentially washed with 1.0 M aqueous citric acid (10 mL) , water (10 mL),
brine (10 mL), dried (Na2SO4), filtered and concentrated.  The residue was diluted with
ethyl acetate (1 mL) and filtered through a plug of Florisil/Celite (1:1 v/v), the plug was
rinsed with ethyl acetate (5 mL) and the filtrate was concentrated.  Purification by
chromatography on SiO2 (30% to 50% ethyl acetate/hexanes) afforded 150a (8.9 mg,
59%, 2 steps) as a clear, colorless wax.
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(9,9’,10,10’)-Didehydrodisorazole C1 (151).  A biphasic mixture of 150a (10.5
mg, 10.0 µmol, 1.0 equiv), CH2Cl2 (1.0 mL) and aqueous phosphate buffer (0.5 M in
Na2HPO4 and 0.5 M in NaH2PO4, 1.0 mL) was treated at rt with DDQ (20.0 mg, 88.0
µmol, 8.8 equiv).  After 15 min, the reaction mixture was poured into saturated aqueous
NaHCO3 (2 mL) and saturated aqueous Na2S2O3 (2 mL) and extracted with ethyl
acetate.  The combined organic layers were washed with brine, dried (Na2SO4), filtered
and concentrated.  The residue was diluted in ethyl acetate, filtered through a plug of
SiO2, and the plug was rinsed with ethyl acetate.  The combined filtrates were
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concentrated to a pale, yellow wax.  Purification by preparative HPLC on SiO2 (10 mm
x 25 mm, 0.5% to 1.5% MeOH/CH2Cl2 over 60 min) afforded 151 (4.7 mg, 61%) as a
clear, colorless wax:  Rf 0.23 (60% ethyl acetate/hexanes); [α]D +187.8 (c 0.37, CHCl3,
22 °C); 1H NMR δ 8.11 (s, 2 H), 6.03 (dd, 2 H, J = 15.9, 7.4 Hz), 5.94 (app dq, 2 H, J =
10.7, 5.3 Hz), 5.68 (d, 2 H, J = 14.9 Hz), 5.57 (d, 2 H, J = 7.4 Hz), 5.71-5.50 (m, 4 H),
5.34 (dd, 2 H, J = 10.9, 2.4 Hz), 4.15-4.09 (m, 2 H), 3.85 (d, 2 H, J = 7.1 Hz), 3.36 (s, 6
H), 3.37-3.26 (m, 2 H), 3.07-2.95 (m, 4 H), 2.53 (bs, 2 H), 2.45-2.35 (m, 2 H), 1.71 (d, 6
H, J = 5.9 Hz), 0.98 (s, 6 H), 0.96 (s, 6 H); 13C NMR δ 162.1, 161.6, 144.1, 141.6, 140.0,
133.4, 129.5, 113.5, 112.7, 91.2, 87.9, 79.7, 57.1, 41.9, 34.6, 31.1, 19.3, 18.7, 18.1; IR
(neat) 3477, 3165, 2969, 2929, 2884, 2854, 2187, 1736, 1629, 1583, 1466, 1451 cm-1;
HRMS (ESI) m/z calcd for C44H54N2O10Na (M+Na) 793.3676, found 793.3702.
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(9,9’,10,10’)-Didehydrodisorazole C1 (151).  A biphasic mixture of 150b (49.8
mg, 46.5 µmol, 1.0 equiv), CH2Cl2 (1.0 mL) and aqueous phosphate buffer (0.5 M in
Na2HPO4 and 0.5 M in NaH2PO4, 1.0 mL) was treated at 0 °C with DDQ (42.0 mg, 185
µmol, 4.0 equiv).  After 15 min, the reaction mixture was poured into saturated aqueous
NaHCO3 (1.0 mL) and saturated aqueous Na2S2O3 (1.0 mL), diluted with water (10 mL)
and extracted with ethyl acetate.  The combined organic layers were washed with
water and brine, dried (Na2SO4), filtered and concentrated.  Purification by
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chromatography on SiO2 (50% to 90% ethyl acetate/hexanes) afforded 151 (27.4 mg,
77%) as a clear, colorless wax.
Me
HO O
Me Me
MeO O
N
Me
OHO
MeMe
OMeO
N
O
O
76
H2 (1 atm), 
Lindlar Catalyst,
quinoline
 
EtOAc
151
(-)-Disorazole C1 (1).  A flask containing a mixture of (9,9’,10,10’)-didehydro-
disorazole C1 (2.1 mg, 2.7 µmol, 1.0 equiv), quinoline (10.0 µL, 85.0 µmol, 31 equiv) and
Lindlar catalyst (5% Pd on CaCO3 poisoned with Pb, 1.2 mg) in ethyl acetate (0.5 mL)
was evacuated and flushed with H2 (3 cycles). The reaction mixture was stirred at rt
under H2 (1 atm) for 1 h and then filtered through a plug of Florisil/Celite (1:1).  The plug
was rinsed with ethyl acetate (5 mL) and the combined filtrates were concentrated.
Purification by preparative HPLC on SiO2 (10 mm x 25 mm, 34% ethyl
acetate/hexanes, 7 mL/min, UV detection at 254 nm) and collection of the fractions
with Rt = 34 to 40 min afforded a clear colorless wax that was further purified by
preparative HPLC on SiO2 (10 mm x 25 mm, 0.5% to 2% MeOH/CH2Cl2 over 60 min, 7
mL/min, UV detection at 254 nm).  Collection of the fractions with Rt = 37 to 40 min
afforded 1 (1.2 mg, 57%) as a clear, colorless wax:  Rf 0.50 (5% MeOH/CH2Cl2, twofold
developed); [α]D -136 (c 0.05, MeOH, 22 °C); lit. [α]D –124.8 (c 0.6, MeOH, 22 °C); UV-
vis (0.22 mM, MeOH, 22 °C) λmax (log ε) 272 nm (3.98); 
1H NMR (600 MHz, CD3OD) δ
8.23 (s, 2 H), 6.50 (dd, 2 H, J = 15.2, 11.5 Hz), 6.40 (app t, 2 H, J = 11.2 Hz), 6.28 (dd, 2
H, J = 11.4, 11.1 Hz), 5.91 (dd, 2 H, J = 11.2, 10.9 Hz), 5.66 (dq, 2 H, J = 15.2, 6.6 Hz),
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5.57 (ddd, 2 H, J = 15.2, 7.8, 1.4 Hz), 5.54 (dd, 2 H, J = 15.0, 8.3 Hz), 5.48 (app dt, 2 H,
J = 10.0, 6.7 Hz), 5.25 (dd, 2 H, J = 11.3, 2.2 Hz), 4.13 (ddd, 2 H, J = 7.8, 7.2, 5.5 Hz),
3.84 (d, 2 H, J = 7.8 Hz), 3.21 (s, 6 H), 2.99 (dd, 2 H, J = 15.5, 7.4 Hz), 2.76 (dd, 2 H, J =
15.5, 5.4 Hz), 2.69 (ddd, 2 H, J = 13.8, 10.9, 10.2 Hz), 2.38 (dd, 2 H, J = 13.8, 6.1 Hz),
1.69 (dd, 6 H, J = 6.4, 1.3 Hz), 1.00 (s, 6 H), 0.95 (s, 6 H); 13C NMR (151 MHz, CD3OD) δ
164.12, 162.26, 145.83, 134.15, 134.09, 131.68, 130.88, 129.96, 129.63, 129.30,
127.36, 126.79, 80.57, 78.75, 77.84, 56.83, 42.70, 35.97, 29.24, 19.41, 19.32, 18.03;
HRMS (ESI) m/z calcd for C44H58N2O10Na (M+Na) 797.3989, found 797.3997.
3.5.2.2. Synthesis of the C14-t-Butyl Analog
t-Bu
OTBS
t-Bu
O
H
1) allyl trimethylsilane,
    (S)-BINOL, TiF4,
    CH3CN, CH2Cl2;
2) HF, CH3CN;
3) TBS-Cl, 
    imidazole, DMF 155154
(S)-3-(t-Butyldimethylsilyloxy)-2,2-dimethylhex-5-ene (155).  A solution of
TiF4 (223.0 mg, 1.800 mmol, 0.1 equiv) in CH3CN (2.5 mL) was treated with (S)-BINOL
(1.030 g, 3.597 mmol, 0.2 equiv) at rt.  The resulting red-brown mixture was stirred at rt
for 15 min, concentrated in vacuo and held under high vacuum for 30 min.  CH2Cl2 (10
mL) was added and the mixture was cooled to 0 °C and treated with allyl
trimethylsilane (10.0 mL, 62.9 mmol, 3.5 equiv).  After stirring for 1.5 h at 0 °C,
pivaldehyde (2.00 mL, 18.0 mmol, 1.0 equiv) was added and the mixture was stirred for
5 h at 0 °C, poured into 50% ethyl ether/hexanes (75 mL) and filtered through a pad of
SiO2.  The pad was washed with 50% ethyl ether/hexanes (100 mL) and the combined
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filtrates were concentrated, diluted with CH3CN (20 mL), and treated with 48%
aqueous HF (1.0 mL).  The mixture was stirred for 30 min at rt then treated with
saturated aqueous NaHCO3 (50 mL) and ethyl ether (25 mL) and stirred at rt for 12 h.
The mixture was extracted with ethyl ether and the combined organic layers were
washed with brine, dried (Na2SO4), filtered and concentrated.  Purification by
chromatography on SiO2 (5% acetone/hexanes) afforded the known homoallylic
alcohol174 as a clear, colorless oil (1.288 g, 56%) that was used without further
purification.
A solution of (S)-2,2-dimethylhex-5-en-3-ol (1.20 g, 9.36 mmol, 1.0 equiv) in
DMF (2.0 mL) was treated with imidazole (1.60 g, 23.5 mmol, 2.5 equiv) and t-
butyldimethylsilyl chloride (2.12 g, 14.1 mmol, 1.5 equiv) and stirred at 60 °C (oil bath
temp).  After 18 h, additional imidazole (0.650 g, 9.55 mmol, 1.0 equiv) and t-
butyldimethylsilyl chloride (0.70 g, 4.64 mmol, 0.5 equiv) was added.  The mixture was
stirred for an additional 18 h, cooled to rt and treated with saturated aqueous NaHCO3
(10 mL) and extracted with ethyl ether.  The combined organic layers were washed with
water, brine, dried (Na2SO4), filtered and concentrated to a yellow oil.  Purification by
chromatography on SiO2 (hexanes) afforded 155 as a clear colorless oil (2.249 g, 99%).
[α]D +3.5 (c 12.0, CHCl3, 22 °C); Lit: [α]D +3.8 (c 12.2, CHCl3, 20 °C).
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t-Bu
OH
TIPS
1) O3, Sudan III then 
    PPh3, CH2Cl2; 
2) 1,3-bis(triisopropylsilyl)-
    propyne, n-BuLi, THF;
3) aq. HF (48%), CH3CN
t-Bu
OTBS
155 (Z)-156 / (E)-156
(S,Z)-2,2-Dimethyl-8-(triisopropylsilyl)oct-5-en-7-yn-3-ol [(Z)-156] and (S,E)-
2,2-dimethyl-8-(triisopropylsilyl)oct-5-en-7-yn-3-ol [(E)-156].  A solution of 155 (1.04
g, 4.27 mmol, 1.0 equiv) and Sudan III (1.0 mg) in CH2Cl2 (20.0 mL) was cooled to –78
°C and treated with a stream of O3/O2 until the red color dissipated.  PPh3 (1.23 g, 4.69
mmol, 1.1 equiv) was added and the mixture was warmed to rt, stirred for 2 h, diluted
with hexanes (25 mL) and poured onto a pad of SiO2.  The pad was rinsed (50%
CH2Cl2/hexanes, 100 mL) and the combined filtrate was concentrated to a clear,
colorless syrup that was contaminated with PPh3 and used without further purification.
A solution of 1,3-bis(triispropylsilyl)propyne (2.15 g, 6.10 mmol, 1.4 equiv) in THF
(20 mL) was cooled to 0 °C and treated with n-BuLi (1.5 M in hexanes, 3.70 mL, 5.55
mmol, 1.3 equiv), warmed to rt, stirred for 1 h and cooled to –78 °C.  A solution of the
aldehyde in THF (5.0 mL + 5.0 mL rinse) was added via cannula.  The mixture was
stirred at –78 °C for 1.5 h, warmed to 0 °C for 25 min and treated with saturated
aqueous NH4Cl (10 mL) and water (10 mL) and extracted with ethyl ether.  The
combined organic layers were dried (Na2SO4), filtered and concentrated.  Purification
by chromatography on SiO2 (100% hexanes) to remove the polar impurities afforded a
pale yellow oil that was used without further purification.
A biphasic mixture of the TBS ether in CH3CN (20 mL) in a glass reaction vessel
was treated with 48% aqueous HF (2.0 mL), stirred at rt for 36 h and then added
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portionwise to saturated aqueous NaHCO3 (50 mL).  The mixture was extracted with
ethyl ether and the combined organic layers were dried (Na2SO4), filtered and
concentrated.  Purification by chromatography on SiO2 (100% hexanes to 10% ethyl
ether/hexanes) afforded (Z)-156 (572.1 mg, 43%, 3-steps) and (E)-156 (136.0 mg, 10%,
3 steps).  (Z)-156:  Rf 0.32 (20% ethyl ether/hexanes); [α]D –0.50 (c 1.40, CHCl3, 22 °C);
1H NMR δ 6.10 (ddd, 1 H, J = 10.8, 7.7, 7.1 Hz), 5.66 (app dt, 1 H, J = 10.8, 1.2 Hz),
3.32 (bd, 1 H, J = 10.4 Hz), 2.58 (dddd, 1 H, J = 14.5, 6.9, 2.5, 1.5 Hz), 2.42 (dddd, 1 H,
J = 14.5, 10.3, 7.8, 1.1 Hz), 1.51 (bs, 1 H), 1.08 (s, 21 H), 0.93 (s, 9 H); 13C NMR δ 142.6,
111.9, 103.7, 95.8, 79.3, 35.2, 33.4, 25.9, 18.9, 11.5; IR (neat) 3416, 2958, 2944, 2893,
2866, 2145, 1464 cm-1; MS (EI) m/z (rel. intensity) 265 (M+, 14), 247 ([M-H2O]
+, 46), 222
([M-C3H7]
+, 87), 179 ([M-C6H14]
+, 30), 157 (100), 131 (87), 103 (96), 75 (89); HRMS (EI)
m/z calcd for C16H29OSi (M-C3H7) 265.1988, found 265.1978;  (E)-156:  Rf 0.54 (20%
ethyl ether/hexanes); [α]D –33.8 (c 2.88, CHCl3, 22 °C); 
1H NMR δ 6.26 (ddd, 1 H, J =
15.7, 8.0, 6.7 Hz), 5.62 (d, 1 H, J = 15.8 Hz), 3.28 (bd, 1 H, J = 10.2 Hz), 2.37 (ddt, 1 H,
J = 14.3, 6.5, 1.7 Hz), 2.05 (app dt, 1 H, J = 14.3, 10.1 Hz), 1.58 (bs, 1 H), 1.07 (s, 21 H),
0.91 (s, 9 H); 13C NMR δ 143.3, 112.8, 105.7, 89.7, 78.7, 35.9, 35.0, 25.9, 18.8, 11.5; IR
(neat) 3456, 2958, 2944, 2889, 2866, 2172, 2131, 1464 cm-1; MS (EI) m/z (rel. intensity)
308 (M+, 3), 293 ([M-CH3]
+, 4), 265 ([M-C3H7]
+, 100), 222 ([M-C6H14]
+, 53), 180 (22), 157
(42); HRMS (EI) m/z calcd for C16H29OSi (M-C3H7) 265.1988, found 265.1985.
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t-Bu
OH
t-Bu
OH
TIPS
TBAF, AcOH,
THF
(Z)-156 153
(3S,5Z)-2,2-Dimethyloct-5-en-7-yn-3-ol (153).  A solution of (Z)-156 (572.0 mg,
1.854 mmol, 1.0 equiv) in THF (10.0 mL) was treated with glacial AcOH (110 µL, 1.91
mmol, 1.0 equiv) and TBAF (1.0 M in THF, 2.10 mL, 2.10 mmol, 1.1 equiv) and stirred
for 12 h at rt.  The mixture was treated with saturated aqueous NaHCO3 (5 mL), poured
into H2O (10 mL) and extracted with ethyl ether.  The combined organic layers were
dried (Na2SO4), filtered and concentrated.  Purification by chromatography on SiO2
(100% hexanes to 20% ethyl ether/hexanes) afforded 153 (215.0 mg, 76%) as a clear,
colorless oil:  Rf 0.41 (40% ethyl ether/hexanes); [α]D –38.4 (c 2.81, CHCl3, 22 °C); 
1H
NMR δ 6.17 (dtd, 1 H, J = 10.8, 7.1, 0.8 Hz), 5.57 (d, 1 H, J = 10.8 Hz), 3.31 (bd, 1 H, J
= 10.1 Hz), 3.10 (d, 1 H, J = 1.9 Hz), 2.57 (app ddt, 1 H, J = 14.4, 7.1, 1.8 Hz), 2.34
(dddd, 1 H, J = 14.4, 10.2, 7.9, 1.1 Hz), 1.59 (bs, 1 H), 0.93 (s, 9 H); 13C NMR δ 143.9,
110.2, 82.1, 80.5, 79.4, 35.2, 33.1, 25.8; IR (neat) 3424, 3311, 3032, 2959, 2907, 2870,
2097, 1614, 1479 cm-1.
t-Bu
OH
MeO O
N
t-Bu
OH
N
O
MeO2C
I
OMe
CO2Me
PdCl2(PPh3)2,
CuI, Et3N,
CH3CN 157
153
119
2-((2R,3E,7Z,10S)-10-Hydroxy-2-methoxy-11,11-dimethyldodeca-3,7-dien-
5-ynyl)oxazole-4-carboxylic acid methyl ester (157).  A mixture of 153 (121.0 mg,
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0.795 mmol, 1.2 equiv) and 119 (227.0 mg, 0.673 mmol, 1.0 equiv) was dissolved in
CH3CN (4.0 mL).  The solution was degassed by freeze-pump-thaw (2 cycles).
PdCl2(PPh3)2 (29.0 mg, 41.3 µmol, 0.06 equiv) and CuI (34.0 mg, 0.178 mmol, 0.3 equiv)
were added and the mixture was degassed by freeze-pump-thaw (1 cycle), placed in a
0 °C bath under N2, and treated with triethylamine (660 µL, 4.71 µmol, 7.0 equiv).  The
yellow mixture became almost colorless before turning to a dark red-brown color.  The
reaction mixture was stirred at 0 °C for 2 h, quenched with aqueous phosphate buffer
(0.5 M Na2HSO4, 0.5 M NaH2SO4, 4.0 mL), poured into water (10 mL) and extracted
with ethyl acetate.  The combined organic layers were dried (Na2SO4), filtered and
concentrated.  Purification by chromatography on SiO2 (30% to 50% ethyl
acetate/hexanes) afforded 157 (227.8 mg, 94%) as a pale yellow syrup:  Rf 0.36 (50%
ethyl acetate/hexanes); [α]D –24.1 (c 1.34, CHCl3, 22 °C); 
1H NMR δ 8.16 (s, 1 H), 6.10
(app dt, 1 H, J = 10.7, 7.4 Hz), 5.97 (d of AB, 1 H, J = 15.9, 7.1 Hz), 5.86 (d of AB, 1 H,
J = 15.9, 2.0 Hz), 5.69 (d, 1 H, J = 8.9 Hz), 4.17 (app dt, 1 H, J = 7.3, 6.0 Hz), 3.90 (s, 3
H), 3.34-3.25 (m, 2 H), 3.27 (s, 3 H), 3.10 (d of AB, 1 H, J = 15.0, 7.7 Hz), 2.99 (d of AB,
1 H, J = 15.0, 5.8 Hz), 2.55 (ddd of AB, 1 H, J = 14.5, 7.0, 2.4, 1.5 Hz), 2.32 (ddd of AB,
1 H, J = 14.5, 10.3, 7.8, 1.0 Hz), 0.93 (s, 9 H); 13C NMR δ 162.4, 161.7, 144.1, 142.4,
140.5, 133.4, 113.7, 110.8, 91.4, 87.9, 79.3, 79.2, 56.9, 52.2, 35.2, 34.6, 33.1, 25.7; IR
(neat) 3467, 3162, 2954, 2909, 2870, 2827, 2185, 1743, 1586 cm-1; HRMS (ESI) m/z
calcd for C20H27NO5Na (M+Na) 384.1787, found 384.1793.
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t-Bu
O
MeO O
N
t-Bu
O
OMeO
N
O
O
t-Bu
OH
MeO O
N
OMeO
1) aq. LiOH, THF;
2) 2,4,6-TCBC, Et3N, 
    THF then DMAP, 
    toluene
+  cyclo-monomers (159, 160)
157
158
2-((2R,3E,7Z,10S)-10-Hydroxy-2-methoxy-11,11-dimethyldodeca-3,7-dien-
5-ynyl)oxazole-4-carboxylic ester cyclodimer (158), (4S,6Z,10E,12R)-4-tert-butyl-
12-methoxy-3,15-dioxa-17-azabicyclo[12.2.1]heptadeca-1(16),6,10,14(17)-tetraen-
8-yn-2-one (159) and (4S,6Z,10Z,12R)-4-tert-butyl-12-methoxy-3,15-dioxa-17-aza-
bicyclo[12.2.1]heptadeca-1(16),6,10,14(17)-tetraen-8-yn-2-one (160).  A solution of
157 (44.9 mg, 0.124 mmol, 1.0 equiv) in THF (2.0 mL) and water (0.2 mL) was treated at
rt with 1.0 M aqueous LiOH solution (270 µL, 0.270 mmol, 2.2 equiv).  After 20 h, the
reaction mixture was poured into 2.0 M aqueous NaHSO4 (10 mL) and extracted with
ethyl acetate.  The combined organic layers were dried (Na2SO4), filtered and
concentrated to afford a yellow wax (45.0 mg, 104%) that was diluted with anhydrous
ethyl ether, filtered through a plug of cotton and concentrated to a yellow wax (42.0
mg, 97%) that was used without further purification.
A solution of the crude hydroxyacid (18.6 mg, 0.535 mmol, 1.0 equiv) in THF (2.0
mL) was treated with triethylamine (40.0 µL, 0.285 mmol, 5.3 equiv) and 2,4,6-
trichlorobenzoyl chloride (30.0 µL, 0.192 mmol, 3.6 equiv).  The mixture was stirred at rt
for 2 h, diluted with toluene to give 3.0 mL solution, which was added to a solution of
DMAP (65.0 mg, 0.532 mmol, 9.9 equiv) in toluene (2.0 mL) via syringe pump (4.1
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mL/h).  After the addition was complete, the mixture was stirred at rt for an additional 2
h, treated with 1.0 M aqueous citric acid (5.0 mL), poured into H2O (5.0 mL) and
extracted with ethyl acetate.  The combined organic layer was sequentially washed
with water, saturated aqueous NaHCO3, and brine, dried (Na2SO4), filtered and
concentrated.  Purification by chromatography on SiO2 (10% to 50% ethyl
acetate/hexanes) afforded a mixture of cyclomonomers 159/160 (3.1 mg) and dimer
158 (6.0 mg).  The dimer was further purified by semi-prep HPLC (SiO2, 20% ethyl
acetate/hexanes, 8 mL/min, 254 nm) to afford 158 (4.6 mg, 26%) as a clear, colorless
wax.  The cyclomonomers 159/160 were separated by semi-prep HPLC (SiO2, 10%
ethyl acetate/hexanes, 8 mL/min, 254 nm) to afford 159 (1.4 mg, 8%) and 160 (1.4 mg,
8%) as clear, colorless waxes.  158: Rf 0.27 (40% ethyl acetate/hexanes); [α]D +183.6 (c
0.76, CHCl3, 22 °C); 
1H NMR δ 8.06 (s, 2 H), 6.00 (dd, 2 H, J = 15.9, 7.6 Hz), 5.95 (dt, 2
H, J = 10.6, 5.1 Hz), 5.65 (dd, 2 H, J = 15.9, 1.8 Hz), 5.54 (d, 2 H, J = 10.7 Hz), 5.08 (dd,
2 H, J = 11.1, 2.5 Hz), 4.16-4.09 (m, 2 H), 3.37 (s, 6 H), 3.31 (dd, 2 H, J = 14.1, 3.7 Hz),
3.03 (dd, 2 H, J = 14.1, 9.6 Hz), 2.96-2.88 (m, 2 H), 2.39-2.33 (m, 2 H), 1.01 (s, 18 H);
13C NMR δ 161.9, 161.0, 143.6, 141.5, 140.3, 133.7, 113.7, 112.5, 91.0, 88.0, 79.9,
79.8, 57.1, 34.9, 34.6, 31.3, 26.2; IR (neat) 3164, 3027, 2964, 2931, 2872, 2828, 2191,
1739, 1583 cm-1; HRMS (ESI) m/z calcd for C38H46N2O8Na (M+Na) 681.3152, found
681.3152.
159:  Rf 0.23 (20% ethyl acetate, hexanes); [α]D +98.0 (c
0.41, CHCl3, 22 °C); 
1H NMR δ 8.11 (s, 1 H), 5.96 (dt, 1 H, J =
10.6, 7.2 Hz), 5.92 (dd, 1 H, J = 16.0, 8.7 Hz), 5.59 (dd, 1 H, J =
MeO
N
O
t-Bu
O
O
H
H
H H
159
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10.9, 2.4 Hz), 5.22 (dd, 1 H, J = 16.0, 2.5 Hz), 4.82 (dd, 1 H, J = 6.5, 1.9 Hz), 3.96 (dt, 1
H, J = 8.7, 6.5 Hz), 3.10 (dd, 1 H, J = 13.4, 8.7 Hz), 3.32 (s, 3 H), 3.36 (dd, 1 H, J = 13.4,
6.5 Hz), 2.71 (ddd, 1 H, J = 14.3, 10.4, 6.5 Hz), 2.42 (dd, 1 H, J = 13.2, 7.2 Hz), 1.03 (s,
9 H); 13C NMR δ 161.7, 161.6, 144.3, 141.6, 140.2, 134.6, 112.1, 111.6, 91.5, 88.2,
81.6, 80.5, 57.3, 35.5, 35.1, 32.3, 26.0; IR (neat) 3161, 3119, 3020, 2961, 2932, 2872,
2825, 2182, 1721, 1578 cm-1; HRMS (ESI) m/z  calcd for C19H23NO4Na (M+Na)
352.1525, found 352.1494
160:  Rf 0.24 (20% ethyl acetate/hexanes); [α]D +6.94 (c
0.49, CHCl3, 22 °C); 
1H NMR δ 8.11 (s, 1 H), 5.99 (dd, 1 H, J =
11.3, 1.8 Hz), 5.84 (dd, 1 H, J = 11.3, 7.4 Hz), 5.84 (dt, 1 H, J =
11.0, 5.5 Hz), 5.47 (d, 1 H, J = 10.8 Hz), 4.89 (dd, 1 H, J = 11.0,
1.3 Hz), 4.17 (t, 1 H, J = 9.3 Hz), 3.33 (s, 3 H), 3.20 (dd, 1 H, J =
14.3, 2.0 Hz), 3.01 (dd, 1 H, J = 14.3, 10.6 Hz), 2.80 (dt, 1 H, J =
13.0, 11.0 Hz), 2.24 (dd, 1 H, J = 13.0, 5.6 Hz), 1.04 (s, 9 H); 13C NMR δ 162.3, 161.0,
144.1, 141.0, 139.1, 135.2, 114.0, 113.0, 92.7, 90.2, 81.5, 77.7, 56.8, 34.7, 33.6, 31.6,
26.3; IR (neat) 3162, 3118, 3022, 2962, 2928, 2872, 1719, 1577 cm-1; HRMS (ESI) m/z
calcd for C19H23NO4Na (M+Na) 352.1525, found 352.1509.
t-Bu
O
O
N
O
MeO
H
H
H
H
160
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O
O
N
t-Bu
O
O
N
O
O
MeO
OMe
t-Bu
O
MeO O
N
t-Bu
O
OMeO
N
O
O
H2 (1 atm),
5% Pd/BaSO4,
quinoline,
EtOAc
t-Bu
158 152
2-((2R,3E,5Z,7Z,10S)-10-Hydroxy-2-methoxy-11,11-dimethyldodeca-3,5,7-
trienyl)oxazole-4-carboxylic ester cyclodimer (152).  A solution of 158 (7.5 mg, 11.4
µmol, 1.0 equiv), quinoline (13.0 µL, 110 µmol, 9.7 equiv) and 5% Pd/BaSO4 was
suspended in ethyl acetate (1.0 mL) and the flask was flushed with H2 (evacuate/flush,
3 cycles).  The mixture was stirred at rt for 30 min and TLC (30% acetone/hexanes,
threefold developed) indicated that the starting material was consumed.  The mixture
was filtered through a plug of Florisil/Celite (1:1).  The plug was rinsed with ethyl
acetate and the combined filtrates were concentrated.  Purification by semi-prep HPLC
(SiO2, 20% ethyl acetate/hexanes, 8 mL/min, 254 nm) afforded 152 (3.2 mg, 43%) as a
clear, colorless wax:  Rf 0.47 (50% ethyl acetate/hexanes); [α]D –27.8 (c 0.46, CHCl3, 22
°C); 1H NMR δ 7.91 (s, 2 H), 6.44 (dd, 2 H, J = 15.0, 11.3 Hz), 6.35 (app t, 2 H, J = 11.8
Hz), 6.20 (app t, 2 H, J = 11.2 Hz), 5.93 (app t, 2 H, J = 10.9 Hz), 5.60-5.49 (m, 2 H),
5.56 (app dt, 2 H, J = 15.0, 8.6 Hz), 5.07 (dd, 2 H, J = 10.9, 2.0 Hz), 4.13 (dd, 2 H, J =
13.9, 7.8 Hz), 3.27 (s, 6 H), 3.14 (dd, 2 H, J = 14.8, 5.7 Hz), 2.82 (dd, 2 H, J = 14.8, 7.6
Hz), 2.55 (app t of AB, 2 H, J = 14.3, 10.0 Hz), 2.39 (app t of AB, 2 H, J = 14.8, 5.9 Hz),
0.97 (s, 18 H); 13C NMR δ 162.5, 161.1, 143.4, 133.5, 133.4, 130.1, 129.1, 128.3, 125.9,
125.6, 80.6, 80.1, 56.8, 35.2, 35.0, 28.3, 26.2; IR (neat) 3166, 2964, 2929, 2871, 1740,
1584 cm-1; HRMS (ESI) m/z calcd for C38H50N2O8Na (M+Na) 685.3465, found 685.3479.
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3.5.2.3. Synthesis of the C17-18-Cyclopropyl Analog
HO O
Me Me
Me
O
MeMe
HO O
Me Me
Me
O
MeMeCH2I2,
Et2Zn,
CH2Cl2
129a 163
(S)-2-((S)-2,2-Dimethyl-1,3-dioxan-4-yl)-2-methyl-1-((1R,2R)-2-
methylcyclopropyl)propan-1-ol (163).  A solution of 129a (309.9 mg, 1.357 mmol, 1.0
equiv) in CH2Cl2 (10.0 mL) at 0 °C was treated with CH2I2 (1.10 mL, 13.7 mmol, 10.1
equiv) and a solution of Et2Zn (1.0 M in hexanes, 6.80 mL, 6.90 mmol, 5.0 equiv).  The
resulting opaque, white mixture was stirred at 0 °C for 1 h and then treated with a
mixture of 1.0 M aqueous sodium tartrate (5.0 mL) and brine (5.0 mL).  The mixture was
warmed to rt, poured into water (10 mL) and extracted with ethyl ether.  The combined
organic layers were washed with brine, dried (Na2SO4), filtered and concentrated. 
1H
NMR analysis indicated a d.r. > 9:1 (α/β).  Purification by chromatography on SiO2
(2.5% ethyl ether, 1% triethylamine/hexanes to 20% ethyl ether, 1%
triethylamine/hexanes) afforded 163 (321.4 mg, 98%) as a white, crystalline solid.
Recrystallization from hexanes at –40 °C (freezer) afforded colorless needles:  Rf 0.27
(40% ethyl ether/hexanes); Mp 81.4-82.2 °C (hexanes); [α]D –36.4 (c 1.82, CHCl3, 22
°C); 1H NMR δ 3.99-3.83 (m, 3 H), 3.59 (bs, 1 H), 2.87 (d, 1 H, J = 5.8 Hz), 1.77 (qd, 1 H,
J = 12.0, 5.6 Hz), 1.44 (s, 3 H), 1.36 (s, 3 H), 1.36-1.31 (m, 1 H), 1.02 (d, 3 H, J = 5.5
Hz), 0.96 (s, 3 H), 0.92 (s, 3 H), 0.65-0.48 (m, 3 H), 0.29-0.24 (m, 1 H); 13C NMR δ 98.8,
81.0, 76.8, 60.4, 40.9, 30.0, 25.4, 22.2, 21.2, 20.7, 19.1, 18.4, 12.4, 10.5; IR (KBr) 3511,
3072, 2999, 2960, 2946, 2889 cm-1; MS (EI) m/z (rel. intensity) 227 ([M-CH3]
+, 0.7), 167
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([M-C3H7O2]
+, 0.8), 143 (11), 74 (54), 59 (100); HRMS (EI) m/z calcd for C13H23O3 (M-CH3)
227.1647, found 227.1679.
HO O
Me Me
Me
O
MeMe
3,4-DMBO OH
Me Me
Me OH
1) 3,4-DMB-Br, KHMDS, 
    Et3N, THF;
2) AcOH, THF, H2O
163 164
(3S,5S)-5-(3,4-Dimethoxybenzyloxy)-4,4-dimethyl-5-((1R,2R)-2-
methylcyclopropyl)pentane-1,3-diol (164).  A solution of freshly prepared 3,4-
dimethoxybenzylbromide (776.0, 3.358 mmol, 3.0 equiv) in THF (5.0 mL) was treated
with triethylamine (950 µL, 6.77 mmol, 6.0 equiv).  A precipitate formed and a solution
of 163 (271.3, 1.120 mmol, 1.0 equiv) in THF (2.5 mL + 2.5 mL rinse) was added via
cannula.  The mixture was cooled to –78 °C and a solution of KHMDS (95% purity, 700
mg, 3.34 mmol, 3.0 equiv) in THF (2.0 mL) was added via cannula.  The resulting bright
yellow mixture was stirred for 10 min at – 78 °C and then warmed to 0 °C for 20 min.
The yellow color faded and a precipitate formed.  The resulting milky-white mixture
was warmed to rt for 30 min, treated with saturated aqueous NH4Cl (5.0 mL) and water
(15 mL) and extracted with ethyl ether.  The combined organic layers were
concentrated and the residue was diluted with THF (2.0 mL), treated with water (2.0
mL) and glacial acetic acid (8.0 mL), stirred at rt for 48 h, diluted with ethyl acetate (20
mL) and washed with 2.0 M aqueous NaOH until the washings were pH>9.  The
combined aqueous washings were backwashed with ethyl acetate and the combined
organic layers were dried (Na2SO4), filtered and concentrated.  Purification by
chromatography on SiO2 (50% to 80% ethyl acetate/hexanes) afforded 164 (331.2 mg,
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84%, 2 steps) as a clear, colorless wax:  Rf 0.33 (60% ethyl acetate/hexanes); [α]D
–18.3 (c 1.53, CHCl3, 22 °C); 
1H NMR δ 6.87-6.80 (m, 3 H), 4.81 (d, 1 H, J = 10.8 Hz),
4.41 (d, 1 H, J = 4.5 Hz), 4.35 (d, 1 H, J = 10.8 Hz), 3.88 (s, 3 H), 3.86 (s, 3 H), 3.88-3.81
(m, 2 H), 3.37 (bs, 1 H), 2.78 (d, 3 H, J = 8.9 Hz), 1.75-1.59 (m, 3 H), 1.08 (d, 3 H, J =
5.2 Hz), 1.00 (s, 3 H), 0.99 (s, 3 H), 0.71-0.48 (m, 4 H); 13C NMR δ 149.1, 148.8, 130.8,
120.5, 111.2, 111.1, 91.5, 79.7, 72.3, 63.1, 56.1, 56.0, 42.5, 33.1, 22.4, 22.3, 19.4, 18.3,
12.9, 10.5; IR (neat) 3424, 3064, 2951, 2873, 2837, 1609, 1594, 1517 cm-1; MS (EI) m/z
(rel. intensity) 352 (M+, 0.4), 199 (6), 168 (18), 151 (100); HRMS (EI) m/z calcd for
C20H32O5 352.2250, found 352.2261.
3,4-DMBO OH
Me Me
Me
TIPS
3,4-DMBO OH
Me Me
Me OH
1) TES-OTf, 2,6-lutidine, CH2Cl2;
2) oxalyl chloride, DMSO, 
    Et3N, CH2Cl2;
3) 1,3-bis(triisopropylsilyl)-
    propyne, n-BuLi, THF;
4) chloroacetic acid, MeOH, CH2Cl2164 (Z)-166 / (E)-166
(1S,3S,Z)-1-(3,4-Dimethoxybenzyloxy)-2,2-dimethyl-1-((1R,2R)-2-
methylcyclopropyl)-8-(triisopropylsilyl)oct-5-en-7-yn-3-ol [(Z)-166] and (1S,3S,E)-
1-(3,4-dimethoxybenzyloxy)-2,2-dimethyl-1-((1R,2R)-2-methylcyclopropyl)-8-
(triisopropylsilyl)oct-5-en-7-yn-3-ol [(E)-166].  A solution of 164 (331.2 mg, 0.940
mmol, 1.0 equiv) in CH2Cl2 (10 mL) was cooled to 0 °C and treated with 2,6-lutidine
(880 µL, 7.55 mmol, 8.0 equiv) and triethysilyl triflate (880 µL, 3.891 mmol, 4.1 equiv),
stirred for 35 min at 0 °C and treated with saturated aqueous NH4Cl (5.0 mL) and water
(5.0 mL) and extracted with CH2Cl2.  The combined organic layers were washed with
1.0 M aqueous citric acid (25 mL), water (25 mL) and brine (25 mL).  The combined
aqueous washings were backwashed with CH2Cl2 and the combined organic layers
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were dried (Na2SO4), filtered and concentrated.  The residue was diluted with
anhydrous ethyl ether (5.0 mL) and filtered through a plug of Florisil/Celite (1:1 v/v) to
afford the bis(triethylsilyl)ether as a clear, pale yellow syrup (827.9 mg) that was used
without further purification.
A solution of oxalyl chloride (330 µL, 3.78 mmol, 4.0 equiv) in CH2Cl2 (10 mL)
was cooled to –78 °C and a solution of DMSO (535 µL, 7.54, 8.0 equiv) in CH2Cl2 (1.0
mL + 1.0 mL rinse) was added.  The mixture was stirred for 20 min at –78 °C and a
solution of the bis(triethylsilyl)ether in CH2Cl2 (2.5 mL + 2.5 mL rinse) was added via
cannula.  The mixture was stirred at –78 °C for 5 min, warmed to –40 °C for 20 min,
cooled to –78 °C for 20 min, treated with triethylamine (2.00 mL, 14.3 mmol, 15.2
equiv), warmed to rt over 30 min and treated with water (20 mL). The mixture was
extracted with CH2Cl2.  The combined organic layers were washed with water, dried
(Na2SO4), filtered and concentrated.  The residue was diluted with anhydrous ethyl
ether (2.0 mL), filtered through a plug of Florisil/Celite (1:1 v/v) and the filtrate was
concentrated to a yellow oil that was used without further purification.
A solution of 1,3-bis(triisopropylsilyl)propyne (686.0 mg, 1.944 mmol, 2.0 equiv)
was azeotropically dried at reduced pressure with hexanes (3 mL), diluted with THF
(5.0 mL), cooled to 0 °C and treated with a solution of n-BuLi (1.5 M in hexanes, 1.00
mL, 1.50 mmol, 1.6 equiv).  The mixture was warmed to rt for 1 h, cooled to –78 °C and
treated with a solution of the aldehyde in THF (2.5 mL + 2.5 mL rinse).  The mixture
was stirred for 4 h at –78 °C, warmed to 0 °C for 15 min, treated with saturated
aqueous NH4Cl (5.0 mL) and water (5.0 mL) and extracted with ethyl ether.  The
combined organic layers were dried (Na2SO4), filtered  and concentrated.  Purification
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of the residue by chromatography on SiO2 (10% ethyl ether/hexanes) removed the
polar impurities, giving a pale yellow syrup that was diluted with CH2Cl2 (5.0 mL) and
MeOH (15 mL), treated with chloroacetic acid (200 mg, 2.116 mmol, 2.25 equiv), stirred
at rt for 36 h, quenched with saturated aqueous NaHCO3 (10 mL) and extracted with
CH2Cl2.  The combined organic layers were dried (Na2SO4), filtered and concentrated.
Purification by chromatography on SiO2 (10 to 30% ethyl ether/hexanes) afforded (E)-
166 (62.1 mg, 12%, 4 steps) and (Z)-166 (160.0 mg, 32%, 4 steps).  (E)-166: Rf 0.47
(40% ethyl ether/hexanes); [α]D –30.1 (c 1.83, CHCl3, 22 °C); 
1H NMR δ 6.86-6.79 (m, 3
H), 6.35 (app dt, 1 H, J = 15.9, 7.1 Hz), 5.60 (d, 1 H, J = 15.9 Hz), 4.79 (d, 1 H, J = 10.9
Hz), 4.35 (d, 1 H, J = 10.9 Hz), 3.89-3.86 (m, 1 H), 3.87 (s, 3 H), 3.86 (s, 3 H), 3.68 (ddd,
1 H, J = 9.8, 4.3, 2.4 Hz), 2.76 (d, 1 H, J = 9.0 Hz), 2.28 (dd, 1 H, J = 14.3, 7.2 Hz),
2.20-2.10 (m, 1 H), 1.11-1.05 (m, 24 H), 0.99 (s, 3 H), 0.98 (s, 3 H), 0.70-0.47 (m, 4 H);
13C NMR δ 149.2, 148.8, 144.0, 131.1, 120.4, 111.6, 111.2, 111.1, 106.0, 91.0, 89.1,
72.3, 56.1, 56.0, 42.8, 36.1, 22.5, 21.8, 19.5, 18.8, 18.7, 18.3, 12.9, 11.7, 11.5, 10.5; IR
(neat) 3482, 2943, 2889, 2865, 2131, 1610, 1593 cm-1; MS (EI) m/z (rel. intensity) 528
(M+, 1.9), 485 ([M-C3H7]
+, 2.3), 151 (100); HRMS (EI) m/z calcd for C32H52O4Si 528.3635,
found 528.3625.  (Z)-166: Rf 0.32 (40% ethyl ether/hexanes); [α]D –29.4 (c 2.84, CHCl3,
22 °C); 1H NMR δ 6.84-6.76 (m, 3 H), 6.19 (ddd, 1 H, J = 10.9, 7.7, 6.3 Hz), 5.58 (d, 1 H,
J = 10.9 Hz), 4.78 (d, 1 H, J = 10.8 Hz), 4.33 (d, 1 H, J = 10.8 Hz), 3.85 (s, 3 H), 3.83 (s,
3 H), 3.69-3.65 (m, 1 H), 2.77 (d, 1 H, J = 8.8 Hz), 2.66 (dd, 1 H, J = 14.3, 7.8 Hz), 2.39-
2.29 (m, 1 H), 1.06 (s, 21 H), 1.15-1.03 (m, 3 H), 1.01 (s, 3 H), 1.00 (s, 3 H), 0.69-0.45
(m, 4 H); 13C NMR δ 149.3, 148.8, 143.4, 131.3, 120.2, 111.4 (2 C), 110.3, 104.2, 95.1,
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91.0, 77.3, 72.4, 56.1, 56.0, 42.9, 33.6, 22.3, 21.7, 19.6, 18.8, 18.2, 12.7, 11.5, 10.5; IR
(neat) 3479, 2943, 2865, 2144, 1609, 1594, 1518 cm-1; HRMS (ESI) m/z calcd for
C32H52O4SiNa 551.3533, found 551.3500.
3,4-DMBO OH
Me Me
Me
TIPS(Z)-166
3,4-DMBO OH
Me Me
Me
162
TBAF, AcOH,
THF
(1S,3S,Z)-1-(3,4-Dimethoxybenzyloxy)-2,2-dimethyl-1-((1R,2R)-2-
methylcyclopropyl)oct-5-en-7-yn-3-ol (162).  A solution of (Z)-166 (160.0 mg, 0.303
mmol, 1.0 equiv) in THF (3.0 mL) at rt was treated with glacial acetic acid (35.0 µL,
0.606 mmol, 2.0 equiv) and a solution of TBAF (1.0 M in THF, 0.600 mL, 0.600 mmol,
2.0 equiv), stirred at rt for 36 h, poured into saturated aqueous NaHCO3 (10 mL) and
extracted with ethyl ether.  The combined organic layers were dried (Na2SO4), filtered
and concentrated.  Purification by chromatography on SiO2 (10% to 50% ethyl
ether/hexanes) afforded 162 (100.1 mg, 89%) as a clear, colorless syrup: Rf 0.26 (40%
ethyl ether/hexanes); [α]D –30.0 (c 1.07, CHCl3, 22 °C); 
1H NMR δ 6.85-6.78 (m, 3 H),
6.24 (app dt, 1 H, J = 10.9, 7.2 Hz), 5.53 (dd, 1 H, J = 10.8, 2.1 Hz), 4.80 (d, 1 H, J =
10.8 Hz), 4.35 (d, 1 H, J = 10.8 Hz), 3.90-3.85 (m, 1 H), 3.86 (s, 3 H), 3.85 (s, 3 H), 3.66
(ddd, 1 H, J = 9.9, 4.4, 2.4 Hz), 3.07 (d, 1 H, J = 1.6 Hz), 2.80 (d, 1 H, J = 8.2 Hz), 2.59
(ddt, 1 H, J = 14.0, 7.4, 1.5 Hz), 2.35 (dddd, 1 H, J = 14.4, 10.0, 6.9, 1.0 Hz), 1.07 (d, 3
H, J = 5.5 Hz), 1.04 (s, 3 H), 1.01 (s, 3 H), 0.70-0.46 (m, 4 H); 13C NMR δ 149.1, 148.7,
144.6, 131.1, 120.3, 111.2, 111.1, 109.0, 90.9, 81.7, 80.9, 77.9, 72.2, 56.0 (2 C), 42.8,
33.4, 22.4, 22.1, 19.5, 18.3, 12.9, 10.4; IR (neat) 3472, 3288, 3063, 2949, 2868, 2836,
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2094, 1608, 1593, 1516 cm-1; MS (EI) m/z (rel. intensity) 372 (M+, 1.4), 288 (1.3), 151
(100); HRMS (EI) m/z calcd for C23H32O4 372.2301, found 372.2292.
3,4-DMBO OH
Me Me
Me PdCl2(PPh3)2,
CuI, Et3N, 
CH3CN
3,4-DMBO OH
Me Me
Me
N
O
CO2Me
MeO
N
O
MeO2C OMe
I
119
162
167
Methyl 2-((2R ,3E,7Z,10S,12S)-12-(3,4-dimethoxybenzyloxy)-10-hydroxy-2-
methoxy-11,11-dimethyl-12-((1R,2R)-2-methylcyclopropyl)dodeca-3,7-dien-5-
ynyl)oxazole-4-carboxylate (167).  A solution of 162 (52.5, 0.141 mmol, 1.1 equiv) and
119 (43.0 mg, 0.128 mmol, 1.0 equiv) in CH3CN (1.0 mL) was degassed (freeze-pump-
thaw, 2 cycles), treated with PdCl2(PPh3)2 (5.0 mg, 7.1 µmol, 0.05 equiv) and CuI (5.0
mg, 0.026 mmol, 0.2 equiv), degassed (1 cycle), placed in a 0 °C bath and treated with
triethylamine (120 µL, 0.855 mmol, 6.7 equiv).  The mixture became almost colorless
then rust-brown and was stirred at 0 °C for 1 h, warmed to rt for 30 min and treated
with phosphate buffer (0.5 M Na2HPO4, 0.5 M NaH2PO4, 1.0 mL).  After stirring at rt for
30 min, the mixture was diluted with water (10 mL) and extracted with ethyl acetate.
The combined organic layers were dried (Na2SO4), filtered and concentrated.
Purification by chromatography on SiO2 (40% to 60% ethyl acetate/hexanes) afforded
167 (70.0 mg, 94%) as a clear, colorless wax:  Rf 0.35 (50% ethyl acetate/hexanes);
[α]D –34.0 (c 1.69, CHCl3, 22 °C); 
1H NMR δ 8.14 (s, 1 H), 6.86-6.78 (m, 3 H), 6.19 (dt, 1
H, J = 10.7, 7.2 Hz), 5.92 (d of AB, 1 H, J = 15.9, 7.0 Hz), 5.86 (d of AB, 1 H, J = 15.9,
1.8 Hz), 5.66 (d, 1 H, J = 10.7 Hz), 4.81 (d, 1 H, J = 10.8 Hz), 4.35 (d, 1 H, J = 10.8 Hz),
4.14 (app q, 1 H, J = 7.2 Hz), 3.93-3.89 (m, 1 H), 3.90 (s, 3 H), 3.87 (s, 3 H), 3.86 (s, 3
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H), 3.69-3.64 (m, 1 H), 3.24 (s, 3 H), 3.05 (d of AB, 1 H, J = 15.0, 7.8 Hz), 2.96 (d of AB,
1 H, J = 15.0, 5.6 Hz), 2.81 (d, 1 H, J = 8.9 Hz), 2.56 (d of AB, 1 H, J = 14.2, 7.2 Hz),
2.37 (app t of AB, 1 H, J = 14.3, 8.1 Hz), 1.09 (d, 3 H, J = 5.4 Hz), 1.04 (s, 3 H), 1.03 (s,
3 H), 0.71-0.48 (m, 4 H); 13C NMR δ 162.5, 161.7, 149.1, 148.7, 144.1, 143.3, 140.3,
133.4, 131.0, 120.3, 113.9, 111.2, 111.0, 109.8, 91.1, 90.9, 88.4, 79.3, 78.0, 72.2, 56.9,
56.0 (2 C), 52.2, 42.8, 34.6, 33.5, 22.3, 22.2, 19.5, 18.2, 12.9, 10.4; IR (neat) 3468,
2950, 2870, 2835, 2251, 2184, 1745, 1586, 1517 cm-1; HRMS (ESI) m/z calcd for
C33H43NO8Na (M+Na) 604.2886, found 604.2841.
Me
3,4-DMBO O
Me Me
MeO O
N
Me
O(3,4-DMB)O
MeMe
OMeO
N
O
O
1) aq. LiOH, THF;
2) 2,4,6-TCBC, Et3N, 
    THF then DMAP, 
    toluene
Me
3,4-DMBO OH
Me Me
MeO O
N
CO2Me
167
168
+ 169, 170
2-((2R,3E,7Z,10S,12S)-12-(3,4-Dimethoxybenzyloxy)-10-hydroxy-2-methoxy-
11,11-dimethyl-12-((1R,2R)-2-methylcyclopropyl)dodeca-3,7-dien-5-ynyl)oxazole-
4-carboxylic acid ester cyclodimer (168), (4S ,6Z,10Z,12R)-4-((S)-1-(3,4-
dimethoxybenzyloxy)-2-methyl-1-((1R,2R)-2-methylcyclopropyl)propan-2-yl)-12-
methoxy-3,15-dioxa-17-azabicyclo[12.2.1]heptadeca-1(16),6,10,14(17)-tetraen-8-
yn-2-one (169) and (4S,6Z,10E,12R)-4-((S)-1-(3,4-dimethoxybenzyloxy)-2-methyl-1-
((1R,2R)-2-methylcyclopropyl)propan-2-yl)-12-methoxy-3,15-dioxa-17-azabicyclo-
[12.2.1]heptadeca-1(16),6,10,14(17)-tetraen-8-yn-2-one (170).  A solution of 167
(36.2 mg, 0.062 mmol, 1.0 equiv) in THF (1.0 mL) and water (0.1 mL) was treated with
1.0 M aqueous LiOH (140 µL, 0.140 mmol, 2.2 equiv), stirred at rt for 12 h, poured into
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2.0 M aqueous NaHSO4 (10 mL), diluted with water (10 mL) and extracted with ethyl
acetate.  The combined organic layers were dried (Na2SO4), filtered and concentrated
to afford the crude hydroxyacid that was used within several hours of preparation: 1H
NMR δ 8.21 (s, 1 H), 6.87-6.78 (m, 3 H), 6.19 (dt, 1 H, J = 10.6, 7.2 Hz), 5.92 (d of AB, 1
H, J = 15.9, 6.9 Hz), 5.87 (AB, 1 H, J = 15.9 Hz), 5.66 (d, 1 H, J = 10.5 Hz), 4.81 (d, 1 H,
J = 10.7 Hz), 4.36 (d, 1 H, J = 10.7 Hz), 4.15 (app q, 1 H, J = 6.7 Hz), 3.86 (s, 3 H), 3.85
(s, 3 H), 3.82-3.89 (m, 1 H), 3.69 (dd, 1 H, J = 10.0, 2.3 Hz), 3.24 (s, 3 H), 3.07 (d of AB,
1 H, J = 14.9, 7.7 Hz), 2.98 (d of AB, 1 H, J = 15.1, 5.5 Hz), 2.82 (d, 1 H, J = 8.9 Hz),
2.58 (dd, 1 H, J = 14.1, 7.4 Hz), 2.42-2.32 (m, 1 H), 1.08 (d, 3 H, J = 5.3 Hz), 1.05 (s, 3
H), 1.03 (s, 3 H), 0.69-0.49 (m, 4 H).
A solution of the dry hydroxyacid in THF (2.0 mL) at rt was treated with
triethylamine (85.0 µL, 0.606 mmol, 9.7 equiv) and 2,4,6-trichlorobenzoylchloride (50.0
µL, 0.320 mmol, 5.1 equiv), stirred at rt for 1 h, diluted with toluene (8.0 mL) and added
to a solution of DMAP (153 mg, 1.25 mmol, 20 equiv) in toluene (20.0 mL) via syringe
pump (3.9 mL/h).  After the addition was complete, the syringe was rinsed with toluene
(1.0 mL) and this solution was added to the reaction mixture.  After stirring for an
additional 4 h at rt, the mixture was treated with 1.0 M aqueous citric acid (10 mL),
diluted with water (10 mL) and extracted with ethyl acetate.  The combined organic
layers were sequentially washed with water, saturated aqueous NaHCO3, water and
brine, dried (Na2SO4), filtered and concentrated.  Purification by chromatography on
SiO2 (10% to 60% ethyl acetate/hexanes) afforded 168 (14.7 mg) and a mixture of 169
and 170 (4.1 mg).  Purification of 168 by semi-prep HPLC (35% ethyl acetate/hexanes,
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8 mL/min, 254 nm, Rt ≈  20 min) on SiO2 afforded 168 (9.3 mg, 27%) as a clear,
colorless wax:  Rf 0.34 (50% ethyl acetate/hexanes); [α]D +144.6 (c 1.29, CHCl3, 22 °C);
1H NMR δ 7.98 (s, 2 H), 7.05 (d, 2 H, J = 1.8 Hz), 6.93 (dd, 2 H, J = 8.1, 1.7 Hz), 6.80 (d,
2 H, J = 8.2 Hz), 5.99-5.90 (m, 2 H), 5.96 (dd, 2 H, J = 15.9, 7.5 Hz), 5.66 (dd, 2 H, J =
11.0, 2.3 Hz), 5.64 (dd, 2 H, J = 15.7, 1.9 Hz), 5.51 (d, 2 H, J = 9.6 Hz), 4.71 (d, 2 H, J =
10.4 Hz), 4.25 (d, 2 H, J = 10.3 Hz), 4.16-4.09 (m, 2 H), 3.90 (s, 6 H), 3.86 (s, 6 H), 3.36
(s, 6 H), 3.30 (dd, 2 H, J = 14.1, 3.8 Hz), 3.05-2.94 (m, 4 H), 2.55 (d, 2 H, J = 8.5 Hz),
2.33 (bd, 2 H, J = 11.2 Hz), 1.12 (s, 6 H), 1.09 (d, 6 H, J = 5.4 Hz), 1.05 (s, 6 H), 0.63-
0.61 (m, 4 H), 0.50-0.44 (m, 4 H); 13C NMR δ 161.8, 160.9, 149.1, 148.6, 143.6, 141.3,
140.6, 133.9, 132.4, 120.4, 113.7, 112.2, 111.9, 111.2, 91.1, 88.0 87.1, 79.9, 76.6, 72.7,
57.1, 56.2, 56.1, 43.8, 34.6, 31.7, 20.2, 20.0, 19.9, 18.3, 12.7, 10.6; IR (neat) 2943,
2866, 2834, 1737, 1584, 1516 cm-1; HRMS (EI) m/z calcd for C64H78N2O14Na (M+Na)
1121.5351, found 1121.5295
Purification by semi-prep HPLC (20% ethyl acetate/hexanes, 8 mL/min, 254 nm)
on SiO2 of the combined mixture of cyclomonomers from several reactions (8.8 mg)
afforded 169 (Rt ≈ 14 min, 4.8 mg, 55% of the mixture) and 170  (Rt ≈ 17 min, 2.5 mg,
28% of the mixture).
169: Rf 0.41 (40% ethyl acetate/hexanes); [α]D +23.6
(c 0.36, CHCl3, 22 °C); 
1H NMR δ 8.09 (s, 1 H), 7.05 (d, 1 H,
J = 1.7 Hz), 6.95 (dd, 1 H, J = 8.1, 1.6 Hz), 6.82 (d, 1 H, J =
8.1 Hz), 5.96 (dd, 1 H, J = 11.4, 1.7 Hz), 5.85 (d, 1 H, J = 8.0
Hz), 5.87-5.78 (m, 1 H), 5.51 (d, 1 H, J = 10.8 Hz), 5.45 (d, 1
O
O
N
O
MeO
H
H
Me
O(3,4-DMB)
Me
Me
169
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H, J = 10.8 Hz), 4.73 (d, 1 H, J = 10.6 Hz), 4.32 (d, 1 H, J = 10.6 Hz), 4.16 (app t, 1 H, J
= 9.0 Hz), 3.91 (s, 3 H), 3.87 (s, 3 H), 3.33 (s, 3 H), 3.20 (dd, 1 H, J = 14.0, 1.9 Hz), 3.00
(dd, 1 H, J = 14.0, 10.6 Hz), 3.00 (dd, 1 H, J = 10.6 Hz), 2.84 (app q, 1 H, J = 11.7 Hz),
2.66 (d, 1 H, J = 8.8 Hz), 2.22 (dd, 1 H, J = 13.1, 5.4 Hz), 1.14 (s, 3 H), 1.10 (d, 3 H, J =
5.9 Hz), 1.09 (s, 3 H), 0.68-0.51 (m, 3 H), 0.46-0.41 (m, 1 H); 13C NMR δ 162.2, 161.0,
149.0, 148.4, 144.3, 141.1, 139.4, 135.5, 132.4, 120.2, 113.8, 112.8, 111.6, 110.9, 92.6,
90.1, 86.9, 78.3, 77.9, 77.4, 72.6, 56.8, 56.1, 43.5, 33.7, 32.0, 31.1, 20.0, 19.9, 18.3,
12.6, 10.7; IR (neat) 2929, 2866, 2847, 1716, 1590, 1577 cm-1; MS analysis pending.
170: Rf 0.33 (40% ethyl acetate/hexanes); [α]D +77.2
(c 0.25, CHCl3, 22 °C); 
1H NMR δ 8.07 (s, 1 H), 7.06 (d, 1 H,
J = 1.6 Hz), 6.92 (dd, 1 H, J = 8.1, 1.6 Hz), 6.81 (d, 1 H, J =
8.2 Hz), 5.96 (dd, 1 H, J = 10.7, 7.1 Hz), 5.90 (dd, 1 H, J =
16.0, 8.6 Hz), 5.58 (dd, 1 H, J = 11.0, 2.3 Hz), 5.42 (dd, 1 H,
J = 6.5, 1.5 Hz), 5.23 (dd, 1 H, J = 16.0, 2.4 Hz), 4.72 (d, 1
H, J = 10.5 Hz), 4.29 (d, 1 H, J = 10.5 Hz), 4.01-3.87 (m, 1
H), 3.90 (s, 3 H), 3.87 (s, 3 H), 3.37 (dd, 1 H, J = 13.5, 6.6 Hz), 3.32 (s, 3 H), 3.09 (dd, 1
H, J = 13.5, 8.4 Hz), 2.71 (ddd, 1 H, J = 14.6, 10.5, 6.8 Hz), 2.63 (d, 1 H, J = 8.6 Hz),
2.47 (dd, 1 H, J = 14.5, 6.8 Hz), 1.11 (s, 6 H), 1.10 (d, 3 H, J = 6.5 Hz), 0.64-0.44 (m, 4
H); 13C NMR δ (characteristic signals) 161.7, 161.2, 149.0, 148.4, 144.3, 134.7, 132.4,
120.2, 112.0, 111.6, 110.9, 91.5, 88.4, 86.9, 72.6, 57.3, 56.1, 44.1, 20.0, 19.5, 18.3,
12.7; IR (neat) 2962, 2927, 2853, 1721 cm-1; MS analysis pending.
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168 171
(17R,17’R,18R,18’R)-(C17-18C17’-18’)-Bis(cyclopropyl)-(9,9’,10,10’)-didehydro-
disorazole C1 (171).  A solution of 168 (11.3 mg, 10.3 µmol, 1.0 equiv) in CH2Cl2 (1.0
mL) and phosphate buffer (0.5 M NaHPO4, 0.5 M NaH2PO4, 1.0 mL) was cooled to 0 °C,
treated with DDQ (10.0 mg, 44.1 mmol, 4.3 equiv) and stirred for 30 min, while slowly
warming to rt.  Saturated aqueous NaHCO3 (1.0 mL) and saturated aqueous Na2S2O3
(1.0 mL) was added and the mixture was diluted with water (10 mL) and extracted with
ethyl acetate.  The combined organic layers were washed with brine, dried (Na2SO4),
filtered and concentrated.  Purification by chromatography on SiO2 (20% to 80% ethyl
acetate/hexanes) afforded 171 (7.5 mg, 91%) as a clear, colorless wax:  Rf 0.27 (60%
ethyl acetate/hexanes); [α]D +189.9 (c 0.85, CHCl3, 22 °C); 
1H NMR δ 8.08 (s, 2 H), 6.02
(dd, 2 H, J = 15.9, 7.5 Hz), 5.94 (app dt, 2 H, J = 5.0, 10.6 Hz), 5.66 (dd, 2 H, J = 15.9,
1.8 Hz), 5.56 (bd, 2 H, J = 10.6 Hz), 5.38 (dd, 2 H, J = 11.1, 2.2 Hz), 4.14-4.07 (m, 2 H),
3.37 (s, 6 H), 3.30 (dd, 2 H, J = 14.2, 4.2 Hz), 3.08-2.96 (m, 4 H), 2.72 (d, 2 H, J = 8.6
Hz), 2.44-2.34 (m, 4 H), 1.07-1.04 (m, 18 H), 0.71-0.57 (m, 4 H), 0.45 (app dt, 2 H, J =
8.6, 4.6 Hz), 0.29 (app dt, 2 H, J = 8.1, 4.8 Hz); 13C NMR δ 162.1, 161.5, 144.0, 141.7,
140.1, 133.5, 113.5, 112.6, 91.2, 88.0, 79.8, 78.9, 78.9, 78.0, 57.1, 42.8, 34.6, 31.2,
22.1, 19.7, 18.9, 18.3, 13.4, 10.7; IR (neat) 3515, 2970, 2930, 2188, 1734, 1583 cm-1;
HRMS (ESI) m/z calcd for C46H58N2O10Na (M+Na) 821.3989, found 821.4019.
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(17R,18R)-C17-18C17’-18’-Bis(cyclopropyl) disorazole C1 (161).  A mixture of 171
(4.0 mg, 5.0 µmol, 1.0 equiv), Pd/BaSO4 (4.0 mg), quinoline (8.0 µL, 68 µmol, 14 equiv),
and 3-hexyne (7.0 µL, 62 µmol, 12 equiv) was suspended in ethyl acetate (0.5 mL,
degassed under vacuum at rt), stirred under H2 (1 atm)  for 1.5 h and filtered through a
plug of Florisil/Celite (1:1 v/v).  The plug was rinsed with additional ethyl acetate and
the combined filtrate was concentrated.  Purification by SiO2 semi-preparative HPLC
(45% ethyl acetate/hexanes, 8 mL/min, 254 nm, Rt ≈ 16.0 min) afforded semi-pure 161
(1.1 mg, 28%).  The material (3.3 mg) from 3 reductions and purifications was pooled
and further purified by SiO2 semi-preparative HPLC (1% to 2% MeOH/CH2Cl2 over 30
min, 8 mL/min, 254 nm, Rt = 23.4-25.3 min) to afford 161 (2.6 mg, 79%, 22% overall
yield) as a clear, colorless wax: Rf 0.39 (80% ethyl acetate/hexanes); [α]D –57.3 (c 0.26,
CHCl3, 22 °C); 
1H NMR δ 7.90 (s, 2 H), 6.44 (dd, 2 H, J = 15.1, 11.3 Hz), 6.37 (app t, 2
H, J = 11.0 Hz), 6.26 (app t, 2 H, J = 11.1 Hz), 5.96 (app t, 2 H, J = 10.9 Hz), 5.59 (dd, 2
H, J = 15.2, 8.4 Hz), 5.52 (bt, 2 H, J = 9.9 Hz), 5.34 (d, 2 H, J = 10.0 Hz), 4.12 (app q, 2
H, J = 6.4 Hz), 3.26 (s, 6 H), 3.05 (d of AB, 2 H, J = 15.2, 6.0 Hz), 2.84 (d of AB, 2 H, J =
15.2, 6.5 Hz), 2.75-2.63 (m, 4 H), 2.41-2.34 (m, 4 H), 1.06-1.02 (m, 18 H), 0.69-0.54 (m,
4 H), 0.44 (app dt, 2 H, J = 8.6, 4.4 Hz), 0.28 (app dt, 2 H, J = 8.5, 4.7 Hz); 13C NMR δ
162.5, 161.6, 144.0, 133.6, 133.1, 129.9, 128.9, 128.5, 126.3, 125.6, 79.7, 78.9, 78.5,
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56.9, 42.8, 35.3, 28.2, 22.0, 19.5, 18.8, 18.3, 13.4, 10.7; IR (neat) 3467, 2954, 2925,
2854, 1732, 1583 cm-1; HRMS (ESI) m/z calcd for C46H62N2O10Na (M+Na) 825.4302,
found 825.4315.
3.5.2.4. Attempted Synthesis of the C6-Desmethoxy Analog
O
N
H
MeO2C
HO
HO2C
Ser-OMe•HCl,
EDC, HOBT, NMM,
CH2Cl2, DMF
174 175
Methyl 3-hydroxy-2-pent-4-ynamidopropanoate (175).  A mixture of 4-
pentynoic acid (174) (1.00g, 10.2 mmol, 1.0 equiv), serine methyl ester hydrochloride
(2.380 g, 15.30 mmol, 1.5 equiv), and HOBT (275 mg, 2.04 mmol, 0.2 equiv) was
dissolved in DMF (2.0 mL), diluted with CH2Cl2 (10 mL) and treated with EDC (2.630 g,
13.72 mmol, 1.3 equiv).  The mixture was cooled to 0 °C, treated with NMM (3.00 mL,
27.2 mmol, 2.7 equiv) and allowed to warm to rt.  After 12 h, the reaction mixture was
quenched with saturated aqueous NaHCO3 (20 mL), stirred for 30 min at rt and
separated.  The aqueous layer was extracted with ethyl acetate and the combined
organic layers were washed with 1.0 M aqueous citric acid (75 mL), water, brine, dried
(Na2SO4), filtered and concentrated.  Purification by chromatography on SiO2 (80%
ethyl acetate/hexanes to 100% ethyl acetate) afforded 175 (682.8 mg, 34%) as a clear,
colorless syrup:  Rf 0.39 (ethyl acetate); 
1H NMR δ 7.03 (d, 1 H, J = 7.8 Hz), 4.60 (dt, 1
H, J = 7.8, 3.5 Hz), 3.92 (d of AB, 1 H, J = 11.3, 3.8 Hz), 3.80 (d of AB, 1 H, J = 11.3,
3.4 Hz), 3.72 (s, 3 H), 2.46 (app s, 4 H), 2.00 (s, 1 H); 13C NMR δ 171.9, 171.2, 82.8,
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69.6, 62.9, 54.7, 52.8, 34.9, 14.8; IR (neat) 3366, 3291, 3079, 2955, 2888, 2118, 1743,
1651, 1538 cm-1; HRMS (ESI) m/z calcd for C9H13NO4Na (M+Na) 222.0742, found
222.0733.
N
O
MeO2C
Br
O
N
H
MeO2C
HO 1) DAST then K2CO3,     CH2Cl2, DMF;
2) BrCCl3, DBU, CH2Cl2;
3) NBS, AgNO3, DMF175 176
Methyl 2-(4-bromobut-3-ynyl)oxazole-4-carboxylate (176).  A solution of 175
(680.0 mg, 3.414 mmol, 1.0 equiv) in CH2Cl2 (20.0 mL) and DMF (0.1 mL) was cooled to
–78 °C, treated with DAST (500 µL, 3.78 mmol, 1.1 equiv), stirred for 30 min and
treated with anhydrous K2CO3 (1.420 g, 10.27 mmol, 3.0 equiv).  The mixture was
stirred for 5 min, warmed to 0 °C for 10 min, quenched with saturated aqueous
NaHCO3 (20 mL) and stirred at rt for 2 h.  The mixture was extracted with ethyl acetate
and the combined organic layers were washed with 4.0 M aqueous LiCl (10 mL), dried
(Na2SO4), filtered and concentrated to a red oil.  The red oil was azeotropically dried at
reduced pressure with toluene (10 mL) and diluted with CH2Cl2 (20.0 mL).  The resulting
solution was cooled to 0 °C and treated with BrCCl3 (1.01 mL, 10.2 mmol, 3.0 equiv)
and DBU (1.53 mL, 10.2 mmol, 3.0 equiv).  The mixture was allowed to warm to rt over
3 h, diluted with ethyl ether (20 mL) and filtered through a pad of SiO2 (40 mm x 40
mm).  The pad was rinsed with ethyl ether (200 mL) and the combined filtrate was
concentrated to an orange oil.  Purification by chromatography on SiO2 (20% to 40%
ethyl acetate/hexanes) afforded a yellow syrup that crystallized to a yellow solid under
vacuum.  The yellow solid was dissolved in DMF (5.0 mL) and treated with N-
bromosuccinimide (530 mg, 2.99 mmol, 1.1 equiv) and silver nitrate (45.0 mg, 0.265
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mmol, 0.7 equiv) and stirred at rt for 4 h.  The mixture was diluted with ethyl ether (20
mL), washed with water (2x) and brine, dried (Na2SO4), filtered and concentrated.
Purification by chromatography on SiO2 (10% to 20% acetone/hexanes) afforded 176
(453.0 mg, 51%, 3 steps) as a white crystalline solid:  Rf 0.23 (20% acetone/hexanes);
Mp 91.4-92.3 °C (acetone/hexanes); 1H NMR (CDCl3) δ 8.15 (s, 1 H), 3.88 (s, 3 H), 3.02
(t, 2 H, J = 7.4 Hz), 2.69 (t, 2 H, J = 7.4 Hz); 1H NMR (acetone-d6) δ 8.47 (s, 1 H), 3.81
(s, 3 H), 3.03 (t, 2 H, J = 7.3 Hz), 2.73 (t, 2 H, J = 7.3 Hz); 13C NMR (CDCl3) δ 163.7,
161.7, 144.2, 133.4, 77.7, 52.3, 40.3, 27.4, 17.8; 13C NMR (acetone-d6) δ 164.4, 162.0,
145.5, 134.0, 79.2, 51.9, 40.4, 27.6, 17.7; IR (KBr) 3154, 3120, 2954, 2854, 2221, 2206,
1723, 1587, 1574 cm-1; MS (EI) m/z (rel. intensity) 257 (M+, 3), 242 ([M-CH3]
+, 17), 227
([M-CH3O]
+, 34), 199 ([M-CO2CH3]
+, 82), 178 ([M-Br]+, 37); HRMS (EI) m/z calcd for
C8H5NO3Br (M-CH3) 241.9453, found 241.9449.
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n-Bu3SnH,  
PdCl2(PPh3)2,
then I2, 
THF
176 173
(E)-Methyl 2-(4-iodobut-3-enyl)oxazole-4-carboxylate (173).  A solution of
176 (450.0 mg, 1.744 mmol, 1.0 equiv) in THF (10.0 mL) was cooled to –78 °C and
treated with PdCl2(PPh3)2 (11.5 mg, 16.4 µmol, 0.01 equiv) and n-Bu3SnH (960 µL, 3.57
mmol, 2.05 equiv).  The mixture was stirred at –78 °C for 1 h, warmed to 0 °C for 2 h
and treated with a solution of I2 (530 mg, 2.09 mmol, 1.2 equiv) in THF (2.0 mL).  The
resulting brown solution was stirred at 0 °C for 25 min, treated with saturated aqueous
Na2S2O3 (15 mL), saturated aqueous NaHCO3 (10 mL) and saturated aqueous KF (2.0
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mL), stirred for 30 min at rt and extracted with ethyl acetate.  The combined organic
layers were dried (Na2SO4), filtered and concentrated.  Purification by chromatography
on SiO2 (10% acetone/hexanes) afforded 173 (434.9 mg, 81%) as a white crystalline
solid:  Rf 0.39 (30% acetone/hexanes); Mp 56.0-57.5 °C (acetone/hexanes); 
1H NMR δ
8.15 (s, 1 H), 6.53 (app dt, 1 H, J = 14.3, 7.1 Hz), 6.14 (d, 1 H, J = 14.4 Hz), 3.90 (s, 3
H), 2.91 (app t, 2 H, J = 7.4 Hz), 2.55 (app q, 2 H, J = 7.1 Hz); 13C NMR δ 164.1, 161.4,
143.8, 143.3, 133.1, 76.9, 52.0, 32.8, 26.8; IR (KBr) 3153, 3113, 3057, 2959, 2927,
2852, 1724, 1585, 1438, 1316 cm-1; MS (EI) m/z (rel. intensity) 307 (M+, 0.8),  276 ([M-
OCH3]
+, 2.8), 180 ([M-I]+,100); HRMS (EI) m/z calcd for C8H7NO2I 275.9522 (M-OCH3)
275.9522, found 275.9522.
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2-((3E,7Z,10S,12S,13E)-10-Hydroxy-12-(4-methoxybenzyloxy)-11,11-
dimethylpentadeca-3,7,13-trien-5-ynyl)oxazole-4-methyl carboxylate (177).  A
solution of 173 (104.0 mg, 0.339 mmol, 1.0 equiv) and 188a (122.0 mg, 0.371 mmol,
1.1 equiv) in CH3CN (2.0 mL) was degassed by freeze-pump-thaw (2 cycles).
PdCl2(PPh3)2 (12.0 mg, 17.1 µmol, 0.05 equiv) and CuI (12.0 mg, 63.0 µmol, 0.2 equiv)
were added and the mixture was degassed by freeze-pump-thaw (1 cycle),  placed in a
0 °C bath under N2, and treated with triethylamine (300 µL, 2.14 mmol, 6.3 equiv).  The
yellow mixture became almost colorless before turning to a dark red-brown color.
After 1.5 h at 0 °C, the reaction mixture was quenched with phosphate buffer (0.5 M
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NaH2PO4, 0.5 M Na2HPO4, 3.0 mL), poured into water (10.0 mL) and extracted with
ethyl acetate.  The combined organic layers were washed with brine, dried (Na2SO4),
filtered and concentrated.  Purification by chromatography on SiO2 (2 columns, 10% to
30% acetone/hexanes, then 20% to 50% ethyl acetate/hexanes) afforded 177 (96.4
mg, 56%) as a clear, colorless syrup:  Rf 0.32 (40% ethyl acetate/hexanes); [α]D –9.7 (c
1.50, CHCl3, 22 °C); 
1H NMR δ 8.13 (s, 1 H), 7.20 (d, 2 H, J = 8.7 Hz), 6.84 (d, 2 H, J =
8.7 Hz), 6.16-6.08 (m, 1 H), 6.06 (dt, 1 H, J = 15.4, 7.0 Hz), 5.73-5.61 (m, 3 H), 5.47
(ddq, 1 H, J = 15.4, 8.6, 1.5 Hz), 4.49 (d, 1 H, J = 11.2 Hz), 4.18 (d, 1 H, J = 11.2 Hz),
3.90 (s, 3 H), 3.78 (s, 3 H), 3.64 (d, 1 H, J = 8.5 Hz), 3.57 (dd, 1 H, J = 10.0, 2.4 Hz),
2.90 (d, 1 H, J = 8.6 Hz), 2.88 (d, 1 H, J = 8.0 Hz), 2.64-2.47 (m, 3 H), 2.24 (dddd, 1 H, J
= 15.7, 10.0, 6.7, 1.2 Hz), 1.79 (dd, 3 H, J = 6.3, 1.4 Hz), 0.89 (s, 3 H), 0.87 (s, 3 H); 13C
NMR δ 164.8, 161.9, 159.4, 144.0, 142.4, 140.6, 133.4, 131.7, 130.2, 129.7, 127.7,
114.0, 112.1, 110.0, 92.0, 87.9, 86.4, 77.4, 70.0, 55.5, 52.3, 41.1, 33.3, 30.3, 27.7, 21.9,
21.2, 18.1; IR (neat) 3478, 3163, 2964, 2916, 2875, 2215, 2180, 1747, 1612, 1586 cm-1;
HRMS (ESI) m/z calcd for C30H37NO6Na (M+Na) 530.2519, found 530.2499.
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2-((3E,7Z,10S,12S,13E)-10-Hydroxy-12-(4-methoxybenzyloxy)-11,11-
dimethylpentadeca-3,7,13-trien-5-ynyl)oxazole-4-carboxylic ester cyclodimer
(178).  A solution of 177 (22.0 mg, 43.3 µmol, 1.0 equiv) in THF (1.0 mL) and water (0.1
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mL) at rt was treated with 1.0 M aqueous LiOH (100 µL, 100 µmol, 2.3 equiv), stirred for
12 h, poured in 2.0 M aqueous NaHSO4 (10 mL) and extracted with ethyl acetate.  The
combined organic layers were dried (Na2SO4), filtered and concentrated to an orange
colored wax, which was diluted with anhydrous ethyl ether and filtered through a plug
of cotton.  The cotton plug was rinsed with ethyl ether and the combined filtrate was
concentrated to a red-colored wax (19.4 mg, 91%) that was used without further
purification.
A solution of the monomer acid (19.4 mg, 39.3 µmol, 1.0 equiv) in THF (2.5 mL)
at rt was treated with triethylamine (110 µL, 0.784 mmol, 20.0 eqiv) and 2,4,6-
trichlorobenzoyl chloride (60.0 µL, 0.384 mmol, 10.0 equiv).  The mixture was stirred at
rt for 1.5 h and diluted with toluene to give a solution (10 mL) that was added via
syringe pump (2.6 mL/h) to a solution of DMAP (224.0 mg, 1.834 mmol, 46.7 equiv) in
toluene (9.0 mL) at rt.  After the addition was complete, the mixture was stirred for an
additional 12 h, quenched with 1.0 M citric acid (10 mL) and extracted with ethyl
acetate.  The combined organic layers were washed with water and brine, dried
(Na2SO4), filtered and concentrated.  The residue was diluted with ethyl acetate,
washed with saturated aqueous NaHCO3, water and brine, dried (Na2SO4), filtered and
concentrated.  Purification by chromatography on SiO2 (10 to 40% ethyl
acetate/hexanes) afforded 178 (2.0 mg, 11%) as a pale yellow wax.  See below for
spectroscopic data.
282
1) 179, DCC, 
    DMAP, CH2Cl2;
2) 118a, PdCl2(PPh3)2,
    CuI, Et3N, CH3CN
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(2E,4S,6S,8Z,12E)-4-(4-Methoxybenzyloxy)-15-(4-(methoxycarbonyl)oxazol-
2-yl)-5,5-dimethylpentadeca-2,8,12-trien-10-yn-6-yl 2-((3E,7Z,10S,12S,13E)-10-
hydroxy-12-(4-methoxybenzyloxy)-11,11-dimethylpentadeca-3,7,13-trien-5-
ynyl)oxazole-4-carboxylate (180).  A solution of 177 (74.4 mg, 0.147 mmol, 1.0 equiv)
and 179 (85.0 mg, 0.290 mmol, 2.0 equiv) in CH2Cl2 (1.0 mL) was treated at 0 °C with
DMAP (18.0 mg, 0.146 mmol, 1.0 equiv) and DCC (151.0 mg, 0.732 mmol, 5.0 equiv).
The cold bath was removed and the mixture was stirred at rt for 18 h, diluted with
hexanes (5.0 mL) and poured onto a pad of SiO2.  The pad was rinsed with 50% ethyl
acetate/hexanes (200 mL) and the filtrate was concentrated to an orange oily residue.
Purification by chromatography on SiO2 (40% to 50% ethyl acetate/hexanes) afforded
the vinyl iodide (42.4 mg, 37%) that was used without further purification.
A solution of the vinyl iodide (40.0 mg, 51.1 µmol, 1.0 equiv) and 118a (33.6 mg,
102 µmol, 2.0 equiv) in CH3CN (1.0 mL) was degassed (freeze-pump-thaw, 2 cycles)
and treated with CuI (2.0 mg, 11 µmol, 0.2 equiv) and PdCl2(PPh3)2 (3.5 mg, 5.0 µmol,
0.1 equiv).  The mixture was degassed (1 cycle), cooled to 0 °C, treated with
triethylamine (43.0 µL, 0.307 mmol, 6.0 equiv), stirred for 2 h at 0 °C and then treated
with pH 7 aqueous phosphate buffer (1.0 mL).  The mixture was warmed to rt, poured
into water (10 mL) and extracted with ethyl acetate.  The combined organic layers were
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washed with brine, dried (Na2SO4), filtered and concentrated.  Purification by
chromatography on SiO2 (30% to 50% ethyl acetate/hexanes) afforded 180 (41.0 mg,
82%) as a yellow wax that was used without further purification.
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1) aq LiOH, THF;
2) 2,4,6-TCBC,  
    Et3N, THF then
    DMAP, toluene
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2-((3E,7Z,10S,12S,13E)-10-Hydroxy-12-(4-methoxybenzyloxy)-11,11-
dimethylpentadeca-3,7,13-trien-5-ynyl)oxazole-4-carboxylic ester cyclodimer
(178).  A solution of 180 (26.0 mg, 26.4 µmol, 1.0 equiv) in THF (1.0 mL) was treated at
rt with 1.0 M aqueous LiOH (60.0 µL, 60.0 µmol, 2.3 equiv), stirred for 24 h, poured into
2.0 M NaHSO4 (10 mL) and extracted with ethyl acetate.  The combined organic layers
were dried (Na2SO4), filtered and concentrated to a reddish-orange wax that was
dissolved in anhydrous ethyl ether and filtered through a cotton plug to remove the
reddish-orange solids.  The cotton plug was rinsed with anhydrous ethyl ether and the
combined filtrate was concentrated to afford the seco-acid (18.9 mg, 73%) as a yellow
wax that was used without further purification.
A solution of the seco-acid (18.9 mg, 19.5 µmol, 1.0 equiv) in THF (2.0 mL) was
treated at rt with triethylamine (27.0 µL, 0.193 mmol, 9.9 equiv) and 2,4,6-
trichlorobenzoyl chloride (15.0 µL, 96.0 µmol, 4.9 equiv), stirred for 2 h and diluted with
toluene to give a solution (6.0 mL) that was added via syringe pump (1.5 mL/h) to a
solution of DMAP (50.0 mg, 0.409 mmol, 21.0 equiv) in toluene (5.0 mL).  After 18 h
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(total reaction time), the mixture was poured into 1.0 M aqueous citric acid (10 mL) and
extracted with ethyl acetate.  The combined organic layers were washed with saturated
aqueous NaHCO3 and brine, dried (Na2SO4), filtered and concentrated.  Purification by
chromatography on SiO2 (40% ethyl acetate/hexanes) afforded a clear colorless wax
that was further purified by semi-preparative HPLC (SiO2, 20% ethyl acetate/hexanes,
8.0 mL/min, 254 nm) to afford 178 (4.9 mg, 26%) as a clear, colorless wax that
consisted of one major and two minor compounds.  Major compound:  1H NMR δ 7.96
(s, 1 H), 7.28-7.22 (m, 2 H), 6.82 (app dt, 2 H, J = 8.7, 2.6 Hz), 6.07 (dt, 1 H, J = 15.7,
7.2 Hz), 5.89 (dq, 1 H, J = 10.4, 5.2 Hz), 5.70-5.58 (m, 3 H), 5.52 (d, 1 H, J = 10.4 Hz),
5.47-5.44 (m, 1 H), 5.40 (dd, 1 H, J = 10.6, 2.6 Hz), 4.37 (d, 1 H, J = 10.9 Hz), 4.11 (d, 1
H, J = 10.9 Hz), 3.78 (s, 3 H), 3.46 (d, 1 H, J = 8.5 Hz), 3.02-2.81 (m, 3 H), 2.65-2.60 (m,
1 H), 2.42-2.32 (m, 1 H), 1.75 (d, 3 H, J = 6.2 Hz), 0.96 (s, 3 H), 0.95 (s, 3 H); 13C NMR δ
164.7, 160.9, 159.1, 143.6, 141.2, 139.7, 133.8, 131.2, 129.8, 128.1, 113.7, 112.2, 92.1,
86.3, 84.2, 77.4, 76.7 (2 C), 69.7, 55.4, 41.9, 31.6, 30.7, 27.9, 19.7, 19.5, 18.1.
3.5.2.5. Additional Analogs
Me
HO O
Me Me
O
N
Me
OHO
MeMe
O
N
O
O
MeO
OMe
isomers
H2, Pd/ C,
methanol
181
(7,7’,8,8’,9,9’,10,10’,11,11’,12,12’,17,17’,18,18’)-Octahydrodisorazole C1 (182).
A solution of the byproducts from the semi-reduction of 151 (4.0 mg, 5.2 mmol, 1.0
285
equiv) in MeOH (2.0 mL) was treated with 3% Pd on carbon.  The flask was evacuated,
flushed with H2 and stirred at rt for 2 h.  The mixture was filtered through a plug of
Florisil/Celite (1:1 v/v).  The plug was rinsed with acetone and the combined filtrate was
concentrated.  Purification by chromatography on SiO2 (2 columns: 10% to 20%
acetone/hexanes, then 10% to 80% ethyl acetate/hexanes) afforded 181 (2.5 mg,
61%) as a clear, colorless wax:  Rf 0.47 (40% acetone/hexanes); [α]D -0.40 (c 0.20,
CHCl3, 22 °C); 
1H NMR δ 8.14 (s, 2 H), 5.21 (d, 2 H, J = 8.8 Hz), 3.63 (app tt, 2 H, J =
6.0, 6.0 Hz), 3.38 (s, 6 H), 3.25 (bs, 2 H), 3.14-3.07 (m, 2 H), 3.05 (d of AB, 2 H, J =
15.1, 4.7 Hz), 2.96 (d of AB, 2 H, J = 15.1, 7.0 Hz), 1.64-1.13 (m, 36 H), 0.88 (s, 6 H),
0.86 (s, 6 H), 0.95-0.78 (m, 6 H); 13C NMR δ 163.6, 162.6, 144.1, 133.3, 80.3, 79.0, 74.8,
74.4, 57.2, 42.0, 33.9, 33.0, 32.4, 29.6, 29.4, 29.3, 26.5, 25.3, 20.6, 19.2, 18.1, 14.4; IR
(neat)  3518, 3153, 3104, 2929, 2857, 1719, 1583, 1465 cm-1; HRMS (ESI) m/z calcd for
C44H75N2O10 (M+H) 791.5422, found 791.5464; m/z calcd for C44H74N2O10Na (M+Na)
813.5241, found 813.5278.
Dess-Martin
periodinane,
NaHCO3,
CH2Cl2 (wet)
Me
O
Me Me
MeO O
N
Me
O
MeMe
OMeO
N
O
O
151
O
O
182
(9,9’,10,10’,16,16’)-Tetradehydrodisorazole C1 (182).  A solution of 151 (2.8
mg, 3.6 µmol, 1.0 equiv) in CH2Cl2 (0.5 mL, wetted by shaking with brine in a
separatory funnel) was treated at 0 °C with NaHCO3 (5.5 mg, 65 µmol, 18 equiv) and
Dess-Martin periodinane (7.5 mg, 18 µmol, 4.9 equiv).  The cold bath was removed and
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the resulting milky-white reaction mixture was stirred for 1 h at rt, and treated with a
mixture of saturated aqueous NaHCO3 (2.0 mL) and saturated aqueous Na2S2O3 (2.0
mL).  After stirring for 10 min at rt, the mixture was extracted with CH2Cl2.  The
combined organic layers were dried (Na2SO4), filtered and concentrated.  Purification
by chromatography on SiO2 (10% to 60% ethyl acetate/hexanes) afforded 182 (2.5 mg,
89%) as a clear, colorless wax:  Rf 0.52 (60% ethyl acetate/hexanes); [α]D +153.1 (c
0.42, CHCl3, 22 °C); 
1H NMR δ 8.04 (s, 2 H), 6.98 (dq, 2 H, J = 13.8, 6.8 Hz), 6.58 (dd, 2
H, J = 15.1, 1.2 Hz), 5.98 (dd, 2 H, J = 16.0, 7.4 Hz), 5.91 (dd, 2 H, J = 10.4, 5.3 Hz),
5.65 (dd, 2 H, J = 16.1, 1.9 Hz), 5.60 (dd, 2 H, J = 10.9, 2.6 Hz), 5.54 (d, 2 H, J = 10.6
Hz), 4.13 (app dt, 2 H, J = 9.2, 3.9 Hz), 3.36 (s, 6 H), 3.33-3.26 (m, 2 H), 3.03 (dd, 2 H, J
= 14.3, 9.5 Hz), 2.91 (dt, 2 H, J = 13.7, 10.7 Hz), 2.26 (bd, 2 H, J = 13.6 Hz), 1.90 (d, 6
H, J = 6.4 Hz), 1.26 (s, 6 H), 1.23 (s, 6 H); 13C NMR δ 200.8, 162.0, 160.6, 144.6, 143.9,
141.5, 139.2, 133.4, 126.2, 113.6, 112.9, 91.3, 87.7, 79.6, 76.1, 57.1, 50.3, 34.6, 31.9,
21.7, 19.9, 18.6; IR (neat) 2966, 2927, 2854, 2192, 1741, 1688, 1624, 1584 cm-1; HRMS
(ESI) m/z calcd for C44H50N2O10Na (M+Na) 789.3363, found 789.3417.
Dess-Martin
periodinane,
NaHCO3,
CH2Cl2 (wet)
76 Me
O
Me Me
O
N
Me
O
MeMe
O
N
O
O
MeO
OMe
O
O
183
(16,16’)-Didehydrodisorazole C1 (183).  A solution of 76 (1.0 mg, 1.3 µmol, 1.0
equiv) in wet CH2Cl2 (0.5 mL) was cooled to 0 °C and treated with NaHCO3 (5.0 mg, 60
µmol, 46 equiv) and Dess-Martin periodinane (7.0 mg, 17 µmol, 12 equiv).  The cold
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bath was removed and the mixture was stirred at rt for 30 min.  A mixture of saturated
aqueous NaHCO3 (1.0 mL) and saturated aqueous Na2S2O3 (1.0 mL) was added and
the mixture was stirred at rt for 30 min and then extracted with CH2Cl2.  The combined
organic layers were dried (Na2SO4), filtered and concentrated.  Purification by
chromatography on SiO2 (10% to 60% ethyl acetate/hexanes) afforded 183 (0.9 mg,
91%) as a slightly impure clear, colorless wax.  Due to the small amount of sample,
only partial characterization was possible:  Rf 0.44 (60% ethyl acetate/hexanes); Rf 0.44
(60% ethyl acetate/hexanes); [α]D –27.1 (c 0.14, CHCl3, 22 °C); 
1H NMR δ 7.90 (s, 2 H),
6.98 (app dq, 2 H, J = 14.0, 7.0 Hz), 6.57 (dd, 2 H, J = 15.1, 1.5 Hz), 6.41 (dd, 2 H, J =
15.1, 11.2 Hz), 6.34 (app t, 2 H, J = 11.1 Hz), 6.14 (app t, 2 H, J = 11.2 Hz), 5.91 (app t,
2 H, J = 10.9 Hz), 5.59-5.45 (m, 6 H), 4.13 (app q, 2 H, J = 7.7 Hz), 3.27 (s, 6 H), 3.14
(dd, 2 H, J = 14.8, 5.6 Hz), 2.83 (dd, 2 H, J = 14.7, 7.8 Hz), 2.52 (app dt, 2 H, J = 14.3,
10.4 Hz), 2.28 (dd, 2 H, J = 15.1, 6.3 Hz), 1.90 (dd, 6 H, J = 6.9, 1.2 Hz), 1.22 (s, 6 H),
1.18 (s, 6 H); IR (neat) 2962, 2924, 2853, 1740, 1688, 1625 cm-1; HRMS (EI) m/z calcd
for C44H54N2O10Na (M+Na) 793.3676, found 793.3655.
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4. APPENDIX
4.1. Disorazole C1
Me
HO O
Me Me
OMe
O
N O
Me
HOO
MeMe
MeO
O
NO
(-)-disorazole C1 (76)
1
2
3
4
5
6
7
8
9
10
11
12
13
1415
1617
18
19
20,21
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Comparison of 1H NMR Data:
literature34 experimental
Proton # d [ppm] mult J [Hz] d [ppm] mult J [Hz]
3-H 8.28 s - 8.23 s -
5-Ha 3.04 dd 7.4, 15.5 2.99 dd 7.4, 15.5
5-Hb 2.81 dd 5.4, 15.5 2.76 dd 5.4, 15.5
6-H 4.17 ddd 5.4, 7.4, 8.5 4.13 ddd 5.5, 7.2, 7.8
7-H 5.58 dd 8.5, 15.1 5.54 dd 8.3, 15.0
8-H 6.54 dd 11.4, 15.1 6.50 dd 11.5, 15.2
9-H 5.96 dd 11, 11.4 5.91 dd 11.2, 10.9
10-H 6.32 dd 11, 11.4 6.28 dd 11.1, 11.4
11-H 6.44 dd 11.1, 11.4 6.40 app t 11.2
12-H 5.53 ddd 6.3, 11, 11 5.48
app
dt 10.0, 6.7
13-Ha 2.72 ddd 10.9, 11.3, 13.6 2.69 ddd 10.2, 10.9, 13.8
13-Hb 2.43 dd 6.3, 13.6 2.38 dd 6.1, 13.8
14-H 5.30 dd 2.2, 11.3 5.25 dd 2.2, 11.3
16-H 3.88 d 7.8 3.84 d 7.8
17-H 5.61 ddq 7.8, 15.2, 1.2 5.57 ddd 7.8, 15.2, 1.4
18-H 5.71 dq 15.2, 6.3 5.66 dq 15.2, 6.6
19-H3 1.74 dd 1.2, 6.3 1.69 dd 1.3, 6.4
20-H3 1.05 s - 1.00 s -
21-H3 0.99 s - 0.95 s -
6-OCH3 3.25 s - 3.21 s -
16-OH - - - - - -
16-OH - - - - - -
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Comparison of 13C NMR Data:
Literature34 Experimental Lit. - Exp.
Carbon # d [ppm] d [ppm] Δd [ppm]
1 162.27 162.26 0.01
2 134.12 134.09 0.03
3 145.81 145.83 -0.02
4 164.13 164.12 0.01
5 35.97 35.97 0.00
6 80.59 80.57 0.02
7 134.17 134.15 0.02
8 129.94 129.96 -0.02
9 129.31 129.30 0.01
10 126.79 126.79 0.00
11 127.35 127.36 -0.01
12 130.88 130.88 0.00
13 29.27 29.24 0.03
14 78.81 78.75 0.06
15 42.73 42.70 0.03
16 77.85 77.84 0.01
17 131.70 131.68 0.02
18 129.62 129.63 -0.01
19 18.02 18.03 -0.01
20 19.45 19.41 0.04
21 19.34 19.32 0.02
6-OCH3 56.84 56.83 0.01
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4.2. Crystal Structure of the Cyclopropane Adduct
Figure 29.  Crystal structure of cyclopropane adduct 163.
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4.3. Minimized Conformations for Disorazole C1 and Analogs
Figure 30.  Minimized conformation of (-)-disorazole C1 (76).
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Me
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Figure 31.  Minimized conformation alkyne precursor 151.
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Figure 32.  Minimized conformation of the t-butyl analog 152.
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Figure 33.  Minimized conformation of cyclopropyl analog 161.
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Figure 34.  Minimized conformation of the enone analog 183.
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Figure 35.  Minimized conformation of disorazole A1.
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